data_2yra_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2yra _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 744' ' ' GLY . . . . . 0.46 ' N ' HD23 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 3.0 m -46.76 170.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 110.895 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 70.4 m -97.35 138.4 34.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.865 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.26 123.94 5.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.857 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 748' ' ' LEU . . . . . 0.427 ' CD1' HG21 ' A' ' 769' ' ' ILE . 24.2 mt -69.42 144.1 94.1 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.611 0.719 . . . . 0.0 110.873 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 143.74 51.8 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.693 2.262 . . . . 0.0 112.325 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -52.12 133.55 33.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 1.5 tt -100.77 143.78 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.138 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -82.49 136.39 34.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 5.8 m120 58.71 37.4 25.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -178.23 166.45 36.47 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.474 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -147.48 150.46 34.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.817 0.341 . . . . 0.0 110.912 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -91.54 148.87 21.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 39.5 p . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 179.964 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 55.9 mt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.863 0.364 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.09 170.59 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.119 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 40.8 mtt85 -53.91 132.69 42.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 94.24 -26.17 18.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.48 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -45.99 142.62 2.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.799 0.333 . . . . 0.0 111.084 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 768' ' ' ARG . . . . . 0.471 ' HG2' ' CG2' ' A' ' 784' ' ' THR . 15.6 ttm-85 -119.72 122.88 42.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 769' ' ' ILE . . . . . 0.626 ' CG1' ' CH2' ' A' ' 793' ' ' TRP . 37.3 mm -99.87 143.45 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.077 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 12.0 m -121.11 125.99 48.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.131 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -101.66 121.54 42.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -122.45 130.29 52.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.922 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 74.9 m -108.57 174.16 6.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -60.75 159.72 24.14 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.606 0.717 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 114.51 3.73 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.638 2.225 . . . . 0.0 112.332 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 122.01 -22.2 7.66 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.461 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -94.38 174.39 7.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.896 0.379 . . . . 0.0 110.909 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -131.87 155.36 47.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.842 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 7.4 mt -97.39 141.0 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 780' ' ' VAL . . . . . 0.42 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 61.0 t -114.1 109.47 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.093 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 125.91 -131.06 7.39 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.481 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 782' ' ' SER . . . . . 0.406 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 1.5 t -107.9 108.52 19.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.852 0.358 . . . . 0.0 110.86 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.45 -31.15 67.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 784' ' ' THR . . . . . 0.471 ' CG2' ' HG2' ' A' ' 768' ' ' ARG . 20.8 m -115.49 131.38 56.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.122 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 785' ' ' LEU . . . . . 0.406 ' CD1' ' O ' ' A' ' 782' ' ' SER . 10.4 mp -123.74 127.65 48.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 26.6 m -107.78 159.61 16.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.144 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 6.5 t -94.47 119.09 32.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -73.62 176.76 5.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -73.39 -7.74 52.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -100.94 12.94 36.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 791' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 744' ' ' GLY . 66.6 mt 61.78 26.92 16.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 14.8 m -130.39 127.35 39.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.873 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 793' ' ' TRP . . . . . 0.626 ' CH2' ' CG1' ' A' ' 769' ' ' ILE . 73.6 m95 -58.38 140.64 53.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.946 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 794' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 793' ' ' TRP . 28.8 t -37.13 -47.98 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.837 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 37.4 m -154.75 167.04 31.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.841 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -51.63 155.8 2.59 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.63 0.729 . . . . 0.0 110.842 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 145.32 56.68 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.677 2.251 . . . . 0.0 112.329 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.85 -165.28 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.659 2.239 . . . . 0.0 112.348 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 799' ' ' PHE . . . . . 0.42 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.7 p90 -153.67 170.5 20.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.911 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 8.4 m -101.94 135.01 44.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.909 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -130.36 143.04 50.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 744' ' ' GLY . . . . . 0.482 ' CA ' ' O ' ' A' ' 763' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 745' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 763' ' ' LEU . 7.5 m -44.86 150.56 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.847 0.356 . . . . 0.0 110.832 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 16.4 m -71.56 147.91 47.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.825 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -60.69 137.34 58.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.906 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 748' ' ' LEU . . . . . 0.465 HD21 ' CD1' ' A' ' 793' ' ' TRP . 12.4 mt -97.0 144.28 27.58 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.631 0.729 . . . . 0.0 110.884 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 163.57 37.82 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.716 2.277 . . . . 0.0 112.361 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -62.32 149.0 43.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.89 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.0 tt -103.08 148.61 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.129 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -85.22 135.28 34.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 5.7 m120 53.92 46.6 25.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 754' ' ' GLY . . . . . 0.465 ' CA ' ' O ' ' A' ' 772' ' ' GLN . . . 175.98 -169.15 41.72 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.462 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 15.0 p90 -156.54 171.78 19.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.816 0.341 . . . . 0.0 110.961 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 17.7 pttm -134.74 159.92 39.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.87 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 77.3 p . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 763' ' ' LEU . . . . . 0.482 ' O ' ' CA ' ' A' ' 744' ' ' GLY . 21.9 mt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.844 0.354 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 26.9 m -108.38 175.24 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.155 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -41.88 136.63 1.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.861 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 88.1 -29.88 5.37 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.459 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -54.1 130.91 39.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.81 0.338 . . . . 0.0 111.143 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -121.51 150.06 42.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 6.8 mm -115.57 132.4 65.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.174 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 79.0 m -103.46 116.22 31.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.177 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -98.54 127.36 44.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.926 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 772' ' ' GLN . . . . . 0.465 ' O ' ' CA ' ' A' ' 754' ' ' GLY . 22.9 tp60 -122.5 137.84 54.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.896 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 64.9 m -115.83 172.05 7.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -60.57 157.06 39.43 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.625 0.726 . . . . 0.0 110.823 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.77 119.1 6.1 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.659 2.239 . . . . 0.0 112.31 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 117.96 -15.06 12.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.452 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -100.12 176.48 5.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 0.0 110.924 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -133.57 157.79 44.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 4.6 mt -97.96 139.29 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.122 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 780' ' ' VAL . . . . . 0.564 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 65.2 t -115.75 113.66 43.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.14 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 116.15 -143.01 17.92 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.535 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 12.6 m -97.99 103.13 15.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.873 0.368 . . . . 0.0 110.823 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -57.8 -52.99 63.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.878 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 784' ' ' THR . . . . . 0.402 ' C ' ' CD1' ' A' ' 785' ' ' LEU . 44.6 m -86.06 141.93 29.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.13 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 785' ' ' LEU . . . . . 0.402 ' CD1' ' C ' ' A' ' 784' ' ' THR . 7.6 mp -132.03 113.07 12.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.915 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 27.2 m -96.6 154.88 17.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.104 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 4.3 t -95.66 109.56 21.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -61.5 -176.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -69.99 -26.8 64.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.947 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -86.85 20.86 2.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 791' ' ' LEU . . . . . 0.416 HD13 ' N ' ' A' ' 744' ' ' GLY . 57.5 mt 51.92 44.64 29.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 30.1 t -130.5 156.11 45.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 793' ' ' TRP . . . . . 0.465 ' CD1' HD21 ' A' ' 748' ' ' LEU . 73.8 m95 -84.54 133.07 34.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 40.3 t -37.27 -48.83 0.91 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 8.6 t -157.9 174.62 14.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.801 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.98 156.51 3.45 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.612 0.72 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 145.37 57.16 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.654 2.236 . . . . 0.0 112.356 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -167.5 0.23 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.689 2.259 . . . . 0.0 112.354 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 799' ' ' PHE . . . . . 0.564 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 1.3 p90 -159.79 164.2 33.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 3.5 m -101.76 133.15 46.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -145.78 140.44 27.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.889 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 57.3 m -53.99 152.22 6.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.822 0.344 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 22.9 t -90.48 165.19 13.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.862 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -59.59 159.09 8.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.876 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 13.7 mt -110.29 149.0 39.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.629 0.728 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 146.08 59.19 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.71 2.273 . . . . 0.0 112.358 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -54.96 141.12 35.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.907 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 1.9 tt -103.82 146.49 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.077 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -87.15 136.7 32.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.921 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 60.5 47.33 8.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 169.79 170.57 34.39 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.5 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 17.5 p90 -148.39 152.75 37.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.829 0.347 . . . . 0.0 110.93 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -96.71 168.94 10.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.147 179.951 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.86 0.362 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 31.6 m -125.65 172.09 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -47.52 128.17 12.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 98.92 -18.77 56.36 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.485 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -56.94 132.27 52.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.743 0.306 . . . . 0.0 111.09 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 768' ' ' ARG . . . . . 0.423 ' HD2' ' C ' ' A' ' 768' ' ' ARG . 3.9 tmm_? -128.13 132.78 48.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.881 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 63.7 mt -113.59 144.09 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.167 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 87.3 m -110.41 131.94 54.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.113 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -103.96 118.21 36.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -110.29 136.39 49.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.937 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 83.8 m -115.83 171.87 7.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -60.99 159.53 26.85 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.588 0.709 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 122.02 8.69 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.674 2.25 . . . . 0.0 112.337 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 113.76 -22.3 14.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.453 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 777' ' ' TYR . . . . . 0.404 ' CE2' ' HB2' ' A' ' 802' ' ' LYS . 18.6 m-85 -86.5 178.56 7.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.912 0.387 . . . . 0.0 110.902 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.75 135.33 26.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.866 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 3.6 mt -74.54 150.42 7.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 780' ' ' VAL . . . . . 0.556 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 89.6 t -128.49 108.82 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.094 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 123.67 -134.02 9.13 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.488 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 43.7 m -105.22 98.81 8.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.883 0.373 . . . . 0.0 110.879 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.72 -39.21 76.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.827 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 25.8 m -93.18 141.75 28.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.16 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 785' ' ' LEU . . . . . . . . . . . . . 9.4 mp -133.5 119.09 19.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 1.2 m -114.93 153.88 29.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.08 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 3.2 t -92.44 121.77 34.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.849 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -86.48 173.85 9.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 5.1 p90 -55.32 -17.07 4.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.927 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -94.13 23.05 5.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.82 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 23.1 mt 45.38 24.98 0.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.949 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.4 t -117.14 150.44 38.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 793' ' ' TRP . . . . . 0.404 ' O ' ' C ' ' A' ' 794' ' ' SER . 86.3 m95 -77.08 142.99 39.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.935 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 794' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 793' ' ' TRP . 40.5 t -37.66 -42.85 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.828 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 5.1 t -171.3 173.19 4.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -46.43 154.54 0.64 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.632 0.73 . . . . 0.0 110.884 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 145.79 58.7 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.695 2.263 . . . . 0.0 112.369 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 177.86 5.15 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.678 2.252 . . . . 0.0 112.39 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 799' ' ' PHE . . . . . 0.556 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 0.8 OUTLIER -142.95 166.64 24.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 11.9 m -102.48 124.48 48.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -118.75 133.09 56.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 802' ' ' LYS . . . . . 0.404 ' HB2' ' CE2' ' A' ' 777' ' ' TYR . 32.0 tttt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 744' ' ' GLY . . . . . 0.402 ' CA ' HD21 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 1.8 m -59.04 162.14 4.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.867 0.365 . . . . 0.0 110.869 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 23.5 p -92.08 144.74 25.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -38.27 150.13 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.866 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 14.8 mt -106.46 151.95 40.48 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.651 0.739 . . . . 0.0 110.925 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 141.29 44.57 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.657 2.238 . . . . 0.0 112.364 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -54.0 145.59 16.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 2.1 tt -100.95 147.73 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.111 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -90.83 139.51 30.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 50.41 41.64 25.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -177.37 -173.62 43.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.504 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -157.4 159.41 37.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.784 0.326 . . . . 0.0 110.949 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 756' ' ' LYS . . . . . 0.41 ' C ' ' HD2' ' A' ' 756' ' ' LYS . 0.0 OUTLIER -118.62 152.44 36.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.939 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 55.7 p . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.19 179.946 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 86.0 mt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.861 0.362 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' A' ' 765' ' ' ARG . 28.3 m -101.55 156.75 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 765' ' ' ARG . 25.4 mtm105 -34.73 139.52 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 87.75 -25.6 8.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -57.11 139.9 51.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.787 0.327 . . . . 0.0 111.095 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -115.08 157.36 23.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.904 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 769' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 770' ' ' THR . 34.0 mm -114.27 140.19 36.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.144 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 770' ' ' THR . . . . . 0.408 ' N ' HG23 ' A' ' 769' ' ' ILE . 89.1 m -113.52 119.5 37.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.181 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -97.68 121.67 39.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -121.34 124.7 45.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.93 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 62.9 m -110.51 174.35 5.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.46 157.48 35.69 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.592 0.711 . . . . 0.0 110.882 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 106.99 1.77 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.671 2.247 . . . . 0.0 112.337 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 131.87 -15.03 5.17 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.461 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -104.4 169.88 8.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.882 0.373 . . . . 0.0 110.919 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.12 160.78 30.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 8.7 mt -96.71 139.34 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.114 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 780' ' ' VAL . . . . . 0.505 ' HB ' ' CE1' ' A' ' 799' ' ' PHE . 72.0 t -114.0 106.43 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 125.82 -149.62 17.32 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.506 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 782' ' ' SER . . . . . 0.476 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 93.0 p -82.03 103.02 11.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.885 0.374 . . . . 0.0 110.842 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -57.14 -44.56 83.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 31.4 m -105.98 124.29 49.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.152 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 785' ' ' LEU . . . . . 0.476 ' CD1' ' O ' ' A' ' 782' ' ' SER . 10.7 mp -113.45 120.0 39.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.923 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 26.0 m -107.41 154.03 21.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.174 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 6.6 t -94.46 125.1 38.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.835 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -75.91 177.04 7.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 2.2 p90 -69.76 -19.06 63.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.964 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . 0.421 ' CG ' ' O ' ' A' ' 790' ' ' ASP . 23.2 t0 -96.24 23.65 6.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 791' ' ' LEU . . . . . 0.402 HD21 ' CA ' ' A' ' 744' ' ' GLY . 15.8 mt 51.21 35.8 14.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.91 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 49.4 m -120.77 135.56 55.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 793' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -72.22 147.11 46.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 5.0 t -48.54 -41.64 30.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.859 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 1.3 t -175.06 -178.72 1.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -54.32 147.06 29.21 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.599 0.714 . . . . 0.0 110.846 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 142.98 49.51 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.648 2.232 . . . . 0.0 112.349 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -164.73 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.695 2.263 . . . . 0.0 112.36 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 799' ' ' PHE . . . . . 0.505 ' CE1' ' HB ' ' A' ' 780' ' ' VAL . 18.6 p90 -161.9 173.95 13.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.882 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 3.4 m -103.07 136.14 43.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.913 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -146.99 131.53 17.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.925 179.908 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 744' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 745' ' ' CYS . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 745' ' ' CYS . . . . . 0.41 ' HB3' ' CE2' ' A' ' 793' ' ' TRP . 9.8 m -37.51 152.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 0.0 110.893 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 60.8 p -84.7 155.69 21.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -62.42 142.66 57.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 58.7 mt -90.43 149.4 40.91 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.624 0.726 . . . . 0.0 110.927 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 134.2 27.38 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.693 2.262 . . . . 0.0 112.347 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -42.35 146.63 0.31 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.911 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 2.7 tt -102.91 148.86 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -88.18 137.98 31.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 18.0 t30 51.97 43.15 30.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 178.08 176.62 46.19 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.477 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -149.31 179.03 8.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.805 0.336 . . . . 0.0 110.956 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.54 172.09 13.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.897 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 20.4 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 179.96 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.894 0.378 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.89 152.43 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.083 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -41.22 131.16 2.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 98.76 -23.45 36.28 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -58.7 147.5 32.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.82 0.343 . . . . 0.0 111.047 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -135.46 145.09 46.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 769' ' ' ILE . . . . . 0.441 HD12 ' CH2' ' A' ' 793' ' ' TRP . 25.3 mt -120.0 142.96 33.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.148 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 3.5 t -109.4 153.47 23.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -119.41 129.6 54.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.913 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -125.8 122.4 36.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.96 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 60.2 m -106.55 174.07 6.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.5 158.98 26.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.642 0.734 . . . . 0.0 110.876 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 111.18 2.74 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.701 2.268 . . . . 0.0 112.332 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 126.98 -14.68 6.61 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.49 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -104.72 173.28 6.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.889 0.376 . . . . 0.0 110.96 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -134.6 147.75 50.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.837 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 779' ' ' ILE . . . . . 0.446 HG23 ' N ' ' A' ' 780' ' ' VAL . 24.1 mt -82.96 144.87 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.141 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 780' ' ' VAL . . . . . 0.547 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 58.3 t -118.15 105.87 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.162 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 125.11 -150.46 17.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.507 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 782' ' ' SER . . . . . 0.402 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 43.7 m -85.2 106.73 16.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 0.0 110.832 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -57.27 -49.16 76.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.855 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 21.0 m -102.12 126.79 49.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 785' ' ' LEU . . . . . 0.402 ' CD1' ' O ' ' A' ' 782' ' ' SER . 7.0 mp -113.61 111.01 21.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 32.6 m -94.37 159.4 15.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.163 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 7.0 t -96.93 117.59 31.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -75.5 175.37 8.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 11.6 p-90 -62.15 -21.87 65.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -88.98 20.61 3.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.884 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 23.3 mt 51.2 31.85 7.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 36.1 t -121.97 153.83 38.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 793' ' ' TRP . . . . . 0.441 ' CH2' HD12 ' A' ' 769' ' ' ILE . 88.6 m95 -83.99 140.73 31.7 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 794' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 793' ' ' TRP . 8.5 t -34.55 -44.83 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 8.6 t -173.03 173.03 3.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -44.93 151.04 0.67 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.586 0.708 . . . . 0.0 110.856 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 147.82 63.78 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.678 2.252 . . . . 0.0 112.39 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -163.87 0.12 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.697 2.265 . . . . 0.0 112.385 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 799' ' ' PHE . . . . . 0.547 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 3.9 p90 -160.6 170.24 21.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 19.9 m -104.21 119.41 38.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.876 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -128.19 126.16 40.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.986 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 745' ' ' CYS . . . . . 0.5 ' HB3' ' CE2' ' A' ' 793' ' ' TRP . 1.8 m -40.23 152.91 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.841 0.353 . . . . 0.0 110.886 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 27.1 m -79.79 140.46 36.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.82 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -44.11 141.0 1.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.867 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 43.7 mt -93.08 148.59 36.0 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.595 0.712 . . . . 0.0 110.932 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -174.09 0.84 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.697 2.265 . . . . 0.0 112.339 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -95.24 143.27 26.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.0 tt -100.72 144.37 12.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.077 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 19.7 mp0 -78.17 132.09 37.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.912 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 55.59 40.22 31.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -174.26 176.4 46.64 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.513 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 32.6 p90 -157.24 161.59 39.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.799 0.333 . . . . 0.0 110.916 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -108.84 159.01 17.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.902 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 56.5 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.143 179.951 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 78.4 mt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.801 0.334 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 34.4 m -96.4 159.91 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -45.65 132.95 8.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 101.94 -39.99 2.57 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.485 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -46.77 157.58 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 111.114 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -123.99 172.93 8.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 8.2 mm -143.12 134.08 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 17.1 m -100.6 113.67 26.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.129 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -96.79 124.24 40.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.918 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -126.79 137.57 53.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 75.2 m -115.2 174.19 6.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.904 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -60.54 157.47 36.44 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.636 0.732 . . . . 0.0 110.829 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 112.93 3.21 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.665 2.243 . . . . 0.0 112.365 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 124.84 -22.23 6.47 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.484 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -95.32 178.24 5.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.896 0.379 . . . . 0.0 110.868 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -136.67 156.42 48.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.876 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 779' ' ' ILE . . . . . 0.466 HG21 ' N ' ' A' ' 780' ' ' VAL . 74.3 mt -98.69 135.26 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.14 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 780' ' ' VAL . . . . . 0.566 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 61.8 t -112.16 106.77 21.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.136 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 128.0 -149.0 17.97 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.448 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 21.9 m -83.06 107.47 15.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.866 0.365 . . . . 0.0 110.849 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.25 -46.17 90.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 25.6 m -101.93 122.11 43.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 785' ' ' LEU . . . . . . . . . . . . . 9.8 mp -103.3 114.46 28.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 786' ' ' THR . . . . . 0.431 HG22 ' N ' ' A' ' 787' ' ' CYS . 10.1 m -107.92 147.27 31.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.136 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 787' ' ' CYS . . . . . 0.431 ' N ' HG22 ' A' ' 786' ' ' THR . 8.8 t -92.51 137.55 32.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.847 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -87.97 169.4 12.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -56.0 -25.09 42.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -86.75 21.2 2.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.836 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 7.4 mt 51.22 37.47 18.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 90.4 p -122.38 136.41 54.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.825 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 793' ' ' TRP . . . . . 0.5 ' CE2' ' HB3' ' A' ' 745' ' ' CYS . 97.1 m95 -67.9 140.53 56.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.928 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 1.5 t -42.73 -48.62 5.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.899 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 8.4 t -168.78 173.82 6.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.855 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.97 151.16 4.72 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.576 0.703 . . . . 0.0 110.851 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 144.49 53.96 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.67 2.246 . . . . 0.0 112.345 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 -175.25 1.08 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.715 2.277 . . . . 0.0 112.332 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 799' ' ' PHE . . . . . 0.566 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.4 p90 -145.27 165.4 28.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 2.6 m -103.75 128.26 51.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -129.83 151.0 50.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 802' ' ' LYS . . . . . 0.421 ' C ' ' HD2' ' A' ' 802' ' ' LYS . 1.6 tmmm? . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 9.1 m -78.98 155.03 29.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.817 0.342 . . . . 0.0 110.918 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 77.5 p -73.24 149.45 42.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.862 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -54.09 163.09 0.84 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 748' ' ' LEU . . . . . 0.444 ' CD1' HD12 ' A' ' 769' ' ' ILE . 11.7 mt -115.27 148.17 40.17 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.574 0.702 . . . . 0.0 110.932 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 144.28 53.42 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.726 2.284 . . . . 0.0 112.319 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -54.23 147.44 13.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 1.5 tt -105.17 144.1 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.093 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -89.04 145.47 25.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 47.3 47.9 16.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 179.96 179.96 48.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.461 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 47.3 p90 -154.96 154.23 32.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.839 0.352 . . . . 0.0 110.888 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -124.55 159.43 30.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.922 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 76.3 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.096 -179.981 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 7.8 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.815 0.34 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 765' ' ' ARG . 33.1 m -86.11 175.68 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.12 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 764' ' ' VAL . 88.2 mtm180 -36.54 137.82 0.27 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 90.25 -31.55 5.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.486 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -50.54 125.5 13.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.737 0.304 . . . . 0.0 111.116 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -119.41 140.87 49.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.867 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 769' ' ' ILE . . . . . 0.519 HD11 ' CH2' ' A' ' 793' ' ' TRP . 68.1 mt -121.92 142.0 40.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.121 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 770' ' ' THR . . . . . 0.426 ' N ' HG23 ' A' ' 769' ' ' ILE . 6.2 t -107.21 154.27 21.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.167 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -124.81 120.05 30.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -119.25 128.22 53.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.918 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 69.1 m -109.8 173.54 6.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -60.45 159.03 26.0 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.588 0.709 . . . . 0.0 110.858 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 121.12 7.81 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.711 2.274 . . . . 0.0 112.337 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 104.71 11.12 31.41 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -116.99 172.24 7.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.905 0.383 . . . . 0.0 110.881 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -126.95 155.17 43.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.848 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 5.3 mt -103.32 138.39 27.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.138 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 780' ' ' VAL . . . . . 0.554 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 56.3 t -114.51 107.98 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 129.53 -134.03 7.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.473 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 782' ' ' SER . . . . . 0.446 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 1.6 t -109.82 109.86 20.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.862 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -57.44 -37.33 72.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.845 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 16.7 m -108.84 134.28 51.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 785' ' ' LEU . . . . . 0.446 ' CD1' ' O ' ' A' ' 782' ' ' SER . 8.7 mp -127.11 120.31 28.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 16.6 m -111.07 160.79 16.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.107 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 16.5 t -94.46 135.39 35.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -91.62 177.56 6.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 3.0 p90 -73.03 -3.55 26.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -107.44 17.37 22.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.897 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 31.7 mt 57.6 28.66 15.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.8 t -123.24 148.65 45.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 793' ' ' TRP . . . . . 0.519 ' CH2' HD11 ' A' ' 769' ' ' ILE . 95.9 m95 -85.51 137.98 32.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.93 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 794' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 793' ' ' TRP . 37.9 t -34.8 -50.27 0.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.838 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 45.5 m -164.24 152.83 13.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -37.84 153.53 0.13 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.635 0.731 . . . . 0.0 110.863 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 145.84 57.94 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.676 2.251 . . . . 0.0 112.329 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -164.91 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.666 2.244 . . . . 0.0 112.397 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 799' ' ' PHE . . . . . 0.554 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.6 p90 -154.78 169.1 24.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.854 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 4.0 m -104.97 121.11 43.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.872 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -129.63 121.68 27.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 30.6 tttm . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 179.966 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 744' ' ' GLY . . . . . 0.411 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 2.0 m -59.75 154.77 17.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.862 0.363 . . . . 0.0 110.848 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 84.8 p -71.27 141.01 50.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -46.15 144.36 1.99 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.88 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 35.0 mt -92.11 144.93 29.88 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.597 0.713 . . . . 0.0 110.911 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 156.73 62.6 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.624 2.216 . . . . 0.0 112.325 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.32 147.03 53.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.0 tt -102.66 149.66 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.16 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -90.77 141.75 28.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 46.16 49.73 12.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 177.82 -173.67 46.23 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.45 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 755' ' ' TRP . . . . . 0.432 ' NE1' ' HB2' ' A' ' 772' ' ' GLN . 15.4 p90 -154.94 -177.94 6.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.852 0.358 . . . . 0.0 110.896 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.67 165.82 25.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 -179.964 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 37.8 mt . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.857 0.361 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.99 177.47 7.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -52.78 108.11 0.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 103.32 10.41 36.31 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.458 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -65.63 140.24 58.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.793 0.33 . . . . 0.0 111.105 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -130.22 119.56 23.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 68.8 mt -116.53 144.9 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.136 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 770' ' ' THR . . . . . 0.421 HG21 ' N ' ' A' ' 771' ' ' TYR . 19.1 m -110.0 143.85 39.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.132 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 771' ' ' TYR . . . . . 0.421 ' N ' HG21 ' A' ' 770' ' ' THR . 52.1 m-85 -113.18 121.99 46.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.889 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 772' ' ' GLN . . . . . 0.432 ' HB2' ' NE1' ' A' ' 755' ' ' TRP . 22.1 mp0 -110.28 137.43 48.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.942 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 77.5 m -114.59 171.89 7.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.871 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 774' ' ' ASP . . . . . 0.454 ' HB2' ' CD1' ' A' ' 777' ' ' TYR . 0.3 OUTLIER -64.01 154.49 81.71 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.605 0.717 . . . . 0.0 110.832 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 96.03 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.679 2.253 . . . . 0.0 112.368 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 139.32 -5.53 2.96 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.465 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 777' ' ' TYR . . . . . 0.454 ' CD1' ' HB2' ' A' ' 774' ' ' ASP . 18.8 m-85 -106.23 179.26 4.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.868 0.366 . . . . 0.0 110.953 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -134.61 146.08 49.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 11.0 mt -91.2 142.13 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.158 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 780' ' ' VAL . . . . . 0.569 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 50.9 t -120.83 108.64 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.111 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 127.21 -134.75 8.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 782' ' ' SER . . . . . 0.465 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 1.3 t -106.84 112.22 25.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.831 0.348 . . . . 0.0 110.877 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -61.17 -36.88 81.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.872 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 15.4 m -110.32 123.55 50.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.136 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 785' ' ' LEU . . . . . 0.465 ' CD1' ' O ' ' A' ' 782' ' ' SER . 7.3 mp -115.06 122.25 45.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.945 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 20.4 m -107.01 156.82 18.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.132 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 41.4 t -95.81 109.96 22.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.895 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -61.38 168.08 2.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -62.61 -17.77 60.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -94.02 19.91 8.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.848 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 791' ' ' LEU . . . . . 0.411 HD22 ' CA ' ' A' ' 744' ' ' GLY . 80.5 mt 54.14 37.45 27.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 13.4 m -132.4 123.26 26.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 793' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -58.09 133.45 55.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 15.2 t -37.27 -42.62 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 37.9 m -164.31 164.17 22.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.58 154.77 4.33 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.597 0.713 . . . . 0.0 110.858 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 144.82 55.21 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.656 2.237 . . . . 0.0 112.339 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -164.19 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.68 2.253 . . . . 0.0 112.324 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 799' ' ' PHE . . . . . 0.569 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.9 p90 -156.71 165.52 36.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.882 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 3.8 m -102.24 117.51 34.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -117.68 134.47 54.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.935 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 64.0 tttt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 744' ' ' GLY . . . . . 0.443 ' CA ' HD23 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 3.6 m -60.72 161.25 8.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.86 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 67.4 m -74.84 141.92 44.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -48.86 155.45 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 69.9 mt -105.1 149.05 37.19 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.635 0.731 . . . . 0.0 110.933 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 164.59 33.96 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.684 2.256 . . . . 0.0 112.329 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -73.89 142.08 46.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.5 tt -100.74 150.09 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -94.85 141.44 28.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 9.2 m120 54.29 43.34 30.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.856 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 167.67 -179.75 40.88 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.471 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -154.35 164.75 38.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.878 0.37 . . . . 0.0 110.914 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -101.38 156.69 17.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 45.3 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.127 179.974 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 69.4 mt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.844 0.354 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 24.9 m -131.14 -179.09 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -60.2 127.63 32.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 95.67 -21.41 44.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.477 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -52.89 141.85 20.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.75 0.309 . . . . 0.0 111.094 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -123.01 140.88 52.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.897 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 769' ' ' ILE . . . . . 0.436 ' CG1' ' CH2' ' A' ' 793' ' ' TRP . 18.5 mm -106.32 148.84 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.162 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 95.6 m -121.04 113.56 20.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.148 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -97.39 124.16 41.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.969 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 43.5 tp60 -127.06 140.95 51.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.948 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 38.9 m -118.3 171.77 7.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.49 159.5 23.7 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.553 0.692 . . . . 0.0 110.888 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 104.29 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.678 2.252 . . . . 0.0 112.357 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 137.28 -19.1 3.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.494 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -100.59 177.04 5.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.0 110.887 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -136.08 151.04 49.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.824 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 3.4 mt -88.81 137.5 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.107 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 780' ' ' VAL . . . . . 0.563 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 65.7 t -115.74 107.32 22.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.155 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 127.73 -140.57 11.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.497 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 782' ' ' SER . . . . . 0.432 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 3.8 m -105.56 102.23 11.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.879 0.371 . . . . 0.0 110.889 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.58 -53.25 59.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.895 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 33.0 m -83.47 132.8 34.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.132 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 785' ' ' LEU . . . . . 0.433 ' HB3' ' CE3' ' A' ' 793' ' ' TRP . 9.1 mp -127.03 125.37 41.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 1.8 m -106.36 148.13 28.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.139 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 21.4 t -93.87 115.23 27.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.905 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -71.0 169.58 14.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 789' ' ' TRP . . . . . 0.458 ' O ' ' CE3' ' A' ' 789' ' ' TRP . 10.3 p-90 -66.73 -7.37 20.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -100.58 15.77 26.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.875 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 791' ' ' LEU . . . . . 0.443 HD23 ' CA ' ' A' ' 744' ' ' GLY . 82.5 mt 56.25 31.31 18.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 38.3 m -126.58 128.88 47.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 793' ' ' TRP . . . . . 0.436 ' CH2' ' CG1' ' A' ' 769' ' ' ILE . 98.6 m95 -59.53 137.74 57.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 9.3 t -48.17 -39.48 20.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 78.1 p -155.46 167.73 29.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.59 156.54 32.06 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.59 0.709 . . . . 0.0 110.86 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 141.15 44.53 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.665 2.243 . . . . 0.0 112.403 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -168.15 0.26 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.69 2.26 . . . . 0.0 112.382 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 799' ' ' PHE . . . . . 0.563 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 9.1 p90 -160.0 170.87 20.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.85 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 12.0 m -102.52 145.8 29.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.875 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -148.02 134.13 19.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.871 179.97 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 2.2 m -47.72 154.25 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.847 0.356 . . . . 0.0 110.913 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 41.6 m -69.58 150.82 46.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -72.78 139.29 46.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.891 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 9.6 mt -94.31 146.63 31.9 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.671 0.748 . . . . 0.0 110.867 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -179.78 3.14 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.678 2.252 . . . . 0.0 112.379 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -79.75 142.93 34.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.2 tt -101.16 149.25 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.127 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -94.17 137.75 32.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 62.84 36.83 12.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.922 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 174.4 -177.42 46.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.498 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 755' ' ' TRP . . . . . 0.418 ' CD1' ' C ' ' A' ' 755' ' ' TRP . 2.4 p90 -156.02 169.36 24.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.858 0.361 . . . . 0.0 110.885 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -118.68 161.93 19.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 24.4 p . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.119 -179.974 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 16.6 mt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.9 0.381 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 27.2 m -111.16 176.01 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.105 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -48.27 138.07 10.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 88.16 -30.74 5.02 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.465 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -40.08 129.07 2.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 34.3 mtt85 -122.0 127.37 50.21 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.846 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 59.1 mt -104.85 148.87 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.141 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 55.7 m -118.31 125.53 50.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.177 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -96.74 132.89 41.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.955 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -126.0 121.89 34.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.973 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 82.9 m -103.86 174.45 5.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.84 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -60.42 156.91 38.7 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.592 0.71 . . . . 0.0 110.899 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 109.93 2.43 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.67 2.247 . . . . 0.0 112.41 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 127.64 -13.07 6.54 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.502 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -105.07 179.03 4.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.879 0.371 . . . . 0.0 110.937 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -139.91 152.06 46.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.825 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 779' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 780' ' ' VAL . 57.0 mt -89.67 135.55 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.193 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 780' ' ' VAL . . . . . 0.542 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 60.5 t -108.62 106.68 21.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 126.5 -147.68 16.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.484 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 54.1 p -84.62 103.05 13.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.0 110.874 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.8 -34.21 74.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 98.0 m -112.12 121.97 46.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 785' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.64 135.84 48.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 2.3 m -119.46 150.61 39.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 17.4 t -94.9 107.81 19.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -63.66 162.39 13.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -58.05 -17.04 15.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.38 20.32 12.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 74.3 mt 55.16 25.0 6.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.938 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 19.9 m -109.56 125.86 52.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 793' ' ' TRP . . . . . 0.416 ' O ' ' C ' ' A' ' 794' ' ' SER . 75.7 m95 -67.13 135.74 54.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 794' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 793' ' ' TRP . 4.3 t -36.93 -44.1 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 10.9 m -173.06 167.06 4.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.832 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -43.79 152.15 0.46 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.596 0.712 . . . . 0.0 110.898 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 146.37 60.46 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -167.55 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.685 2.257 . . . . 0.0 112.314 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 799' ' ' PHE . . . . . 0.542 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 1.1 p90 -154.62 170.27 21.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 14.7 m -101.95 127.96 48.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -139.88 126.12 20.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 12.9 tttt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 -179.994 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 744' ' ' GLY . . . . . 0.469 ' CA ' HD23 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 9.9 m -45.16 163.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 110.873 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 79.1 p -91.71 163.22 14.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.893 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -61.35 158.72 13.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 46.0 mt -111.52 150.84 42.76 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.59 0.71 . . . . 0.0 110.871 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 157.57 59.95 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.678 2.252 . . . . 0.0 112.362 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.47 148.81 51.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.9 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 2.0 tt -109.06 150.8 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.1 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -103.25 140.61 37.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.933 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 7.4 m120 57.0 43.95 23.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 174.55 -179.94 45.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.537 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 16.5 p90 -156.93 161.19 39.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 110.965 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -116.26 168.27 10.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 179.984 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 69.7 mt . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.84 0.352 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 34.5 m -112.27 -179.53 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.177 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -59.06 130.01 44.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.866 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 97.56 -35.25 4.6 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.507 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -52.72 145.13 12.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.819 0.342 . . . . 0.0 111.104 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -134.99 151.52 50.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.833 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 769' ' ' ILE . . . . . 0.418 HG23 ' N ' ' A' ' 770' ' ' THR . 29.3 mt -118.44 143.22 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.141 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 770' ' ' THR . . . . . 0.418 ' N ' HG23 ' A' ' 769' ' ' ILE . 98.5 m -104.98 124.03 48.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.143 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -96.95 128.87 44.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -124.62 145.11 49.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.912 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 100.0 m -124.12 174.28 7.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.89 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -60.78 158.28 33.54 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.607 0.717 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 112.84 3.19 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.66 2.24 . . . . 0.0 112.363 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 123.81 -16.28 7.84 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.509 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 777' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 802' ' ' LYS . 13.9 m-85 -104.01 178.66 4.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 0.0 110.939 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -137.9 155.93 48.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 46.9 mt -91.01 133.7 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.14 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 780' ' ' VAL . . . . . 0.57 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 74.2 t -108.69 111.51 36.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.167 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 124.87 -143.63 14.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.504 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 3.5 m -94.05 101.18 13.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.914 0.387 . . . . 0.0 110.909 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.04 -47.97 76.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.888 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 22.6 m -94.15 134.02 37.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.141 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 785' ' ' LEU . . . . . . . . . . . . . 7.9 mp -122.42 108.84 13.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.928 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 23.0 m -97.1 156.8 16.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 13.6 t -98.05 125.18 42.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -86.38 169.14 13.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.933 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 789' ' ' TRP . . . . . 0.442 ' CE2' ' OD1' ' A' ' 790' ' ' ASP . 5.9 p-90 -65.53 -8.49 19.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.938 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . 0.442 ' OD1' ' CE2' ' A' ' 789' ' ' TRP . 87.6 m-20 -100.93 23.29 10.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 791' ' ' LEU . . . . . 0.469 HD23 ' CA ' ' A' ' 744' ' ' GLY . 40.5 mt 50.26 42.75 26.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.902 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.6 t -134.7 149.89 50.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.85 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 793' ' ' TRP . . . . . 0.429 ' O ' ' C ' ' A' ' 794' ' ' SER . 94.3 m95 -86.02 144.53 27.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 794' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 793' ' ' TRP . 27.9 t -36.38 -40.77 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.838 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 1.7 t -172.29 -175.96 1.51 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.67 157.08 29.52 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.624 0.726 . . . . 0.0 110.832 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 141.11 44.07 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.667 2.244 . . . . 0.0 112.299 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -176.76 1.61 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.647 2.231 . . . . 0.0 112.361 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 799' ' ' PHE . . . . . 0.57 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 6.6 p90 -153.27 169.96 21.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 3.0 m -101.75 125.88 48.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.888 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -137.82 120.08 15.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 802' ' ' LYS . . . . . 0.406 ' HB2' ' CE2' ' A' ' 777' ' ' TYR . 6.2 ttpm? . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 745' ' ' CYS . . . . . 0.405 ' SG ' ' C ' ' A' ' 791' ' ' LEU . 1.8 m -61.41 152.69 29.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.831 0.348 . . . . 0.0 110.854 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 2.9 m -73.81 166.85 22.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.811 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.39 152.21 38.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.884 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 15.1 mt -103.3 146.85 33.23 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.597 0.713 . . . . 0.0 110.909 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.7 162.65 41.22 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.716 2.278 . . . . 0.0 112.373 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.3 143.97 42.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 5.6 tt -100.69 151.11 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.126 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -94.18 140.49 29.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 28.9 t30 53.71 41.4 32.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -179.99 -176.92 47.75 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.488 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -153.13 159.09 42.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.833 0.349 . . . . 0.0 110.93 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.9 160.85 22.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 3.0 p . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.099 -179.97 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 22.3 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.85 0.357 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 35.6 m -103.51 158.87 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.133 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -41.83 122.72 2.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 112.25 -31.91 6.64 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.502 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -56.62 162.07 2.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.759 0.314 . . . . 0.0 111.144 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -131.2 146.86 52.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.871 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 5.3 mm -113.14 145.83 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.125 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 6.7 m -111.73 149.21 31.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.199 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -130.74 134.68 47.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.933 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -133.45 126.83 32.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 84.9 m -108.75 174.36 5.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.17 158.05 38.81 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.601 0.715 . . . . 0.0 110.872 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 106.95 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.733 2.289 . . . . 0.0 112.378 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 126.56 -10.92 7.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.474 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -106.77 167.54 9.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.865 0.364 . . . . 0.0 110.938 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -128.14 156.86 42.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.861 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 779' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 780' ' ' VAL . 75.8 mt -99.49 134.67 37.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.151 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 780' ' ' VAL . . . . . 0.561 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 93.7 t -106.35 107.8 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.073 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 132.56 -132.59 6.68 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.488 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 2.9 m -109.99 110.37 21.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.879 0.371 . . . . 0.0 110.871 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -58.22 -51.71 68.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.814 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 23.7 m -96.89 123.57 40.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 785' ' ' LEU . . . . . . . . . . . . . 8.7 mp -106.99 113.46 26.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 786' ' ' THR . . . . . 0.451 HG21 ' N ' ' A' ' 787' ' ' CYS . 26.3 m -101.32 144.59 29.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.146 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 787' ' ' CYS . . . . . 0.451 ' N ' HG21 ' A' ' 786' ' ' THR . 36.5 t -93.35 140.18 29.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -95.26 166.73 11.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -52.98 -19.37 2.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.936 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -88.82 22.77 2.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.825 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 791' ' ' LEU . . . . . 0.405 ' C ' ' SG ' ' A' ' 745' ' ' CYS . 18.6 mt 46.93 35.45 3.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.928 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 22.7 t -121.99 158.36 29.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.839 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 793' ' ' TRP . . . . . 0.419 ' O ' ' C ' ' A' ' 794' ' ' SER . 95.6 m95 -96.05 139.37 32.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 794' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 793' ' ' TRP . 6.6 t -36.8 -47.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.871 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 6.1 m -170.16 174.38 5.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.827 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -50.53 155.31 1.88 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.614 0.721 . . . . 0.0 110.842 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 146.21 59.28 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.715 2.277 . . . . 0.0 112.313 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 798' ' ' PRO . . . . . 0.437 ' HB2' ' CG2' ' A' ' 779' ' ' ILE . 53.9 Cg_endo -69.74 -166.99 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.679 2.253 . . . . 0.0 112.353 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 799' ' ' PHE . . . . . 0.561 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.6 p90 -154.96 165.59 36.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 9.1 m -101.63 128.0 48.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.9 143.99 47.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 28.8 tttp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.928 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 745' ' ' CYS . . . . . 0.443 ' HB3' ' CE2' ' A' ' 793' ' ' TRP . 1.8 m -44.84 154.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 0.0 110.863 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 17.7 m -64.53 137.4 57.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -55.58 155.34 5.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 12.4 mt -119.02 145.49 38.14 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.64 0.733 . . . . 0.0 110.884 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -177.43 1.86 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.674 2.249 . . . . 0.0 112.366 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -88.28 148.3 24.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 2.3 tt -101.98 148.67 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.121 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -86.54 142.35 28.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 3.0 m120 51.48 40.61 27.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -173.63 176.84 46.17 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.501 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 755' ' ' TRP . . . . . 0.446 ' CZ2' ' HG2' ' A' ' 772' ' ' GLN . 44.5 p90 -145.93 151.08 37.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.353 . . . . 0.0 110.897 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -118.98 153.38 34.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 23.3 p . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.155 179.962 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 38.0 mt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.841 0.353 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.32 174.55 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.142 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -59.21 126.5 27.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 94.0 -17.01 59.62 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.513 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -60.61 140.16 57.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.782 0.325 . . . . 0.0 111.151 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 29.8 ptt85 -127.81 143.9 51.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 94.8 mt -107.37 129.95 60.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.108 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 84.3 m -96.3 120.68 37.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.113 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -98.5 118.21 34.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.925 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 772' ' ' GLN . . . . . 0.446 ' HG2' ' CZ2' ' A' ' 755' ' ' TRP . 3.9 tp-100 -113.32 141.44 47.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 74.1 m -119.37 173.47 6.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.46 158.16 31.35 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.589 0.709 . . . . 0.0 110.867 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 106.77 1.73 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.652 2.235 . . . . 0.0 112.351 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 123.26 0.79 9.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.477 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 777' ' ' TYR . . . . . 0.457 ' CE2' ' HB2' ' A' ' 802' ' ' LYS . 23.9 m-85 -115.21 170.17 8.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.848 0.356 . . . . 0.0 110.974 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -129.71 154.76 46.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 779' ' ' ILE . . . . . 0.446 ' CG2' ' HB2' ' A' ' 798' ' ' PRO . 72.8 mt -97.17 134.62 34.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.142 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 780' ' ' VAL . . . . . 0.551 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 59.8 t -105.61 109.4 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 126.94 -145.12 15.55 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.477 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 782' ' ' SER . . . . . 0.448 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 58.4 m -91.84 96.53 10.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.861 0.362 . . . . 0.0 110.865 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -46.77 -43.76 18.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.857 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 6.2 m -106.34 141.24 37.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.168 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 785' ' ' LEU . . . . . 0.448 ' CD1' ' O ' ' A' ' 782' ' ' SER . 7.5 mp -126.33 110.13 13.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.937 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 7.0 m -94.43 152.39 18.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.109 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 13.8 t -93.15 118.8 31.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -71.98 179.47 3.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 3.2 m95 -71.11 -14.83 62.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -101.87 21.86 13.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.894 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 69.3 mt 53.59 26.17 5.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.929 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 4.4 m -113.69 122.71 47.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 793' ' ' TRP . . . . . 0.443 ' CE2' ' HB3' ' A' ' 745' ' ' CYS . 91.6 m95 -61.97 136.07 57.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.918 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 1.4 t -38.38 -44.34 0.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.804 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 58.3 m -161.3 -179.6 7.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -65.17 157.34 77.48 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.588 0.708 . . . . 0.0 110.864 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 140.73 43.11 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.648 2.232 . . . . 0.0 112.293 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 798' ' ' PRO . . . . . 0.446 ' HB2' ' CG2' ' A' ' 779' ' ' ILE . 54.1 Cg_endo -69.71 -164.28 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.675 2.25 . . . . 0.0 112.405 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 799' ' ' PHE . . . . . 0.551 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 6.1 p90 -156.13 173.19 17.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 35.4 m -101.96 137.96 39.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -143.66 142.58 31.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 802' ' ' LYS . . . . . 0.457 ' HB2' ' CE2' ' A' ' 777' ' ' TYR . 4.8 ttpm? . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 744' ' ' GLY . . . . . 0.413 ' C ' HD21 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.9 171.37 0.51 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.364 . . . . 0.0 110.843 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 3.4 t -90.38 167.34 12.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -75.4 132.23 40.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.56 152.26 60.07 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.628 0.728 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 167.5 24.37 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.662 2.241 . . . . 0.0 112.296 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -74.87 145.67 42.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.6 tt -100.72 146.52 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.115 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -91.8 130.48 37.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.937 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 61.99 44.34 8.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 179.99 -173.99 45.47 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.453 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 45.6 p90 -157.78 170.13 23.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.799 0.333 . . . . 0.0 110.971 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -118.96 165.55 13.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.917 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 58.6 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.144 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 31.7 mt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.836 0.35 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 35.1 m -107.86 -175.0 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . 0.401 ' CD ' ' HA ' ' A' ' 789' ' ' TRP . 73.7 mtm180 -68.99 134.71 49.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 95.96 -20.56 49.41 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.49 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -60.02 152.94 22.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.809 0.338 . . . . 0.0 111.092 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.62 136.65 43.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.855 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 769' ' ' ILE . . . . . 0.436 HG23 ' N ' ' A' ' 770' ' ' THR . 56.5 mt -114.48 135.99 52.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.118 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 770' ' ' THR . . . . . 0.436 ' N ' HG23 ' A' ' 769' ' ' ILE . 51.8 m -107.67 122.34 46.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.151 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -97.12 126.01 41.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -123.53 135.12 53.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 20.8 m -117.72 173.07 6.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -61.18 159.62 28.06 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.586 0.708 . . . . 0.0 110.852 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 114.98 3.88 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.683 2.255 . . . . 0.0 112.324 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 125.13 -25.2 5.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.468 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -90.83 170.35 10.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 0.0 110.926 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -129.15 154.62 46.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 10.9 mt -95.59 137.82 22.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 780' ' ' VAL . . . . . 0.555 ' HB ' ' CE1' ' A' ' 799' ' ' PHE . 58.3 t -114.45 110.38 31.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.128 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 128.33 -132.67 7.41 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.507 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.93 107.56 17.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 110.911 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.02 -34.94 63.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 23.7 m -109.39 136.12 49.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.159 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 785' ' ' LEU . . . . . . . . . . . . . 10.1 mp -126.71 118.61 25.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.93 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 1.2 m -105.83 151.98 23.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.16 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 48.6 t -95.41 108.82 21.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.86 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -62.0 175.67 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 789' ' ' TRP . . . . . 0.401 ' HA ' ' CD ' ' A' ' 765' ' ' ARG . 23.7 p-90 -73.3 -8.22 54.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -98.95 20.37 13.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 791' ' ' LEU . . . . . 0.413 HD21 ' C ' ' A' ' 744' ' ' GLY . 79.2 mt 54.28 32.9 17.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 73.6 m -131.34 135.65 47.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 793' ' ' TRP . . . . . 0.422 ' O ' ' C ' ' A' ' 794' ' ' SER . 93.4 m95 -73.85 136.66 43.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.919 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 794' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 793' ' ' TRP . 11.9 t -35.92 -47.06 0.5 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.829 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 58.5 p -159.12 165.43 33.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -53.78 157.86 3.69 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.617 0.722 . . . . 0.0 110.878 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 141.39 44.95 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.687 2.258 . . . . 0.0 112.342 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 -167.11 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 0.0 112.389 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 799' ' ' PHE . . . . . 0.555 ' CE1' ' HB ' ' A' ' 780' ' ' VAL . 8.1 p90 -153.33 169.19 23.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 2.8 m -103.33 122.31 44.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.874 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -122.51 147.94 45.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 20.1 tttp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 -179.98 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 1.8 m -48.09 158.37 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.878 0.37 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 3.3 m -80.89 148.38 29.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -48.41 159.46 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.879 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 748' ' ' LEU . . . . . 0.569 HD21 ' CD1' ' A' ' 793' ' ' TRP . 92.2 mt -118.24 146.72 40.06 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.662 0.744 . . . . 0.0 110.875 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 139.27 39.7 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.68 2.253 . . . . 0.0 112.31 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -46.81 156.68 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.84 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 1.6 tt -102.04 139.85 22.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.114 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -83.96 130.85 34.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 5.6 t30 55.45 45.02 26.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 177.94 -170.76 43.16 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.491 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 755' ' ' TRP . . . . . 0.45 ' CD1' ' C ' ' A' ' 755' ' ' TRP . 1.6 p90 -153.0 173.01 15.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.874 0.369 . . . . 0.0 110.9 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -135.07 172.0 13.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.138 -179.987 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 74.3 mt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.887 0.375 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 28.9 m -113.24 162.17 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.076 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 57.7 mtm-85 -40.94 145.27 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.927 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 82.38 -36.61 2.59 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.491 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -47.02 147.52 1.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.778 0.323 . . . . 0.0 111.076 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -124.85 164.67 19.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 769' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 770' ' ' THR . 35.1 mm -118.12 140.3 41.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.123 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 770' ' ' THR . . . . . 0.449 ' N ' HG23 ' A' ' 769' ' ' ILE . 90.8 m -109.93 125.51 52.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.072 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 771' ' ' TYR . . . . . 0.554 ' CE2' ' HD2' ' A' ' 798' ' ' PRO . 24.6 m-85 -107.69 142.86 37.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.95 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -146.91 123.58 11.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 63.7 m -108.89 174.51 5.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.35 161.51 13.46 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.655 0.74 . . . . 0.0 110.859 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 120.57 7.34 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.718 2.279 . . . . 0.0 112.287 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 118.84 -29.09 6.41 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.493 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 777' ' ' TYR . . . . . 0.566 ' CE2' ' HB2' ' A' ' 802' ' ' LYS . 28.9 m-85 -89.94 179.46 5.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.918 0.389 . . . . 0.0 110.926 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -142.3 154.57 44.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.847 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 779' ' ' ILE . . . . . 0.468 HG21 ' N ' ' A' ' 780' ' ' VAL . 75.9 mt -87.21 135.22 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.184 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 780' ' ' VAL . . . . . 0.561 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 66.5 t -103.06 105.0 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 126.03 -129.22 6.69 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.486 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 1.1 t -114.46 107.68 15.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.884 0.374 . . . . 0.0 110.86 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -55.19 -36.92 66.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 784' ' ' THR . . . . . 0.425 ' C ' HD13 ' A' ' 785' ' ' LEU . 33.3 m -101.27 139.39 37.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.139 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 785' ' ' LEU . . . . . 0.425 HD13 ' C ' ' A' ' 784' ' ' THR . 11.2 mp -130.37 111.81 12.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.943 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 786' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 787' ' ' CYS . 11.1 m -90.71 149.96 21.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.134 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 787' ' ' CYS . . . . . 0.412 ' N ' HG22 ' A' ' 786' ' ' THR . 9.3 t -93.23 107.48 19.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -57.79 -179.18 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.953 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 41.3 p-90 -72.44 -25.48 61.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.67 27.79 1.45 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.862 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 20.1 mt 49.67 40.83 20.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.8 t -130.98 147.14 52.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 793' ' ' TRP . . . . . 0.569 ' CD1' HD21 ' A' ' 748' ' ' LEU . 83.3 m95 -80.87 134.98 35.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.941 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 794' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 793' ' ' TRP . 2.3 m -34.74 -47.34 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.824 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 79.4 p -159.98 165.41 32.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.831 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -44.6 152.96 0.49 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.609 0.719 . . . . 0.0 110.841 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 146.69 60.94 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.661 2.241 . . . . 0.0 112.354 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 798' ' ' PRO . . . . . 0.554 ' HD2' ' CE2' ' A' ' 771' ' ' TYR . 53.6 Cg_endo -69.71 -169.31 0.32 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.687 2.258 . . . . 0.0 112.392 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 799' ' ' PHE . . . . . 0.561 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 4.9 p90 -157.76 172.74 17.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.875 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 7.2 m -101.96 136.14 42.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -146.71 135.7 22.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 802' ' ' LYS . . . . . 0.566 ' HB2' ' CE2' ' A' ' 777' ' ' TYR . 44.5 tttm . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.944 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 744' ' ' GLY . . . . . 0.46 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 3.9 m -40.54 154.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 110.895 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 4.4 m -75.9 147.38 39.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.22 117.89 6.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.84 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 10.2 mt -70.62 149.34 95.4 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.598 0.713 . . . . 0.0 110.895 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 159.92 51.61 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.666 2.244 . . . . 0.0 112.342 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.08 149.95 43.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.7 tt -100.65 148.54 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.121 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -93.41 123.42 36.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.945 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 70.08 41.68 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.883 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 177.54 -174.24 46.77 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.494 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 3.2 p90 -151.35 166.11 32.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.835 0.35 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.24 156.2 43.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 49.2 p . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 179.981 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 65.8 mt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.844 0.354 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 24.0 m -87.89 162.13 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 765' ' ' ARG . 25.9 mtm105 -51.75 132.88 31.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 99.52 -25.4 28.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.461 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -62.81 131.52 49.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 0.0 111.102 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 19.6 ptt-85 -111.23 147.47 34.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 8.9 mm -104.13 139.98 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.121 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 22.8 m -104.69 119.72 39.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.142 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -104.19 130.45 51.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -135.41 132.48 37.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 39.9 m -112.56 171.81 7.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -60.48 160.63 17.38 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.629 0.728 . . . . 0.0 110.865 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 107.98 1.99 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.663 2.242 . . . . 0.0 112.359 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 133.43 -24.42 3.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.436 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -92.72 170.73 9.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.876 0.37 . . . . 0.0 110.948 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -130.86 155.63 46.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.852 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 11.5 mt -91.68 141.62 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.165 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 780' ' ' VAL . . . . . 0.495 HG12 ' CZ ' ' A' ' 799' ' ' PHE . 58.4 t -116.15 106.6 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 124.61 -126.38 6.04 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 782' ' ' SER . . . . . 0.478 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 1.3 t -113.52 108.09 16.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.916 0.389 . . . . 0.0 110.871 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.7 -33.87 66.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.904 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 9.9 m -111.61 129.22 56.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.123 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 785' ' ' LEU . . . . . 0.478 ' CD1' ' O ' ' A' ' 782' ' ' SER . 8.8 mp -121.45 118.81 30.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.898 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 51.8 m -96.65 152.59 18.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.087 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 20.0 t -95.63 112.05 23.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -65.41 170.97 4.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.949 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -69.36 -6.58 30.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -105.95 24.28 12.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.844 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 791' ' ' LEU . . . . . 0.46 HD22 ' CA ' ' A' ' 744' ' ' GLY . 34.5 mt 50.5 33.52 8.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.887 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 6.8 m -128.31 123.13 33.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 793' ' ' TRP . . . . . 0.429 ' O ' ' C ' ' A' ' 794' ' ' SER . 86.9 m95 -66.17 137.2 56.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.958 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 794' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 793' ' ' TRP . 23.0 t -35.67 -50.56 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.814 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 38.8 p -154.96 165.17 37.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.866 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -51.1 156.74 1.69 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.568 0.699 . . . . 0.0 110.884 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 141.81 46.2 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.663 2.242 . . . . 0.0 112.343 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -164.07 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.679 2.252 . . . . 0.0 112.321 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 799' ' ' PHE . . . . . 0.495 ' CZ ' HG12 ' A' ' 780' ' ' VAL . 6.7 p90 -158.56 172.28 18.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 2.7 m -101.7 138.36 38.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -146.72 150.04 34.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 5.3 tttm . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 179.971 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 744' ' ' GLY . . . . . 0.456 ' CA ' HD23 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 5.1 m -40.55 155.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.858 0.361 . . . . 0.0 110.867 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 2.8 m -78.5 133.45 37.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -44.53 140.62 2.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 748' ' ' LEU . . . . . 0.463 ' CD2' HD12 ' A' ' 769' ' ' ILE . 4.0 mm? -76.47 148.18 79.86 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.598 0.713 . . . . 0.0 110.932 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.63 168.74 20.51 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.677 2.251 . . . . 0.0 112.38 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -74.31 135.75 42.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 1.4 tt -108.05 141.78 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.15 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -83.1 146.84 28.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.939 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 42.44 48.67 4.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 176.74 172.56 41.5 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.477 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 45.5 p90 -153.88 152.55 30.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.81 0.338 . . . . 0.0 110.901 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -109.42 164.26 12.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.098 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 65.3 mt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.853 0.359 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 29.3 m -120.62 174.06 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 49.6 mtm180 -46.78 133.97 10.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.92 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 767' ' ' ALA . . . 91.48 -34.37 4.36 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.515 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 766' ' ' GLY . . . -38.02 131.8 1.05 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 0.0 111.027 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 768' ' ' ARG . . . . . 0.447 ' CG ' HG21 ' A' ' 784' ' ' THR . 7.3 tmm_? -117.04 130.86 56.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.872 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 769' ' ' ILE . . . . . 0.463 HD12 ' CD2' ' A' ' 748' ' ' LEU . 56.9 mt -112.64 141.09 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.18 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 5.7 t -111.53 152.9 26.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.167 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -120.49 116.95 26.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.913 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -110.83 124.43 52.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.942 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 77.4 m -109.21 174.22 5.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -60.43 153.08 62.03 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.665 0.745 . . . . 0.0 110.856 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 93.97 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.708 2.272 . . . . 0.0 112.357 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 140.78 -9.82 2.85 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.535 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -100.91 176.31 5.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.885 0.374 . . . . 0.0 110.947 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -128.57 159.53 35.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.865 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 4.4 mt -104.44 143.34 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 780' ' ' VAL . . . . . 0.561 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 86.4 t -124.04 108.93 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.095 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 128.42 -135.82 8.78 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.493 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 3.0 m -107.29 98.99 8.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.371 . . . . 0.0 110.908 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.57 -48.8 57.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.857 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 784' ' ' THR . . . . . 0.447 HG21 ' CG ' ' A' ' 768' ' ' ARG . 87.5 m -95.42 135.54 36.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.15 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 785' ' ' LEU . . . . . 0.413 HD11 ' C ' ' A' ' 784' ' ' THR . 7.6 mp -122.19 122.35 38.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.96 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 8.1 m -109.5 150.62 27.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.154 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 6.6 t -95.06 120.44 35.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -81.67 -176.69 6.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.938 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -68.72 -16.87 63.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.8 16.14 16.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.862 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 791' ' ' LEU . . . . . 0.456 HD23 ' CA ' ' A' ' 744' ' ' GLY . 68.4 mt 53.99 25.13 5.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.946 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 44.0 m -115.35 131.38 56.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 793' ' ' TRP . . . . . 0.401 ' O ' ' C ' ' A' ' 794' ' ' SER . 83.5 m95 -63.05 137.84 58.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 794' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 793' ' ' TRP . 9.4 t -37.87 -47.2 1.02 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 68.0 m -156.74 161.99 39.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.866 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -46.4 158.97 0.36 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.59 0.709 . . . . 0.0 110.854 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 140.74 43.08 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.673 2.249 . . . . 0.0 112.293 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -169.77 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.671 2.247 . . . . 0.0 112.37 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 799' ' ' PHE . . . . . 0.561 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 4.1 p90 -159.29 167.41 29.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 3.0 m -103.55 138.51 40.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -141.3 112.79 7.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 24.4 tttt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.908 179.992 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 3.6 m -45.39 152.22 0.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.881 0.372 . . . . 0.0 110.859 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 68.4 m -75.91 146.24 39.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -56.26 130.31 43.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 12.4 mt -79.45 149.23 71.64 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.606 0.717 . . . . 0.0 110.895 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 165.1 32.16 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.726 2.284 . . . . 0.0 112.312 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -73.67 144.52 45.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 6.7 tt -100.57 151.86 5.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.127 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -97.45 124.44 41.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 67.17 39.41 3.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -173.41 177.54 45.75 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.465 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -158.34 156.72 31.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.815 0.34 . . . . 0.0 110.935 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -98.24 165.14 12.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 81.0 p . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.123 -179.995 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.824 0.345 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 27.7 m -112.77 155.78 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.122 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -48.84 116.09 1.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 112.61 -26.38 10.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.509 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -45.85 129.07 9.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.774 0.321 . . . . 0.0 111.147 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -115.17 120.79 40.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.861 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 769' ' ' ILE . . . . . 0.554 HD12 ' CH2' ' A' ' 793' ' ' TRP . 52.3 mt -102.18 150.33 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.129 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 50.1 m -124.06 128.09 48.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.147 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -98.56 136.92 37.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -129.7 129.95 44.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 35.0 m -110.42 173.4 6.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.78 161.14 23.0 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.575 0.703 . . . . 0.0 110.84 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 117.5 5.12 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.656 2.237 . . . . 0.0 112.315 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 121.92 -22.52 7.62 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.479 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -96.55 172.83 7.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.877 0.37 . . . . 0.0 110.935 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -137.47 149.79 47.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.836 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 779' ' ' ILE . . . . . 0.44 HG23 ' N ' ' A' ' 780' ' ' VAL . 66.8 mt -88.11 134.26 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.118 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 780' ' ' VAL . . . . . 0.555 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 63.6 t -108.25 108.23 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.12 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 124.45 -156.56 18.56 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.48 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 58.2 m -76.87 95.44 4.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.868 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -49.36 -55.2 13.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.861 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 87.4 m -92.27 142.19 27.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.076 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 785' ' ' LEU . . . . . . . . . . . . . 8.2 mp -128.04 143.09 51.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 55.8 m -128.42 151.99 48.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.144 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 14.4 t -94.6 107.08 19.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -61.15 -179.95 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -69.61 -20.27 63.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.871 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -91.92 23.71 3.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.866 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 39.3 mt 51.02 29.55 4.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.8 t -117.9 147.34 43.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.825 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 793' ' ' TRP . . . . . 0.554 ' CH2' HD12 ' A' ' 769' ' ' ILE . 95.0 m95 -83.78 134.63 34.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.881 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 794' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 793' ' ' TRP . 2.3 t -34.47 -50.51 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 97.7 p -162.07 168.45 22.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.836 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.21 153.14 0.95 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.619 0.723 . . . . 0.0 110.822 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 148.07 64.37 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.707 2.271 . . . . 0.0 112.345 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -167.77 0.24 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.699 2.266 . . . . 0.0 112.339 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 799' ' ' PHE . . . . . 0.555 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 1.6 p90 -157.67 164.61 37.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 5.4 m -102.93 113.49 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -126.6 126.13 43.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.971 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 7.1 m -48.8 152.63 0.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.809 0.337 . . . . 0.0 110.879 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 32.4 m -72.96 156.69 38.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.817 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.93 131.96 45.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.831 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 12.2 mt -79.93 148.66 68.83 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.566 0.698 . . . . 0.0 110.928 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 175.47 8.01 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.705 2.27 . . . . 0.0 112.36 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -77.93 149.41 34.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 2.0 tt -106.52 145.76 13.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.129 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -89.8 132.27 35.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 4.7 m120 59.92 44.59 13.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.854 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 178.17 179.72 48.24 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.488 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 755' ' ' TRP . . . . . 0.462 ' CZ2' ' HG2' ' A' ' 772' ' ' GLN . 19.0 p90 -156.06 168.56 26.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.834 0.35 . . . . 0.0 110.94 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.91 165.67 14.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.91 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 51.4 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.112 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 55.8 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.866 0.365 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 23.7 m -84.99 -175.92 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.154 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -53.35 130.68 35.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 103.12 -32.96 6.99 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -50.48 125.14 12.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.755 0.312 . . . . 0.0 111.144 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 768' ' ' ARG . . . . . 0.438 ' HG2' ' CG2' ' A' ' 784' ' ' THR . 8.9 ttp-105 -116.52 145.56 43.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.862 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 769' ' ' ILE . . . . . 0.549 HD11 ' CH2' ' A' ' 793' ' ' TRP . 39.4 mt -123.89 140.45 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.11 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 18.7 m -108.5 123.01 48.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.147 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -99.67 121.37 41.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.911 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 772' ' ' GLN . . . . . 0.462 ' HG2' ' CZ2' ' A' ' 755' ' ' TRP . 4.3 tp-100 -118.09 143.54 46.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.857 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 73.6 m -124.36 171.1 10.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -62.06 159.68 35.9 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.578 0.704 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 119.66 6.57 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.725 2.283 . . . . 0.0 112.311 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 117.77 -20.21 10.97 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.481 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -96.3 179.31 5.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.882 0.372 . . . . 0.0 110.953 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -141.92 150.41 41.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.847 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 5.6 mt -87.58 144.96 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 780' ' ' VAL . . . . . 0.55 ' HB ' ' CE1' ' A' ' 799' ' ' PHE . 75.3 t -120.69 106.14 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.125 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 126.65 -132.62 7.77 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 3.0 m -101.75 88.34 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.888 0.375 . . . . 0.0 110.891 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -41.65 -33.73 0.51 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.875 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 784' ' ' THR . . . . . 0.438 ' CG2' ' HG2' ' A' ' 768' ' ' ARG . 16.7 m -114.7 142.8 46.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 785' ' ' LEU . . . . . 0.449 HD11 ' N ' ' A' ' 785' ' ' LEU . 9.6 mp -126.64 144.92 50.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 1.9 m -138.18 157.43 46.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.199 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 8.1 t -92.62 118.12 30.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.828 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -77.34 171.85 14.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 1.6 m-90 -59.52 -12.9 7.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -98.0 25.1 6.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 90.3 mt 48.08 25.76 0.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.4 t -121.35 147.34 45.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.84 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 793' ' ' TRP . . . . . 0.549 ' CH2' HD11 ' A' ' 769' ' ' ILE . 98.0 m95 -77.79 141.15 39.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.958 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 794' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 793' ' ' TRP . 36.4 t -34.52 -46.41 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 19.4 p -173.11 170.72 4.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.12 151.54 0.2 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.593 0.711 . . . . 0.0 110.862 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 143.95 52.46 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.626 2.218 . . . . 0.0 112.367 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 798' ' ' PRO . . . . . 0.408 ' HD3' ' CD1' ' A' ' 785' ' ' LEU . 54.0 Cg_endo -69.75 177.51 5.5 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.696 2.264 . . . . 0.0 112.331 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 799' ' ' PHE . . . . . 0.55 ' CE1' ' HB ' ' A' ' 780' ' ' VAL . 10.0 p90 -149.55 172.55 14.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 12.6 m -102.79 129.51 49.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -129.68 129.66 44.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.896 179.95 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 1.8 m -48.29 171.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.348 . . . . 0.0 110.885 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 56.9 p -100.55 140.7 34.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -46.25 144.01 2.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 16.3 mt -94.85 151.09 38.75 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.619 0.723 . . . . 0.0 110.94 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 151.45 68.99 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.67 2.246 . . . . 0.0 112.349 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -62.97 143.32 57.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 6.7 tt -100.54 153.24 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -97.39 128.42 44.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 61.92 41.3 11.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -173.46 176.21 46.12 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.458 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -152.22 170.52 19.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.827 0.346 . . . . 0.0 110.931 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 756' ' ' LYS . . . . . 0.465 ' HE3' ' CG2' ' A' ' 769' ' ' ILE . 9.9 ptmt -130.51 168.43 17.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 40.1 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.129 -179.995 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 77.6 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.901 0.382 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 29.4 m -105.55 154.94 6.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.098 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -43.43 124.79 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 105.23 -25.22 25.65 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.485 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -53.88 137.9 37.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 111.084 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -121.95 130.47 53.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 769' ' ' ILE . . . . . 0.465 ' CG2' ' HE3' ' A' ' 756' ' ' LYS . 69.1 mt -110.68 131.93 60.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 31.1 m -99.01 130.78 45.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.147 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -98.57 120.19 38.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.937 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -117.83 124.21 47.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.917 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 72.1 m -107.55 173.39 6.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.66 157.49 37.62 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.6 0.714 . . . . 0.0 110.888 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 111.3 2.78 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.653 2.236 . . . . 0.0 112.371 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 125.13 -19.84 6.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.473 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -97.75 168.52 10.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.863 0.364 . . . . 0.0 110.932 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -125.72 162.93 23.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.869 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 779' ' ' ILE . . . . . 0.467 HG22 ' N ' ' A' ' 780' ' ' VAL . 65.4 mt -103.8 135.13 42.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 780' ' ' VAL . . . . . 0.528 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 61.7 t -112.34 107.52 23.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.12 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 127.99 -150.32 18.35 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.449 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 5.2 p -81.28 105.29 12.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.857 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.66 -50.48 73.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 30.7 m -102.47 121.24 41.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.174 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 785' ' ' LEU . . . . . . . . . . . . . 7.8 mp -106.91 148.68 28.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 37.8 m -137.77 153.03 49.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.116 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 12.4 t -93.94 115.91 28.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.912 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -71.86 -177.51 2.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.882 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 53.5 p-90 -71.42 -16.31 62.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.885 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -92.34 23.68 3.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.833 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 32.3 mt 48.63 37.5 9.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.6 t -134.47 147.57 50.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.846 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 793' ' ' TRP . . . . . 0.458 ' CH2' HD12 ' A' ' 769' ' ' ILE . 88.7 m95 -82.44 141.67 32.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.936 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 794' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 793' ' ' TRP . 1.3 t -35.41 -45.49 0.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.884 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 22.6 t -171.68 171.55 5.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -47.56 150.6 1.68 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.647 0.737 . . . . 0.0 110.833 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 149.17 66.25 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.685 2.257 . . . . 0.0 112.285 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.83 -171.79 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.678 2.252 . . . . 0.0 112.355 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 799' ' ' PHE . . . . . 0.528 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 3.2 p90 -147.22 167.71 23.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.912 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 3.9 m -102.05 119.18 38.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -123.32 132.59 54.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 24.3 tttp . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 15.3 t -107.91 88.16 2.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.914 0.387 . . . . 0.0 110.833 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 52.0 m -155.55 134.96 12.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.817 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -111.98 -107.25 2.91 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.533 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 3.9 t 64.76 41.54 5.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.905 0.383 . . . . 0.0 110.887 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 73.4 m -122.65 133.34 54.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.852 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 744' ' ' GLY . . . . . 0.46 ' N ' HD23 ' A' ' 791' ' ' LEU . . . 171.65 142.8 3.82 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.504 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 3.0 m -46.76 170.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 110.895 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 70.4 m -97.35 138.4 34.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.865 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.26 123.94 5.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.857 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 748' ' ' LEU . . . . . 0.427 ' CD1' HG21 ' A' ' 769' ' ' ILE . 24.2 mt -69.42 144.1 94.1 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.611 0.719 . . . . 0.0 110.873 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 143.74 51.8 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.693 2.262 . . . . 0.0 112.325 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -52.12 133.55 33.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 1.5 tt -100.77 143.78 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.138 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -82.49 136.39 34.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 5.8 m120 58.71 37.4 25.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -178.23 166.45 36.47 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.474 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -147.48 150.46 34.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.817 0.341 . . . . 0.0 110.912 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -91.54 148.87 21.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 39.5 p -139.92 113.37 8.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.09 145.12 51.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.133 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 24.0 t -64.09 -63.48 1.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -80.78 125.94 30.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.822 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 95.1 m -63.83 -55.29 24.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.173 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -66.81 111.71 3.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 55.9 mt -65.81 111.14 3.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.944 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.09 170.59 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.119 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 40.8 mtt85 -53.91 132.69 42.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 94.24 -26.17 18.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.48 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -45.99 142.62 2.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.799 0.333 . . . . 0.0 111.084 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 768' ' ' ARG . . . . . 0.471 ' HG2' ' CG2' ' A' ' 784' ' ' THR . 15.6 ttm-85 -119.72 122.88 42.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 769' ' ' ILE . . . . . 0.626 ' CG1' ' CH2' ' A' ' 793' ' ' TRP . 37.3 mm -99.87 143.45 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.077 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 12.0 m -121.11 125.99 48.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.131 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -101.66 121.54 42.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -122.45 130.29 52.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.922 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 74.9 m -108.57 174.16 6.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -60.75 159.72 24.14 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.606 0.717 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 114.51 3.73 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.638 2.225 . . . . 0.0 112.332 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 122.01 -22.2 7.66 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.461 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -94.38 174.39 7.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.896 0.379 . . . . 0.0 110.909 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -131.87 155.36 47.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.842 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 7.4 mt -97.39 141.0 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 780' ' ' VAL . . . . . 0.42 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 61.0 t -114.1 109.47 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.093 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 125.91 -131.06 7.39 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.481 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 782' ' ' SER . . . . . 0.406 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 1.5 t -107.9 108.52 19.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.852 0.358 . . . . 0.0 110.86 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.45 -31.15 67.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 784' ' ' THR . . . . . 0.471 ' CG2' ' HG2' ' A' ' 768' ' ' ARG . 20.8 m -115.49 131.38 56.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.122 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 785' ' ' LEU . . . . . 0.406 ' CD1' ' O ' ' A' ' 782' ' ' SER . 10.4 mp -123.74 127.65 48.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 26.6 m -107.78 159.61 16.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.144 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 6.5 t -94.47 119.09 32.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -73.62 176.76 5.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -73.39 -7.74 52.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -100.94 12.94 36.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 791' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 744' ' ' GLY . 66.6 mt 61.78 26.92 16.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 14.8 m -130.39 127.35 39.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.873 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 793' ' ' TRP . . . . . 0.626 ' CH2' ' CG1' ' A' ' 769' ' ' ILE . 73.6 m95 -58.38 140.64 53.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.946 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 794' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 793' ' ' TRP . 28.8 t -37.13 -47.98 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.837 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 37.4 m -154.75 167.04 31.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.841 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -51.63 155.8 2.59 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.63 0.729 . . . . 0.0 110.842 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 145.32 56.68 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.677 2.251 . . . . 0.0 112.329 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.85 -165.28 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.659 2.239 . . . . 0.0 112.348 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 799' ' ' PHE . . . . . 0.42 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.7 p90 -153.67 170.5 20.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.911 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 8.4 m -101.94 135.01 44.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.909 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -130.36 143.04 50.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 802' ' ' LYS . . . . . 0.413 ' HD2' ' N ' ' A' ' 803' ' ' THR . 0.4 OUTLIER -81.28 139.18 35.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 803' ' ' THR . . . . . 0.413 ' N ' ' HD2' ' A' ' 802' ' ' LYS . 84.7 m -100.05 148.93 24.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.2 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -68.87 89.03 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.862 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -147.9 146.98 29.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 70.5 p -131.18 110.61 11.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.847 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . 83.96 159.15 28.57 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.519 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -32.66 18.19 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.713 2.275 . . . . 0.0 112.302 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 16.1 m -115.17 133.88 55.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.86 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 50.3 p -43.66 -57.6 3.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.506 -179.967 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 5.9 t -63.19 -52.19 63.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.941 0.4 . . . . 0.0 110.853 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 89.7 p -83.94 41.5 0.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.887 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 102.73 111.53 3.54 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.531 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 8.7 t -67.26 -51.92 47.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.889 0.376 . . . . 0.0 110.847 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 2.2 m 40.76 44.43 1.88 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.84 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 744' ' ' GLY . . . . . 0.482 ' CA ' ' O ' ' A' ' 763' ' ' LEU . . . -176.15 153.8 15.45 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.499 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 745' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 763' ' ' LEU . 7.5 m -44.86 150.56 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.847 0.356 . . . . 0.0 110.832 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 16.4 m -71.56 147.91 47.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.825 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -60.69 137.34 58.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.906 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 748' ' ' LEU . . . . . 0.465 HD21 ' CD1' ' A' ' 793' ' ' TRP . 12.4 mt -97.0 144.28 27.58 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.631 0.729 . . . . 0.0 110.884 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 163.57 37.82 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.716 2.277 . . . . 0.0 112.361 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -62.32 149.0 43.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.89 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.0 tt -103.08 148.61 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.129 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -85.22 135.28 34.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 5.7 m120 53.92 46.6 25.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . 0.465 ' CA ' ' O ' ' A' ' 772' ' ' GLN . . . 175.98 -169.15 41.72 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.462 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 15.0 p90 -156.54 171.78 19.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.816 0.341 . . . . 0.0 110.961 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 17.7 pttm -134.74 159.92 39.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.87 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 77.3 p -133.49 175.19 9.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 70.7 p -137.87 114.07 10.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.161 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 11.9 t -63.43 -58.24 7.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.85 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -88.02 155.26 19.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.815 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 42.2 p -55.08 -50.83 68.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.107 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.92 141.03 46.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.87 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 763' ' ' LEU . . . . . 0.482 ' O ' ' CA ' ' A' ' 744' ' ' GLY . 21.9 mt -69.47 75.96 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.941 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 26.9 m -108.38 175.24 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.155 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -41.88 136.63 1.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.861 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 88.1 -29.88 5.37 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.459 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -54.1 130.91 39.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.81 0.338 . . . . 0.0 111.143 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -121.51 150.06 42.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 6.8 mm -115.57 132.4 65.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.174 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 79.0 m -103.46 116.22 31.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.177 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -98.54 127.36 44.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.926 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 772' ' ' GLN . . . . . 0.465 ' O ' ' CA ' ' A' ' 754' ' ' GLY . 22.9 tp60 -122.5 137.84 54.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.896 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 64.9 m -115.83 172.05 7.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -60.57 157.06 39.43 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.625 0.726 . . . . 0.0 110.823 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.77 119.1 6.1 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.659 2.239 . . . . 0.0 112.31 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 117.96 -15.06 12.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.452 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -100.12 176.48 5.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 0.0 110.924 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -133.57 157.79 44.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 4.6 mt -97.96 139.29 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.122 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 780' ' ' VAL . . . . . 0.564 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 65.2 t -115.75 113.66 43.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.14 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 116.15 -143.01 17.92 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.535 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 12.6 m -97.99 103.13 15.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.873 0.368 . . . . 0.0 110.823 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -57.8 -52.99 63.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.878 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 784' ' ' THR . . . . . 0.402 ' C ' ' CD1' ' A' ' 785' ' ' LEU . 44.6 m -86.06 141.93 29.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.13 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 785' ' ' LEU . . . . . 0.402 ' CD1' ' C ' ' A' ' 784' ' ' THR . 7.6 mp -132.03 113.07 12.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.915 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 27.2 m -96.6 154.88 17.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.104 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 4.3 t -95.66 109.56 21.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -61.5 -176.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -69.99 -26.8 64.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.947 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -86.85 20.86 2.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 791' ' ' LEU . . . . . 0.416 HD13 ' N ' ' A' ' 744' ' ' GLY . 57.5 mt 51.92 44.64 29.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 30.1 t -130.5 156.11 45.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 793' ' ' TRP . . . . . 0.465 ' CD1' HD21 ' A' ' 748' ' ' LEU . 73.8 m95 -84.54 133.07 34.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 40.3 t -37.27 -48.83 0.91 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 8.6 t -157.9 174.62 14.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.801 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.98 156.51 3.45 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.612 0.72 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 145.37 57.16 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.654 2.236 . . . . 0.0 112.356 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -167.5 0.23 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.689 2.259 . . . . 0.0 112.354 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 799' ' ' PHE . . . . . 0.564 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 1.3 p90 -159.79 164.2 33.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 3.5 m -101.76 133.15 46.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -145.78 140.44 27.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.889 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.55 132.74 54.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 4.6 m -53.03 144.08 15.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.145 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 804' ' ' GLU . . . . . 0.443 ' O ' ' CD ' ' A' ' 804' ' ' GLU . 1.8 pp20? -104.18 36.67 2.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.941 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -75.08 159.22 31.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.918 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 22.8 t -108.93 118.22 36.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.86 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -128.46 -160.51 10.38 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.509 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -1.17 7.98 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.741 2.294 . . . . 0.0 112.305 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 10.6 m -126.25 115.02 19.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.841 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 10.7 t -59.19 114.04 2.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.891 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.506 -179.94 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.388 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 8.2 t -141.08 121.46 14.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.827 0.346 . . . . 0.0 110.895 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 3.7 m 48.65 43.71 20.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.843 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 73.04 110.09 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.468 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 78.1 p -76.23 -30.28 57.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 110.841 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 51.9 m -122.41 101.83 7.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.859 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . 129.1 164.29 11.45 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 57.3 m -53.99 152.22 6.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.822 0.344 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 22.9 t -90.48 165.19 13.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.862 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -59.59 159.09 8.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.876 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 13.7 mt -110.29 149.0 39.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.629 0.728 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 146.08 59.19 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.71 2.273 . . . . 0.0 112.358 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -54.96 141.12 35.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.907 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 1.9 tt -103.82 146.49 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.077 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -87.15 136.7 32.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.921 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 60.5 47.33 8.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 169.79 170.57 34.39 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.5 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 17.5 p90 -148.39 152.75 37.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.829 0.347 . . . . 0.0 110.93 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -96.71 168.94 10.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 5.0 t -161.14 119.66 2.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.147 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 3.9 t -146.19 133.3 20.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.172 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 4.5 m -92.96 47.03 1.25 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.849 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -124.5 97.66 5.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.888 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 24.0 p -43.99 -48.54 8.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -122.11 119.8 32.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 82.5 mt -59.17 102.18 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.901 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 31.6 m -125.65 172.09 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -47.52 128.17 12.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 98.92 -18.77 56.36 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.485 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -56.94 132.27 52.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.743 0.306 . . . . 0.0 111.09 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 768' ' ' ARG . . . . . 0.423 ' HD2' ' C ' ' A' ' 768' ' ' ARG . 3.9 tmm_? -128.13 132.78 48.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.881 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 63.7 mt -113.59 144.09 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.167 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 87.3 m -110.41 131.94 54.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.113 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -103.96 118.21 36.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -110.29 136.39 49.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.937 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 83.8 m -115.83 171.87 7.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -60.99 159.53 26.85 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.588 0.709 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 122.02 8.69 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.674 2.25 . . . . 0.0 112.337 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 113.76 -22.3 14.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.453 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 777' ' ' TYR . . . . . 0.404 ' CE2' ' HB2' ' A' ' 802' ' ' LYS . 18.6 m-85 -86.5 178.56 7.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.912 0.387 . . . . 0.0 110.902 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.75 135.33 26.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.866 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 3.6 mt -74.54 150.42 7.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 780' ' ' VAL . . . . . 0.556 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 89.6 t -128.49 108.82 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.094 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 123.67 -134.02 9.13 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.488 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 43.7 m -105.22 98.81 8.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.883 0.373 . . . . 0.0 110.879 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.72 -39.21 76.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.827 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 25.8 m -93.18 141.75 28.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.16 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 785' ' ' LEU . . . . . . . . . . . . . 9.4 mp -133.5 119.09 19.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 1.2 m -114.93 153.88 29.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.08 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 3.2 t -92.44 121.77 34.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.849 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -86.48 173.85 9.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 5.1 p90 -55.32 -17.07 4.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.927 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -94.13 23.05 5.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.82 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 23.1 mt 45.38 24.98 0.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.949 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.4 t -117.14 150.44 38.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 793' ' ' TRP . . . . . 0.404 ' O ' ' C ' ' A' ' 794' ' ' SER . 86.3 m95 -77.08 142.99 39.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.935 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 794' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 793' ' ' TRP . 40.5 t -37.66 -42.85 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.828 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 5.1 t -171.3 173.19 4.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -46.43 154.54 0.64 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.632 0.73 . . . . 0.0 110.884 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 145.79 58.7 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.695 2.263 . . . . 0.0 112.369 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 177.86 5.15 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.678 2.252 . . . . 0.0 112.39 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 799' ' ' PHE . . . . . 0.556 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 0.8 OUTLIER -142.95 166.64 24.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 11.9 m -102.48 124.48 48.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -118.75 133.09 56.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 802' ' ' LYS . . . . . 0.404 ' HB2' ' CE2' ' A' ' 777' ' ' TYR . 32.0 tttt -73.88 145.56 44.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 32.7 p -60.16 141.01 56.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.154 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -83.62 88.15 7.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -53.43 -61.44 2.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.932 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 1.7 t -106.09 -51.31 3.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . 70.74 -158.76 53.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.492 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 810' ' ' SER . 53.7 Cg_endo -69.73 -13.82 35.28 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.714 2.276 . . . . 0.0 112.311 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 7.8 t -54.2 87.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 810' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 808' ' ' PRO . 87.0 p -95.08 139.17 31.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.553 -179.973 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 4.7 m -49.52 130.66 20.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 110.868 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 15.3 t -89.61 55.45 3.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 157.09 81.35 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.44 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 84.0 p -136.06 139.04 42.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.9 0.381 . . . . 0.0 110.849 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 19.0 m -135.32 161.03 36.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.925 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 744' ' ' GLY . . . . . 0.402 ' CA ' HD21 ' A' ' 791' ' ' LEU . . . 136.17 -169.9 23.47 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.49 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 1.8 m -59.04 162.14 4.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.867 0.365 . . . . 0.0 110.869 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 23.5 p -92.08 144.74 25.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -38.27 150.13 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.866 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 14.8 mt -106.46 151.95 40.48 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.651 0.739 . . . . 0.0 110.925 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 141.29 44.57 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.657 2.238 . . . . 0.0 112.364 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -54.0 145.59 16.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 2.1 tt -100.95 147.73 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.111 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -90.83 139.51 30.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 50.41 41.64 25.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -177.37 -173.62 43.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.504 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -157.4 159.41 37.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.784 0.326 . . . . 0.0 110.949 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . 0.41 ' C ' ' HD2' ' A' ' 756' ' ' LYS . 0.0 OUTLIER -118.62 152.44 36.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.939 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 55.7 p -138.65 136.67 36.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.19 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 71.2 p -100.31 149.7 23.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.16 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 2.0 t -106.31 42.98 1.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.842 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -163.4 165.58 23.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 34.9 m -71.51 -43.72 65.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.124 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 764' ' ' VAL . 3.0 tm-20 -133.78 138.45 45.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.71 74.86 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.959 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' A' ' 762' ' ' GLU . 28.3 m -101.55 156.75 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 765' ' ' ARG . 25.4 mtm105 -34.73 139.52 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 87.75 -25.6 8.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -57.11 139.9 51.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.787 0.327 . . . . 0.0 111.095 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -115.08 157.36 23.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.904 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 769' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 770' ' ' THR . 34.0 mm -114.27 140.19 36.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.144 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 770' ' ' THR . . . . . 0.408 ' N ' HG23 ' A' ' 769' ' ' ILE . 89.1 m -113.52 119.5 37.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.181 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -97.68 121.67 39.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -121.34 124.7 45.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.93 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 62.9 m -110.51 174.35 5.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.46 157.48 35.69 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.592 0.711 . . . . 0.0 110.882 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 106.99 1.77 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.671 2.247 . . . . 0.0 112.337 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 131.87 -15.03 5.17 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.461 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -104.4 169.88 8.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.882 0.373 . . . . 0.0 110.919 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.12 160.78 30.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 8.7 mt -96.71 139.34 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.114 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 780' ' ' VAL . . . . . 0.505 ' HB ' ' CE1' ' A' ' 799' ' ' PHE . 72.0 t -114.0 106.43 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 125.82 -149.62 17.32 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.506 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 782' ' ' SER . . . . . 0.476 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 93.0 p -82.03 103.02 11.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.885 0.374 . . . . 0.0 110.842 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -57.14 -44.56 83.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 31.4 m -105.98 124.29 49.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.152 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 785' ' ' LEU . . . . . 0.476 ' CD1' ' O ' ' A' ' 782' ' ' SER . 10.7 mp -113.45 120.0 39.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.923 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 26.0 m -107.41 154.03 21.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.174 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 6.6 t -94.46 125.1 38.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.835 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -75.91 177.04 7.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 2.2 p90 -69.76 -19.06 63.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.964 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . 0.421 ' CG ' ' O ' ' A' ' 790' ' ' ASP . 23.2 t0 -96.24 23.65 6.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 791' ' ' LEU . . . . . 0.402 HD21 ' CA ' ' A' ' 744' ' ' GLY . 15.8 mt 51.21 35.8 14.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.91 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 49.4 m -120.77 135.56 55.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 793' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -72.22 147.11 46.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 5.0 t -48.54 -41.64 30.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.859 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 1.3 t -175.06 -178.72 1.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -54.32 147.06 29.21 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.599 0.714 . . . . 0.0 110.846 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 142.98 49.51 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.648 2.232 . . . . 0.0 112.349 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -164.73 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.695 2.263 . . . . 0.0 112.36 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 799' ' ' PHE . . . . . 0.505 ' CE1' ' HB ' ' A' ' 780' ' ' VAL . 18.6 p90 -161.9 173.95 13.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.882 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 3.4 m -103.07 136.14 43.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.913 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -146.99 131.53 17.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -50.84 124.85 12.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.925 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 803' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 804' ' ' GLU . 25.1 m -60.16 144.13 50.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.19 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 804' ' ' GLU . . . . . 0.438 ' N ' HG22 ' A' ' 803' ' ' THR . 0.1 OUTLIER -83.34 42.03 0.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -56.13 -58.48 7.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.829 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 8.4 t -96.23 95.61 8.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.847 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -133.32 -158.77 8.85 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.51 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -179.12 2.7 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.682 2.254 . . . . 0.0 112.322 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 22.0 p -134.07 155.33 50.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.897 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 3.2 m -156.83 105.93 2.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.887 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.466 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 3.3 t -82.23 141.63 32.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.887 0.375 . . . . 0.0 110.866 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 78.1 p -109.75 -27.19 9.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.826 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -100.6 178.5 28.79 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.482 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 40.6 t -137.7 135.5 36.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.831 0.348 . . . . 0.0 110.881 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 23.7 m -51.91 168.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 744' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 745' ' ' CYS . . . 104.4 149.41 19.75 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.524 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 745' ' ' CYS . . . . . 0.41 ' HB3' ' CE2' ' A' ' 793' ' ' TRP . 9.8 m -37.51 152.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 0.0 110.893 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 60.8 p -84.7 155.69 21.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -62.42 142.66 57.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 58.7 mt -90.43 149.4 40.91 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.624 0.726 . . . . 0.0 110.927 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 134.2 27.38 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.693 2.262 . . . . 0.0 112.347 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -42.35 146.63 0.31 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.911 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 2.7 tt -102.91 148.86 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -88.18 137.98 31.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 18.0 t30 51.97 43.15 30.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 178.08 176.62 46.19 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.477 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -149.31 179.03 8.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.805 0.336 . . . . 0.0 110.956 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.54 172.09 13.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.897 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 20.4 p -154.28 106.18 2.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 758' ' ' THR . . . . . 0.402 HG21 ' N ' ' A' ' 759' ' ' SER . 26.7 m -58.32 153.69 14.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.173 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 759' ' ' SER . . . . . 0.402 ' N ' HG21 ' A' ' 758' ' ' THR . 12.2 t -78.68 -48.53 14.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.849 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -108.33 147.82 30.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.897 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 95.6 m -53.44 -55.25 26.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -97.23 120.92 38.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 94.3 mt -54.92 101.53 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.965 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.89 152.43 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.083 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -41.22 131.16 2.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 98.76 -23.45 36.28 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -58.7 147.5 32.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.82 0.343 . . . . 0.0 111.047 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -135.46 145.09 46.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 769' ' ' ILE . . . . . 0.441 HD12 ' CH2' ' A' ' 793' ' ' TRP . 25.3 mt -120.0 142.96 33.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.148 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 3.5 t -109.4 153.47 23.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -119.41 129.6 54.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.913 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -125.8 122.4 36.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.96 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 60.2 m -106.55 174.07 6.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.5 158.98 26.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.642 0.734 . . . . 0.0 110.876 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 111.18 2.74 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.701 2.268 . . . . 0.0 112.332 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 126.98 -14.68 6.61 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.49 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -104.72 173.28 6.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.889 0.376 . . . . 0.0 110.96 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -134.6 147.75 50.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.837 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 779' ' ' ILE . . . . . 0.446 HG23 ' N ' ' A' ' 780' ' ' VAL . 24.1 mt -82.96 144.87 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.141 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 780' ' ' VAL . . . . . 0.547 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 58.3 t -118.15 105.87 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.162 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 125.11 -150.46 17.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.507 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 782' ' ' SER . . . . . 0.402 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 43.7 m -85.2 106.73 16.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 0.0 110.832 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -57.27 -49.16 76.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.855 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 21.0 m -102.12 126.79 49.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 785' ' ' LEU . . . . . 0.402 ' CD1' ' O ' ' A' ' 782' ' ' SER . 7.0 mp -113.61 111.01 21.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 32.6 m -94.37 159.4 15.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.163 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 7.0 t -96.93 117.59 31.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -75.5 175.37 8.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 11.6 p-90 -62.15 -21.87 65.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -88.98 20.61 3.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.884 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 23.3 mt 51.2 31.85 7.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 36.1 t -121.97 153.83 38.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 793' ' ' TRP . . . . . 0.441 ' CH2' HD12 ' A' ' 769' ' ' ILE . 88.6 m95 -83.99 140.73 31.7 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 794' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 793' ' ' TRP . 8.5 t -34.55 -44.83 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 8.6 t -173.03 173.03 3.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -44.93 151.04 0.67 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.586 0.708 . . . . 0.0 110.856 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 147.82 63.78 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.678 2.252 . . . . 0.0 112.39 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -163.87 0.12 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.697 2.265 . . . . 0.0 112.385 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 799' ' ' PHE . . . . . 0.547 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 3.9 p90 -160.6 170.24 21.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 19.9 m -104.21 119.41 38.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.876 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -128.19 126.16 40.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -51.42 141.69 15.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 80.8 p -39.92 144.21 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.103 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -98.01 129.35 44.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.855 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -90.9 58.07 3.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.877 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 4.0 m -99.16 147.88 24.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.847 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . 135.56 -97.65 0.28 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.481 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -25.98 28.32 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.637 2.225 . . . . 0.0 112.36 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 35.7 t -49.87 141.9 9.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.866 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 38.9 t -126.82 116.49 20.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.861 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.477 179.994 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 71.0 p -74.56 99.65 3.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.908 0.385 . . . . 0.0 110.832 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 20.1 m -75.23 117.38 16.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.887 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -90.14 49.75 3.3 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.465 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 27.5 t -95.57 121.9 37.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.368 . . . . 0.0 110.877 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 44.0 m -142.52 162.33 35.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.846 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . 129.83 164.38 11.37 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.489 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 745' ' ' CYS . . . . . 0.5 ' HB3' ' CE2' ' A' ' 793' ' ' TRP . 1.8 m -40.23 152.91 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.841 0.353 . . . . 0.0 110.886 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 27.1 m -79.79 140.46 36.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.82 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -44.11 141.0 1.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.867 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 43.7 mt -93.08 148.59 36.0 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.595 0.712 . . . . 0.0 110.932 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -174.09 0.84 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.697 2.265 . . . . 0.0 112.339 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -95.24 143.27 26.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.0 tt -100.72 144.37 12.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.077 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 19.7 mp0 -78.17 132.09 37.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.912 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 55.59 40.22 31.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -174.26 176.4 46.64 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.513 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 32.6 p90 -157.24 161.59 39.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.799 0.333 . . . . 0.0 110.916 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -108.84 159.01 17.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.902 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 56.5 p -148.62 120.3 8.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.143 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 4.5 t -134.74 131.38 37.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 89.7 p -67.34 -42.1 84.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -70.91 129.86 40.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 88.1 m -73.37 -66.85 0.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.108 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -72.94 107.94 5.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.908 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 78.4 mt -64.41 82.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 34.4 m -96.4 159.91 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -45.65 132.95 8.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 101.94 -39.99 2.57 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.485 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -46.77 157.58 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 111.114 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -123.99 172.93 8.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 8.2 mm -143.12 134.08 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 17.1 m -100.6 113.67 26.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.129 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -96.79 124.24 40.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.918 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -126.79 137.57 53.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 75.2 m -115.2 174.19 6.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.904 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -60.54 157.47 36.44 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.636 0.732 . . . . 0.0 110.829 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 112.93 3.21 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.665 2.243 . . . . 0.0 112.365 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 124.84 -22.23 6.47 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.484 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -95.32 178.24 5.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.896 0.379 . . . . 0.0 110.868 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -136.67 156.42 48.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.876 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 779' ' ' ILE . . . . . 0.466 HG21 ' N ' ' A' ' 780' ' ' VAL . 74.3 mt -98.69 135.26 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.14 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 780' ' ' VAL . . . . . 0.566 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 61.8 t -112.16 106.77 21.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.136 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 128.0 -149.0 17.97 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.448 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 21.9 m -83.06 107.47 15.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.866 0.365 . . . . 0.0 110.849 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.25 -46.17 90.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 25.6 m -101.93 122.11 43.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 785' ' ' LEU . . . . . . . . . . . . . 9.8 mp -103.3 114.46 28.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 786' ' ' THR . . . . . 0.431 HG22 ' N ' ' A' ' 787' ' ' CYS . 10.1 m -107.92 147.27 31.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.136 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 787' ' ' CYS . . . . . 0.431 ' N ' HG22 ' A' ' 786' ' ' THR . 8.8 t -92.51 137.55 32.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.847 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -87.97 169.4 12.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -56.0 -25.09 42.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -86.75 21.2 2.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.836 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 7.4 mt 51.22 37.47 18.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 90.4 p -122.38 136.41 54.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.825 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 793' ' ' TRP . . . . . 0.5 ' CE2' ' HB3' ' A' ' 745' ' ' CYS . 97.1 m95 -67.9 140.53 56.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.928 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 1.5 t -42.73 -48.62 5.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.899 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 8.4 t -168.78 173.82 6.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.855 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.97 151.16 4.72 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.576 0.703 . . . . 0.0 110.851 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 144.49 53.96 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.67 2.246 . . . . 0.0 112.345 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 -175.25 1.08 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.715 2.277 . . . . 0.0 112.332 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 799' ' ' PHE . . . . . 0.566 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.4 p90 -145.27 165.4 28.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 2.6 m -103.75 128.26 51.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -129.83 151.0 50.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 802' ' ' LYS . . . . . 0.421 ' C ' ' HD2' ' A' ' 802' ' ' LYS . 1.6 tmmm? -73.85 135.95 43.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 36.7 p -94.87 134.76 37.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.121 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -82.52 124.89 30.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -122.57 86.52 2.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 3.1 t 59.2 44.46 15.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.912 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -153.02 146.04 14.12 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.515 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 177.17 5.85 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.639 2.226 . . . . 0.0 112.36 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 80.2 p -153.91 165.33 36.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.855 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 35.6 p -128.13 123.91 35.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.248 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.464 -179.987 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 2.5 t -64.43 114.75 4.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.894 0.378 . . . . 0.0 110.884 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 19.6 t 66.49 41.05 3.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.873 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -94.02 -58.65 1.22 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.513 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 80.1 p -172.0 121.43 0.47 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.854 0.359 . . . . 0.0 110.871 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 5.8 m -93.35 30.98 1.57 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.846 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . 52.78 -163.81 1.94 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.474 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 9.1 m -78.98 155.03 29.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.817 0.342 . . . . 0.0 110.918 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 77.5 p -73.24 149.45 42.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.862 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -54.09 163.09 0.84 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 748' ' ' LEU . . . . . 0.444 ' CD1' HD12 ' A' ' 769' ' ' ILE . 11.7 mt -115.27 148.17 40.17 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.574 0.702 . . . . 0.0 110.932 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 144.28 53.42 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.726 2.284 . . . . 0.0 112.319 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -54.23 147.44 13.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 1.5 tt -105.17 144.1 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.093 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -89.04 145.47 25.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 47.3 47.9 16.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 179.96 179.96 48.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.461 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 47.3 p90 -154.96 154.23 32.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.839 0.352 . . . . 0.0 110.888 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -124.55 159.43 30.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.922 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 76.3 p -143.43 148.03 35.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.096 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 10.2 t -169.09 135.18 1.68 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.147 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 15.7 m -121.86 79.07 1.53 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.844 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 760' ' ' HIS . . . . . 0.462 ' CD2' ' HA ' ' A' ' 767' ' ' ALA . 25.6 m80 -132.04 -179.54 5.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.849 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 65.8 p -103.22 106.79 17.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.151 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 763' ' ' LEU . 16.0 mt-10 55.06 36.92 28.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 763' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 762' ' ' GLU . 7.8 mt 33.27 53.56 0.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.927 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 765' ' ' ARG . 33.1 m -86.11 175.68 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.12 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 764' ' ' VAL . 88.2 mtm180 -36.54 137.82 0.27 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 90.25 -31.55 5.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.486 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . 0.462 ' HA ' ' CD2' ' A' ' 760' ' ' HIS . . . -50.54 125.5 13.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.737 0.304 . . . . 0.0 111.116 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -119.41 140.87 49.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.867 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 769' ' ' ILE . . . . . 0.519 HD11 ' CH2' ' A' ' 793' ' ' TRP . 68.1 mt -121.92 142.0 40.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.121 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 770' ' ' THR . . . . . 0.426 ' N ' HG23 ' A' ' 769' ' ' ILE . 6.2 t -107.21 154.27 21.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.167 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -124.81 120.05 30.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -119.25 128.22 53.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.918 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 69.1 m -109.8 173.54 6.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -60.45 159.03 26.0 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.588 0.709 . . . . 0.0 110.858 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 121.12 7.81 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.711 2.274 . . . . 0.0 112.337 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 104.71 11.12 31.41 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -116.99 172.24 7.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.905 0.383 . . . . 0.0 110.881 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -126.95 155.17 43.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.848 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 5.3 mt -103.32 138.39 27.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.138 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 780' ' ' VAL . . . . . 0.554 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 56.3 t -114.51 107.98 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 129.53 -134.03 7.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.473 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 782' ' ' SER . . . . . 0.446 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 1.6 t -109.82 109.86 20.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.862 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -57.44 -37.33 72.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.845 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 16.7 m -108.84 134.28 51.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 785' ' ' LEU . . . . . 0.446 ' CD1' ' O ' ' A' ' 782' ' ' SER . 8.7 mp -127.11 120.31 28.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 16.6 m -111.07 160.79 16.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.107 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 16.5 t -94.46 135.39 35.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -91.62 177.56 6.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 3.0 p90 -73.03 -3.55 26.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -107.44 17.37 22.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.897 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 31.7 mt 57.6 28.66 15.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.8 t -123.24 148.65 45.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 793' ' ' TRP . . . . . 0.519 ' CH2' HD11 ' A' ' 769' ' ' ILE . 95.9 m95 -85.51 137.98 32.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.93 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 794' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 793' ' ' TRP . 37.9 t -34.8 -50.27 0.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.838 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 45.5 m -164.24 152.83 13.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -37.84 153.53 0.13 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.635 0.731 . . . . 0.0 110.863 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 145.84 57.94 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.676 2.251 . . . . 0.0 112.329 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -164.91 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.666 2.244 . . . . 0.0 112.397 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 799' ' ' PHE . . . . . 0.554 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.6 p90 -154.78 169.1 24.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.854 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 4.0 m -104.97 121.11 43.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.872 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -129.63 121.68 27.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -52.24 121.13 6.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 77.4 p -50.8 158.31 0.68 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.15 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -71.73 136.18 47.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -78.7 124.47 28.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 7.8 t -85.5 109.91 18.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.847 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -112.14 172.12 14.57 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.516 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 153.09 69.07 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.652 2.235 . . . . 0.0 112.287 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 84.6 p -74.88 -43.94 51.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.848 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 29.8 t -73.9 138.42 44.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.87 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.487 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 4.3 m -143.67 154.03 43.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 110.859 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 34.0 t -119.71 136.97 54.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.856 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 133.55 44.33 0.13 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.477 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 2.6 t -61.44 114.8 3.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.897 0.379 . . . . 0.0 110.855 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 40.1 t -144.25 169.81 17.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.814 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 744' ' ' GLY . . . . . 0.411 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . 129.1 151.55 7.41 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.533 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 2.0 m -59.75 154.77 17.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.862 0.363 . . . . 0.0 110.848 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 84.8 p -71.27 141.01 50.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -46.15 144.36 1.99 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.88 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 35.0 mt -92.11 144.93 29.88 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.597 0.713 . . . . 0.0 110.911 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 156.73 62.6 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.624 2.216 . . . . 0.0 112.325 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.32 147.03 53.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.0 tt -102.66 149.66 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.16 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -90.77 141.75 28.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 46.16 49.73 12.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 177.82 -173.67 46.23 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.45 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 755' ' ' TRP . . . . . 0.432 ' NE1' ' HB2' ' A' ' 772' ' ' GLN . 15.4 p90 -154.94 -177.94 6.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.852 0.358 . . . . 0.0 110.896 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.67 165.82 25.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 8.8 t -166.09 146.03 6.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 6.1 t -149.46 151.01 33.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.152 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 18.7 m -98.69 -50.53 4.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -41.06 157.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 44.9 p -54.78 -178.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.142 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -42.1 161.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 37.8 mt -53.73 100.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.955 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.99 177.47 7.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -52.78 108.11 0.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 103.32 10.41 36.31 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.458 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -65.63 140.24 58.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.793 0.33 . . . . 0.0 111.105 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -130.22 119.56 23.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 68.8 mt -116.53 144.9 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.136 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 770' ' ' THR . . . . . 0.421 HG21 ' N ' ' A' ' 771' ' ' TYR . 19.1 m -110.0 143.85 39.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.132 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 771' ' ' TYR . . . . . 0.421 ' N ' HG21 ' A' ' 770' ' ' THR . 52.1 m-85 -113.18 121.99 46.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.889 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 772' ' ' GLN . . . . . 0.432 ' HB2' ' NE1' ' A' ' 755' ' ' TRP . 22.1 mp0 -110.28 137.43 48.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.942 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 77.5 m -114.59 171.89 7.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.871 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 774' ' ' ASP . . . . . 0.454 ' HB2' ' CD1' ' A' ' 777' ' ' TYR . 0.3 OUTLIER -64.01 154.49 81.71 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.605 0.717 . . . . 0.0 110.832 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 96.03 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.679 2.253 . . . . 0.0 112.368 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 139.32 -5.53 2.96 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.465 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 777' ' ' TYR . . . . . 0.454 ' CD1' ' HB2' ' A' ' 774' ' ' ASP . 18.8 m-85 -106.23 179.26 4.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.868 0.366 . . . . 0.0 110.953 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 778' ' ' ASP . . . . . 0.402 ' CG ' HG23 ' A' ' 803' ' ' THR . 1.6 m-20 -134.61 146.08 49.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 11.0 mt -91.2 142.13 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.158 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 780' ' ' VAL . . . . . 0.569 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 50.9 t -120.83 108.64 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.111 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 127.21 -134.75 8.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 782' ' ' SER . . . . . 0.465 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 1.3 t -106.84 112.22 25.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.831 0.348 . . . . 0.0 110.877 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -61.17 -36.88 81.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.872 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 15.4 m -110.32 123.55 50.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.136 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 785' ' ' LEU . . . . . 0.465 ' CD1' ' O ' ' A' ' 782' ' ' SER . 7.3 mp -115.06 122.25 45.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.945 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 20.4 m -107.01 156.82 18.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.132 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 41.4 t -95.81 109.96 22.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.895 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -61.38 168.08 2.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -62.61 -17.77 60.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -94.02 19.91 8.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.848 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 791' ' ' LEU . . . . . 0.411 HD22 ' CA ' ' A' ' 744' ' ' GLY . 80.5 mt 54.14 37.45 27.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 13.4 m -132.4 123.26 26.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 793' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -58.09 133.45 55.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 15.2 t -37.27 -42.62 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 37.9 m -164.31 164.17 22.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.58 154.77 4.33 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.597 0.713 . . . . 0.0 110.858 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 144.82 55.21 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.656 2.237 . . . . 0.0 112.339 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -164.19 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.68 2.253 . . . . 0.0 112.324 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 799' ' ' PHE . . . . . 0.569 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.9 p90 -156.71 165.52 36.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.882 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 3.8 m -102.24 117.51 34.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -117.68 134.47 54.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.935 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -80.59 110.53 16.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 803' ' ' THR . . . . . 0.402 HG23 ' CG ' ' A' ' 778' ' ' ASP . 81.1 p -84.24 151.45 24.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.157 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -137.18 165.3 26.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -96.05 -44.84 7.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.843 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 36.4 m -43.87 163.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.849 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -130.03 -158.18 9.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.427 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 121.33 8.02 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.681 2.254 . . . . 0.0 112.341 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 54.4 p -103.51 147.19 27.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 12.3 t -97.07 -50.9 4.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.456 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 1.3 t -162.07 151.07 15.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.894 0.378 . . . . 0.0 110.826 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 50.2 m -69.09 106.57 2.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.854 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -73.66 -78.95 0.54 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.475 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 50.9 p -118.62 131.85 56.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.872 0.368 . . . . 0.0 110.854 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 52.8 m -120.22 44.13 2.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 744' ' ' GLY . . . . . 0.443 ' CA ' HD23 ' A' ' 791' ' ' LEU . . . 53.27 170.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.465 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 3.6 m -60.72 161.25 8.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.86 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 67.4 m -74.84 141.92 44.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -48.86 155.45 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 69.9 mt -105.1 149.05 37.19 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.635 0.731 . . . . 0.0 110.933 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 164.59 33.96 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.684 2.256 . . . . 0.0 112.329 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -73.89 142.08 46.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.5 tt -100.74 150.09 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -94.85 141.44 28.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 9.2 m120 54.29 43.34 30.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.856 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 167.67 -179.75 40.88 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.471 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -154.35 164.75 38.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.878 0.37 . . . . 0.0 110.914 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -101.38 156.69 17.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 45.3 p -134.57 97.48 3.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.127 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 12.1 t -131.04 45.0 2.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.114 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 88.9 p -84.41 43.81 0.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.865 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -99.25 -59.81 1.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.847 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 761' ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' ' 762' ' ' GLU . 6.8 m -160.55 146.5 15.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.128 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 761' ' ' THR . 30.5 mt-10 -35.03 136.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 69.4 mt -48.76 99.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.954 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 24.9 m -131.14 -179.09 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -60.2 127.63 32.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 95.67 -21.41 44.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.477 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -52.89 141.85 20.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.75 0.309 . . . . 0.0 111.094 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -123.01 140.88 52.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.897 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 769' ' ' ILE . . . . . 0.436 ' CG1' ' CH2' ' A' ' 793' ' ' TRP . 18.5 mm -106.32 148.84 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.162 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 95.6 m -121.04 113.56 20.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.148 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -97.39 124.16 41.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.969 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 43.5 tp60 -127.06 140.95 51.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.948 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 38.9 m -118.3 171.77 7.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.49 159.5 23.7 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.553 0.692 . . . . 0.0 110.888 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 104.29 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.678 2.252 . . . . 0.0 112.357 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 137.28 -19.1 3.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.494 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -100.59 177.04 5.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.0 110.887 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 778' ' ' ASP . . . . . 0.426 ' OD1' ' CG2' ' A' ' 803' ' ' THR . 1.5 m-20 -136.08 151.04 49.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.824 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 3.4 mt -88.81 137.5 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.107 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 780' ' ' VAL . . . . . 0.563 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 65.7 t -115.74 107.32 22.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.155 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 127.73 -140.57 11.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.497 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 782' ' ' SER . . . . . 0.432 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 3.8 m -105.56 102.23 11.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.879 0.371 . . . . 0.0 110.889 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.58 -53.25 59.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.895 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 33.0 m -83.47 132.8 34.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.132 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 785' ' ' LEU . . . . . 0.433 ' HB3' ' CE3' ' A' ' 793' ' ' TRP . 9.1 mp -127.03 125.37 41.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 1.8 m -106.36 148.13 28.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.139 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 21.4 t -93.87 115.23 27.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.905 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -71.0 169.58 14.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 789' ' ' TRP . . . . . 0.458 ' O ' ' CE3' ' A' ' 789' ' ' TRP . 10.3 p-90 -66.73 -7.37 20.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -100.58 15.77 26.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.875 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 791' ' ' LEU . . . . . 0.443 HD23 ' CA ' ' A' ' 744' ' ' GLY . 82.5 mt 56.25 31.31 18.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 38.3 m -126.58 128.88 47.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 793' ' ' TRP . . . . . 0.436 ' CH2' ' CG1' ' A' ' 769' ' ' ILE . 98.6 m95 -59.53 137.74 57.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 9.3 t -48.17 -39.48 20.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 78.1 p -155.46 167.73 29.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.59 156.54 32.06 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.59 0.709 . . . . 0.0 110.86 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 141.15 44.53 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.665 2.243 . . . . 0.0 112.403 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -168.15 0.26 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.69 2.26 . . . . 0.0 112.382 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 799' ' ' PHE . . . . . 0.563 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 9.1 p90 -160.0 170.87 20.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.85 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 12.0 m -102.52 145.8 29.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.875 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -148.02 134.13 19.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -68.69 127.35 32.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.871 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 803' ' ' THR . . . . . 0.426 ' CG2' ' OD1' ' A' ' 778' ' ' ASP . 37.4 p -52.4 127.59 22.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -71.42 117.44 12.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -108.57 -53.64 2.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.843 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 51.7 m -68.54 131.26 44.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -164.32 146.76 11.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.5 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -14.55 36.06 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.656 2.237 . . . . 0.0 112.365 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 80.3 p -97.12 155.34 16.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.824 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 2.7 m -113.42 -47.96 2.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.842 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.447 -179.972 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 88.7 p -89.01 99.34 12.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.883 0.373 . . . . 0.0 110.863 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 53.5 p -67.57 164.51 18.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.87 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 123.92 -59.58 0.62 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.477 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 53.2 p -60.94 159.96 10.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.852 0.358 . . . . 0.0 110.919 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 2.5 m -162.34 121.99 2.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.858 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . 168.33 175.18 37.74 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.485 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 2.2 m -47.72 154.25 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.847 0.356 . . . . 0.0 110.913 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 41.6 m -69.58 150.82 46.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -72.78 139.29 46.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.891 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 9.6 mt -94.31 146.63 31.9 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.671 0.748 . . . . 0.0 110.867 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -179.78 3.14 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.678 2.252 . . . . 0.0 112.379 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -79.75 142.93 34.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.2 tt -101.16 149.25 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.127 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -94.17 137.75 32.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 62.84 36.83 12.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.922 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 174.4 -177.42 46.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.498 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 755' ' ' TRP . . . . . 0.418 ' CD1' ' C ' ' A' ' 755' ' ' TRP . 2.4 p90 -156.02 169.36 24.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.858 0.361 . . . . 0.0 110.885 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -118.68 161.93 19.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 24.4 p -137.18 149.11 47.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.119 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 25.4 p -142.3 176.51 8.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.182 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 28.0 p -121.77 -67.27 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.833 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -64.2 147.72 51.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 75.7 p -67.46 -13.88 62.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.138 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.62 143.14 43.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 16.6 mt -84.4 101.02 11.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.924 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 27.2 m -111.16 176.01 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.105 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -48.27 138.07 10.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 88.16 -30.74 5.02 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.465 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -40.08 129.07 2.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 34.3 mtt85 -122.0 127.37 50.21 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.846 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 59.1 mt -104.85 148.87 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.141 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 55.7 m -118.31 125.53 50.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.177 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -96.74 132.89 41.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.955 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -126.0 121.89 34.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.973 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 82.9 m -103.86 174.45 5.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.84 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -60.42 156.91 38.7 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.592 0.71 . . . . 0.0 110.899 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 109.93 2.43 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.67 2.247 . . . . 0.0 112.41 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 127.64 -13.07 6.54 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.502 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -105.07 179.03 4.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.879 0.371 . . . . 0.0 110.937 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -139.91 152.06 46.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.825 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 779' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 780' ' ' VAL . 57.0 mt -89.67 135.55 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.193 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 780' ' ' VAL . . . . . 0.542 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 60.5 t -108.62 106.68 21.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 126.5 -147.68 16.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.484 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 54.1 p -84.62 103.05 13.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.0 110.874 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.8 -34.21 74.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 98.0 m -112.12 121.97 46.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 785' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.64 135.84 48.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 2.3 m -119.46 150.61 39.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 17.4 t -94.9 107.81 19.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -63.66 162.39 13.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -58.05 -17.04 15.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.38 20.32 12.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 74.3 mt 55.16 25.0 6.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.938 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 19.9 m -109.56 125.86 52.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 793' ' ' TRP . . . . . 0.416 ' O ' ' C ' ' A' ' 794' ' ' SER . 75.7 m95 -67.13 135.74 54.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 794' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 793' ' ' TRP . 4.3 t -36.93 -44.1 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 10.9 m -173.06 167.06 4.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.832 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -43.79 152.15 0.46 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.596 0.712 . . . . 0.0 110.898 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 146.37 60.46 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -167.55 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.685 2.257 . . . . 0.0 112.314 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 799' ' ' PHE . . . . . 0.542 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 1.1 p90 -154.62 170.27 21.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 14.7 m -101.95 127.96 48.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -139.88 126.12 20.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -49.17 140.18 9.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 14.7 m -51.72 165.86 0.16 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.131 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -94.4 109.06 20.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 39.98 49.01 2.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.846 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -43.16 -26.8 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.831 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -165.75 146.95 11.6 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.457 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 -37.79 8.86 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.731 2.287 . . . . 0.0 112.388 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 4.8 t 66.24 33.99 6.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.84 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 36.0 t -79.32 -56.07 4.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.479 179.991 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 2.4 m 43.05 48.34 5.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 0.0 110.857 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 5.0 t -70.5 132.27 45.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 69.86 91.65 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.48 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 5.4 t -66.35 104.13 1.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.951 0.405 . . . . 0.0 110.852 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 45.9 m -119.76 163.75 16.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.897 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 744' ' ' GLY . . . . . 0.469 ' CA ' HD23 ' A' ' 791' ' ' LEU . . . 137.65 160.2 8.46 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.493 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 9.9 m -45.16 163.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 110.873 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 79.1 p -91.71 163.22 14.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.893 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -61.35 158.72 13.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 46.0 mt -111.52 150.84 42.76 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.59 0.71 . . . . 0.0 110.871 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 157.57 59.95 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.678 2.252 . . . . 0.0 112.362 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.47 148.81 51.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.9 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 2.0 tt -109.06 150.8 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.1 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -103.25 140.61 37.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.933 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 7.4 m120 57.0 43.95 23.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 174.55 -179.94 45.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.537 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 16.5 p90 -156.93 161.19 39.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 110.965 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -116.26 168.27 10.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 18.8 p -130.08 113.34 14.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 56.8 p -109.25 114.3 27.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.139 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 94.7 p -107.27 38.68 2.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.864 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -143.8 119.25 10.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 67.7 p -38.62 -51.11 1.64 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.172 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -135.01 129.14 33.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 69.7 mt -58.87 101.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.922 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 34.5 m -112.27 -179.53 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.177 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -59.06 130.01 44.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.866 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 97.56 -35.25 4.6 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.507 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -52.72 145.13 12.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.819 0.342 . . . . 0.0 111.104 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -134.99 151.52 50.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.833 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 769' ' ' ILE . . . . . 0.418 HG23 ' N ' ' A' ' 770' ' ' THR . 29.3 mt -118.44 143.22 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.141 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 770' ' ' THR . . . . . 0.418 ' N ' HG23 ' A' ' 769' ' ' ILE . 98.5 m -104.98 124.03 48.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.143 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -96.95 128.87 44.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -124.62 145.11 49.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.912 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 100.0 m -124.12 174.28 7.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.89 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -60.78 158.28 33.54 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.607 0.717 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 112.84 3.19 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.66 2.24 . . . . 0.0 112.363 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 123.81 -16.28 7.84 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.509 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 777' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 802' ' ' LYS . 13.9 m-85 -104.01 178.66 4.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 0.0 110.939 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -137.9 155.93 48.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 46.9 mt -91.01 133.7 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.14 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 780' ' ' VAL . . . . . 0.57 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 74.2 t -108.69 111.51 36.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.167 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 124.87 -143.63 14.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.504 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 3.5 m -94.05 101.18 13.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.914 0.387 . . . . 0.0 110.909 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.04 -47.97 76.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.888 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 22.6 m -94.15 134.02 37.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.141 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 785' ' ' LEU . . . . . . . . . . . . . 7.9 mp -122.42 108.84 13.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.928 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 23.0 m -97.1 156.8 16.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 13.6 t -98.05 125.18 42.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -86.38 169.14 13.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.933 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 789' ' ' TRP . . . . . 0.442 ' CE2' ' OD1' ' A' ' 790' ' ' ASP . 5.9 p-90 -65.53 -8.49 19.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.938 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . 0.442 ' OD1' ' CE2' ' A' ' 789' ' ' TRP . 87.6 m-20 -100.93 23.29 10.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 791' ' ' LEU . . . . . 0.469 HD23 ' CA ' ' A' ' 744' ' ' GLY . 40.5 mt 50.26 42.75 26.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.902 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.6 t -134.7 149.89 50.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.85 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 793' ' ' TRP . . . . . 0.429 ' O ' ' C ' ' A' ' 794' ' ' SER . 94.3 m95 -86.02 144.53 27.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 794' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 793' ' ' TRP . 27.9 t -36.38 -40.77 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.838 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 1.7 t -172.29 -175.96 1.51 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.67 157.08 29.52 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.624 0.726 . . . . 0.0 110.832 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 141.11 44.07 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.667 2.244 . . . . 0.0 112.299 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -176.76 1.61 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.647 2.231 . . . . 0.0 112.361 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 799' ' ' PHE . . . . . 0.57 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 6.6 p90 -153.27 169.96 21.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 3.0 m -101.75 125.88 48.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.888 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -137.82 120.08 15.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 802' ' ' LYS . . . . . 0.406 ' HB2' ' CE2' ' A' ' 777' ' ' TYR . 6.2 ttpm? -53.59 114.35 1.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 27.6 m -83.9 153.85 23.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 33.8 mp0 -64.66 146.08 55.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -148.06 148.13 30.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 60.2 p -67.03 122.48 17.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . 144.99 -160.98 28.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.504 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 97.34 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.683 2.255 . . . . 0.0 112.338 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 15.5 p -143.54 176.74 8.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.807 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 77.4 p -162.86 148.39 12.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.854 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.52 179.992 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 5.5 t -65.51 -58.66 5.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.35 . . . . 0.0 110.878 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 87.3 p -115.74 174.04 6.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.858 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -141.11 54.01 0.64 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.465 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 3.0 m -107.69 129.54 55.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.87 0.367 . . . . 0.0 110.854 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 15.9 m -122.74 31.07 6.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.845 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . 48.66 -177.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.484 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 745' ' ' CYS . . . . . 0.405 ' SG ' ' C ' ' A' ' 791' ' ' LEU . 1.8 m -61.41 152.69 29.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.831 0.348 . . . . 0.0 110.854 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 2.9 m -73.81 166.85 22.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.811 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.39 152.21 38.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.884 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 15.1 mt -103.3 146.85 33.23 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.597 0.713 . . . . 0.0 110.909 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.7 162.65 41.22 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.716 2.278 . . . . 0.0 112.373 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.3 143.97 42.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 5.6 tt -100.69 151.11 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.126 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -94.18 140.49 29.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 28.9 t30 53.71 41.4 32.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -179.99 -176.92 47.75 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.488 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -153.13 159.09 42.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.833 0.349 . . . . 0.0 110.93 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.9 160.85 22.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 3.0 p -146.49 112.19 5.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.099 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 758' ' ' THR . . . . . 0.413 ' CG2' ' CD2' ' A' ' 763' ' ' LEU . 2.4 m -64.69 140.0 58.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.135 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 18.6 m -86.65 -58.14 2.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -81.21 134.58 35.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.882 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 88.6 m -41.87 -58.83 1.9 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -99.57 129.53 45.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.926 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 763' ' ' LEU . . . . . 0.413 ' CD2' ' CG2' ' A' ' 758' ' ' THR . 22.3 mt -71.81 69.0 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.899 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 35.6 m -103.51 158.87 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.133 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -41.83 122.72 2.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 112.25 -31.91 6.64 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.502 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -56.62 162.07 2.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.759 0.314 . . . . 0.0 111.144 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -131.2 146.86 52.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.871 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 5.3 mm -113.14 145.83 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.125 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 6.7 m -111.73 149.21 31.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.199 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -130.74 134.68 47.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.933 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -133.45 126.83 32.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 84.9 m -108.75 174.36 5.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.17 158.05 38.81 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.601 0.715 . . . . 0.0 110.872 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 106.95 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.733 2.289 . . . . 0.0 112.378 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 126.56 -10.92 7.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.474 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -106.77 167.54 9.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.865 0.364 . . . . 0.0 110.938 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -128.14 156.86 42.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.861 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 779' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 780' ' ' VAL . 75.8 mt -99.49 134.67 37.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.151 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 780' ' ' VAL . . . . . 0.561 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 93.7 t -106.35 107.8 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.073 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 132.56 -132.59 6.68 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.488 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 2.9 m -109.99 110.37 21.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.879 0.371 . . . . 0.0 110.871 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -58.22 -51.71 68.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.814 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 23.7 m -96.89 123.57 40.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 785' ' ' LEU . . . . . . . . . . . . . 8.7 mp -106.99 113.46 26.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 786' ' ' THR . . . . . 0.451 HG21 ' N ' ' A' ' 787' ' ' CYS . 26.3 m -101.32 144.59 29.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.146 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 787' ' ' CYS . . . . . 0.451 ' N ' HG21 ' A' ' 786' ' ' THR . 36.5 t -93.35 140.18 29.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -95.26 166.73 11.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -52.98 -19.37 2.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.936 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -88.82 22.77 2.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.825 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 791' ' ' LEU . . . . . 0.405 ' C ' ' SG ' ' A' ' 745' ' ' CYS . 18.6 mt 46.93 35.45 3.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.928 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 22.7 t -121.99 158.36 29.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.839 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 793' ' ' TRP . . . . . 0.419 ' O ' ' C ' ' A' ' 794' ' ' SER . 95.6 m95 -96.05 139.37 32.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 794' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 793' ' ' TRP . 6.6 t -36.8 -47.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.871 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 6.1 m -170.16 174.38 5.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.827 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -50.53 155.31 1.88 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.614 0.721 . . . . 0.0 110.842 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 146.21 59.28 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.715 2.277 . . . . 0.0 112.313 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 798' ' ' PRO . . . . . 0.437 ' HB2' ' CG2' ' A' ' 779' ' ' ILE . 53.9 Cg_endo -69.74 -166.99 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.679 2.253 . . . . 0.0 112.353 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 799' ' ' PHE . . . . . 0.561 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.6 p90 -154.96 165.59 36.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 9.1 m -101.63 128.0 48.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.9 143.99 47.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 28.8 tttp -68.14 141.78 55.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 27.1 m -62.73 152.99 34.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.13 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -82.11 111.45 18.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.86 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -87.75 120.34 28.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 4.5 t -62.3 145.19 54.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . 97.1 179.66 34.17 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.51 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -21.19 33.59 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.637 2.225 . . . . 0.0 112.327 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 4.2 m -40.78 110.88 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.848 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 6.0 t -136.05 154.47 51.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.505 -179.972 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.437 -0.265 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 64.6 m -137.26 162.36 33.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 0.0 110.83 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 2.3 t -151.26 155.84 39.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.87 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -61.73 -128.43 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.485 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 22.9 t -53.22 150.01 6.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.868 0.366 . . . . 0.0 110.842 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 58.5 p -110.01 156.26 20.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . 168.22 160.13 15.3 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 745' ' ' CYS . . . . . 0.443 ' HB3' ' CE2' ' A' ' 793' ' ' TRP . 1.8 m -44.84 154.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 0.0 110.863 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 17.7 m -64.53 137.4 57.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -55.58 155.34 5.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 12.4 mt -119.02 145.49 38.14 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.64 0.733 . . . . 0.0 110.884 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -177.43 1.86 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.674 2.249 . . . . 0.0 112.366 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -88.28 148.3 24.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 2.3 tt -101.98 148.67 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.121 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -86.54 142.35 28.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 3.0 m120 51.48 40.61 27.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -173.63 176.84 46.17 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.501 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 755' ' ' TRP . . . . . 0.446 ' CZ2' ' HG2' ' A' ' 772' ' ' GLN . 44.5 p90 -145.93 151.08 37.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.353 . . . . 0.0 110.897 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -118.98 153.38 34.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 23.3 p -123.29 152.38 41.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.155 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 38.4 p -125.61 167.09 15.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.156 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 75.4 m -103.29 127.07 50.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 760' ' ' HIS . . . . . 0.443 ' O ' ' N ' ' A' ' 762' ' ' GLU . 71.5 m-70 49.11 36.46 8.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 761' ' ' THR . . . . . 0.406 ' C ' ' O ' ' A' ' 760' ' ' HIS . 2.7 m 37.29 31.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.127 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 760' ' ' HIS . 14.2 mm-40 -146.24 119.74 9.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 38.0 mt -78.46 107.16 10.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.863 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.32 174.55 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.142 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -59.21 126.5 27.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 94.0 -17.01 59.62 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.513 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -60.61 140.16 57.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.782 0.325 . . . . 0.0 111.151 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 29.8 ptt85 -127.81 143.9 51.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 94.8 mt -107.37 129.95 60.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.108 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 84.3 m -96.3 120.68 37.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.113 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -98.5 118.21 34.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.925 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 772' ' ' GLN . . . . . 0.446 ' HG2' ' CZ2' ' A' ' 755' ' ' TRP . 3.9 tp-100 -113.32 141.44 47.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 74.1 m -119.37 173.47 6.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.46 158.16 31.35 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.589 0.709 . . . . 0.0 110.867 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 106.77 1.73 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.652 2.235 . . . . 0.0 112.351 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 123.26 0.79 9.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.477 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 777' ' ' TYR . . . . . 0.457 ' CE2' ' HB2' ' A' ' 802' ' ' LYS . 23.9 m-85 -115.21 170.17 8.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.848 0.356 . . . . 0.0 110.974 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 778' ' ' ASP . . . . . 0.437 ' OD2' ' CG2' ' A' ' 803' ' ' THR . 45.1 m-20 -129.71 154.76 46.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 779' ' ' ILE . . . . . 0.446 ' CG2' ' HB2' ' A' ' 798' ' ' PRO . 72.8 mt -97.17 134.62 34.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.142 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 780' ' ' VAL . . . . . 0.551 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 59.8 t -105.61 109.4 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 126.94 -145.12 15.55 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.477 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 782' ' ' SER . . . . . 0.448 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 58.4 m -91.84 96.53 10.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.861 0.362 . . . . 0.0 110.865 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -46.77 -43.76 18.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.857 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 6.2 m -106.34 141.24 37.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.168 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 785' ' ' LEU . . . . . 0.448 ' CD1' ' O ' ' A' ' 782' ' ' SER . 7.5 mp -126.33 110.13 13.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.937 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 7.0 m -94.43 152.39 18.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.109 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 13.8 t -93.15 118.8 31.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -71.98 179.47 3.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 3.2 m95 -71.11 -14.83 62.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -101.87 21.86 13.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.894 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 69.3 mt 53.59 26.17 5.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.929 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 4.4 m -113.69 122.71 47.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 793' ' ' TRP . . . . . 0.443 ' CE2' ' HB3' ' A' ' 745' ' ' CYS . 91.6 m95 -61.97 136.07 57.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.918 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 1.4 t -38.38 -44.34 0.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.804 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 58.3 m -161.3 -179.6 7.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -65.17 157.34 77.48 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.588 0.708 . . . . 0.0 110.864 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 140.73 43.11 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.648 2.232 . . . . 0.0 112.293 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 798' ' ' PRO . . . . . 0.446 ' HB2' ' CG2' ' A' ' 779' ' ' ILE . 54.1 Cg_endo -69.71 -164.28 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.675 2.25 . . . . 0.0 112.405 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 799' ' ' PHE . . . . . 0.551 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 6.1 p90 -156.13 173.19 17.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 35.4 m -101.96 137.96 39.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -143.66 142.58 31.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 802' ' ' LYS . . . . . 0.457 ' HB2' ' CE2' ' A' ' 777' ' ' TYR . 4.8 ttpm? -83.37 126.14 32.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 803' ' ' THR . . . . . 0.437 ' CG2' ' OD2' ' A' ' 778' ' ' ASP . 42.2 p -49.87 140.33 12.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.103 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -65.25 123.88 20.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -85.98 139.96 30.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 10.1 m -98.06 122.45 41.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . 113.63 -158.79 14.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.522 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.72 -176.41 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.693 2.262 . . . . 0.0 112.392 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 38.8 t -153.23 141.48 20.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 70.9 p -93.99 132.87 38.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.499 179.981 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 9.8 m -46.6 132.15 10.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.839 0.352 . . . . 0.0 110.849 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 5.8 m -120.71 165.5 15.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.841 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -173.12 154.04 19.6 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.465 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 32.7 m -112.45 -51.14 2.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.892 0.377 . . . . 0.0 110.855 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 64.4 m -127.73 152.95 47.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.846 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 744' ' ' GLY . . . . . 0.413 ' C ' HD21 ' A' ' 791' ' ' LEU . . . -160.73 177.54 37.09 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.497 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.9 171.37 0.51 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.364 . . . . 0.0 110.843 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 3.4 t -90.38 167.34 12.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -75.4 132.23 40.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.56 152.26 60.07 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.628 0.728 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 167.5 24.37 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.662 2.241 . . . . 0.0 112.296 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -74.87 145.67 42.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.6 tt -100.72 146.52 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.115 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -91.8 130.48 37.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.937 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 61.99 44.34 8.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 179.99 -173.99 45.47 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.453 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 45.6 p90 -157.78 170.13 23.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.799 0.333 . . . . 0.0 110.971 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -118.96 165.55 13.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.917 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 58.6 p -136.25 119.84 17.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.144 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 25.9 p -128.12 148.52 50.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.172 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 47.1 m -93.15 -49.69 5.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -100.32 113.36 26.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.86 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 56.7 p -38.06 -47.36 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.135 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -82.6 124.71 30.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 31.7 mt -86.25 106.18 17.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 35.1 m -107.86 -175.0 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . 0.401 ' CD ' ' HA ' ' A' ' 789' ' ' TRP . 73.7 mtm180 -68.99 134.71 49.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 95.96 -20.56 49.41 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.49 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -60.02 152.94 22.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.809 0.338 . . . . 0.0 111.092 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.62 136.65 43.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.855 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 769' ' ' ILE . . . . . 0.436 HG23 ' N ' ' A' ' 770' ' ' THR . 56.5 mt -114.48 135.99 52.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.118 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 770' ' ' THR . . . . . 0.436 ' N ' HG23 ' A' ' 769' ' ' ILE . 51.8 m -107.67 122.34 46.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.151 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -97.12 126.01 41.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -123.53 135.12 53.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 20.8 m -117.72 173.07 6.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -61.18 159.62 28.06 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.586 0.708 . . . . 0.0 110.852 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 114.98 3.88 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.683 2.255 . . . . 0.0 112.324 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 125.13 -25.2 5.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.468 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -90.83 170.35 10.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 0.0 110.926 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -129.15 154.62 46.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 10.9 mt -95.59 137.82 22.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 780' ' ' VAL . . . . . 0.555 ' HB ' ' CE1' ' A' ' 799' ' ' PHE . 58.3 t -114.45 110.38 31.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.128 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 128.33 -132.67 7.41 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.507 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.93 107.56 17.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 110.911 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.02 -34.94 63.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 23.7 m -109.39 136.12 49.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.159 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 785' ' ' LEU . . . . . . . . . . . . . 10.1 mp -126.71 118.61 25.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.93 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 1.2 m -105.83 151.98 23.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.16 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 48.6 t -95.41 108.82 21.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.86 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -62.0 175.67 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 789' ' ' TRP . . . . . 0.401 ' HA ' ' CD ' ' A' ' 765' ' ' ARG . 23.7 p-90 -73.3 -8.22 54.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -98.95 20.37 13.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 791' ' ' LEU . . . . . 0.413 HD21 ' C ' ' A' ' 744' ' ' GLY . 79.2 mt 54.28 32.9 17.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 73.6 m -131.34 135.65 47.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 793' ' ' TRP . . . . . 0.422 ' O ' ' C ' ' A' ' 794' ' ' SER . 93.4 m95 -73.85 136.66 43.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.919 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 794' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 793' ' ' TRP . 11.9 t -35.92 -47.06 0.5 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.829 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 58.5 p -159.12 165.43 33.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -53.78 157.86 3.69 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.617 0.722 . . . . 0.0 110.878 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 141.39 44.95 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.687 2.258 . . . . 0.0 112.342 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 -167.11 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 0.0 112.389 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 799' ' ' PHE . . . . . 0.555 ' CE1' ' HB ' ' A' ' 780' ' ' VAL . 8.1 p90 -153.33 169.19 23.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 2.8 m -103.33 122.31 44.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.874 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -122.51 147.94 45.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 20.1 tttp -80.21 128.24 33.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 70.8 p -56.81 162.71 2.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.139 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -143.8 148.68 35.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -94.27 -63.3 1.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.934 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 23.3 m -126.93 139.57 52.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.858 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -68.69 -175.8 11.05 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.467 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 102.43 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.688 2.258 . . . . 0.0 112.365 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 41.1 t -46.56 141.48 3.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.835 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 15.1 t -56.58 -46.63 80.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.841 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.503 -179.978 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 4.6 t -73.68 95.58 2.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.877 0.37 . . . . 0.0 110.878 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 2.7 m 49.89 43.64 25.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -116.29 62.06 0.39 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.475 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 55.4 p -52.25 140.51 21.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.883 0.373 . . . . 0.0 110.892 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 68.5 m -93.45 90.69 6.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.877 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . -164.71 164.63 37.03 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.492 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 1.8 m -48.09 158.37 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.878 0.37 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 3.3 m -80.89 148.38 29.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -48.41 159.46 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.879 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 748' ' ' LEU . . . . . 0.569 HD21 ' CD1' ' A' ' 793' ' ' TRP . 92.2 mt -118.24 146.72 40.06 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.662 0.744 . . . . 0.0 110.875 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 139.27 39.7 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.68 2.253 . . . . 0.0 112.31 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -46.81 156.68 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.84 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 1.6 tt -102.04 139.85 22.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.114 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -83.96 130.85 34.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 5.6 t30 55.45 45.02 26.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 177.94 -170.76 43.16 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.491 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 755' ' ' TRP . . . . . 0.45 ' CD1' ' C ' ' A' ' 755' ' ' TRP . 1.6 p90 -153.0 173.01 15.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.874 0.369 . . . . 0.0 110.9 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -135.07 172.0 13.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 3.4 t -164.59 149.66 9.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.138 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 61.2 p -119.42 143.02 47.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.134 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 27.2 t -82.66 -48.14 11.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -61.37 163.42 6.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.865 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 28.0 m -67.67 -45.87 74.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -133.1 165.68 24.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 74.3 mt -75.76 83.28 2.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 28.9 m -113.24 162.17 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.076 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 57.7 mtm-85 -40.94 145.27 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.927 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 82.38 -36.61 2.59 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.491 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -47.02 147.52 1.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.778 0.323 . . . . 0.0 111.076 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -124.85 164.67 19.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 769' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 770' ' ' THR . 35.1 mm -118.12 140.3 41.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.123 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 770' ' ' THR . . . . . 0.449 ' N ' HG23 ' A' ' 769' ' ' ILE . 90.8 m -109.93 125.51 52.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.072 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 771' ' ' TYR . . . . . 0.554 ' CE2' ' HD2' ' A' ' 798' ' ' PRO . 24.6 m-85 -107.69 142.86 37.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.95 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -146.91 123.58 11.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 63.7 m -108.89 174.51 5.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.35 161.51 13.46 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.655 0.74 . . . . 0.0 110.859 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 120.57 7.34 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.718 2.279 . . . . 0.0 112.287 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 118.84 -29.09 6.41 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.493 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 777' ' ' TYR . . . . . 0.566 ' CE2' ' HB2' ' A' ' 802' ' ' LYS . 28.9 m-85 -89.94 179.46 5.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.918 0.389 . . . . 0.0 110.926 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -142.3 154.57 44.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.847 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 779' ' ' ILE . . . . . 0.468 HG21 ' N ' ' A' ' 780' ' ' VAL . 75.9 mt -87.21 135.22 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.184 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 780' ' ' VAL . . . . . 0.561 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 66.5 t -103.06 105.0 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 126.03 -129.22 6.69 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.486 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 1.1 t -114.46 107.68 15.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.884 0.374 . . . . 0.0 110.86 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -55.19 -36.92 66.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 784' ' ' THR . . . . . 0.425 ' C ' HD13 ' A' ' 785' ' ' LEU . 33.3 m -101.27 139.39 37.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.139 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 785' ' ' LEU . . . . . 0.425 HD13 ' C ' ' A' ' 784' ' ' THR . 11.2 mp -130.37 111.81 12.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.943 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 786' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 787' ' ' CYS . 11.1 m -90.71 149.96 21.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.134 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 787' ' ' CYS . . . . . 0.412 ' N ' HG22 ' A' ' 786' ' ' THR . 9.3 t -93.23 107.48 19.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -57.79 -179.18 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.953 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 41.3 p-90 -72.44 -25.48 61.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.67 27.79 1.45 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.862 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 20.1 mt 49.67 40.83 20.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.8 t -130.98 147.14 52.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 793' ' ' TRP . . . . . 0.569 ' CD1' HD21 ' A' ' 748' ' ' LEU . 83.3 m95 -80.87 134.98 35.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.941 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 794' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 793' ' ' TRP . 2.3 m -34.74 -47.34 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.824 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 79.4 p -159.98 165.41 32.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.831 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -44.6 152.96 0.49 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.609 0.719 . . . . 0.0 110.841 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 146.69 60.94 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.661 2.241 . . . . 0.0 112.354 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 798' ' ' PRO . . . . . 0.554 ' HD2' ' CE2' ' A' ' 771' ' ' TYR . 53.6 Cg_endo -69.71 -169.31 0.32 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.687 2.258 . . . . 0.0 112.392 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 799' ' ' PHE . . . . . 0.561 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 4.9 p90 -157.76 172.74 17.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.875 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 7.2 m -101.96 136.14 42.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -146.71 135.7 22.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 802' ' ' LYS . . . . . 0.566 ' HB2' ' CE2' ' A' ' 777' ' ' TYR . 44.5 tttm -67.56 118.28 10.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.944 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 22.3 p -85.72 164.68 17.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.152 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -47.83 138.71 8.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -86.72 -24.61 25.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 11.2 t 49.17 49.18 20.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -98.21 -163.26 30.79 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.498 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 -13.38 34.56 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.656 2.237 . . . . 0.0 112.339 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 13.7 t -86.92 101.34 13.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 810' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 811' ' ' GLY . 3.8 m -105.84 146.2 30.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 811' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 810' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.495 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 4.5 t -69.5 88.35 0.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 0.0 110.823 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 39.0 t -118.32 147.8 43.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 145.28 125.87 1.81 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.512 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 79.1 p -88.06 -44.23 11.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.88 0.371 . . . . 0.0 110.864 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 6.1 m -53.22 152.93 4.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.88 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 744' ' ' GLY . . . . . 0.46 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . 171.18 145.17 4.69 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.501 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 3.9 m -40.54 154.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 110.895 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 4.4 m -75.9 147.38 39.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.22 117.89 6.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.84 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 10.2 mt -70.62 149.34 95.4 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.598 0.713 . . . . 0.0 110.895 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 159.92 51.61 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.666 2.244 . . . . 0.0 112.342 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.08 149.95 43.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.7 tt -100.65 148.54 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.121 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -93.41 123.42 36.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.945 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 70.08 41.68 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.883 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 177.54 -174.24 46.77 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.494 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 3.2 p90 -151.35 166.11 32.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.835 0.35 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.24 156.2 43.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 49.2 p -133.33 125.44 29.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 73.7 p -81.34 171.09 15.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 47.6 m -100.22 -66.6 0.9 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.867 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -98.6 171.88 7.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.839 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 2.9 t -72.33 -3.54 24.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.153 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 764' ' ' VAL . 18.2 mt-10 -144.48 124.81 13.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.911 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 65.8 mt -64.97 74.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 762' ' ' GLU . 24.0 m -87.89 162.13 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 765' ' ' ARG . 25.9 mtm105 -51.75 132.88 31.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 99.52 -25.4 28.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.461 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -62.81 131.52 49.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 0.0 111.102 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 19.6 ptt-85 -111.23 147.47 34.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 8.9 mm -104.13 139.98 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.121 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 22.8 m -104.69 119.72 39.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.142 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -104.19 130.45 51.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -135.41 132.48 37.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 39.9 m -112.56 171.81 7.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -60.48 160.63 17.38 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.629 0.728 . . . . 0.0 110.865 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 107.98 1.99 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.663 2.242 . . . . 0.0 112.359 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 133.43 -24.42 3.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.436 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -92.72 170.73 9.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.876 0.37 . . . . 0.0 110.948 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -130.86 155.63 46.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.852 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 11.5 mt -91.68 141.62 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.165 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 780' ' ' VAL . . . . . 0.495 HG12 ' CZ ' ' A' ' 799' ' ' PHE . 58.4 t -116.15 106.6 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 124.61 -126.38 6.04 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 782' ' ' SER . . . . . 0.478 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 1.3 t -113.52 108.09 16.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.916 0.389 . . . . 0.0 110.871 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.7 -33.87 66.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.904 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 9.9 m -111.61 129.22 56.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.123 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 785' ' ' LEU . . . . . 0.478 ' CD1' ' O ' ' A' ' 782' ' ' SER . 8.8 mp -121.45 118.81 30.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.898 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 51.8 m -96.65 152.59 18.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.087 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 20.0 t -95.63 112.05 23.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -65.41 170.97 4.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.949 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -69.36 -6.58 30.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -105.95 24.28 12.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.844 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 791' ' ' LEU . . . . . 0.46 HD22 ' CA ' ' A' ' 744' ' ' GLY . 34.5 mt 50.5 33.52 8.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.887 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 6.8 m -128.31 123.13 33.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 793' ' ' TRP . . . . . 0.429 ' O ' ' C ' ' A' ' 794' ' ' SER . 86.9 m95 -66.17 137.2 56.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.958 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 794' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 793' ' ' TRP . 23.0 t -35.67 -50.56 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.814 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 38.8 p -154.96 165.17 37.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.866 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -51.1 156.74 1.69 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.568 0.699 . . . . 0.0 110.884 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 141.81 46.2 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.663 2.242 . . . . 0.0 112.343 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -164.07 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.679 2.252 . . . . 0.0 112.321 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 799' ' ' PHE . . . . . 0.495 ' CZ ' HG12 ' A' ' 780' ' ' VAL . 6.7 p90 -158.56 172.28 18.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 2.7 m -101.7 138.36 38.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -146.72 150.04 34.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -65.36 119.53 11.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 10.1 m -65.13 147.77 52.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.164 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -105.45 136.34 45.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -123.57 -54.0 1.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 25.0 p -111.57 162.29 15.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -78.76 146.18 29.53 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.473 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 119.0 6.02 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.66 2.24 . . . . 0.0 112.377 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 43.5 t -97.13 78.8 2.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.821 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 9.5 t -127.98 178.13 6.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.907 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.447 179.948 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 66.2 m -68.08 172.99 4.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.924 0.392 . . . . 0.0 110.841 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 3.5 m -125.5 104.37 8.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.834 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 57.01 49.69 69.75 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.483 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 4.4 m -93.8 160.71 14.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.868 0.366 . . . . 0.0 110.873 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 92.0 p -97.54 102.61 14.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.846 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 744' ' ' GLY . . . . . 0.456 ' CA ' HD23 ' A' ' 791' ' ' LEU . . . 172.96 140.34 3.12 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.475 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 5.1 m -40.55 155.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.858 0.361 . . . . 0.0 110.867 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 2.8 m -78.5 133.45 37.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -44.53 140.62 2.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 748' ' ' LEU . . . . . 0.463 ' CD2' HD12 ' A' ' 769' ' ' ILE . 4.0 mm? -76.47 148.18 79.86 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.598 0.713 . . . . 0.0 110.932 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.63 168.74 20.51 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.677 2.251 . . . . 0.0 112.38 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -74.31 135.75 42.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 1.4 tt -108.05 141.78 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.15 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -83.1 146.84 28.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.939 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 42.44 48.67 4.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 176.74 172.56 41.5 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.477 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 45.5 p90 -153.88 152.55 30.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.81 0.338 . . . . 0.0 110.901 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -109.42 164.26 12.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -159.45 153.18 22.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.098 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -157.32 131.9 8.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.107 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 4.1 t -56.1 -63.26 1.24 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.884 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -54.6 101.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.831 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 45.2 m -52.65 -56.68 13.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.149 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -77.18 105.87 8.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 65.3 mt -58.16 94.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.942 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 29.3 m -120.62 174.06 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 49.6 mtm180 -46.78 133.97 10.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.92 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 767' ' ' ALA . . . 91.48 -34.37 4.36 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.515 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 766' ' ' GLY . . . -38.02 131.8 1.05 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 0.0 111.027 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 768' ' ' ARG . . . . . 0.447 ' CG ' HG21 ' A' ' 784' ' ' THR . 7.3 tmm_? -117.04 130.86 56.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.872 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 769' ' ' ILE . . . . . 0.463 HD12 ' CD2' ' A' ' 748' ' ' LEU . 56.9 mt -112.64 141.09 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.18 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 5.7 t -111.53 152.9 26.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.167 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -120.49 116.95 26.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.913 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -110.83 124.43 52.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.942 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 77.4 m -109.21 174.22 5.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -60.43 153.08 62.03 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.665 0.745 . . . . 0.0 110.856 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 93.97 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.708 2.272 . . . . 0.0 112.357 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 140.78 -9.82 2.85 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.535 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -100.91 176.31 5.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.885 0.374 . . . . 0.0 110.947 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -128.57 159.53 35.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.865 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 4.4 mt -104.44 143.34 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 780' ' ' VAL . . . . . 0.561 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 86.4 t -124.04 108.93 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.095 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 128.42 -135.82 8.78 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.493 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 3.0 m -107.29 98.99 8.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.371 . . . . 0.0 110.908 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.57 -48.8 57.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.857 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 784' ' ' THR . . . . . 0.447 HG21 ' CG ' ' A' ' 768' ' ' ARG . 87.5 m -95.42 135.54 36.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.15 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 785' ' ' LEU . . . . . 0.413 HD11 ' C ' ' A' ' 784' ' ' THR . 7.6 mp -122.19 122.35 38.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.96 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 8.1 m -109.5 150.62 27.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.154 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 6.6 t -95.06 120.44 35.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -81.67 -176.69 6.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.938 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -68.72 -16.87 63.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.8 16.14 16.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.862 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 791' ' ' LEU . . . . . 0.456 HD23 ' CA ' ' A' ' 744' ' ' GLY . 68.4 mt 53.99 25.13 5.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.946 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 44.0 m -115.35 131.38 56.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 793' ' ' TRP . . . . . 0.401 ' O ' ' C ' ' A' ' 794' ' ' SER . 83.5 m95 -63.05 137.84 58.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 794' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 793' ' ' TRP . 9.4 t -37.87 -47.2 1.02 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 68.0 m -156.74 161.99 39.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.866 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -46.4 158.97 0.36 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.59 0.709 . . . . 0.0 110.854 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 140.74 43.08 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.673 2.249 . . . . 0.0 112.293 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -169.77 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.671 2.247 . . . . 0.0 112.37 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 799' ' ' PHE . . . . . 0.561 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 4.1 p90 -159.29 167.41 29.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 3.0 m -103.55 138.51 40.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -141.3 112.79 7.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -44.96 132.61 6.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.908 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 74.4 p -80.21 172.67 13.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.117 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -133.77 121.05 21.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -100.96 -43.69 5.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 50.5 m -159.16 164.98 34.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.841 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -170.72 -97.63 0.11 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.456 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 120.81 7.54 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.718 2.279 . . . . 0.0 112.32 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 3.7 m -92.93 -48.22 6.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.832 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 4.0 m -110.25 97.6 7.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.856 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.524 179.975 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.484 -0.247 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 87.7 p -103.8 -13.32 16.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.903 0.382 . . . . 0.0 110.899 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 7.9 t -120.57 154.19 35.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.899 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -131.9 -113.35 1.5 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.461 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 84.7 p -81.33 114.88 20.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.95 0.405 . . . . 0.0 110.838 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 24.0 m -163.22 129.6 3.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.855 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . 159.51 -167.77 35.22 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.489 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 3.6 m -45.39 152.22 0.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.881 0.372 . . . . 0.0 110.859 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 68.4 m -75.91 146.24 39.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -56.26 130.31 43.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 12.4 mt -79.45 149.23 71.64 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.606 0.717 . . . . 0.0 110.895 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 165.1 32.16 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.726 2.284 . . . . 0.0 112.312 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -73.67 144.52 45.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 6.7 tt -100.57 151.86 5.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.127 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -97.45 124.44 41.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 67.17 39.41 3.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -173.41 177.54 45.75 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.465 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -158.34 156.72 31.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.815 0.34 . . . . 0.0 110.935 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -98.24 165.14 12.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 81.0 p -124.65 40.61 3.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.123 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 758' ' ' THR . . . . . 0.471 HG22 ' CE1' ' A' ' 760' ' ' HIS . 47.7 m -57.13 102.81 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.121 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 83.2 p -82.75 -1.43 51.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.846 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 760' ' ' HIS . . . . . 0.471 ' CE1' HG22 ' A' ' 758' ' ' THR . 17.8 p-80 -107.85 122.3 46.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 82.5 p -62.61 -54.58 37.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.122 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.39 119.17 38.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 10.5 mt -64.34 107.94 1.47 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.914 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 27.7 m -112.77 155.78 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.122 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -48.84 116.09 1.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 112.61 -26.38 10.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.509 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -45.85 129.07 9.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.774 0.321 . . . . 0.0 111.147 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -115.17 120.79 40.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.861 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 769' ' ' ILE . . . . . 0.554 HD12 ' CH2' ' A' ' 793' ' ' TRP . 52.3 mt -102.18 150.33 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.129 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 50.1 m -124.06 128.09 48.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.147 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -98.56 136.92 37.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -129.7 129.95 44.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 35.0 m -110.42 173.4 6.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.78 161.14 23.0 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.575 0.703 . . . . 0.0 110.84 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 117.5 5.12 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.656 2.237 . . . . 0.0 112.315 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 121.92 -22.52 7.62 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.479 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -96.55 172.83 7.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.877 0.37 . . . . 0.0 110.935 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -137.47 149.79 47.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.836 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 779' ' ' ILE . . . . . 0.44 HG23 ' N ' ' A' ' 780' ' ' VAL . 66.8 mt -88.11 134.26 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.118 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 780' ' ' VAL . . . . . 0.555 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 63.6 t -108.25 108.23 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.12 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 124.45 -156.56 18.56 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.48 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 58.2 m -76.87 95.44 4.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.868 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -49.36 -55.2 13.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.861 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 87.4 m -92.27 142.19 27.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.076 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 785' ' ' LEU . . . . . . . . . . . . . 8.2 mp -128.04 143.09 51.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 55.8 m -128.42 151.99 48.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.144 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 14.4 t -94.6 107.08 19.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -61.15 -179.95 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -69.61 -20.27 63.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.871 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -91.92 23.71 3.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.866 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 39.3 mt 51.02 29.55 4.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.8 t -117.9 147.34 43.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.825 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 793' ' ' TRP . . . . . 0.554 ' CH2' HD12 ' A' ' 769' ' ' ILE . 95.0 m95 -83.78 134.63 34.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.881 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 794' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 793' ' ' TRP . 2.3 t -34.47 -50.51 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 97.7 p -162.07 168.45 22.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.836 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.21 153.14 0.95 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.619 0.723 . . . . 0.0 110.822 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 148.07 64.37 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.707 2.271 . . . . 0.0 112.345 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -167.77 0.24 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.699 2.266 . . . . 0.0 112.339 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 799' ' ' PHE . . . . . 0.555 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 1.6 p90 -157.67 164.61 37.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 5.4 m -102.93 113.49 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -126.6 126.13 43.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -57.76 122.47 12.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 57.0 m -85.38 146.77 26.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.102 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -42.26 161.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.903 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.33 90.4 8.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.902 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 1.4 t -40.34 113.97 0.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . 148.28 -167.48 29.03 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.49 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 87.66 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.627 2.218 . . . . 0.0 112.359 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 2.9 t -100.16 86.09 3.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 53.4 p -70.15 166.92 18.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.865 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.498 -179.998 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 1.9 t -54.24 128.63 32.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 0.0 110.871 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 15.7 m -65.37 127.69 32.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.823 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 74.29 158.52 5.92 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 11.2 t -132.91 -45.07 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 0.0 110.876 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 743' ' ' SER . . . . . 0.44 ' O ' ' CG1' ' A' ' 764' ' ' VAL . 96.8 p -90.82 161.24 15.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . 178.84 158.11 20.69 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.484 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 7.1 m -48.8 152.63 0.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.809 0.337 . . . . 0.0 110.879 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 32.4 m -72.96 156.69 38.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.817 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.93 131.96 45.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.831 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 12.2 mt -79.93 148.66 68.83 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.566 0.698 . . . . 0.0 110.928 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 175.47 8.01 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.705 2.27 . . . . 0.0 112.36 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -77.93 149.41 34.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 2.0 tt -106.52 145.76 13.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.129 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -89.8 132.27 35.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 4.7 m120 59.92 44.59 13.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.854 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 178.17 179.72 48.24 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.488 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 755' ' ' TRP . . . . . 0.462 ' CZ2' ' HG2' ' A' ' 772' ' ' GLN . 19.0 p90 -156.06 168.56 26.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.834 0.35 . . . . 0.0 110.94 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.91 165.67 14.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.91 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 51.4 p -146.25 134.62 21.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.112 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 80.7 p -139.61 148.19 42.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.159 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 10.1 m -96.9 -46.82 6.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -69.92 177.89 2.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 90.7 m -113.03 -49.96 2.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.162 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -80.15 128.46 33.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 55.8 mt -84.28 46.76 1.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . 0.44 ' CG1' ' O ' ' A' ' 743' ' ' SER . 23.7 m -84.99 -175.92 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.154 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -53.35 130.68 35.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 103.12 -32.96 6.99 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -50.48 125.14 12.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.755 0.312 . . . . 0.0 111.144 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 768' ' ' ARG . . . . . 0.438 ' HG2' ' CG2' ' A' ' 784' ' ' THR . 8.9 ttp-105 -116.52 145.56 43.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.862 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 769' ' ' ILE . . . . . 0.549 HD11 ' CH2' ' A' ' 793' ' ' TRP . 39.4 mt -123.89 140.45 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.11 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 18.7 m -108.5 123.01 48.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.147 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -99.67 121.37 41.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.911 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 772' ' ' GLN . . . . . 0.462 ' HG2' ' CZ2' ' A' ' 755' ' ' TRP . 4.3 tp-100 -118.09 143.54 46.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.857 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 73.6 m -124.36 171.1 10.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -62.06 159.68 35.9 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.578 0.704 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 119.66 6.57 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.725 2.283 . . . . 0.0 112.311 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 117.77 -20.21 10.97 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.481 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -96.3 179.31 5.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.882 0.372 . . . . 0.0 110.953 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -141.92 150.41 41.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.847 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 5.6 mt -87.58 144.96 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 780' ' ' VAL . . . . . 0.55 ' HB ' ' CE1' ' A' ' 799' ' ' PHE . 75.3 t -120.69 106.14 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.125 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 126.65 -132.62 7.77 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 3.0 m -101.75 88.34 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.888 0.375 . . . . 0.0 110.891 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -41.65 -33.73 0.51 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.875 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 784' ' ' THR . . . . . 0.438 ' CG2' ' HG2' ' A' ' 768' ' ' ARG . 16.7 m -114.7 142.8 46.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 785' ' ' LEU . . . . . 0.449 HD11 ' N ' ' A' ' 785' ' ' LEU . 9.6 mp -126.64 144.92 50.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 1.9 m -138.18 157.43 46.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.199 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 8.1 t -92.62 118.12 30.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.828 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -77.34 171.85 14.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 1.6 m-90 -59.52 -12.9 7.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -98.0 25.1 6.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 90.3 mt 48.08 25.76 0.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.4 t -121.35 147.34 45.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.84 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 793' ' ' TRP . . . . . 0.549 ' CH2' HD11 ' A' ' 769' ' ' ILE . 98.0 m95 -77.79 141.15 39.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.958 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 794' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 793' ' ' TRP . 36.4 t -34.52 -46.41 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 19.4 p -173.11 170.72 4.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.12 151.54 0.2 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.593 0.711 . . . . 0.0 110.862 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 143.95 52.46 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.626 2.218 . . . . 0.0 112.367 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 798' ' ' PRO . . . . . 0.408 ' HD3' ' CD1' ' A' ' 785' ' ' LEU . 54.0 Cg_endo -69.75 177.51 5.5 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.696 2.264 . . . . 0.0 112.331 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 799' ' ' PHE . . . . . 0.55 ' CE1' ' HB ' ' A' ' 780' ' ' VAL . 10.0 p90 -149.55 172.55 14.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 12.6 m -102.79 129.51 49.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -129.68 129.66 44.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -59.81 136.73 58.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.896 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 5.3 t -65.17 168.89 6.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.133 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -104.81 164.39 11.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.928 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -147.39 130.81 16.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 3.0 t -93.04 116.41 29.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.855 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . 137.54 147.17 5.21 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.511 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 179.17 3.89 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.656 2.238 . . . . 0.0 112.364 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 85.0 p -113.05 122.64 48.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.871 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 4.0 m -112.32 -54.79 2.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.857 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.462 179.997 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 17.4 m -140.54 176.49 8.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 110.836 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 47.1 p -44.05 -55.11 4.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.829 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 135.95 47.59 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.506 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 55.9 p -93.1 144.37 25.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.868 0.366 . . . . 0.0 110.868 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 66.5 m -141.38 120.22 12.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.843 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . -92.79 -150.02 25.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.486 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 1.8 m -48.29 171.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.348 . . . . 0.0 110.885 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 56.9 p -100.55 140.7 34.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -46.25 144.01 2.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 16.3 mt -94.85 151.09 38.75 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.619 0.723 . . . . 0.0 110.94 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 151.45 68.99 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.67 2.246 . . . . 0.0 112.349 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -62.97 143.32 57.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 6.7 tt -100.54 153.24 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -97.39 128.42 44.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 61.92 41.3 11.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -173.46 176.21 46.12 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.458 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -152.22 170.52 19.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.827 0.346 . . . . 0.0 110.931 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 756' ' ' LYS . . . . . 0.465 ' HE3' ' CG2' ' A' ' 769' ' ' ILE . 9.9 ptmt -130.51 168.43 17.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 40.1 p -126.06 142.91 51.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.129 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 59.3 p -125.82 133.76 51.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.136 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 1.1 t -96.34 -55.53 2.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -81.64 131.96 35.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.855 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 8.9 t -43.38 -44.37 5.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.115 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -118.87 142.99 47.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.92 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 77.6 mt -67.79 93.69 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.929 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 29.4 m -105.55 154.94 6.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.098 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -43.43 124.79 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 105.23 -25.22 25.65 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.485 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -53.88 137.9 37.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 111.084 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -121.95 130.47 53.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 769' ' ' ILE . . . . . 0.465 ' CG2' ' HE3' ' A' ' 756' ' ' LYS . 69.1 mt -110.68 131.93 60.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 31.1 m -99.01 130.78 45.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.147 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -98.57 120.19 38.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.937 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -117.83 124.21 47.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.917 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 72.1 m -107.55 173.39 6.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.66 157.49 37.62 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.6 0.714 . . . . 0.0 110.888 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 111.3 2.78 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.653 2.236 . . . . 0.0 112.371 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 125.13 -19.84 6.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.473 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -97.75 168.52 10.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.863 0.364 . . . . 0.0 110.932 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -125.72 162.93 23.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.869 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 779' ' ' ILE . . . . . 0.467 HG22 ' N ' ' A' ' 780' ' ' VAL . 65.4 mt -103.8 135.13 42.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 780' ' ' VAL . . . . . 0.528 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 61.7 t -112.34 107.52 23.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.12 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 127.99 -150.32 18.35 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.449 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 5.2 p -81.28 105.29 12.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.857 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.66 -50.48 73.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 30.7 m -102.47 121.24 41.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.174 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 785' ' ' LEU . . . . . . . . . . . . . 7.8 mp -106.91 148.68 28.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 37.8 m -137.77 153.03 49.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.116 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 12.4 t -93.94 115.91 28.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.912 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -71.86 -177.51 2.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.882 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 53.5 p-90 -71.42 -16.31 62.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.885 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -92.34 23.68 3.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.833 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 32.3 mt 48.63 37.5 9.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.6 t -134.47 147.57 50.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.846 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 793' ' ' TRP . . . . . 0.458 ' CH2' HD12 ' A' ' 769' ' ' ILE . 88.7 m95 -82.44 141.67 32.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.936 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 794' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 793' ' ' TRP . 1.3 t -35.41 -45.49 0.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.884 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 22.6 t -171.68 171.55 5.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -47.56 150.6 1.68 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.647 0.737 . . . . 0.0 110.833 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 149.17 66.25 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.685 2.257 . . . . 0.0 112.285 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.83 -171.79 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.678 2.252 . . . . 0.0 112.355 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 799' ' ' PHE . . . . . 0.528 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 3.2 p90 -147.22 167.71 23.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.912 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 3.9 m -102.05 119.18 38.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -123.32 132.59 54.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -58.75 137.8 57.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 22.1 m -95.96 144.92 25.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.139 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 804' ' ' GLU . . . . . 0.431 ' OE2' ' C ' ' A' ' 805' ' ' GLU . 2.2 tm-20 -140.27 129.64 23.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 805' ' ' GLU . . . . . 0.431 ' C ' ' OE2' ' A' ' 804' ' ' GLU . 0.0 OUTLIER -105.84 115.89 31.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.93 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 69.2 p -118.31 100.81 7.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . 76.58 148.86 2.76 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.479 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -45.35 1.61 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.65 2.234 . . . . 0.0 112.348 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 58.9 m -134.51 140.8 46.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.831 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 16.1 m -159.78 150.33 19.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.851 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.472 -179.994 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 3.0 m -46.76 170.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 110.895 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 70.4 m -97.35 138.4 34.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.865 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.26 123.94 5.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.857 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 748' ' ' LEU . . . . . 0.485 HD13 ' OH ' ' A' ' 771' ' ' TYR . 24.2 mt -69.42 144.1 94.1 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.611 0.719 . . . . 0.0 110.873 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 143.74 51.8 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.693 2.262 . . . . 0.0 112.325 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -52.12 133.55 33.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 751' ' ' ILE . . . . . 0.498 HG23 ' O ' ' A' ' 754' ' ' GLY . 1.5 tt -100.77 143.78 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.138 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 752' ' ' GLN . . . . . 0.412 ' N ' HG13 ' A' ' 751' ' ' ILE . 26.8 pt20 -82.49 136.39 34.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 5.8 m120 58.71 37.4 25.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 754' ' ' GLY . . . . . 0.498 ' O ' HG23 ' A' ' 751' ' ' ILE . . . -178.23 166.45 36.47 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.474 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -147.48 150.46 34.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.817 0.341 . . . . 0.0 110.912 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -91.54 148.87 21.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 39.5 p . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 179.964 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 55.9 mt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.863 0.364 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.09 170.59 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.119 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 40.8 mtt85 -53.91 132.69 42.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 94.24 -26.17 18.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.48 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -45.99 142.62 2.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.799 0.333 . . . . 0.0 111.084 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 768' ' ' ARG . . . . . 0.528 ' HD3' HG21 ' A' ' 784' ' ' THR . 15.6 ttm-85 -119.72 122.88 42.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 769' ' ' ILE . . . . . 0.626 ' CG1' ' CH2' ' A' ' 793' ' ' TRP . 37.3 mm -99.87 143.45 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.077 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 12.0 m -121.11 125.99 48.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.131 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 771' ' ' TYR . . . . . 0.485 ' OH ' HD13 ' A' ' 748' ' ' LEU . 35.0 m-85 -101.66 121.54 42.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -122.45 130.29 52.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.922 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 74.9 m -108.57 174.16 6.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -60.75 159.72 24.14 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.606 0.717 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 114.51 3.73 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.638 2.225 . . . . 0.0 112.332 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 122.01 -22.2 7.66 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.461 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -94.38 174.39 7.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.896 0.379 . . . . 0.0 110.909 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -131.87 155.36 47.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.842 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 779' ' ' ILE . . . . . 0.4 HG23 ' HB2' ' A' ' 798' ' ' PRO . 7.4 mt -97.39 141.0 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 780' ' ' VAL . . . . . 0.428 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 61.0 t -114.1 109.47 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.093 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 125.91 -131.06 7.39 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.481 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 782' ' ' SER . . . . . 0.406 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 1.5 t -107.9 108.52 19.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.852 0.358 . . . . 0.0 110.86 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.45 -31.15 67.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.595 ' C ' HD12 ' A' ' 785' ' ' LEU . 20.8 m -115.49 131.38 56.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.122 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 785' ' ' LEU . . . . . 0.595 HD12 ' C ' ' A' ' 784' ' ' THR . 10.4 mp -123.74 127.65 48.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 786' ' ' THR . . . . . 0.496 HG22 ' N ' ' A' ' 787' ' ' CYS . 26.6 m -107.78 159.61 16.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.144 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 787' ' ' CYS . . . . . 0.496 ' N ' HG22 ' A' ' 786' ' ' THR . 6.5 t -94.47 119.09 32.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -73.62 176.76 5.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -73.39 -7.74 52.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -100.94 12.94 36.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 66.6 mt 61.78 26.92 16.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 14.8 m -130.39 127.35 39.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.873 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 793' ' ' TRP . . . . . 0.626 ' CH2' ' CG1' ' A' ' 769' ' ' ILE . 73.6 m95 -58.38 140.64 53.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.946 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 794' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 793' ' ' TRP . 28.8 t -37.13 -47.98 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.837 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 37.4 m -154.75 167.04 31.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.841 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -51.63 155.8 2.59 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.63 0.729 . . . . 0.0 110.842 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 797' ' ' PRO . . . . . 0.448 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.5 Cg_endo -69.78 145.32 56.68 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.677 2.251 . . . . 0.0 112.329 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 798' ' ' PRO . . . . . 0.4 ' HB2' HG23 ' A' ' 779' ' ' ILE . 54.0 Cg_endo -69.85 -165.28 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.659 2.239 . . . . 0.0 112.348 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 799' ' ' PHE . . . . . 0.428 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.7 p90 -153.67 170.5 20.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.911 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 8.4 m -101.94 135.01 44.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.909 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -130.36 143.04 50.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 744' ' ' GLY . . . . . 0.482 ' CA ' ' O ' ' A' ' 763' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 745' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 763' ' ' LEU . 7.5 m -44.86 150.56 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.847 0.356 . . . . 0.0 110.832 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 16.4 m -71.56 147.91 47.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.825 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -60.69 137.34 58.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.906 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 748' ' ' LEU . . . . . 0.531 HD13 ' OH ' ' A' ' 771' ' ' TYR . 12.4 mt -97.0 144.28 27.58 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.631 0.729 . . . . 0.0 110.884 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 163.57 37.82 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.716 2.277 . . . . 0.0 112.361 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -62.32 149.0 43.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.89 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.0 tt -103.08 148.61 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.129 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -85.22 135.28 34.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 5.7 m120 53.92 46.6 25.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 754' ' ' GLY . . . . . 0.465 ' CA ' ' O ' ' A' ' 772' ' ' GLN . . . 175.98 -169.15 41.72 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.462 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 15.0 p90 -156.54 171.78 19.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.816 0.341 . . . . 0.0 110.961 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 17.7 pttm -134.74 159.92 39.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.87 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 77.3 p . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 763' ' ' LEU . . . . . 0.482 ' O ' ' CA ' ' A' ' 744' ' ' GLY . 21.9 mt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.844 0.354 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 26.9 m -108.38 175.24 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.155 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -41.88 136.63 1.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.861 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 88.1 -29.88 5.37 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.459 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -54.1 130.91 39.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.81 0.338 . . . . 0.0 111.143 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -121.51 150.06 42.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 769' ' ' ILE . . . . . 0.462 HD11 HD22 ' A' ' 763' ' ' LEU . 6.8 mm -115.57 132.4 65.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.174 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 79.0 m -103.46 116.22 31.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.177 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 771' ' ' TYR . . . . . 0.531 ' OH ' HD13 ' A' ' 748' ' ' LEU . 38.9 m-85 -98.54 127.36 44.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.926 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 772' ' ' GLN . . . . . 0.465 ' O ' ' CA ' ' A' ' 754' ' ' GLY . 22.9 tp60 -122.5 137.84 54.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.896 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 64.9 m -115.83 172.05 7.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -60.57 157.06 39.43 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.625 0.726 . . . . 0.0 110.823 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.77 119.1 6.1 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.659 2.239 . . . . 0.0 112.31 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 117.96 -15.06 12.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.452 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -100.12 176.48 5.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 0.0 110.924 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -133.57 157.79 44.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 4.6 mt -97.96 139.29 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.122 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 780' ' ' VAL . . . . . 0.573 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 65.2 t -115.75 113.66 43.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.14 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 116.15 -143.01 17.92 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.535 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 12.6 m -97.99 103.13 15.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.873 0.368 . . . . 0.0 110.823 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -57.8 -52.99 63.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.878 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.844 ' C ' HD12 ' A' ' 785' ' ' LEU . 44.6 m -86.06 141.93 29.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.13 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 785' ' ' LEU . . . . . 0.844 HD12 ' C ' ' A' ' 784' ' ' THR . 7.6 mp -132.03 113.07 12.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.915 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 786' ' ' THR . . . . . 0.414 HG22 ' N ' ' A' ' 787' ' ' CYS . 27.2 m -96.6 154.88 17.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.104 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 787' ' ' CYS . . . . . 0.414 ' N ' HG22 ' A' ' 786' ' ' THR . 4.3 t -95.66 109.56 21.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -61.5 -176.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -69.99 -26.8 64.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.947 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -86.85 20.86 2.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 791' ' ' LEU . . . . . 0.427 HD22 ' HA2' ' A' ' 744' ' ' GLY . 57.5 mt 51.92 44.64 29.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 30.1 t -130.5 156.11 45.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 793' ' ' TRP . . . . . 0.418 ' CD1' HD21 ' A' ' 748' ' ' LEU . 73.8 m95 -84.54 133.07 34.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 40.3 t -37.27 -48.83 0.91 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 8.6 t -157.9 174.62 14.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.801 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.98 156.51 3.45 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.612 0.72 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 797' ' ' PRO . . . . . 0.464 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.8 Cg_endo -69.72 145.37 57.16 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.654 2.236 . . . . 0.0 112.356 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -167.5 0.23 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.689 2.259 . . . . 0.0 112.354 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 799' ' ' PHE . . . . . 0.573 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 1.3 p90 -159.79 164.2 33.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 3.5 m -101.76 133.15 46.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -145.78 140.44 27.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.889 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 744' ' ' GLY . . . . . 0.751 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 57.3 m -53.99 152.22 6.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.822 0.344 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 22.9 t -90.48 165.19 13.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.862 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -59.59 159.09 8.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.876 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 13.7 mt -110.29 149.0 39.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.629 0.728 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 146.08 59.19 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.71 2.273 . . . . 0.0 112.358 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -54.96 141.12 35.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.907 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 751' ' ' ILE . . . . . 0.421 HG13 ' N ' ' A' ' 752' ' ' GLN . 1.9 tt -103.82 146.49 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.077 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 752' ' ' GLN . . . . . 0.421 ' N ' HG13 ' A' ' 751' ' ' ILE . 21.1 mt-30 -87.15 136.7 32.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.921 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 60.5 47.33 8.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 169.79 170.57 34.39 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.5 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 17.5 p90 -148.39 152.75 37.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.829 0.347 . . . . 0.0 110.93 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -96.71 168.94 10.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 757' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 757' ' ' THR . 5.0 t . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.147 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.86 0.362 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 31.6 m -125.65 172.09 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -47.52 128.17 12.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 98.92 -18.77 56.36 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.485 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -56.94 132.27 52.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.743 0.306 . . . . 0.0 111.09 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 768' ' ' ARG . . . . . 0.42 ' HD2' ' C ' ' A' ' 768' ' ' ARG . 3.9 tmm_? -128.13 132.78 48.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.881 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 63.7 mt -113.59 144.09 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.167 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 87.3 m -110.41 131.94 54.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.113 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -103.96 118.21 36.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -110.29 136.39 49.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.937 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 83.8 m -115.83 171.87 7.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -60.99 159.53 26.85 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.588 0.709 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 122.02 8.69 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.674 2.25 . . . . 0.0 112.337 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 113.76 -22.3 14.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.453 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 777' ' ' TYR . . . . . 0.4 ' CE2' ' HB2' ' A' ' 802' ' ' LYS . 18.6 m-85 -86.5 178.56 7.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.912 0.387 . . . . 0.0 110.902 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.75 135.33 26.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.866 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 3.6 mt -74.54 150.42 7.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 780' ' ' VAL . . . . . 0.566 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 89.6 t -128.49 108.82 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.094 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 123.67 -134.02 9.13 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.488 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 43.7 m -105.22 98.81 8.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.883 0.373 . . . . 0.0 110.879 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.72 -39.21 76.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.827 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.801 ' C ' HD12 ' A' ' 785' ' ' LEU . 25.8 m -93.18 141.75 28.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.16 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 785' ' ' LEU . . . . . 0.801 HD12 ' C ' ' A' ' 784' ' ' THR . 9.4 mp -133.5 119.09 19.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 1.2 m -114.93 153.88 29.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.08 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 3.2 t -92.44 121.77 34.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.849 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -86.48 173.85 9.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 5.1 p90 -55.32 -17.07 4.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.927 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -94.13 23.05 5.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.82 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 791' ' ' LEU . . . . . 0.751 HD22 ' HA2' ' A' ' 744' ' ' GLY . 23.1 mt 45.38 24.98 0.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.949 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.4 t -117.14 150.44 38.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 793' ' ' TRP . . . . . 0.404 ' O ' ' C ' ' A' ' 794' ' ' SER . 86.3 m95 -77.08 142.99 39.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.935 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 794' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 793' ' ' TRP . 40.5 t -37.66 -42.85 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.828 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 5.1 t -171.3 173.19 4.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -46.43 154.54 0.64 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.632 0.73 . . . . 0.0 110.884 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 145.79 58.7 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.695 2.263 . . . . 0.0 112.369 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 798' ' ' PRO . . . . . 0.467 ' HD3' HD11 ' A' ' 785' ' ' LEU . 54.3 Cg_endo -69.75 177.86 5.15 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.678 2.252 . . . . 0.0 112.39 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 799' ' ' PHE . . . . . 0.566 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 0.8 OUTLIER -142.95 166.64 24.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 11.9 m -102.48 124.48 48.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -118.75 133.09 56.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 802' ' ' LYS . . . . . 0.4 ' HB2' ' CE2' ' A' ' 777' ' ' TYR . 32.0 tttt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 744' ' ' GLY . . . . . 0.426 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 1.8 m -59.04 162.14 4.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.867 0.365 . . . . 0.0 110.869 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 23.5 p -92.08 144.74 25.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -38.27 150.13 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.866 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 14.8 mt -106.46 151.95 40.48 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.651 0.739 . . . . 0.0 110.925 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 141.29 44.57 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.657 2.238 . . . . 0.0 112.364 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -54.0 145.59 16.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 751' ' ' ILE . . . . . 0.422 HG13 ' N ' ' A' ' 752' ' ' GLN . 2.1 tt -100.95 147.73 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.111 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 752' ' ' GLN . . . . . 0.422 ' N ' HG13 ' A' ' 751' ' ' ILE . 40.8 mt-30 -90.83 139.51 30.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 50.41 41.64 25.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -177.37 -173.62 43.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.504 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -157.4 159.41 37.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.784 0.326 . . . . 0.0 110.949 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 756' ' ' LYS . . . . . 0.41 ' C ' ' HD2' ' A' ' 756' ' ' LYS . 0.0 OUTLIER -118.62 152.44 36.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.939 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 55.7 p . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.19 179.946 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 86.0 mt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.861 0.362 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 764' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' A' ' 765' ' ' ARG . 28.3 m -101.55 156.75 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 765' ' ' ARG . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 765' ' ' ARG . 25.4 mtm105 -34.73 139.52 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 87.75 -25.6 8.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -57.11 139.9 51.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.787 0.327 . . . . 0.0 111.095 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -115.08 157.36 23.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.904 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 34.0 mm -114.27 140.19 36.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.144 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 89.1 m -113.52 119.5 37.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.181 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -97.68 121.67 39.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -121.34 124.7 45.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.93 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 62.9 m -110.51 174.35 5.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.46 157.48 35.69 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.592 0.711 . . . . 0.0 110.882 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 106.99 1.77 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.671 2.247 . . . . 0.0 112.337 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 131.87 -15.03 5.17 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.461 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -104.4 169.88 8.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.882 0.373 . . . . 0.0 110.919 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.12 160.78 30.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 8.7 mt -96.71 139.34 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.114 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 780' ' ' VAL . . . . . 0.516 ' HB ' ' CE1' ' A' ' 799' ' ' PHE . 72.0 t -114.0 106.43 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 125.82 -149.62 17.32 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.506 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 782' ' ' SER . . . . . 0.476 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 93.0 p -82.03 103.02 11.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.885 0.374 . . . . 0.0 110.842 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -57.14 -44.56 83.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 31.4 m -105.98 124.29 49.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.152 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 785' ' ' LEU . . . . . 0.476 ' CD1' ' O ' ' A' ' 782' ' ' SER . 10.7 mp -113.45 120.0 39.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.923 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 26.0 m -107.41 154.03 21.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.174 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 6.6 t -94.46 125.1 38.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.835 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -75.91 177.04 7.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 2.2 p90 -69.76 -19.06 63.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.964 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 790' ' ' ASP . . . . . 0.421 ' O ' ' CG ' ' A' ' 790' ' ' ASP . 23.2 t0 -96.24 23.65 6.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 791' ' ' LEU . . . . . 0.426 HD22 ' CA ' ' A' ' 744' ' ' GLY . 15.8 mt 51.21 35.8 14.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.91 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 49.4 m -120.77 135.56 55.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 793' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -72.22 147.11 46.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 5.0 t -48.54 -41.64 30.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.859 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 1.3 t -175.06 -178.72 1.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -54.32 147.06 29.21 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.599 0.714 . . . . 0.0 110.846 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 142.98 49.51 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.648 2.232 . . . . 0.0 112.349 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -164.73 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.695 2.263 . . . . 0.0 112.36 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 799' ' ' PHE . . . . . 0.516 ' CE1' ' HB ' ' A' ' 780' ' ' VAL . 18.6 p90 -161.9 173.95 13.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.882 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 800' ' ' CYS . . . . . 0.407 ' SG ' HD11 ' A' ' 751' ' ' ILE . 3.4 m -103.07 136.14 43.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.913 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -146.99 131.53 17.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.925 179.908 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 744' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 745' ' ' CYS . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 745' ' ' CYS . . . . . 0.413 ' HB3' ' CE2' ' A' ' 793' ' ' TRP . 9.8 m -37.51 152.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 0.0 110.893 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 60.8 p -84.7 155.69 21.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -62.42 142.66 57.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 58.7 mt -90.43 149.4 40.91 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.624 0.726 . . . . 0.0 110.927 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 134.2 27.38 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.693 2.262 . . . . 0.0 112.347 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -42.35 146.63 0.31 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.911 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 751' ' ' ILE . . . . . 0.487 HD11 ' SG ' ' A' ' 800' ' ' CYS . 2.7 tt -102.91 148.86 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -88.18 137.98 31.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 18.0 t30 51.97 43.15 30.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 754' ' ' GLY . . . . . 0.449 ' O ' HG23 ' A' ' 751' ' ' ILE . . . 178.08 176.62 46.19 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.477 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -149.31 179.03 8.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.805 0.336 . . . . 0.0 110.956 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.54 172.09 13.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.897 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 20.4 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 179.96 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.894 0.378 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.89 152.43 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.083 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -41.22 131.16 2.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 98.76 -23.45 36.28 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -58.7 147.5 32.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.82 0.343 . . . . 0.0 111.047 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -135.46 145.09 46.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 25.3 mt -120.0 142.96 33.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.148 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 3.5 t -109.4 153.47 23.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 771' ' ' TYR . . . . . 0.431 ' HD2' HD13 ' A' ' 751' ' ' ILE . 25.4 m-85 -119.41 129.6 54.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.913 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -125.8 122.4 36.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.96 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 60.2 m -106.55 174.07 6.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.5 158.98 26.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.642 0.734 . . . . 0.0 110.876 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 111.18 2.74 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.701 2.268 . . . . 0.0 112.332 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 126.98 -14.68 6.61 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.49 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -104.72 173.28 6.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.889 0.376 . . . . 0.0 110.96 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -134.6 147.75 50.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.837 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 779' ' ' ILE . . . . . 0.426 HD11 ' O ' ' A' ' 771' ' ' TYR . 24.1 mt -82.96 144.87 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.141 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 780' ' ' VAL . . . . . 0.557 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 58.3 t -118.15 105.87 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.162 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 125.11 -150.46 17.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.507 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 782' ' ' SER . . . . . 0.528 ' O ' HD11 ' A' ' 785' ' ' LEU . 43.7 m -85.2 106.73 16.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 0.0 110.832 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -57.27 -49.16 76.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.855 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.544 ' C ' HD12 ' A' ' 785' ' ' LEU . 21.0 m -102.12 126.79 49.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 785' ' ' LEU . . . . . 0.57 HD21 ' HA ' ' A' ' 797' ' ' PRO . 7.0 mp -113.61 111.01 21.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 786' ' ' THR . . . . . 0.497 HG22 ' N ' ' A' ' 787' ' ' CYS . 32.6 m -94.37 159.4 15.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.163 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 787' ' ' CYS . . . . . 0.497 ' N ' HG22 ' A' ' 786' ' ' THR . 7.0 t -96.93 117.59 31.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -75.5 175.37 8.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 11.6 p-90 -62.15 -21.87 65.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -88.98 20.61 3.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.884 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 23.3 mt 51.2 31.85 7.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 36.1 t -121.97 153.83 38.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 793' ' ' TRP . . . . . 0.439 ' O ' ' C ' ' A' ' 794' ' ' SER . 88.6 m95 -83.99 140.73 31.7 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 794' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 793' ' ' TRP . 8.5 t -34.55 -44.83 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 8.6 t -173.03 173.03 3.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -44.93 151.04 0.67 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.586 0.708 . . . . 0.0 110.856 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 797' ' ' PRO . . . . . 0.57 ' HA ' HD21 ' A' ' 785' ' ' LEU . 54.2 Cg_endo -69.75 147.82 63.78 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.678 2.252 . . . . 0.0 112.39 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 798' ' ' PRO . . . . . 0.408 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.8 Cg_endo -69.74 -163.87 0.12 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.697 2.265 . . . . 0.0 112.385 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 799' ' ' PHE . . . . . 0.557 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 3.9 p90 -160.6 170.24 21.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 800' ' ' CYS . . . . . 0.487 ' SG ' HD11 ' A' ' 751' ' ' ILE . 19.9 m -104.21 119.41 38.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.876 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -128.19 126.16 40.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.986 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 745' ' ' CYS . . . . . 0.506 ' HB3' ' CE2' ' A' ' 793' ' ' TRP . 1.8 m -40.23 152.91 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.841 0.353 . . . . 0.0 110.886 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 27.1 m -79.79 140.46 36.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.82 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -44.11 141.0 1.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.867 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 43.7 mt -93.08 148.59 36.0 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.595 0.712 . . . . 0.0 110.932 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -174.09 0.84 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.697 2.265 . . . . 0.0 112.339 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -95.24 143.27 26.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 751' ' ' ILE . . . . . 0.485 HD11 ' SG ' ' A' ' 800' ' ' CYS . 3.0 tt -100.72 144.37 12.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.077 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 19.7 mp0 -78.17 132.09 37.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.912 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 55.59 40.22 31.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 754' ' ' GLY . . . . . 0.46 ' C ' HG23 ' A' ' 751' ' ' ILE . . . -174.26 176.4 46.64 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.513 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 32.6 p90 -157.24 161.59 39.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.799 0.333 . . . . 0.0 110.916 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -108.84 159.01 17.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.902 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 56.5 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.143 179.951 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 763' ' ' LEU . . . . . 0.476 HD22 HD11 ' A' ' 769' ' ' ILE . 78.4 mt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.801 0.334 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 34.4 m -96.4 159.91 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 765' ' ' ARG . . . . . 0.559 ' NE ' HD21 ' A' ' 791' ' ' LEU . 6.1 ptp180 -45.65 132.95 8.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 101.94 -39.99 2.57 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.485 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -46.77 157.58 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 111.114 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 768' ' ' ARG . . . . . 0.52 ' O ' HD13 ' A' ' 769' ' ' ILE . 72.4 mtt180 -123.99 172.93 8.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 769' ' ' ILE . . . . . 0.52 HD13 ' O ' ' A' ' 768' ' ' ARG . 8.2 mm -143.12 134.08 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 17.1 m -100.6 113.67 26.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.129 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 771' ' ' TYR . . . . . 0.737 ' HE2' HD22 ' A' ' 785' ' ' LEU . 22.7 m-85 -96.79 124.24 40.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.918 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -126.79 137.57 53.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 75.2 m -115.2 174.19 6.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.904 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -60.54 157.47 36.44 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.636 0.732 . . . . 0.0 110.829 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 112.93 3.21 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.665 2.243 . . . . 0.0 112.365 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 124.84 -22.23 6.47 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.484 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -95.32 178.24 5.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.896 0.379 . . . . 0.0 110.868 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -136.67 156.42 48.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.876 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 779' ' ' ILE . . . . . 0.702 HG23 ' HB2' ' A' ' 798' ' ' PRO . 74.3 mt -98.69 135.26 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.14 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 780' ' ' VAL . . . . . 0.576 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 61.8 t -112.16 106.77 21.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.136 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 128.0 -149.0 17.97 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.448 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 21.9 m -83.06 107.47 15.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.866 0.365 . . . . 0.0 110.849 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.25 -46.17 90.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 25.6 m -101.93 122.11 43.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 785' ' ' LEU . . . . . 0.737 HD22 ' HE2' ' A' ' 771' ' ' TYR . 9.8 mp -103.3 114.46 28.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 10.1 m -107.92 147.27 31.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.136 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 8.8 t -92.51 137.55 32.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.847 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -87.97 169.4 12.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -56.0 -25.09 42.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -86.75 21.2 2.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.836 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 791' ' ' LEU . . . . . 0.559 HD21 ' NE ' ' A' ' 765' ' ' ARG . 7.4 mt 51.22 37.47 18.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 90.4 p -122.38 136.41 54.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.825 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 793' ' ' TRP . . . . . 0.506 ' CE2' ' HB3' ' A' ' 745' ' ' CYS . 97.1 m95 -67.9 140.53 56.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.928 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 1.5 t -42.73 -48.62 5.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.899 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 8.4 t -168.78 173.82 6.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.855 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.97 151.16 4.72 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.576 0.703 . . . . 0.0 110.851 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 797' ' ' PRO . . . . . 0.522 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.7 Cg_endo -69.81 144.49 53.96 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.67 2.246 . . . . 0.0 112.345 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 798' ' ' PRO . . . . . 0.702 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.6 Cg_endo -69.7 -175.25 1.08 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.715 2.277 . . . . 0.0 112.332 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 799' ' ' PHE . . . . . 0.576 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.4 p90 -145.27 165.4 28.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 800' ' ' CYS . . . . . 0.485 ' SG ' HD11 ' A' ' 751' ' ' ILE . 2.6 m -103.75 128.26 51.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -129.83 151.0 50.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 802' ' ' LYS . . . . . 0.42 ' HD2' ' C ' ' A' ' 802' ' ' LYS . 1.6 tmmm? . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 744' ' ' GLY . . . . . 0.409 ' CA ' ' HA ' ' A' ' 764' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 9.1 m -78.98 155.03 29.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.817 0.342 . . . . 0.0 110.918 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 77.5 p -73.24 149.45 42.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.862 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -54.09 163.09 0.84 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 11.7 mt -115.27 148.17 40.17 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.574 0.702 . . . . 0.0 110.932 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 144.28 53.42 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.726 2.284 . . . . 0.0 112.319 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -54.23 147.44 13.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 751' ' ' ILE . . . . . 0.405 HG13 ' N ' ' A' ' 752' ' ' GLN . 1.5 tt -105.17 144.1 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.093 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 752' ' ' GLN . . . . . 0.405 ' N ' HG13 ' A' ' 751' ' ' ILE . 23.2 mt-30 -89.04 145.47 25.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 47.3 47.9 16.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 179.96 179.96 48.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.461 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 47.3 p90 -154.96 154.23 32.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.839 0.352 . . . . 0.0 110.888 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -124.55 159.43 30.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.922 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 76.3 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.096 -179.981 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 763' ' ' LEU . . . . . 0.614 HD22 HD11 ' A' ' 769' ' ' ILE . 7.8 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.815 0.34 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 764' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 765' ' ' ARG . 33.1 m -86.11 175.68 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.12 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 765' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 764' ' ' VAL . 88.2 mtm180 -36.54 137.82 0.27 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 90.25 -31.55 5.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.486 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -50.54 125.5 13.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.737 0.304 . . . . 0.0 111.116 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -119.41 140.87 49.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.867 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 769' ' ' ILE . . . . . 0.614 HD11 HD22 ' A' ' 763' ' ' LEU . 68.1 mt -121.92 142.0 40.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.121 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 6.2 t -107.21 154.27 21.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.167 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 771' ' ' TYR . . . . . 0.468 ' HE2' HD22 ' A' ' 785' ' ' LEU . 47.3 m-85 -124.81 120.05 30.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -119.25 128.22 53.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.918 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 69.1 m -109.8 173.54 6.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -60.45 159.03 26.0 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.588 0.709 . . . . 0.0 110.858 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 121.12 7.81 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.711 2.274 . . . . 0.0 112.337 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 104.71 11.12 31.41 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -116.99 172.24 7.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.905 0.383 . . . . 0.0 110.881 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -126.95 155.17 43.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.848 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 5.3 mt -103.32 138.39 27.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.138 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 780' ' ' VAL . . . . . 0.564 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 56.3 t -114.51 107.98 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 129.53 -134.03 7.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.473 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 782' ' ' SER . . . . . 0.527 ' O ' HD11 ' A' ' 785' ' ' LEU . 1.6 t -109.82 109.86 20.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.862 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -57.44 -37.33 72.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.845 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.723 ' C ' HD12 ' A' ' 785' ' ' LEU . 16.7 m -108.84 134.28 51.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 785' ' ' LEU . . . . . 0.723 HD12 ' C ' ' A' ' 784' ' ' THR . 8.7 mp -127.11 120.31 28.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 786' ' ' THR . . . . . 0.478 HG22 ' N ' ' A' ' 787' ' ' CYS . 16.6 m -111.07 160.79 16.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.107 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 787' ' ' CYS . . . . . 0.478 ' N ' HG22 ' A' ' 786' ' ' THR . 16.5 t -94.46 135.39 35.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -91.62 177.56 6.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 3.0 p90 -73.03 -3.55 26.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -107.44 17.37 22.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.897 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 31.7 mt 57.6 28.66 15.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.8 t -123.24 148.65 45.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 793' ' ' TRP . . . . . 0.431 ' O ' ' C ' ' A' ' 794' ' ' SER . 95.9 m95 -85.51 137.98 32.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.93 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 794' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 793' ' ' TRP . 37.9 t -34.8 -50.27 0.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.838 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 45.5 m -164.24 152.83 13.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -37.84 153.53 0.13 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.635 0.731 . . . . 0.0 110.863 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 797' ' ' PRO . . . . . 0.568 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.4 Cg_endo -69.83 145.84 57.94 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.676 2.251 . . . . 0.0 112.329 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -164.91 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.666 2.244 . . . . 0.0 112.397 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 799' ' ' PHE . . . . . 0.564 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.6 p90 -154.78 169.1 24.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.854 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 4.0 m -104.97 121.11 43.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.872 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -129.63 121.68 27.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 30.6 tttm . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 179.966 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 2.0 m -59.75 154.77 17.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.862 0.363 . . . . 0.0 110.848 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 84.8 p -71.27 141.01 50.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -46.15 144.36 1.99 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.88 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 748' ' ' LEU . . . . . 0.443 HD13 ' OH ' ' A' ' 771' ' ' TYR . 35.0 mt -92.11 144.93 29.88 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.597 0.713 . . . . 0.0 110.911 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 156.73 62.6 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.624 2.216 . . . . 0.0 112.325 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.32 147.03 53.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 751' ' ' ILE . . . . . 0.442 HD11 ' SG ' ' A' ' 800' ' ' CYS . 3.0 tt -102.66 149.66 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.16 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -90.77 141.75 28.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 46.16 49.73 12.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 177.82 -173.67 46.23 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.45 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 755' ' ' TRP . . . . . 0.444 ' NE1' ' HB2' ' A' ' 772' ' ' GLN . 15.4 p90 -154.94 -177.94 6.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.852 0.358 . . . . 0.0 110.896 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.67 165.82 25.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 -179.964 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 763' ' ' LEU . . . . . 0.815 HD21 HD11 ' A' ' 769' ' ' ILE . 37.8 mt . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.857 0.361 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 764' ' ' VAL . . . . . 0.513 ' H ' ' HB2' ' A' ' 767' ' ' ALA . 34.9 m -132.99 177.47 7.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -52.78 108.11 0.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 103.32 10.41 36.31 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.458 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 767' ' ' ALA . . . . . 0.513 ' HB2' ' H ' ' A' ' 764' ' ' VAL . . . -65.63 140.24 58.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.793 0.33 . . . . 0.0 111.105 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 768' ' ' ARG . . . . . 0.403 ' HG3' ' CG2' ' A' ' 784' ' ' THR . 36.5 ttm180 -130.22 119.56 23.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.904 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 769' ' ' ILE . . . . . 0.815 HD11 HD21 ' A' ' 763' ' ' LEU . 68.8 mt -116.53 144.9 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.136 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 19.1 m -110.0 143.85 39.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.132 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 771' ' ' TYR . . . . . 0.443 ' OH ' HD13 ' A' ' 748' ' ' LEU . 52.1 m-85 -113.18 121.99 46.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.889 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 772' ' ' GLN . . . . . 0.444 ' HB2' ' NE1' ' A' ' 755' ' ' TRP . 22.1 mp0 -110.28 137.43 48.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.942 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 77.5 m -114.59 171.89 7.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.871 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 774' ' ' ASP . . . . . 0.456 ' HB2' ' CD1' ' A' ' 777' ' ' TYR . 0.3 OUTLIER -64.01 154.49 81.71 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.605 0.717 . . . . 0.0 110.832 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 96.03 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.679 2.253 . . . . 0.0 112.368 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 139.32 -5.53 2.96 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.465 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 777' ' ' TYR . . . . . 0.456 ' CD1' ' HB2' ' A' ' 774' ' ' ASP . 18.8 m-85 -106.23 179.26 4.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.868 0.366 . . . . 0.0 110.953 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -134.61 146.08 49.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 779' ' ' ILE . . . . . 0.402 HG23 ' HB2' ' A' ' 798' ' ' PRO . 11.0 mt -91.2 142.13 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.158 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 780' ' ' VAL . . . . . 0.578 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 50.9 t -120.83 108.64 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.111 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 127.21 -134.75 8.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 782' ' ' SER . . . . . 0.546 ' O ' HD11 ' A' ' 785' ' ' LEU . 1.3 t -106.84 112.22 25.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.831 0.348 . . . . 0.0 110.877 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -61.17 -36.88 81.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.872 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.532 ' C ' HD12 ' A' ' 785' ' ' LEU . 15.4 m -110.32 123.55 50.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.136 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 785' ' ' LEU . . . . . 0.751 HD21 ' HA ' ' A' ' 797' ' ' PRO . 7.3 mp -115.06 122.25 45.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.945 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 786' ' ' THR . . . . . 0.43 HG22 ' N ' ' A' ' 787' ' ' CYS . 20.4 m -107.01 156.82 18.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.132 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 787' ' ' CYS . . . . . 0.43 ' N ' HG22 ' A' ' 786' ' ' THR . 41.4 t -95.81 109.96 22.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.895 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -61.38 168.08 2.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -62.61 -17.77 60.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -94.02 19.91 8.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.848 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 80.5 mt 54.14 37.45 27.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 13.4 m -132.4 123.26 26.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 793' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -58.09 133.45 55.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 15.2 t -37.27 -42.62 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 37.9 m -164.31 164.17 22.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.58 154.77 4.33 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.597 0.713 . . . . 0.0 110.858 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 797' ' ' PRO . . . . . 0.751 ' HA ' HD21 ' A' ' 785' ' ' LEU . 54.1 Cg_endo -69.77 144.82 55.21 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.656 2.237 . . . . 0.0 112.339 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 798' ' ' PRO . . . . . 0.402 ' HB2' HG23 ' A' ' 779' ' ' ILE . 54.1 Cg_endo -69.75 -164.19 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.68 2.253 . . . . 0.0 112.324 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 799' ' ' PHE . . . . . 0.578 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.9 p90 -156.71 165.52 36.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.882 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 800' ' ' CYS . . . . . 0.442 ' SG ' HD11 ' A' ' 751' ' ' ILE . 3.8 m -102.24 117.51 34.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -117.68 134.47 54.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.935 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 64.0 tttt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 744' ' ' GLY . . . . . 0.431 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 3.6 m -60.72 161.25 8.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.86 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 67.4 m -74.84 141.92 44.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -48.86 155.45 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 69.9 mt -105.1 149.05 37.19 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.635 0.731 . . . . 0.0 110.933 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 164.59 33.96 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.684 2.256 . . . . 0.0 112.329 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -73.89 142.08 46.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 751' ' ' ILE . . . . . 0.699 HD11 ' SG ' ' A' ' 800' ' ' CYS . 3.5 tt -100.74 150.09 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -94.85 141.44 28.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 9.2 m120 54.29 43.34 30.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.856 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 754' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 751' ' ' ILE . . . 167.67 -179.75 40.88 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.471 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -154.35 164.75 38.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.878 0.37 . . . . 0.0 110.914 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -101.38 156.69 17.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 45.3 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.127 179.974 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 69.4 mt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.844 0.354 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 24.9 m -131.14 -179.09 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -60.2 127.63 32.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 95.67 -21.41 44.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.477 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -52.89 141.85 20.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.75 0.309 . . . . 0.0 111.094 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -123.01 140.88 52.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.897 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 769' ' ' ILE . . . . . 0.436 ' CG1' ' CH2' ' A' ' 793' ' ' TRP . 18.5 mm -106.32 148.84 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.162 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 95.6 m -121.04 113.56 20.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.148 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -97.39 124.16 41.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.969 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 43.5 tp60 -127.06 140.95 51.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.948 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 38.9 m -118.3 171.77 7.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.49 159.5 23.7 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.553 0.692 . . . . 0.0 110.888 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 104.29 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.678 2.252 . . . . 0.0 112.357 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 137.28 -19.1 3.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.494 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -100.59 177.04 5.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.0 110.887 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -136.08 151.04 49.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.824 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 3.4 mt -88.81 137.5 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.107 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 780' ' ' VAL . . . . . 0.573 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 65.7 t -115.74 107.32 22.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.155 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 127.73 -140.57 11.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.497 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 782' ' ' SER . . . . . 0.596 ' O ' HD11 ' A' ' 785' ' ' LEU . 3.8 m -105.56 102.23 11.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.879 0.371 . . . . 0.0 110.889 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.58 -53.25 59.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.895 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.714 ' C ' HD12 ' A' ' 785' ' ' LEU . 33.0 m -83.47 132.8 34.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.132 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 785' ' ' LEU . . . . . 0.714 HD12 ' C ' ' A' ' 784' ' ' THR . 9.1 mp -127.03 125.37 41.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 1.8 m -106.36 148.13 28.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.139 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 21.4 t -93.87 115.23 27.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.905 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -71.0 169.58 14.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 789' ' ' TRP . . . . . 0.458 ' CE3' ' O ' ' A' ' 789' ' ' TRP . 10.3 p-90 -66.73 -7.37 20.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -100.58 15.77 26.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.875 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 791' ' ' LEU . . . . . 0.431 HD22 ' CA ' ' A' ' 744' ' ' GLY . 82.5 mt 56.25 31.31 18.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 38.3 m -126.58 128.88 47.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 793' ' ' TRP . . . . . 0.449 ' CE3' ' HB3' ' A' ' 785' ' ' LEU . 98.6 m95 -59.53 137.74 57.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 9.3 t -48.17 -39.48 20.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 78.1 p -155.46 167.73 29.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.59 156.54 32.06 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.59 0.709 . . . . 0.0 110.86 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 797' ' ' PRO . . . . . 0.427 ' HA ' HD21 ' A' ' 785' ' ' LEU . 54.3 Cg_endo -69.74 141.15 44.53 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.665 2.243 . . . . 0.0 112.403 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -168.15 0.26 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.69 2.26 . . . . 0.0 112.382 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 799' ' ' PHE . . . . . 0.573 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 9.1 p90 -160.0 170.87 20.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.85 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 800' ' ' CYS . . . . . 0.699 ' SG ' HD11 ' A' ' 751' ' ' ILE . 12.0 m -102.52 145.8 29.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.875 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -148.02 134.13 19.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.871 179.97 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 744' ' ' GLY . . . . . 0.415 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 2.2 m -47.72 154.25 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.847 0.356 . . . . 0.0 110.913 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 41.6 m -69.58 150.82 46.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -72.78 139.29 46.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.891 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 9.6 mt -94.31 146.63 31.9 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.671 0.748 . . . . 0.0 110.867 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -179.78 3.14 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.678 2.252 . . . . 0.0 112.379 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -79.75 142.93 34.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.2 tt -101.16 149.25 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.127 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -94.17 137.75 32.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 62.84 36.83 12.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.922 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 174.4 -177.42 46.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.498 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 755' ' ' TRP . . . . . 0.418 ' CD1' ' C ' ' A' ' 755' ' ' TRP . 2.4 p90 -156.02 169.36 24.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.858 0.361 . . . . 0.0 110.885 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -118.68 161.93 19.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 24.4 p . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.119 -179.974 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 16.6 mt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.9 0.381 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 27.2 m -111.16 176.01 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.105 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -48.27 138.07 10.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 88.16 -30.74 5.02 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.465 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -40.08 129.07 2.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 34.3 mtt85 -122.0 127.37 50.21 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.846 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 59.1 mt -104.85 148.87 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.141 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 55.7 m -118.31 125.53 50.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.177 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -96.74 132.89 41.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.955 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -126.0 121.89 34.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.973 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 82.9 m -103.86 174.45 5.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.84 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -60.42 156.91 38.7 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.592 0.71 . . . . 0.0 110.899 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 109.93 2.43 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.67 2.247 . . . . 0.0 112.41 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 127.64 -13.07 6.54 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.502 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -105.07 179.03 4.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.879 0.371 . . . . 0.0 110.937 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -139.91 152.06 46.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.825 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 779' ' ' ILE . . . . . 0.577 HG23 ' HB2' ' A' ' 798' ' ' PRO . 57.0 mt -89.67 135.55 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.193 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 780' ' ' VAL . . . . . 0.552 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 60.5 t -108.62 106.68 21.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 126.5 -147.68 16.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.484 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 54.1 p -84.62 103.05 13.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.0 110.874 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.8 -34.21 74.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 98.0 m -112.12 121.97 46.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 785' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.64 135.84 48.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 2.3 m -119.46 150.61 39.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 17.4 t -94.9 107.81 19.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -63.66 162.39 13.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -58.05 -17.04 15.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.38 20.32 12.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 791' ' ' LEU . . . . . 0.415 HD22 ' HA2' ' A' ' 744' ' ' GLY . 74.3 mt 55.16 25.0 6.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.938 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 19.9 m -109.56 125.86 52.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 793' ' ' TRP . . . . . 0.416 ' O ' ' C ' ' A' ' 794' ' ' SER . 75.7 m95 -67.13 135.74 54.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 794' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 793' ' ' TRP . 4.3 t -36.93 -44.1 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 10.9 m -173.06 167.06 4.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.832 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -43.79 152.15 0.46 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.596 0.712 . . . . 0.0 110.898 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 146.37 60.46 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 798' ' ' PRO . . . . . 0.577 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.8 Cg_endo -69.8 -167.55 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.685 2.257 . . . . 0.0 112.314 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 799' ' ' PHE . . . . . 0.552 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 1.1 p90 -154.62 170.27 21.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 14.7 m -101.95 127.96 48.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -139.88 126.12 20.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 12.9 tttt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 -179.994 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 744' ' ' GLY . . . . . 0.474 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 9.9 m -45.16 163.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 110.873 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 79.1 p -91.71 163.22 14.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.893 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -61.35 158.72 13.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 46.0 mt -111.52 150.84 42.76 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.59 0.71 . . . . 0.0 110.871 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 157.57 59.95 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.678 2.252 . . . . 0.0 112.362 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.47 148.81 51.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.9 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 2.0 tt -109.06 150.8 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.1 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -103.25 140.61 37.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.933 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 7.4 m120 57.0 43.95 23.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 174.55 -179.94 45.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.537 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 16.5 p90 -156.93 161.19 39.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 110.965 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -116.26 168.27 10.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 179.984 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 763' ' ' LEU . . . . . 0.656 HD13 ' HZ2' ' A' ' 793' ' ' TRP . 69.7 mt . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.84 0.352 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 34.5 m -112.27 -179.53 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.177 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -59.06 130.01 44.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.866 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 97.56 -35.25 4.6 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.507 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -52.72 145.13 12.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.819 0.342 . . . . 0.0 111.104 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -134.99 151.52 50.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.833 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 29.3 mt -118.44 143.22 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.141 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 98.5 m -104.98 124.03 48.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.143 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -96.95 128.87 44.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -124.62 145.11 49.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.912 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 100.0 m -124.12 174.28 7.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.89 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -60.78 158.28 33.54 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.607 0.717 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 112.84 3.19 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.66 2.24 . . . . 0.0 112.363 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 123.81 -16.28 7.84 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.509 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 777' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 802' ' ' LYS . 13.9 m-85 -104.01 178.66 4.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 0.0 110.939 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -137.9 155.93 48.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 779' ' ' ILE . . . . . 0.675 HG23 ' HB2' ' A' ' 798' ' ' PRO . 46.9 mt -91.01 133.7 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 780' ' ' VAL . . . . . 0.579 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 74.2 t -108.69 111.51 36.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.167 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 124.87 -143.63 14.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.504 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 3.5 m -94.05 101.18 13.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.914 0.387 . . . . 0.0 110.909 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.04 -47.97 76.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.888 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.644 ' C ' HD12 ' A' ' 785' ' ' LEU . 22.6 m -94.15 134.02 37.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.141 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 785' ' ' LEU . . . . . 0.644 HD12 ' C ' ' A' ' 784' ' ' THR . 7.9 mp -122.42 108.84 13.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.928 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 786' ' ' THR . . . . . 0.439 HG22 ' N ' ' A' ' 787' ' ' CYS . 23.0 m -97.1 156.8 16.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 787' ' ' CYS . . . . . 0.439 ' N ' HG22 ' A' ' 786' ' ' THR . 13.6 t -98.05 125.18 42.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -86.38 169.14 13.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.933 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 789' ' ' TRP . . . . . 0.442 ' CE2' ' OD1' ' A' ' 790' ' ' ASP . 5.9 p-90 -65.53 -8.49 19.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.938 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 790' ' ' ASP . . . . . 0.442 ' OD1' ' CE2' ' A' ' 789' ' ' TRP . 87.6 m-20 -100.93 23.29 10.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 791' ' ' LEU . . . . . 0.474 HD22 ' CA ' ' A' ' 744' ' ' GLY . 40.5 mt 50.26 42.75 26.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.902 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.6 t -134.7 149.89 50.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.85 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 793' ' ' TRP . . . . . 0.656 ' HZ2' HD13 ' A' ' 763' ' ' LEU . 94.3 m95 -86.02 144.53 27.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 794' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 793' ' ' TRP . 27.9 t -36.38 -40.77 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.838 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 1.7 t -172.29 -175.96 1.51 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.67 157.08 29.52 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.624 0.726 . . . . 0.0 110.832 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 797' ' ' PRO . . . . . 0.413 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.3 Cg_endo -69.83 141.11 44.07 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.667 2.244 . . . . 0.0 112.299 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 798' ' ' PRO . . . . . 0.675 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.7 Cg_endo -69.81 -176.76 1.61 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.647 2.231 . . . . 0.0 112.361 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 799' ' ' PHE . . . . . 0.579 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 6.6 p90 -153.27 169.96 21.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 3.0 m -101.75 125.88 48.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.888 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -137.82 120.08 15.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 802' ' ' LYS . . . . . 0.406 ' HB2' ' CE2' ' A' ' 777' ' ' TYR . 6.2 ttpm? . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 744' ' ' GLY . . . . . 0.849 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 745' ' ' CYS . . . . . 0.405 ' SG ' ' C ' ' A' ' 791' ' ' LEU . 1.8 m -61.41 152.69 29.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.831 0.348 . . . . 0.0 110.854 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 2.9 m -73.81 166.85 22.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.811 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.39 152.21 38.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.884 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 15.1 mt -103.3 146.85 33.23 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.597 0.713 . . . . 0.0 110.909 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.7 162.65 41.22 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.716 2.278 . . . . 0.0 112.373 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.3 143.97 42.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 5.6 tt -100.69 151.11 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.126 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -94.18 140.49 29.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 28.9 t30 53.71 41.4 32.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -179.99 -176.92 47.75 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.488 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -153.13 159.09 42.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.833 0.349 . . . . 0.0 110.93 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.9 160.85 22.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 3.0 p . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.099 -179.97 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 22.3 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.85 0.357 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 35.6 m -103.51 158.87 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.133 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -41.83 122.72 2.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 112.25 -31.91 6.64 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.502 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -56.62 162.07 2.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.759 0.314 . . . . 0.0 111.144 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 768' ' ' ARG . . . . . 0.44 ' C ' HD13 ' A' ' 769' ' ' ILE . 5.7 ptp180 -131.2 146.86 52.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.871 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 769' ' ' ILE . . . . . 0.737 HD11 ' HH2' ' A' ' 793' ' ' TRP . 5.3 mm -113.14 145.83 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.125 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 6.7 m -111.73 149.21 31.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.199 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -130.74 134.68 47.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.933 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -133.45 126.83 32.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 84.9 m -108.75 174.36 5.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.17 158.05 38.81 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.601 0.715 . . . . 0.0 110.872 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 106.95 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.733 2.289 . . . . 0.0 112.378 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 126.56 -10.92 7.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.474 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -106.77 167.54 9.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.865 0.364 . . . . 0.0 110.938 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -128.14 156.86 42.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.861 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 779' ' ' ILE . . . . . 0.66 HG23 ' HB2' ' A' ' 798' ' ' PRO . 75.8 mt -99.49 134.67 37.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.151 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 780' ' ' VAL . . . . . 0.571 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 93.7 t -106.35 107.8 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.073 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 132.56 -132.59 6.68 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.488 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 2.9 m -109.99 110.37 21.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.879 0.371 . . . . 0.0 110.871 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -58.22 -51.71 68.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.814 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 23.7 m -96.89 123.57 40.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 785' ' ' LEU . . . . . 0.424 HD21 ' HA ' ' A' ' 797' ' ' PRO . 8.7 mp -106.99 113.46 26.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 26.3 m -101.32 144.59 29.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.146 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 36.5 t -93.35 140.18 29.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -95.26 166.73 11.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -52.98 -19.37 2.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.936 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -88.82 22.77 2.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.825 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 791' ' ' LEU . . . . . 0.849 HD22 ' HA2' ' A' ' 744' ' ' GLY . 18.6 mt 46.93 35.45 3.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.928 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 22.7 t -121.99 158.36 29.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.839 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 793' ' ' TRP . . . . . 0.737 ' HH2' HD11 ' A' ' 769' ' ' ILE . 95.6 m95 -96.05 139.37 32.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 794' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 793' ' ' TRP . 6.6 t -36.8 -47.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.871 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 6.1 m -170.16 174.38 5.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.827 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -50.53 155.31 1.88 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.614 0.721 . . . . 0.0 110.842 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 797' ' ' PRO . . . . . 0.424 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.7 Cg_endo -69.8 146.21 59.28 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.715 2.277 . . . . 0.0 112.313 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 798' ' ' PRO . . . . . 0.66 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.9 Cg_endo -69.74 -166.99 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.679 2.253 . . . . 0.0 112.353 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 799' ' ' PHE . . . . . 0.571 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.6 p90 -154.96 165.59 36.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 9.1 m -101.63 128.0 48.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.9 143.99 47.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 28.8 tttp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.928 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 744' ' ' GLY . . . . . 0.501 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 745' ' ' CYS . . . . . 0.451 ' HB3' ' CE2' ' A' ' 793' ' ' TRP . 1.8 m -44.84 154.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 0.0 110.863 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 17.7 m -64.53 137.4 57.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -55.58 155.34 5.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 748' ' ' LEU . . . . . 0.483 HD12 ' CD1' ' A' ' 769' ' ' ILE . 12.4 mt -119.02 145.49 38.14 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.64 0.733 . . . . 0.0 110.884 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -177.43 1.86 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.674 2.249 . . . . 0.0 112.366 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -88.28 148.3 24.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 751' ' ' ILE . . . . . 0.411 HG13 ' N ' ' A' ' 752' ' ' GLN . 2.3 tt -101.98 148.67 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.121 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 752' ' ' GLN . . . . . 0.411 ' N ' HG13 ' A' ' 751' ' ' ILE . 5.7 pt20 -86.54 142.35 28.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 3.0 m120 51.48 40.61 27.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -173.63 176.84 46.17 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.501 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 755' ' ' TRP . . . . . 0.469 ' CZ2' ' HG2' ' A' ' 772' ' ' GLN . 44.5 p90 -145.93 151.08 37.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.353 . . . . 0.0 110.897 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -118.98 153.38 34.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 23.3 p . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.155 179.962 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 38.0 mt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.841 0.353 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.32 174.55 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.142 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -59.21 126.5 27.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 94.0 -17.01 59.62 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.513 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -60.61 140.16 57.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.782 0.325 . . . . 0.0 111.151 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 29.8 ptt85 -127.81 143.9 51.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 769' ' ' ILE . . . . . 0.483 ' CD1' HD12 ' A' ' 748' ' ' LEU . 94.8 mt -107.37 129.95 60.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.108 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 84.3 m -96.3 120.68 37.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.113 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -98.5 118.21 34.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.925 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 772' ' ' GLN . . . . . 0.469 ' HG2' ' CZ2' ' A' ' 755' ' ' TRP . 3.9 tp-100 -113.32 141.44 47.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 74.1 m -119.37 173.47 6.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.46 158.16 31.35 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.589 0.709 . . . . 0.0 110.867 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 106.77 1.73 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.652 2.235 . . . . 0.0 112.351 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 123.26 0.79 9.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.477 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 777' ' ' TYR . . . . . 0.456 ' CE2' ' HB2' ' A' ' 802' ' ' LYS . 23.9 m-85 -115.21 170.17 8.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.848 0.356 . . . . 0.0 110.974 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -129.71 154.76 46.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 779' ' ' ILE . . . . . 0.624 HG23 ' HB2' ' A' ' 798' ' ' PRO . 72.8 mt -97.17 134.62 34.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.142 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 780' ' ' VAL . . . . . 0.561 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 59.8 t -105.61 109.4 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 126.94 -145.12 15.55 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.477 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 782' ' ' SER . . . . . 0.448 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 58.4 m -91.84 96.53 10.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.861 0.362 . . . . 0.0 110.865 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -46.77 -43.76 18.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.857 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.686 ' C ' HD12 ' A' ' 785' ' ' LEU . 6.2 m -106.34 141.24 37.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.168 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 785' ' ' LEU . . . . . 0.686 HD12 ' C ' ' A' ' 784' ' ' THR . 7.5 mp -126.33 110.13 13.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.937 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 7.0 m -94.43 152.39 18.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.109 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 13.8 t -93.15 118.8 31.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -71.98 179.47 3.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 3.2 m95 -71.11 -14.83 62.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -101.87 21.86 13.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.894 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 791' ' ' LEU . . . . . 0.501 HD22 ' HA2' ' A' ' 744' ' ' GLY . 69.3 mt 53.59 26.17 5.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.929 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 4.4 m -113.69 122.71 47.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 793' ' ' TRP . . . . . 0.451 ' CE2' ' HB3' ' A' ' 745' ' ' CYS . 91.6 m95 -61.97 136.07 57.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.918 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 1.4 t -38.38 -44.34 0.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.804 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 58.3 m -161.3 -179.6 7.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -65.17 157.34 77.48 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.588 0.708 . . . . 0.0 110.864 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 797' ' ' PRO . . . . . 0.538 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.3 Cg_endo -69.83 140.73 43.11 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.648 2.232 . . . . 0.0 112.293 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 798' ' ' PRO . . . . . 0.624 ' HB2' HG23 ' A' ' 779' ' ' ILE . 54.1 Cg_endo -69.71 -164.28 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.675 2.25 . . . . 0.0 112.405 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 799' ' ' PHE . . . . . 0.561 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 6.1 p90 -156.13 173.19 17.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 35.4 m -101.96 137.96 39.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -143.66 142.58 31.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 802' ' ' LYS . . . . . 0.456 ' HB2' ' CE2' ' A' ' 777' ' ' TYR . 4.8 ttpm? . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 744' ' ' GLY . . . . . 0.561 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.9 171.37 0.51 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.364 . . . . 0.0 110.843 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 3.4 t -90.38 167.34 12.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -75.4 132.23 40.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.56 152.26 60.07 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.628 0.728 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 167.5 24.37 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.662 2.241 . . . . 0.0 112.296 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -74.87 145.67 42.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.6 tt -100.72 146.52 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.115 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -91.8 130.48 37.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.937 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 61.99 44.34 8.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 179.99 -173.99 45.47 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.453 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 45.6 p90 -157.78 170.13 23.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.799 0.333 . . . . 0.0 110.971 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -118.96 165.55 13.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.917 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 58.6 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.144 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 31.7 mt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.836 0.35 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 35.1 m -107.86 -175.0 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 765' ' ' ARG . . . . . 0.414 ' CD ' ' HA ' ' A' ' 789' ' ' TRP . 73.7 mtm180 -68.99 134.71 49.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 95.96 -20.56 49.41 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.49 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -60.02 152.94 22.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.809 0.338 . . . . 0.0 111.092 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.62 136.65 43.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.855 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 56.5 mt -114.48 135.99 52.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.118 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 51.8 m -107.67 122.34 46.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.151 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -97.12 126.01 41.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -123.53 135.12 53.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 20.8 m -117.72 173.07 6.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -61.18 159.62 28.06 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.586 0.708 . . . . 0.0 110.852 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 114.98 3.88 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.683 2.255 . . . . 0.0 112.324 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 125.13 -25.2 5.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.468 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -90.83 170.35 10.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 0.0 110.926 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -129.15 154.62 46.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 779' ' ' ILE . . . . . 0.405 HG23 ' HB2' ' A' ' 798' ' ' PRO . 10.9 mt -95.59 137.82 22.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 780' ' ' VAL . . . . . 0.565 ' HB ' ' CE1' ' A' ' 799' ' ' PHE . 58.3 t -114.45 110.38 31.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.128 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 128.33 -132.67 7.41 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.507 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.93 107.56 17.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 110.911 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.02 -34.94 63.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.657 ' C ' HD12 ' A' ' 785' ' ' LEU . 23.7 m -109.39 136.12 49.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.159 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 785' ' ' LEU . . . . . 0.657 HD12 ' C ' ' A' ' 784' ' ' THR . 10.1 mp -126.71 118.61 25.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.93 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 1.2 m -105.83 151.98 23.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.16 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 48.6 t -95.41 108.82 21.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.86 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -62.0 175.67 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 789' ' ' TRP . . . . . 0.414 ' HA ' ' CD ' ' A' ' 765' ' ' ARG . 23.7 p-90 -73.3 -8.22 54.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -98.95 20.37 13.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 791' ' ' LEU . . . . . 0.561 HD22 ' CA ' ' A' ' 744' ' ' GLY . 79.2 mt 54.28 32.9 17.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 73.6 m -131.34 135.65 47.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 793' ' ' TRP . . . . . 0.422 ' O ' ' C ' ' A' ' 794' ' ' SER . 93.4 m95 -73.85 136.66 43.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.919 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 794' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 793' ' ' TRP . 11.9 t -35.92 -47.06 0.5 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.829 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 58.5 p -159.12 165.43 33.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -53.78 157.86 3.69 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.617 0.722 . . . . 0.0 110.878 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 797' ' ' PRO . . . . . 0.492 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.5 Cg_endo -69.8 141.39 44.95 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.687 2.258 . . . . 0.0 112.342 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 798' ' ' PRO . . . . . 0.405 ' HB2' HG23 ' A' ' 779' ' ' ILE . 54.5 Cg_endo -69.7 -167.11 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 0.0 112.389 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 799' ' ' PHE . . . . . 0.565 ' CE1' ' HB ' ' A' ' 780' ' ' VAL . 8.1 p90 -153.33 169.19 23.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 2.8 m -103.33 122.31 44.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.874 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -122.51 147.94 45.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 20.1 tttp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 -179.98 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 744' ' ' GLY . . . . . 0.467 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 1.8 m -48.09 158.37 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.878 0.37 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 3.3 m -80.89 148.38 29.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -48.41 159.46 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.879 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 748' ' ' LEU . . . . . 0.541 HD21 ' CD1' ' A' ' 793' ' ' TRP . 92.2 mt -118.24 146.72 40.06 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.662 0.744 . . . . 0.0 110.875 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 139.27 39.7 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.68 2.253 . . . . 0.0 112.31 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -46.81 156.68 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.84 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 751' ' ' ILE . . . . . 0.623 HD11 ' SG ' ' A' ' 800' ' ' CYS . 1.6 tt -102.04 139.85 22.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.114 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -83.96 130.85 34.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 55.45 45.02 26.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 177.94 -170.76 43.16 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.491 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 755' ' ' TRP . . . . . 0.45 ' C ' ' CD1' ' A' ' 755' ' ' TRP . 1.6 p90 -153.0 173.01 15.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.874 0.369 . . . . 0.0 110.9 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -135.07 172.0 13.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.138 -179.987 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 74.3 mt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.887 0.375 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 28.9 m -113.24 162.17 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.076 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 57.7 mtm-85 -40.94 145.27 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.927 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 82.38 -36.61 2.59 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.491 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -47.02 147.52 1.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.778 0.323 . . . . 0.0 111.076 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -124.85 164.67 19.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 35.1 mm -118.12 140.3 41.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.123 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 90.8 m -109.93 125.51 52.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.072 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 771' ' ' TYR . . . . . 0.553 ' CE2' ' HD2' ' A' ' 798' ' ' PRO . 24.6 m-85 -107.69 142.86 37.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.95 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -146.91 123.58 11.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 63.7 m -108.89 174.51 5.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.35 161.51 13.46 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.655 0.74 . . . . 0.0 110.859 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 120.57 7.34 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.718 2.279 . . . . 0.0 112.287 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 118.84 -29.09 6.41 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.493 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 777' ' ' TYR . . . . . 0.563 ' CE2' ' HB2' ' A' ' 802' ' ' LYS . 28.9 m-85 -89.94 179.46 5.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.918 0.389 . . . . 0.0 110.926 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -142.3 154.57 44.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.847 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 779' ' ' ILE . . . . . 0.622 HG23 ' HB2' ' A' ' 798' ' ' PRO . 75.9 mt -87.21 135.22 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.184 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 780' ' ' VAL . . . . . 0.569 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 66.5 t -103.06 105.0 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 126.03 -129.22 6.69 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.486 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 1.1 t -114.46 107.68 15.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.884 0.374 . . . . 0.0 110.86 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -55.19 -36.92 66.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.65 ' C ' HD12 ' A' ' 785' ' ' LEU . 33.3 m -101.27 139.39 37.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.139 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 785' ' ' LEU . . . . . 0.65 HD12 ' C ' ' A' ' 784' ' ' THR . 11.2 mp -130.37 111.81 12.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.943 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 11.1 m -90.71 149.96 21.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.134 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 9.3 t -93.23 107.48 19.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -57.79 -179.18 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.953 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 41.3 p-90 -72.44 -25.48 61.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.67 27.79 1.45 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.862 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 791' ' ' LEU . . . . . 0.467 HD22 ' HA2' ' A' ' 744' ' ' GLY . 20.1 mt 49.67 40.83 20.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.8 t -130.98 147.14 52.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 793' ' ' TRP . . . . . 0.541 ' CD1' HD21 ' A' ' 748' ' ' LEU . 83.3 m95 -80.87 134.98 35.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.941 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 794' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 793' ' ' TRP . 2.3 m -34.74 -47.34 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.824 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 79.4 p -159.98 165.41 32.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.831 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -44.6 152.96 0.49 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.609 0.719 . . . . 0.0 110.841 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 797' ' ' PRO . . . . . 0.6 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.6 Cg_endo -69.76 146.69 60.94 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.661 2.241 . . . . 0.0 112.354 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 798' ' ' PRO . . . . . 0.622 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.6 Cg_endo -69.71 -169.31 0.32 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.687 2.258 . . . . 0.0 112.392 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 799' ' ' PHE . . . . . 0.569 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 4.9 p90 -157.76 172.74 17.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.875 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 800' ' ' CYS . . . . . 0.623 ' SG ' HD11 ' A' ' 751' ' ' ILE . 7.2 m -101.96 136.14 42.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -146.71 135.7 22.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 802' ' ' LYS . . . . . 0.563 ' HB2' ' CE2' ' A' ' 777' ' ' TYR . 44.5 tttm . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.944 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 744' ' ' GLY . . . . . 0.451 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 3.9 m -40.54 154.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 110.895 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 4.4 m -75.9 147.38 39.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.22 117.89 6.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.84 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 748' ' ' LEU . . . . . 0.427 HD21 ' CD1' ' A' ' 793' ' ' TRP . 10.2 mt -70.62 149.34 95.4 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.598 0.713 . . . . 0.0 110.895 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 159.92 51.61 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.666 2.244 . . . . 0.0 112.342 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.08 149.95 43.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.7 tt -100.65 148.54 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.121 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -93.41 123.42 36.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.945 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 70.08 41.68 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.883 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 177.54 -174.24 46.77 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.494 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 3.2 p90 -151.35 166.11 32.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.835 0.35 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.24 156.2 43.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 49.2 p . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 179.981 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 65.8 mt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.844 0.354 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 24.0 m -87.89 162.13 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 765' ' ' ARG . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 765' ' ' ARG . 25.9 mtm105 -51.75 132.88 31.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 99.52 -25.4 28.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.461 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -62.81 131.52 49.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 0.0 111.102 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 19.6 ptt-85 -111.23 147.47 34.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 8.9 mm -104.13 139.98 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.121 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 22.8 m -104.69 119.72 39.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.142 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -104.19 130.45 51.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -135.41 132.48 37.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 39.9 m -112.56 171.81 7.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -60.48 160.63 17.38 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.629 0.728 . . . . 0.0 110.865 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 107.98 1.99 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.663 2.242 . . . . 0.0 112.359 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 133.43 -24.42 3.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.436 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -92.72 170.73 9.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.876 0.37 . . . . 0.0 110.948 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -130.86 155.63 46.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.852 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 779' ' ' ILE . . . . . 0.438 HG23 ' HB2' ' A' ' 798' ' ' PRO . 11.5 mt -91.68 141.62 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.165 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 780' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 58.4 t -116.15 106.6 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 124.61 -126.38 6.04 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 782' ' ' SER . . . . . 0.5 ' O ' HD11 ' A' ' 785' ' ' LEU . 1.3 t -113.52 108.09 16.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.916 0.389 . . . . 0.0 110.871 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.7 -33.87 66.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.904 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.617 ' C ' HD12 ' A' ' 785' ' ' LEU . 9.9 m -111.61 129.22 56.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.123 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 785' ' ' LEU . . . . . 0.617 HD12 ' C ' ' A' ' 784' ' ' THR . 8.8 mp -121.45 118.81 30.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.898 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 51.8 m -96.65 152.59 18.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.087 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 20.0 t -95.63 112.05 23.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -65.41 170.97 4.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.949 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -69.36 -6.58 30.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -105.95 24.28 12.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.844 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 791' ' ' LEU . . . . . 0.451 HD22 ' CA ' ' A' ' 744' ' ' GLY . 34.5 mt 50.5 33.52 8.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.887 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 6.8 m -128.31 123.13 33.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 793' ' ' TRP . . . . . 0.429 ' O ' ' C ' ' A' ' 794' ' ' SER . 86.9 m95 -66.17 137.2 56.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.958 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 794' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 793' ' ' TRP . 23.0 t -35.67 -50.56 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.814 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 38.8 p -154.96 165.17 37.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.866 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -51.1 156.74 1.69 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.568 0.699 . . . . 0.0 110.884 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 797' ' ' PRO . . . . . 0.549 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.5 Cg_endo -69.77 141.81 46.2 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.663 2.242 . . . . 0.0 112.343 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 798' ' ' PRO . . . . . 0.438 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.6 Cg_endo -69.79 -164.07 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.679 2.252 . . . . 0.0 112.321 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 799' ' ' PHE . . . . . 0.466 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 6.7 p90 -158.56 172.28 18.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 2.7 m -101.7 138.36 38.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -146.72 150.04 34.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 5.3 tttm . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 179.971 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 744' ' ' GLY . . . . . 0.489 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 5.1 m -40.55 155.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.858 0.361 . . . . 0.0 110.867 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 2.8 m -78.5 133.45 37.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -44.53 140.62 2.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 748' ' ' LEU . . . . . 0.553 HD23 ' CD1' ' A' ' 769' ' ' ILE . 4.0 mm? -76.47 148.18 79.86 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.598 0.713 . . . . 0.0 110.932 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.63 168.74 20.51 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.677 2.251 . . . . 0.0 112.38 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -74.31 135.75 42.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 751' ' ' ILE . . . . . 0.635 HD11 ' SG ' ' A' ' 800' ' ' CYS . 1.4 tt -108.05 141.78 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.15 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -83.1 146.84 28.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.939 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 42.44 48.67 4.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 176.74 172.56 41.5 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.477 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 45.5 p90 -153.88 152.55 30.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.81 0.338 . . . . 0.0 110.901 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 756' ' ' LYS . . . . . 0.483 ' O ' HG23 ' A' ' 757' ' ' THR . 7.7 ptpp? -109.42 164.26 12.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 757' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 756' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.098 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 65.3 mt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.853 0.359 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 29.3 m -120.62 174.06 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 49.6 mtm180 -46.78 133.97 10.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.92 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 766' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 767' ' ' ALA . . . 91.48 -34.37 4.36 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.515 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 767' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 766' ' ' GLY . . . -38.02 131.8 1.05 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 0.0 111.027 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 768' ' ' ARG . . . . . 0.551 ' HG2' HG23 ' A' ' 784' ' ' THR . 7.3 tmm_? -117.04 130.86 56.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.872 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 769' ' ' ILE . . . . . 0.553 ' CD1' HD23 ' A' ' 748' ' ' LEU . 56.9 mt -112.64 141.09 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.18 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 5.7 t -111.53 152.9 26.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.167 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -120.49 116.95 26.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.913 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -110.83 124.43 52.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.942 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 77.4 m -109.21 174.22 5.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -60.43 153.08 62.03 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.665 0.745 . . . . 0.0 110.856 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 93.97 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.708 2.272 . . . . 0.0 112.357 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 140.78 -9.82 2.85 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.535 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -100.91 176.31 5.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.885 0.374 . . . . 0.0 110.947 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -128.57 159.53 35.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.865 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 4.4 mt -104.44 143.34 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 780' ' ' VAL . . . . . 0.571 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 86.4 t -124.04 108.93 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.095 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 128.42 -135.82 8.78 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.493 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 3.0 m -107.29 98.99 8.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.371 . . . . 0.0 110.908 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.57 -48.8 57.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.857 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.667 ' C ' HD12 ' A' ' 785' ' ' LEU . 87.5 m -95.42 135.54 36.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.15 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 785' ' ' LEU . . . . . 0.667 HD12 ' C ' ' A' ' 784' ' ' THR . 7.6 mp -122.19 122.35 38.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.96 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 8.1 m -109.5 150.62 27.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.154 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 6.6 t -95.06 120.44 35.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -81.67 -176.69 6.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.938 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -68.72 -16.87 63.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.8 16.14 16.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.862 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 791' ' ' LEU . . . . . 0.489 HD22 ' CA ' ' A' ' 744' ' ' GLY . 68.4 mt 53.99 25.13 5.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.946 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 44.0 m -115.35 131.38 56.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 793' ' ' TRP . . . . . 0.416 ' CE2' HD21 ' A' ' 748' ' ' LEU . 83.5 m95 -63.05 137.84 58.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 794' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 793' ' ' TRP . 9.4 t -37.87 -47.2 1.02 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 68.0 m -156.74 161.99 39.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.866 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -46.4 158.97 0.36 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.59 0.709 . . . . 0.0 110.854 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 140.74 43.08 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.673 2.249 . . . . 0.0 112.293 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -169.77 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.671 2.247 . . . . 0.0 112.37 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 799' ' ' PHE . . . . . 0.571 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 4.1 p90 -159.29 167.41 29.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 800' ' ' CYS . . . . . 0.635 ' SG ' HD11 ' A' ' 751' ' ' ILE . 3.0 m -103.55 138.51 40.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -141.3 112.79 7.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 24.4 tttt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.908 179.992 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 744' ' ' GLY . . . . . 0.556 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 3.6 m -45.39 152.22 0.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.881 0.372 . . . . 0.0 110.859 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 68.4 m -75.91 146.24 39.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -56.26 130.31 43.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 12.4 mt -79.45 149.23 71.64 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.606 0.717 . . . . 0.0 110.895 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 165.1 32.16 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.726 2.284 . . . . 0.0 112.312 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -73.67 144.52 45.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 6.7 tt -100.57 151.86 5.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.127 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -97.45 124.44 41.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 67.17 39.41 3.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -173.41 177.54 45.75 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.465 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -158.34 156.72 31.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.815 0.34 . . . . 0.0 110.935 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -98.24 165.14 12.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 81.0 p . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.123 -179.995 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.824 0.345 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 27.7 m -112.77 155.78 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.122 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -48.84 116.09 1.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 112.61 -26.38 10.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.509 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -45.85 129.07 9.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.774 0.321 . . . . 0.0 111.147 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -115.17 120.79 40.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.861 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 52.3 mt -102.18 150.33 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.129 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 50.1 m -124.06 128.09 48.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.147 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -98.56 136.92 37.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -129.7 129.95 44.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 35.0 m -110.42 173.4 6.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.78 161.14 23.0 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.575 0.703 . . . . 0.0 110.84 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 117.5 5.12 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.656 2.237 . . . . 0.0 112.315 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 121.92 -22.52 7.62 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.479 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -96.55 172.83 7.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.877 0.37 . . . . 0.0 110.935 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -137.47 149.79 47.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.836 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 779' ' ' ILE . . . . . 0.668 HG23 ' HB2' ' A' ' 798' ' ' PRO . 66.8 mt -88.11 134.26 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.118 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 780' ' ' VAL . . . . . 0.565 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 63.6 t -108.25 108.23 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.12 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 124.45 -156.56 18.56 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.48 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 782' ' ' SER . . . . . 0.479 ' O ' HD11 ' A' ' 785' ' ' LEU . 58.2 m -76.87 95.44 4.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.868 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -49.36 -55.2 13.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.861 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.76 ' C ' HD12 ' A' ' 785' ' ' LEU . 87.4 m -92.27 142.19 27.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.076 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 785' ' ' LEU . . . . . 0.76 HD12 ' C ' ' A' ' 784' ' ' THR . 8.2 mp -128.04 143.09 51.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 55.8 m -128.42 151.99 48.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.144 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 14.4 t -94.6 107.08 19.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -61.15 -179.95 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -69.61 -20.27 63.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.871 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -91.92 23.71 3.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.866 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 791' ' ' LEU . . . . . 0.556 HD22 ' HA2' ' A' ' 744' ' ' GLY . 39.3 mt 51.02 29.55 4.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.8 t -117.9 147.34 43.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.825 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 793' ' ' TRP . . . . . 0.432 ' O ' ' C ' ' A' ' 794' ' ' SER . 95.0 m95 -83.78 134.63 34.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.881 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 794' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 793' ' ' TRP . 2.3 t -34.47 -50.51 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 97.7 p -162.07 168.45 22.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.836 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.21 153.14 0.95 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.619 0.723 . . . . 0.0 110.822 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 797' ' ' PRO . . . . . 0.423 ' HA ' HD21 ' A' ' 785' ' ' LEU . 54.0 Cg_endo -69.74 148.07 64.37 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.707 2.271 . . . . 0.0 112.345 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 798' ' ' PRO . . . . . 0.668 ' HB2' HG23 ' A' ' 779' ' ' ILE . 54.3 Cg_endo -69.71 -167.77 0.24 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.699 2.266 . . . . 0.0 112.339 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 799' ' ' PHE . . . . . 0.565 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 1.6 p90 -157.67 164.61 37.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 5.4 m -102.93 113.49 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -126.6 126.13 43.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.971 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 7.1 m -48.8 152.63 0.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.809 0.337 . . . . 0.0 110.879 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 32.4 m -72.96 156.69 38.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.817 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.93 131.96 45.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.831 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 748' ' ' LEU . . . . . 0.448 HD12 HD13 ' A' ' 769' ' ' ILE . 12.2 mt -79.93 148.66 68.83 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.566 0.698 . . . . 0.0 110.928 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 175.47 8.01 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.705 2.27 . . . . 0.0 112.36 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -77.93 149.41 34.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 2.0 tt -106.52 145.76 13.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.129 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -89.8 132.27 35.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 4.7 m120 59.92 44.59 13.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.854 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 178.17 179.72 48.24 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.488 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 755' ' ' TRP . . . . . 0.483 ' CZ2' ' HG2' ' A' ' 772' ' ' GLN . 19.0 p90 -156.06 168.56 26.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.834 0.35 . . . . 0.0 110.94 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.91 165.67 14.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.91 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 51.4 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.112 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 55.8 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.866 0.365 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 23.7 m -84.99 -175.92 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.154 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -53.35 130.68 35.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 103.12 -32.96 6.99 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -50.48 125.14 12.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.755 0.312 . . . . 0.0 111.144 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 768' ' ' ARG . . . . . 0.452 ' HG2' ' CG2' ' A' ' 784' ' ' THR . 8.9 ttp-105 -116.52 145.56 43.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.862 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 769' ' ' ILE . . . . . 0.448 HD13 HD12 ' A' ' 748' ' ' LEU . 39.4 mt -123.89 140.45 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.11 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 18.7 m -108.5 123.01 48.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.147 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -99.67 121.37 41.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.911 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 772' ' ' GLN . . . . . 0.483 ' HG2' ' CZ2' ' A' ' 755' ' ' TRP . 4.3 tp-100 -118.09 143.54 46.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.857 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 73.6 m -124.36 171.1 10.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -62.06 159.68 35.9 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.578 0.704 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 119.66 6.57 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.725 2.283 . . . . 0.0 112.311 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 117.77 -20.21 10.97 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.481 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -96.3 179.31 5.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.882 0.372 . . . . 0.0 110.953 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -141.92 150.41 41.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.847 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 5.6 mt -87.58 144.96 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 780' ' ' VAL . . . . . 0.56 ' HB ' ' CE1' ' A' ' 799' ' ' PHE . 75.3 t -120.69 106.14 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.125 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 126.65 -132.62 7.77 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 3.0 m -101.75 88.34 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.888 0.375 . . . . 0.0 110.891 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -41.65 -33.73 0.51 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.875 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.478 ' C ' HD12 ' A' ' 785' ' ' LEU . 16.7 m -114.7 142.8 46.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 785' ' ' LEU . . . . . 0.88 HD11 ' HD3' ' A' ' 798' ' ' PRO . 9.6 mp -126.64 144.92 50.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 1.9 m -138.18 157.43 46.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.199 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 8.1 t -92.62 118.12 30.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.828 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -77.34 171.85 14.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 1.6 m-90 -59.52 -12.9 7.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -98.0 25.1 6.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 90.3 mt 48.08 25.76 0.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.4 t -121.35 147.34 45.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.84 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 793' ' ' TRP . . . . . 0.447 ' O ' ' C ' ' A' ' 794' ' ' SER . 98.0 m95 -77.79 141.15 39.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.958 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 794' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 793' ' ' TRP . 36.4 t -34.52 -46.41 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 19.4 p -173.11 170.72 4.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.12 151.54 0.2 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.593 0.711 . . . . 0.0 110.862 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 797' ' ' PRO . . . . . 0.466 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.8 Cg_endo -69.76 143.95 52.46 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.626 2.218 . . . . 0.0 112.367 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 798' ' ' PRO . . . . . 0.88 ' HD3' HD11 ' A' ' 785' ' ' LEU . 54.0 Cg_endo -69.75 177.51 5.5 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.696 2.264 . . . . 0.0 112.331 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 799' ' ' PHE . . . . . 0.56 ' CE1' ' HB ' ' A' ' 780' ' ' VAL . 10.0 p90 -149.55 172.55 14.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 12.6 m -102.79 129.51 49.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -129.68 129.66 44.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.896 179.95 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 744' ' ' GLY . . . . . 0.73 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 1.8 m -48.29 171.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.348 . . . . 0.0 110.885 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 56.9 p -100.55 140.7 34.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -46.25 144.01 2.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 16.3 mt -94.85 151.09 38.75 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.619 0.723 . . . . 0.0 110.94 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 151.45 68.99 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.67 2.246 . . . . 0.0 112.349 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -62.97 143.32 57.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 6.7 tt -100.54 153.24 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -97.39 128.42 44.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 61.92 41.3 11.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -173.46 176.21 46.12 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.458 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -152.22 170.52 19.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.827 0.346 . . . . 0.0 110.931 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 756' ' ' LYS . . . . . 0.766 ' HE3' HG21 ' A' ' 769' ' ' ILE . 9.9 ptmt -130.51 168.43 17.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 40.1 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.129 -179.995 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 763' ' ' LEU . . . . . 0.554 HD21 HD11 ' A' ' 769' ' ' ILE . 77.6 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.901 0.382 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 29.4 m -105.55 154.94 6.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.098 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -43.43 124.79 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 105.23 -25.22 25.65 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.485 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -53.88 137.9 37.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 111.084 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -121.95 130.47 53.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 769' ' ' ILE . . . . . 0.766 HG21 ' HE3' ' A' ' 756' ' ' LYS . 69.1 mt -110.68 131.93 60.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 31.1 m -99.01 130.78 45.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.147 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -98.57 120.19 38.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.937 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -117.83 124.21 47.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.917 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 72.1 m -107.55 173.39 6.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.66 157.49 37.62 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.6 0.714 . . . . 0.0 110.888 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 111.3 2.78 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.653 2.236 . . . . 0.0 112.371 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 125.13 -19.84 6.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.473 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -97.75 168.52 10.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.863 0.364 . . . . 0.0 110.932 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -125.72 162.93 23.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.869 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 779' ' ' ILE . . . . . 0.591 HG23 ' HB2' ' A' ' 798' ' ' PRO . 65.4 mt -103.8 135.13 42.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 780' ' ' VAL . . . . . 0.538 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 61.7 t -112.34 107.52 23.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.12 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 127.99 -150.32 18.35 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.449 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 782' ' ' SER . . . . . 0.418 ' O ' HD11 ' A' ' 785' ' ' LEU . 5.2 p -81.28 105.29 12.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.857 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.66 -50.48 73.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 30.7 m -102.47 121.24 41.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.174 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 785' ' ' LEU . . . . . 0.474 HD21 ' HA ' ' A' ' 797' ' ' PRO . 7.8 mp -106.91 148.68 28.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 37.8 m -137.77 153.03 49.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.116 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 12.4 t -93.94 115.91 28.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.912 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -71.86 -177.51 2.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.882 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 53.5 p-90 -71.42 -16.31 62.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.885 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -92.34 23.68 3.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.833 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 791' ' ' LEU . . . . . 0.73 HD22 ' HA2' ' A' ' 744' ' ' GLY . 32.3 mt 48.63 37.5 9.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.6 t -134.47 147.57 50.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.846 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 793' ' ' TRP . . . . . 0.44 ' O ' ' C ' ' A' ' 794' ' ' SER . 88.7 m95 -82.44 141.67 32.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.936 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 794' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 793' ' ' TRP . 1.3 t -35.41 -45.49 0.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.884 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 22.6 t -171.68 171.55 5.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -47.56 150.6 1.68 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.647 0.737 . . . . 0.0 110.833 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 797' ' ' PRO . . . . . 0.474 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.0 Cg_endo -69.8 149.17 66.25 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.685 2.257 . . . . 0.0 112.285 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 798' ' ' PRO . . . . . 0.591 ' HB2' HG23 ' A' ' 779' ' ' ILE . 54.1 Cg_endo -69.83 -171.79 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.678 2.252 . . . . 0.0 112.355 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 799' ' ' PHE . . . . . 0.538 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 3.2 p90 -147.22 167.71 23.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.912 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 3.9 m -102.05 119.18 38.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -123.32 132.59 54.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 24.3 tttp . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 15.3 t -107.91 88.16 2.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.914 0.387 . . . . 0.0 110.833 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 52.0 m -155.55 134.96 12.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.817 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -111.98 -107.25 2.91 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.533 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 3.9 t 64.76 41.54 5.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.905 0.383 . . . . 0.0 110.887 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 73.4 m -122.65 133.34 54.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.852 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . 171.65 142.8 3.82 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.504 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 3.0 m -46.76 170.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 110.895 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 70.4 m -97.35 138.4 34.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.865 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.26 123.94 5.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.857 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 748' ' ' LEU . . . . . 0.485 HD13 ' OH ' ' A' ' 771' ' ' TYR . 24.2 mt -69.42 144.1 94.1 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.611 0.719 . . . . 0.0 110.873 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 143.74 51.8 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.693 2.262 . . . . 0.0 112.325 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -52.12 133.55 33.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 751' ' ' ILE . . . . . 0.498 HG23 ' O ' ' A' ' 754' ' ' GLY . 1.5 tt -100.77 143.78 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.138 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 752' ' ' GLN . . . . . 0.412 ' N ' HG13 ' A' ' 751' ' ' ILE . 26.8 pt20 -82.49 136.39 34.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 5.8 m120 58.71 37.4 25.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 754' ' ' GLY . . . . . 0.498 ' O ' HG23 ' A' ' 751' ' ' ILE . . . -178.23 166.45 36.47 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.474 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -147.48 150.46 34.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.817 0.341 . . . . 0.0 110.912 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -91.54 148.87 21.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 39.5 p -139.92 113.37 8.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.09 145.12 51.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.133 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 24.0 t -64.09 -63.48 1.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -80.78 125.94 30.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.822 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 95.1 m -63.83 -55.29 24.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.173 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -66.81 111.71 3.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 55.9 mt -65.81 111.14 3.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.944 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.09 170.59 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.119 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 40.8 mtt85 -53.91 132.69 42.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 94.24 -26.17 18.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.48 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -45.99 142.62 2.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.799 0.333 . . . . 0.0 111.084 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 768' ' ' ARG . . . . . 0.528 ' HD3' HG21 ' A' ' 784' ' ' THR . 15.6 ttm-85 -119.72 122.88 42.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 769' ' ' ILE . . . . . 0.626 ' CG1' ' CH2' ' A' ' 793' ' ' TRP . 37.3 mm -99.87 143.45 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.077 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 12.0 m -121.11 125.99 48.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.131 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 771' ' ' TYR . . . . . 0.485 ' OH ' HD13 ' A' ' 748' ' ' LEU . 35.0 m-85 -101.66 121.54 42.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -122.45 130.29 52.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.922 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 74.9 m -108.57 174.16 6.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -60.75 159.72 24.14 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.606 0.717 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 114.51 3.73 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.638 2.225 . . . . 0.0 112.332 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 122.01 -22.2 7.66 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.461 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -94.38 174.39 7.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.896 0.379 . . . . 0.0 110.909 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -131.87 155.36 47.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.842 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 779' ' ' ILE . . . . . 0.4 HG23 ' HB2' ' A' ' 798' ' ' PRO . 7.4 mt -97.39 141.0 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 780' ' ' VAL . . . . . 0.428 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 61.0 t -114.1 109.47 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.093 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 125.91 -131.06 7.39 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.481 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 782' ' ' SER . . . . . 0.406 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 1.5 t -107.9 108.52 19.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.852 0.358 . . . . 0.0 110.86 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.45 -31.15 67.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.595 ' C ' HD12 ' A' ' 785' ' ' LEU . 20.8 m -115.49 131.38 56.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.122 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 785' ' ' LEU . . . . . 0.595 HD12 ' C ' ' A' ' 784' ' ' THR . 10.4 mp -123.74 127.65 48.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 786' ' ' THR . . . . . 0.496 HG22 ' N ' ' A' ' 787' ' ' CYS . 26.6 m -107.78 159.61 16.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.144 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 787' ' ' CYS . . . . . 0.496 ' N ' HG22 ' A' ' 786' ' ' THR . 6.5 t -94.47 119.09 32.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -73.62 176.76 5.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -73.39 -7.74 52.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -100.94 12.94 36.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 66.6 mt 61.78 26.92 16.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 14.8 m -130.39 127.35 39.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.873 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 793' ' ' TRP . . . . . 0.626 ' CH2' ' CG1' ' A' ' 769' ' ' ILE . 73.6 m95 -58.38 140.64 53.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.946 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 794' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 793' ' ' TRP . 28.8 t -37.13 -47.98 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.837 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 37.4 m -154.75 167.04 31.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.841 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -51.63 155.8 2.59 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.63 0.729 . . . . 0.0 110.842 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 797' ' ' PRO . . . . . 0.448 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.5 Cg_endo -69.78 145.32 56.68 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.677 2.251 . . . . 0.0 112.329 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 798' ' ' PRO . . . . . 0.4 ' HB2' HG23 ' A' ' 779' ' ' ILE . 54.0 Cg_endo -69.85 -165.28 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.659 2.239 . . . . 0.0 112.348 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 799' ' ' PHE . . . . . 0.428 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.7 p90 -153.67 170.5 20.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.911 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 8.4 m -101.94 135.01 44.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.909 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -130.36 143.04 50.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 802' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 803' ' ' THR . 0.4 OUTLIER -81.28 139.18 35.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 803' ' ' THR . . . . . 0.426 ' N ' ' HD2' ' A' ' 802' ' ' LYS . 84.7 m -100.05 148.93 24.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.2 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -68.87 89.03 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.862 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -147.9 146.98 29.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 70.5 p -131.18 110.61 11.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.847 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . 83.96 159.15 28.57 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.519 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -32.66 18.19 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.713 2.275 . . . . 0.0 112.302 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 16.1 m -115.17 133.88 55.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.86 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 50.3 p -43.66 -57.6 3.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.506 -179.967 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 5.9 t -63.19 -52.19 63.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.941 0.4 . . . . 0.0 110.853 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 89.7 p -83.94 41.5 0.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.887 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 102.73 111.53 3.54 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.531 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 8.7 t -67.26 -51.92 47.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.889 0.376 . . . . 0.0 110.847 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 743' ' ' SER . . . . . 0.468 ' O ' HG12 ' A' ' 764' ' ' VAL . 2.2 m 40.76 44.43 1.88 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.84 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 744' ' ' GLY . . . . . 0.482 ' CA ' ' O ' ' A' ' 763' ' ' LEU . . . -176.15 153.8 15.45 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.499 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 745' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 763' ' ' LEU . 7.5 m -44.86 150.56 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.847 0.356 . . . . 0.0 110.832 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 16.4 m -71.56 147.91 47.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.825 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -60.69 137.34 58.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.906 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 748' ' ' LEU . . . . . 0.531 HD13 ' OH ' ' A' ' 771' ' ' TYR . 12.4 mt -97.0 144.28 27.58 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.631 0.729 . . . . 0.0 110.884 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 163.57 37.82 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.716 2.277 . . . . 0.0 112.361 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -62.32 149.0 43.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.89 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.0 tt -103.08 148.61 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.129 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -85.22 135.28 34.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 5.7 m120 53.92 46.6 25.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 754' ' ' GLY . . . . . 0.465 ' CA ' ' O ' ' A' ' 772' ' ' GLN . . . 175.98 -169.15 41.72 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.462 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 15.0 p90 -156.54 171.78 19.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.816 0.341 . . . . 0.0 110.961 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 17.7 pttm -134.74 159.92 39.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.87 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 77.3 p -133.49 175.19 9.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 70.7 p -137.87 114.07 10.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.161 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 11.9 t -63.43 -58.24 7.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.85 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -88.02 155.26 19.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.815 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 42.2 p -55.08 -50.83 68.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.107 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.92 141.03 46.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.87 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 763' ' ' LEU . . . . . 0.482 ' O ' ' CA ' ' A' ' 744' ' ' GLY . 21.9 mt -69.47 75.96 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.941 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 764' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 743' ' ' SER . 26.9 m -108.38 175.24 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.155 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -41.88 136.63 1.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.861 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 88.1 -29.88 5.37 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.459 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -54.1 130.91 39.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.81 0.338 . . . . 0.0 111.143 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -121.51 150.06 42.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 769' ' ' ILE . . . . . 0.462 HD11 HD22 ' A' ' 763' ' ' LEU . 6.8 mm -115.57 132.4 65.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.174 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 79.0 m -103.46 116.22 31.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.177 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 771' ' ' TYR . . . . . 0.531 ' OH ' HD13 ' A' ' 748' ' ' LEU . 38.9 m-85 -98.54 127.36 44.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.926 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 772' ' ' GLN . . . . . 0.465 ' O ' ' CA ' ' A' ' 754' ' ' GLY . 22.9 tp60 -122.5 137.84 54.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.896 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 64.9 m -115.83 172.05 7.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -60.57 157.06 39.43 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.625 0.726 . . . . 0.0 110.823 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.77 119.1 6.1 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.659 2.239 . . . . 0.0 112.31 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 117.96 -15.06 12.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.452 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -100.12 176.48 5.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 0.0 110.924 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -133.57 157.79 44.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 4.6 mt -97.96 139.29 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.122 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 780' ' ' VAL . . . . . 0.573 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 65.2 t -115.75 113.66 43.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.14 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 116.15 -143.01 17.92 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.535 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 12.6 m -97.99 103.13 15.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.873 0.368 . . . . 0.0 110.823 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -57.8 -52.99 63.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.878 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.844 ' C ' HD12 ' A' ' 785' ' ' LEU . 44.6 m -86.06 141.93 29.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.13 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 785' ' ' LEU . . . . . 0.844 HD12 ' C ' ' A' ' 784' ' ' THR . 7.6 mp -132.03 113.07 12.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.915 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 786' ' ' THR . . . . . 0.414 HG22 ' N ' ' A' ' 787' ' ' CYS . 27.2 m -96.6 154.88 17.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.104 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 787' ' ' CYS . . . . . 0.414 ' N ' HG22 ' A' ' 786' ' ' THR . 4.3 t -95.66 109.56 21.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -61.5 -176.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -69.99 -26.8 64.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.947 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -86.85 20.86 2.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 791' ' ' LEU . . . . . 0.427 HD22 ' HA2' ' A' ' 744' ' ' GLY . 57.5 mt 51.92 44.64 29.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 30.1 t -130.5 156.11 45.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 793' ' ' TRP . . . . . 0.418 ' CD1' HD21 ' A' ' 748' ' ' LEU . 73.8 m95 -84.54 133.07 34.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 40.3 t -37.27 -48.83 0.91 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 8.6 t -157.9 174.62 14.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.801 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.98 156.51 3.45 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.612 0.72 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 797' ' ' PRO . . . . . 0.464 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.8 Cg_endo -69.72 145.37 57.16 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.654 2.236 . . . . 0.0 112.356 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -167.5 0.23 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.689 2.259 . . . . 0.0 112.354 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 799' ' ' PHE . . . . . 0.573 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 1.3 p90 -159.79 164.2 33.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 3.5 m -101.76 133.15 46.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -145.78 140.44 27.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.889 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.55 132.74 54.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 4.6 m -53.03 144.08 15.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.145 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 804' ' ' GLU . . . . . 0.443 ' CD ' ' O ' ' A' ' 804' ' ' GLU . 1.8 pp20? -104.18 36.67 2.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.941 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -75.08 159.22 31.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.918 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 22.8 t -108.93 118.22 36.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.86 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -128.46 -160.51 10.38 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.509 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -1.17 7.98 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.741 2.294 . . . . 0.0 112.305 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 10.6 m -126.25 115.02 19.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.841 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 10.7 t -59.19 114.04 2.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.891 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.506 -179.94 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.388 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 8.2 t -141.08 121.46 14.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.827 0.346 . . . . 0.0 110.895 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 3.7 m 48.65 43.71 20.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.843 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 73.04 110.09 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.468 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 78.1 p -76.23 -30.28 57.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 110.841 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 51.9 m -122.41 101.83 7.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.859 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 744' ' ' GLY . . . . . 0.751 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . 129.1 164.29 11.45 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 57.3 m -53.99 152.22 6.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.822 0.344 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 22.9 t -90.48 165.19 13.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.862 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -59.59 159.09 8.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.876 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 13.7 mt -110.29 149.0 39.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.629 0.728 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 146.08 59.19 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.71 2.273 . . . . 0.0 112.358 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -54.96 141.12 35.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.907 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 751' ' ' ILE . . . . . 0.421 HG13 ' N ' ' A' ' 752' ' ' GLN . 1.9 tt -103.82 146.49 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.077 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 752' ' ' GLN . . . . . 0.421 ' N ' HG13 ' A' ' 751' ' ' ILE . 21.1 mt-30 -87.15 136.7 32.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.921 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 60.5 47.33 8.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 169.79 170.57 34.39 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.5 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 17.5 p90 -148.39 152.75 37.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.829 0.347 . . . . 0.0 110.93 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -96.71 168.94 10.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 757' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 757' ' ' THR . 5.0 t -161.14 119.66 2.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.147 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 3.9 t -146.19 133.3 20.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.172 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 4.5 m -92.96 47.03 1.25 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.849 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -124.5 97.66 5.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.888 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 24.0 p -43.99 -48.54 8.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -122.11 119.8 32.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 82.5 mt -59.17 102.18 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.901 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 31.6 m -125.65 172.09 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -47.52 128.17 12.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 98.92 -18.77 56.36 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.485 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -56.94 132.27 52.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.743 0.306 . . . . 0.0 111.09 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 768' ' ' ARG . . . . . 0.42 ' HD2' ' C ' ' A' ' 768' ' ' ARG . 3.9 tmm_? -128.13 132.78 48.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.881 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 63.7 mt -113.59 144.09 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.167 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 87.3 m -110.41 131.94 54.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.113 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -103.96 118.21 36.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -110.29 136.39 49.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.937 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 83.8 m -115.83 171.87 7.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -60.99 159.53 26.85 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.588 0.709 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 122.02 8.69 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.674 2.25 . . . . 0.0 112.337 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 113.76 -22.3 14.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.453 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 777' ' ' TYR . . . . . 0.4 ' CE2' ' HB2' ' A' ' 802' ' ' LYS . 18.6 m-85 -86.5 178.56 7.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.912 0.387 . . . . 0.0 110.902 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.75 135.33 26.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.866 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 3.6 mt -74.54 150.42 7.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 780' ' ' VAL . . . . . 0.566 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 89.6 t -128.49 108.82 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.094 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 123.67 -134.02 9.13 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.488 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 43.7 m -105.22 98.81 8.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.883 0.373 . . . . 0.0 110.879 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.72 -39.21 76.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.827 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.801 ' C ' HD12 ' A' ' 785' ' ' LEU . 25.8 m -93.18 141.75 28.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.16 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 785' ' ' LEU . . . . . 0.801 HD12 ' C ' ' A' ' 784' ' ' THR . 9.4 mp -133.5 119.09 19.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 1.2 m -114.93 153.88 29.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.08 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 3.2 t -92.44 121.77 34.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.849 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -86.48 173.85 9.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 5.1 p90 -55.32 -17.07 4.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.927 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -94.13 23.05 5.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.82 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 791' ' ' LEU . . . . . 0.751 HD22 ' HA2' ' A' ' 744' ' ' GLY . 23.1 mt 45.38 24.98 0.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.949 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.4 t -117.14 150.44 38.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 793' ' ' TRP . . . . . 0.404 ' O ' ' C ' ' A' ' 794' ' ' SER . 86.3 m95 -77.08 142.99 39.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.935 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 794' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 793' ' ' TRP . 40.5 t -37.66 -42.85 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.828 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 5.1 t -171.3 173.19 4.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -46.43 154.54 0.64 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.632 0.73 . . . . 0.0 110.884 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 145.79 58.7 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.695 2.263 . . . . 0.0 112.369 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 798' ' ' PRO . . . . . 0.467 ' HD3' HD11 ' A' ' 785' ' ' LEU . 54.3 Cg_endo -69.75 177.86 5.15 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.678 2.252 . . . . 0.0 112.39 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 799' ' ' PHE . . . . . 0.566 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 0.8 OUTLIER -142.95 166.64 24.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 11.9 m -102.48 124.48 48.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -118.75 133.09 56.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 802' ' ' LYS . . . . . 0.4 ' HB2' ' CE2' ' A' ' 777' ' ' TYR . 32.0 tttt -73.88 145.56 44.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 32.7 p -60.16 141.01 56.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.154 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -83.62 88.15 7.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -53.43 -61.44 2.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.932 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 1.7 t -106.09 -51.31 3.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . 70.74 -158.76 53.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.492 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 808' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 810' ' ' SER . 53.7 Cg_endo -69.73 -13.82 35.28 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.714 2.276 . . . . 0.0 112.311 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 7.8 t -54.2 87.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 810' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 808' ' ' PRO . 87.0 p -95.08 139.17 31.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.553 -179.973 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 4.7 m -49.52 130.66 20.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 110.868 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 15.3 t -89.61 55.45 3.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 157.09 81.35 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.44 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 84.0 p -136.06 139.04 42.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.9 0.381 . . . . 0.0 110.849 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 19.0 m -135.32 161.03 36.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.925 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 744' ' ' GLY . . . . . 0.426 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . 136.17 -169.9 23.47 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.49 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 1.8 m -59.04 162.14 4.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.867 0.365 . . . . 0.0 110.869 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 23.5 p -92.08 144.74 25.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -38.27 150.13 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.866 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 14.8 mt -106.46 151.95 40.48 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.651 0.739 . . . . 0.0 110.925 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 141.29 44.57 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.657 2.238 . . . . 0.0 112.364 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -54.0 145.59 16.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 751' ' ' ILE . . . . . 0.422 HG13 ' N ' ' A' ' 752' ' ' GLN . 2.1 tt -100.95 147.73 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.111 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 752' ' ' GLN . . . . . 0.422 ' N ' HG13 ' A' ' 751' ' ' ILE . 40.8 mt-30 -90.83 139.51 30.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 50.41 41.64 25.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -177.37 -173.62 43.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.504 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -157.4 159.41 37.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.784 0.326 . . . . 0.0 110.949 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 756' ' ' LYS . . . . . 0.41 ' C ' ' HD2' ' A' ' 756' ' ' LYS . 0.0 OUTLIER -118.62 152.44 36.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.939 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 55.7 p -138.65 136.67 36.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.19 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 758' ' ' THR . . . . . 0.681 HG21 HD21 ' A' ' 763' ' ' LEU . 71.2 p -100.31 149.7 23.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.16 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 2.0 t -106.31 42.98 1.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.842 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -163.4 165.58 23.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 34.9 m -71.51 -43.72 65.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.124 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 762' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 764' ' ' VAL . 3.0 tm-20 -133.78 138.45 45.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 763' ' ' LEU . . . . . 0.681 HD21 HG21 ' A' ' 758' ' ' THR . 86.0 mt -62.71 74.86 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.959 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 764' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' A' ' 762' ' ' GLU . 28.3 m -101.55 156.75 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 765' ' ' ARG . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 765' ' ' ARG . 25.4 mtm105 -34.73 139.52 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 87.75 -25.6 8.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -57.11 139.9 51.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.787 0.327 . . . . 0.0 111.095 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -115.08 157.36 23.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.904 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 769' ' ' ILE . . . . . 0.492 ' CD1' HG22 ' A' ' 758' ' ' THR . 34.0 mm -114.27 140.19 36.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.144 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 89.1 m -113.52 119.5 37.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.181 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -97.68 121.67 39.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -121.34 124.7 45.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.93 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 62.9 m -110.51 174.35 5.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.46 157.48 35.69 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.592 0.711 . . . . 0.0 110.882 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 106.99 1.77 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.671 2.247 . . . . 0.0 112.337 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 131.87 -15.03 5.17 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.461 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -104.4 169.88 8.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.882 0.373 . . . . 0.0 110.919 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.12 160.78 30.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 8.7 mt -96.71 139.34 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.114 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 780' ' ' VAL . . . . . 0.516 ' HB ' ' CE1' ' A' ' 799' ' ' PHE . 72.0 t -114.0 106.43 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 125.82 -149.62 17.32 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.506 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 782' ' ' SER . . . . . 0.476 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 93.0 p -82.03 103.02 11.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.885 0.374 . . . . 0.0 110.842 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -57.14 -44.56 83.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 31.4 m -105.98 124.29 49.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.152 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 785' ' ' LEU . . . . . 0.476 ' CD1' ' O ' ' A' ' 782' ' ' SER . 10.7 mp -113.45 120.0 39.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.923 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 26.0 m -107.41 154.03 21.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.174 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 6.6 t -94.46 125.1 38.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.835 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -75.91 177.04 7.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 2.2 p90 -69.76 -19.06 63.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.964 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 790' ' ' ASP . . . . . 0.421 ' O ' ' CG ' ' A' ' 790' ' ' ASP . 23.2 t0 -96.24 23.65 6.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 791' ' ' LEU . . . . . 0.426 HD22 ' CA ' ' A' ' 744' ' ' GLY . 15.8 mt 51.21 35.8 14.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.91 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 49.4 m -120.77 135.56 55.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 793' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -72.22 147.11 46.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 5.0 t -48.54 -41.64 30.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.859 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 1.3 t -175.06 -178.72 1.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -54.32 147.06 29.21 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.599 0.714 . . . . 0.0 110.846 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 142.98 49.51 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.648 2.232 . . . . 0.0 112.349 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -164.73 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.695 2.263 . . . . 0.0 112.36 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 799' ' ' PHE . . . . . 0.516 ' CE1' ' HB ' ' A' ' 780' ' ' VAL . 18.6 p90 -161.9 173.95 13.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.882 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 800' ' ' CYS . . . . . 0.407 ' SG ' HD11 ' A' ' 751' ' ' ILE . 3.4 m -103.07 136.14 43.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.913 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -146.99 131.53 17.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -50.84 124.85 12.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.925 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 25.1 m -60.16 144.13 50.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.19 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 804' ' ' GLU . . . . . 0.435 ' CD ' ' O ' ' A' ' 804' ' ' GLU . 0.1 OUTLIER -83.34 42.03 0.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -56.13 -58.48 7.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.829 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 8.4 t -96.23 95.61 8.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.847 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -133.32 -158.77 8.85 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.51 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -179.12 2.7 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.682 2.254 . . . . 0.0 112.322 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 22.0 p -134.07 155.33 50.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.897 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 3.2 m -156.83 105.93 2.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.887 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.466 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 3.3 t -82.23 141.63 32.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.887 0.375 . . . . 0.0 110.866 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 78.1 p -109.75 -27.19 9.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.826 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -100.6 178.5 28.79 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.482 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 40.6 t -137.7 135.5 36.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.831 0.348 . . . . 0.0 110.881 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 23.7 m -51.91 168.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 744' ' ' GLY . . . . . 0.675 ' H ' HD13 ' A' ' 791' ' ' LEU . . . 104.4 149.41 19.75 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.524 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 745' ' ' CYS . . . . . 0.413 ' HB3' ' CE2' ' A' ' 793' ' ' TRP . 9.8 m -37.51 152.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 0.0 110.893 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 60.8 p -84.7 155.69 21.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -62.42 142.66 57.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 58.7 mt -90.43 149.4 40.91 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.624 0.726 . . . . 0.0 110.927 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 134.2 27.38 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.693 2.262 . . . . 0.0 112.347 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -42.35 146.63 0.31 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.911 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 751' ' ' ILE . . . . . 0.487 HD11 ' SG ' ' A' ' 800' ' ' CYS . 2.7 tt -102.91 148.86 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -88.18 137.98 31.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 18.0 t30 51.97 43.15 30.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 754' ' ' GLY . . . . . 0.449 ' O ' HG23 ' A' ' 751' ' ' ILE . . . 178.08 176.62 46.19 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.477 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -149.31 179.03 8.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.805 0.336 . . . . 0.0 110.956 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.54 172.09 13.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.897 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 20.4 p -154.28 106.18 2.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 26.7 m -58.32 153.69 14.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.173 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 12.2 t -78.68 -48.53 14.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.849 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -108.33 147.82 30.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.897 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 95.6 m -53.44 -55.25 26.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 762' ' ' GLU . . . . . 0.434 ' O ' HG13 ' A' ' 764' ' ' VAL . 3.8 mm-40 -97.23 120.92 38.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 94.3 mt -54.92 101.53 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.965 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 764' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 762' ' ' GLU . 29.2 m -124.89 152.43 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.083 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -41.22 131.16 2.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 98.76 -23.45 36.28 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -58.7 147.5 32.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.82 0.343 . . . . 0.0 111.047 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -135.46 145.09 46.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 25.3 mt -120.0 142.96 33.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.148 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 3.5 t -109.4 153.47 23.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 771' ' ' TYR . . . . . 0.431 ' HD2' HD13 ' A' ' 751' ' ' ILE . 25.4 m-85 -119.41 129.6 54.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.913 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -125.8 122.4 36.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.96 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 60.2 m -106.55 174.07 6.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.5 158.98 26.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.642 0.734 . . . . 0.0 110.876 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 111.18 2.74 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.701 2.268 . . . . 0.0 112.332 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 126.98 -14.68 6.61 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.49 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -104.72 173.28 6.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.889 0.376 . . . . 0.0 110.96 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -134.6 147.75 50.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.837 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 779' ' ' ILE . . . . . 0.426 HD11 ' O ' ' A' ' 771' ' ' TYR . 24.1 mt -82.96 144.87 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.141 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 780' ' ' VAL . . . . . 0.557 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 58.3 t -118.15 105.87 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.162 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 125.11 -150.46 17.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.507 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 782' ' ' SER . . . . . 0.528 ' O ' HD11 ' A' ' 785' ' ' LEU . 43.7 m -85.2 106.73 16.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 0.0 110.832 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -57.27 -49.16 76.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.855 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.544 ' C ' HD12 ' A' ' 785' ' ' LEU . 21.0 m -102.12 126.79 49.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 785' ' ' LEU . . . . . 0.57 HD21 ' HA ' ' A' ' 797' ' ' PRO . 7.0 mp -113.61 111.01 21.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 786' ' ' THR . . . . . 0.497 HG22 ' N ' ' A' ' 787' ' ' CYS . 32.6 m -94.37 159.4 15.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.163 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 787' ' ' CYS . . . . . 0.497 ' N ' HG22 ' A' ' 786' ' ' THR . 7.0 t -96.93 117.59 31.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -75.5 175.37 8.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 11.6 p-90 -62.15 -21.87 65.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -88.98 20.61 3.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.884 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 791' ' ' LEU . . . . . 0.675 HD13 ' H ' ' A' ' 744' ' ' GLY . 23.3 mt 51.2 31.85 7.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 36.1 t -121.97 153.83 38.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 793' ' ' TRP . . . . . 0.439 ' O ' ' C ' ' A' ' 794' ' ' SER . 88.6 m95 -83.99 140.73 31.7 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 794' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 793' ' ' TRP . 8.5 t -34.55 -44.83 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 8.6 t -173.03 173.03 3.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -44.93 151.04 0.67 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.586 0.708 . . . . 0.0 110.856 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 797' ' ' PRO . . . . . 0.57 ' HA ' HD21 ' A' ' 785' ' ' LEU . 54.2 Cg_endo -69.75 147.82 63.78 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.678 2.252 . . . . 0.0 112.39 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 798' ' ' PRO . . . . . 0.408 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.8 Cg_endo -69.74 -163.87 0.12 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.697 2.265 . . . . 0.0 112.385 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 799' ' ' PHE . . . . . 0.557 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 3.9 p90 -160.6 170.24 21.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 800' ' ' CYS . . . . . 0.487 ' SG ' HD11 ' A' ' 751' ' ' ILE . 19.9 m -104.21 119.41 38.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.876 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -128.19 126.16 40.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -51.42 141.69 15.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 80.8 p -39.92 144.21 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.103 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -98.01 129.35 44.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.855 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -90.9 58.07 3.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.877 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 4.0 m -99.16 147.88 24.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.847 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . 135.56 -97.65 0.28 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.481 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -25.98 28.32 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.637 2.225 . . . . 0.0 112.36 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 35.7 t -49.87 141.9 9.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.866 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 38.9 t -126.82 116.49 20.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.861 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.477 179.994 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 71.0 p -74.56 99.65 3.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.908 0.385 . . . . 0.0 110.832 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 20.1 m -75.23 117.38 16.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.887 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -90.14 49.75 3.3 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.465 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 27.5 t -95.57 121.9 37.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.368 . . . . 0.0 110.877 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 44.0 m -142.52 162.33 35.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.846 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 744' ' ' GLY . . . . . 0.407 ' H ' HD13 ' A' ' 791' ' ' LEU . . . 129.83 164.38 11.37 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.489 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 745' ' ' CYS . . . . . 0.506 ' HB3' ' CE2' ' A' ' 793' ' ' TRP . 1.8 m -40.23 152.91 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.841 0.353 . . . . 0.0 110.886 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 27.1 m -79.79 140.46 36.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.82 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -44.11 141.0 1.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.867 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 43.7 mt -93.08 148.59 36.0 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.595 0.712 . . . . 0.0 110.932 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -174.09 0.84 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.697 2.265 . . . . 0.0 112.339 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -95.24 143.27 26.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 751' ' ' ILE . . . . . 0.485 HD11 ' SG ' ' A' ' 800' ' ' CYS . 3.0 tt -100.72 144.37 12.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.077 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 19.7 mp0 -78.17 132.09 37.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.912 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 55.59 40.22 31.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 754' ' ' GLY . . . . . 0.46 ' C ' HG23 ' A' ' 751' ' ' ILE . . . -174.26 176.4 46.64 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.513 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 32.6 p90 -157.24 161.59 39.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.799 0.333 . . . . 0.0 110.916 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -108.84 159.01 17.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.902 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 56.5 p -148.62 120.3 8.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.143 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 4.5 t -134.74 131.38 37.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 89.7 p -67.34 -42.1 84.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -70.91 129.86 40.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 88.1 m -73.37 -66.85 0.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.108 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -72.94 107.94 5.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.908 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 763' ' ' LEU . . . . . 0.476 HD22 HD11 ' A' ' 769' ' ' ILE . 78.4 mt -64.41 82.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 34.4 m -96.4 159.91 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 765' ' ' ARG . . . . . 0.559 ' NE ' HD21 ' A' ' 791' ' ' LEU . 6.1 ptp180 -45.65 132.95 8.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 101.94 -39.99 2.57 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.485 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -46.77 157.58 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 111.114 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 768' ' ' ARG . . . . . 0.52 ' O ' HD13 ' A' ' 769' ' ' ILE . 72.4 mtt180 -123.99 172.93 8.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 769' ' ' ILE . . . . . 0.52 HD13 ' O ' ' A' ' 768' ' ' ARG . 8.2 mm -143.12 134.08 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 17.1 m -100.6 113.67 26.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.129 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 771' ' ' TYR . . . . . 0.737 ' HE2' HD22 ' A' ' 785' ' ' LEU . 22.7 m-85 -96.79 124.24 40.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.918 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -126.79 137.57 53.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 75.2 m -115.2 174.19 6.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.904 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -60.54 157.47 36.44 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.636 0.732 . . . . 0.0 110.829 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 112.93 3.21 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.665 2.243 . . . . 0.0 112.365 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 124.84 -22.23 6.47 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.484 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -95.32 178.24 5.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.896 0.379 . . . . 0.0 110.868 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -136.67 156.42 48.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.876 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 779' ' ' ILE . . . . . 0.702 HG23 ' HB2' ' A' ' 798' ' ' PRO . 74.3 mt -98.69 135.26 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.14 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 780' ' ' VAL . . . . . 0.576 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 61.8 t -112.16 106.77 21.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.136 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 128.0 -149.0 17.97 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.448 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 21.9 m -83.06 107.47 15.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.866 0.365 . . . . 0.0 110.849 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.25 -46.17 90.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 25.6 m -101.93 122.11 43.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 785' ' ' LEU . . . . . 0.737 HD22 ' HE2' ' A' ' 771' ' ' TYR . 9.8 mp -103.3 114.46 28.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 10.1 m -107.92 147.27 31.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.136 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 8.8 t -92.51 137.55 32.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.847 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -87.97 169.4 12.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -56.0 -25.09 42.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -86.75 21.2 2.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.836 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 791' ' ' LEU . . . . . 0.559 HD21 ' NE ' ' A' ' 765' ' ' ARG . 7.4 mt 51.22 37.47 18.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 90.4 p -122.38 136.41 54.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.825 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 793' ' ' TRP . . . . . 0.506 ' CE2' ' HB3' ' A' ' 745' ' ' CYS . 97.1 m95 -67.9 140.53 56.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.928 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 1.5 t -42.73 -48.62 5.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.899 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 8.4 t -168.78 173.82 6.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.855 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.97 151.16 4.72 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.576 0.703 . . . . 0.0 110.851 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 797' ' ' PRO . . . . . 0.522 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.7 Cg_endo -69.81 144.49 53.96 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.67 2.246 . . . . 0.0 112.345 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 798' ' ' PRO . . . . . 0.702 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.6 Cg_endo -69.7 -175.25 1.08 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.715 2.277 . . . . 0.0 112.332 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 799' ' ' PHE . . . . . 0.576 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.4 p90 -145.27 165.4 28.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 800' ' ' CYS . . . . . 0.485 ' SG ' HD11 ' A' ' 751' ' ' ILE . 2.6 m -103.75 128.26 51.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -129.83 151.0 50.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 802' ' ' LYS . . . . . 0.42 ' HD2' ' C ' ' A' ' 802' ' ' LYS . 1.6 tmmm? -73.85 135.95 43.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 36.7 p -94.87 134.76 37.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.121 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -82.52 124.89 30.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -122.57 86.52 2.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 3.1 t 59.2 44.46 15.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.912 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -153.02 146.04 14.12 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.515 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 177.17 5.85 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.639 2.226 . . . . 0.0 112.36 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 80.2 p -153.91 165.33 36.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.855 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 35.6 p -128.13 123.91 35.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.248 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.464 -179.987 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 2.5 t -64.43 114.75 4.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.894 0.378 . . . . 0.0 110.884 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 19.6 t 66.49 41.05 3.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.873 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -94.02 -58.65 1.22 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.513 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 80.1 p -172.0 121.43 0.47 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.854 0.359 . . . . 0.0 110.871 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 5.8 m -93.35 30.98 1.57 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.846 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 744' ' ' GLY . . . . . 0.409 ' CA ' ' HA ' ' A' ' 764' ' ' VAL . . . 52.78 -163.81 1.94 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.474 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 9.1 m -78.98 155.03 29.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.817 0.342 . . . . 0.0 110.918 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 77.5 p -73.24 149.45 42.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.862 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -54.09 163.09 0.84 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 11.7 mt -115.27 148.17 40.17 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.574 0.702 . . . . 0.0 110.932 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 144.28 53.42 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.726 2.284 . . . . 0.0 112.319 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -54.23 147.44 13.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 751' ' ' ILE . . . . . 0.405 HG13 ' N ' ' A' ' 752' ' ' GLN . 1.5 tt -105.17 144.1 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.093 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 752' ' ' GLN . . . . . 0.405 ' N ' HG13 ' A' ' 751' ' ' ILE . 23.2 mt-30 -89.04 145.47 25.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 47.3 47.9 16.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 179.96 179.96 48.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.461 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 47.3 p90 -154.96 154.23 32.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.839 0.352 . . . . 0.0 110.888 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -124.55 159.43 30.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.922 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 76.3 p -143.43 148.03 35.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.096 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 758' ' ' THR . . . . . 0.412 HG21 HD21 ' A' ' 763' ' ' LEU . 10.2 t -169.09 135.18 1.68 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.147 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 15.7 m -121.86 79.07 1.53 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.844 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 760' ' ' HIS . . . . . 0.505 ' CE1' ' HA ' ' A' ' 767' ' ' ALA . 29.6 m-70 -132.04 -179.54 5.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.849 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 761' ' ' THR . . . . . 0.542 ' O ' HG13 ' A' ' 764' ' ' VAL . 65.8 p -103.22 106.79 17.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.151 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 762' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 763' ' ' LEU . 16.0 mt-10 55.06 36.92 28.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 763' ' ' LEU . . . . . 0.614 HD22 HD11 ' A' ' 769' ' ' ILE . 7.8 mt 33.27 53.56 0.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.927 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 764' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 761' ' ' THR . 33.1 m -86.11 175.68 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.12 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 765' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 764' ' ' VAL . 88.2 mtm180 -36.54 137.82 0.27 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 90.25 -31.55 5.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.486 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 767' ' ' ALA . . . . . 0.505 ' HA ' ' CE1' ' A' ' 760' ' ' HIS . . . -50.54 125.5 13.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.737 0.304 . . . . 0.0 111.116 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -119.41 140.87 49.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.867 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 769' ' ' ILE . . . . . 0.614 HD11 HD22 ' A' ' 763' ' ' LEU . 68.1 mt -121.92 142.0 40.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.121 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 6.2 t -107.21 154.27 21.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.167 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 771' ' ' TYR . . . . . 0.468 ' HE2' HD22 ' A' ' 785' ' ' LEU . 47.3 m-85 -124.81 120.05 30.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -119.25 128.22 53.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.918 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 69.1 m -109.8 173.54 6.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -60.45 159.03 26.0 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.588 0.709 . . . . 0.0 110.858 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 121.12 7.81 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.711 2.274 . . . . 0.0 112.337 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 104.71 11.12 31.41 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -116.99 172.24 7.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.905 0.383 . . . . 0.0 110.881 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -126.95 155.17 43.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.848 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 5.3 mt -103.32 138.39 27.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.138 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 780' ' ' VAL . . . . . 0.564 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 56.3 t -114.51 107.98 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 129.53 -134.03 7.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.473 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 782' ' ' SER . . . . . 0.527 ' O ' HD11 ' A' ' 785' ' ' LEU . 1.6 t -109.82 109.86 20.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.862 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -57.44 -37.33 72.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.845 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.723 ' C ' HD12 ' A' ' 785' ' ' LEU . 16.7 m -108.84 134.28 51.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 785' ' ' LEU . . . . . 0.723 HD12 ' C ' ' A' ' 784' ' ' THR . 8.7 mp -127.11 120.31 28.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 786' ' ' THR . . . . . 0.478 HG22 ' N ' ' A' ' 787' ' ' CYS . 16.6 m -111.07 160.79 16.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.107 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 787' ' ' CYS . . . . . 0.478 ' N ' HG22 ' A' ' 786' ' ' THR . 16.5 t -94.46 135.39 35.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -91.62 177.56 6.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 3.0 p90 -73.03 -3.55 26.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -107.44 17.37 22.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.897 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 31.7 mt 57.6 28.66 15.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.8 t -123.24 148.65 45.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 793' ' ' TRP . . . . . 0.431 ' O ' ' C ' ' A' ' 794' ' ' SER . 95.9 m95 -85.51 137.98 32.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.93 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 794' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 793' ' ' TRP . 37.9 t -34.8 -50.27 0.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.838 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 45.5 m -164.24 152.83 13.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -37.84 153.53 0.13 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.635 0.731 . . . . 0.0 110.863 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 797' ' ' PRO . . . . . 0.568 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.4 Cg_endo -69.83 145.84 57.94 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.676 2.251 . . . . 0.0 112.329 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -164.91 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.666 2.244 . . . . 0.0 112.397 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 799' ' ' PHE . . . . . 0.564 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.6 p90 -154.78 169.1 24.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.854 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 4.0 m -104.97 121.11 43.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.872 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -129.63 121.68 27.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -52.24 121.13 6.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 77.4 p -50.8 158.31 0.68 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.15 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -71.73 136.18 47.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -78.7 124.47 28.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 7.8 t -85.5 109.91 18.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.847 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -112.14 172.12 14.57 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.516 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 153.09 69.07 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.652 2.235 . . . . 0.0 112.287 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 84.6 p -74.88 -43.94 51.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.848 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 29.8 t -73.9 138.42 44.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.87 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.487 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 4.3 m -143.67 154.03 43.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 110.859 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 34.0 t -119.71 136.97 54.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.856 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 133.55 44.33 0.13 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.477 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 2.6 t -61.44 114.8 3.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.897 0.379 . . . . 0.0 110.855 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 40.1 t -144.25 169.81 17.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.814 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . 129.1 151.55 7.41 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.533 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 2.0 m -59.75 154.77 17.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.862 0.363 . . . . 0.0 110.848 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 84.8 p -71.27 141.01 50.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -46.15 144.36 1.99 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.88 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 748' ' ' LEU . . . . . 0.443 HD13 ' OH ' ' A' ' 771' ' ' TYR . 35.0 mt -92.11 144.93 29.88 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.597 0.713 . . . . 0.0 110.911 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 156.73 62.6 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.624 2.216 . . . . 0.0 112.325 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.32 147.03 53.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 751' ' ' ILE . . . . . 0.442 HD11 ' SG ' ' A' ' 800' ' ' CYS . 3.0 tt -102.66 149.66 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.16 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -90.77 141.75 28.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 46.16 49.73 12.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 177.82 -173.67 46.23 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.45 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 755' ' ' TRP . . . . . 0.444 ' NE1' ' HB2' ' A' ' 772' ' ' GLN . 15.4 p90 -154.94 -177.94 6.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.852 0.358 . . . . 0.0 110.896 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.67 165.82 25.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 8.8 t -166.09 146.03 6.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 6.1 t -149.46 151.01 33.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.152 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 18.7 m -98.69 -50.53 4.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -41.06 157.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 44.9 p -54.78 -178.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.142 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -42.1 161.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 763' ' ' LEU . . . . . 0.815 HD21 HD11 ' A' ' 769' ' ' ILE . 37.8 mt -53.73 100.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.955 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 764' ' ' VAL . . . . . 0.513 ' H ' ' HB2' ' A' ' 767' ' ' ALA . 34.9 m -132.99 177.47 7.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -52.78 108.11 0.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 103.32 10.41 36.31 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.458 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 767' ' ' ALA . . . . . 0.513 ' HB2' ' H ' ' A' ' 764' ' ' VAL . . . -65.63 140.24 58.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.793 0.33 . . . . 0.0 111.105 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 768' ' ' ARG . . . . . 0.403 ' HG3' ' CG2' ' A' ' 784' ' ' THR . 36.5 ttm180 -130.22 119.56 23.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.904 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 769' ' ' ILE . . . . . 0.815 HD11 HD21 ' A' ' 763' ' ' LEU . 68.8 mt -116.53 144.9 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.136 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 19.1 m -110.0 143.85 39.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.132 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 771' ' ' TYR . . . . . 0.443 ' OH ' HD13 ' A' ' 748' ' ' LEU . 52.1 m-85 -113.18 121.99 46.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.889 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 772' ' ' GLN . . . . . 0.444 ' HB2' ' NE1' ' A' ' 755' ' ' TRP . 22.1 mp0 -110.28 137.43 48.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.942 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 77.5 m -114.59 171.89 7.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.871 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 774' ' ' ASP . . . . . 0.456 ' HB2' ' CD1' ' A' ' 777' ' ' TYR . 0.3 OUTLIER -64.01 154.49 81.71 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.605 0.717 . . . . 0.0 110.832 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 96.03 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.679 2.253 . . . . 0.0 112.368 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 139.32 -5.53 2.96 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.465 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 777' ' ' TYR . . . . . 0.456 ' CD1' ' HB2' ' A' ' 774' ' ' ASP . 18.8 m-85 -106.23 179.26 4.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.868 0.366 . . . . 0.0 110.953 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -134.61 146.08 49.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 779' ' ' ILE . . . . . 0.402 HG23 ' HB2' ' A' ' 798' ' ' PRO . 11.0 mt -91.2 142.13 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.158 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 780' ' ' VAL . . . . . 0.578 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 50.9 t -120.83 108.64 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.111 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 127.21 -134.75 8.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 782' ' ' SER . . . . . 0.546 ' O ' HD11 ' A' ' 785' ' ' LEU . 1.3 t -106.84 112.22 25.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.831 0.348 . . . . 0.0 110.877 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -61.17 -36.88 81.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.872 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.532 ' C ' HD12 ' A' ' 785' ' ' LEU . 15.4 m -110.32 123.55 50.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.136 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 785' ' ' LEU . . . . . 0.751 HD21 ' HA ' ' A' ' 797' ' ' PRO . 7.3 mp -115.06 122.25 45.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.945 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 786' ' ' THR . . . . . 0.43 HG22 ' N ' ' A' ' 787' ' ' CYS . 20.4 m -107.01 156.82 18.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.132 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 787' ' ' CYS . . . . . 0.43 ' N ' HG22 ' A' ' 786' ' ' THR . 41.4 t -95.81 109.96 22.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.895 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -61.38 168.08 2.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -62.61 -17.77 60.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -94.02 19.91 8.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.848 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 80.5 mt 54.14 37.45 27.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 13.4 m -132.4 123.26 26.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 793' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -58.09 133.45 55.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 15.2 t -37.27 -42.62 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 37.9 m -164.31 164.17 22.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.58 154.77 4.33 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.597 0.713 . . . . 0.0 110.858 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 797' ' ' PRO . . . . . 0.751 ' HA ' HD21 ' A' ' 785' ' ' LEU . 54.1 Cg_endo -69.77 144.82 55.21 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.656 2.237 . . . . 0.0 112.339 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 798' ' ' PRO . . . . . 0.402 ' HB2' HG23 ' A' ' 779' ' ' ILE . 54.1 Cg_endo -69.75 -164.19 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.68 2.253 . . . . 0.0 112.324 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 799' ' ' PHE . . . . . 0.578 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.9 p90 -156.71 165.52 36.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.882 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 800' ' ' CYS . . . . . 0.442 ' SG ' HD11 ' A' ' 751' ' ' ILE . 3.8 m -102.24 117.51 34.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -117.68 134.47 54.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.935 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -80.59 110.53 16.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 81.1 p -84.24 151.45 24.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.157 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -137.18 165.3 26.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -96.05 -44.84 7.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.843 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 36.4 m -43.87 163.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.849 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -130.03 -158.18 9.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.427 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 121.33 8.02 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.681 2.254 . . . . 0.0 112.341 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 54.4 p -103.51 147.19 27.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 12.3 t -97.07 -50.9 4.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.456 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 1.3 t -162.07 151.07 15.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.894 0.378 . . . . 0.0 110.826 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 50.2 m -69.09 106.57 2.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.854 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -73.66 -78.95 0.54 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.475 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 50.9 p -118.62 131.85 56.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.872 0.368 . . . . 0.0 110.854 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 52.8 m -120.22 44.13 2.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 744' ' ' GLY . . . . . 0.431 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . 53.27 170.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.465 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 3.6 m -60.72 161.25 8.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.86 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 67.4 m -74.84 141.92 44.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -48.86 155.45 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 69.9 mt -105.1 149.05 37.19 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.635 0.731 . . . . 0.0 110.933 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 164.59 33.96 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.684 2.256 . . . . 0.0 112.329 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -73.89 142.08 46.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 751' ' ' ILE . . . . . 0.699 HD11 ' SG ' ' A' ' 800' ' ' CYS . 3.5 tt -100.74 150.09 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -94.85 141.44 28.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 9.2 m120 54.29 43.34 30.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.856 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 754' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 751' ' ' ILE . . . 167.67 -179.75 40.88 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.471 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -154.35 164.75 38.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.878 0.37 . . . . 0.0 110.914 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -101.38 156.69 17.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 45.3 p -134.57 97.48 3.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.127 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 758' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 758' ' ' THR . 12.1 t -131.04 45.0 2.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.114 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 88.9 p -84.41 43.81 0.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.865 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 760' ' ' HIS . . . . . 0.461 ' CD2' ' HG1' ' A' ' 761' ' ' THR . 11.7 t60 -99.25 -59.81 1.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.847 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 761' ' ' THR . . . . . 0.461 ' HG1' ' CD2' ' A' ' 760' ' ' HIS . 6.8 m -160.55 146.5 15.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.128 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 762' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 761' ' ' THR . 30.5 mt-10 -35.03 136.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 69.4 mt -48.76 99.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.954 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 764' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 762' ' ' GLU . 24.9 m -131.14 -179.09 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -60.2 127.63 32.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 95.67 -21.41 44.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.477 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -52.89 141.85 20.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.75 0.309 . . . . 0.0 111.094 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -123.01 140.88 52.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.897 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 769' ' ' ILE . . . . . 0.436 ' CG1' ' CH2' ' A' ' 793' ' ' TRP . 18.5 mm -106.32 148.84 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.162 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 95.6 m -121.04 113.56 20.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.148 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -97.39 124.16 41.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.969 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 43.5 tp60 -127.06 140.95 51.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.948 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 38.9 m -118.3 171.77 7.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.49 159.5 23.7 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.553 0.692 . . . . 0.0 110.888 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 104.29 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.678 2.252 . . . . 0.0 112.357 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 137.28 -19.1 3.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.494 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -100.59 177.04 5.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.0 110.887 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 778' ' ' ASP . . . . . 0.426 ' OD1' ' CG2' ' A' ' 803' ' ' THR . 1.5 m-20 -136.08 151.04 49.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.824 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 3.4 mt -88.81 137.5 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.107 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 780' ' ' VAL . . . . . 0.573 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 65.7 t -115.74 107.32 22.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.155 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 127.73 -140.57 11.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.497 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 782' ' ' SER . . . . . 0.596 ' O ' HD11 ' A' ' 785' ' ' LEU . 3.8 m -105.56 102.23 11.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.879 0.371 . . . . 0.0 110.889 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.58 -53.25 59.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.895 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.714 ' C ' HD12 ' A' ' 785' ' ' LEU . 33.0 m -83.47 132.8 34.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.132 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 785' ' ' LEU . . . . . 0.714 HD12 ' C ' ' A' ' 784' ' ' THR . 9.1 mp -127.03 125.37 41.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 1.8 m -106.36 148.13 28.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.139 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 21.4 t -93.87 115.23 27.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.905 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -71.0 169.58 14.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 789' ' ' TRP . . . . . 0.458 ' CE3' ' O ' ' A' ' 789' ' ' TRP . 10.3 p-90 -66.73 -7.37 20.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -100.58 15.77 26.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.875 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 791' ' ' LEU . . . . . 0.431 HD22 ' CA ' ' A' ' 744' ' ' GLY . 82.5 mt 56.25 31.31 18.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 38.3 m -126.58 128.88 47.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 793' ' ' TRP . . . . . 0.449 ' CE3' ' HB3' ' A' ' 785' ' ' LEU . 98.6 m95 -59.53 137.74 57.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 9.3 t -48.17 -39.48 20.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 78.1 p -155.46 167.73 29.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.59 156.54 32.06 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.59 0.709 . . . . 0.0 110.86 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 797' ' ' PRO . . . . . 0.427 ' HA ' HD21 ' A' ' 785' ' ' LEU . 54.3 Cg_endo -69.74 141.15 44.53 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.665 2.243 . . . . 0.0 112.403 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -168.15 0.26 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.69 2.26 . . . . 0.0 112.382 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 799' ' ' PHE . . . . . 0.573 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 9.1 p90 -160.0 170.87 20.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.85 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 800' ' ' CYS . . . . . 0.699 ' SG ' HD11 ' A' ' 751' ' ' ILE . 12.0 m -102.52 145.8 29.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.875 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -148.02 134.13 19.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -68.69 127.35 32.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.871 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 803' ' ' THR . . . . . 0.426 ' CG2' ' OD1' ' A' ' 778' ' ' ASP . 37.4 p -52.4 127.59 22.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -71.42 117.44 12.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -108.57 -53.64 2.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.843 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 51.7 m -68.54 131.26 44.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -164.32 146.76 11.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.5 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -14.55 36.06 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.656 2.237 . . . . 0.0 112.365 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 80.3 p -97.12 155.34 16.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.824 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 2.7 m -113.42 -47.96 2.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.842 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.447 -179.972 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 88.7 p -89.01 99.34 12.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.883 0.373 . . . . 0.0 110.863 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 53.5 p -67.57 164.51 18.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.87 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 123.92 -59.58 0.62 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.477 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 53.2 p -60.94 159.96 10.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.852 0.358 . . . . 0.0 110.919 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 2.5 m -162.34 121.99 2.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.858 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 744' ' ' GLY . . . . . 0.415 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . 168.33 175.18 37.74 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.485 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 2.2 m -47.72 154.25 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.847 0.356 . . . . 0.0 110.913 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 41.6 m -69.58 150.82 46.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -72.78 139.29 46.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.891 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 9.6 mt -94.31 146.63 31.9 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.671 0.748 . . . . 0.0 110.867 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -179.78 3.14 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.678 2.252 . . . . 0.0 112.379 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -79.75 142.93 34.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.2 tt -101.16 149.25 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.127 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -94.17 137.75 32.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 62.84 36.83 12.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.922 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 174.4 -177.42 46.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.498 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 755' ' ' TRP . . . . . 0.418 ' CD1' ' C ' ' A' ' 755' ' ' TRP . 2.4 p90 -156.02 169.36 24.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.858 0.361 . . . . 0.0 110.885 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -118.68 161.93 19.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 24.4 p -137.18 149.11 47.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.119 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 25.4 p -142.3 176.51 8.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.182 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 28.0 p -121.77 -67.27 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.833 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -64.2 147.72 51.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 75.7 p -67.46 -13.88 62.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.138 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.62 143.14 43.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 16.6 mt -84.4 101.02 11.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.924 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 27.2 m -111.16 176.01 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.105 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -48.27 138.07 10.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 88.16 -30.74 5.02 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.465 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -40.08 129.07 2.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 34.3 mtt85 -122.0 127.37 50.21 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.846 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 59.1 mt -104.85 148.87 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.141 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 55.7 m -118.31 125.53 50.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.177 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -96.74 132.89 41.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.955 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -126.0 121.89 34.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.973 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 82.9 m -103.86 174.45 5.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.84 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -60.42 156.91 38.7 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.592 0.71 . . . . 0.0 110.899 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 109.93 2.43 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.67 2.247 . . . . 0.0 112.41 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 127.64 -13.07 6.54 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.502 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -105.07 179.03 4.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.879 0.371 . . . . 0.0 110.937 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -139.91 152.06 46.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.825 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 779' ' ' ILE . . . . . 0.577 HG23 ' HB2' ' A' ' 798' ' ' PRO . 57.0 mt -89.67 135.55 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.193 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 780' ' ' VAL . . . . . 0.552 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 60.5 t -108.62 106.68 21.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 126.5 -147.68 16.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.484 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 54.1 p -84.62 103.05 13.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.0 110.874 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.8 -34.21 74.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 98.0 m -112.12 121.97 46.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 785' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.64 135.84 48.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 2.3 m -119.46 150.61 39.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 17.4 t -94.9 107.81 19.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -63.66 162.39 13.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -58.05 -17.04 15.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.38 20.32 12.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 791' ' ' LEU . . . . . 0.415 HD22 ' HA2' ' A' ' 744' ' ' GLY . 74.3 mt 55.16 25.0 6.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.938 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 19.9 m -109.56 125.86 52.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 793' ' ' TRP . . . . . 0.416 ' O ' ' C ' ' A' ' 794' ' ' SER . 75.7 m95 -67.13 135.74 54.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 794' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 793' ' ' TRP . 4.3 t -36.93 -44.1 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 10.9 m -173.06 167.06 4.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.832 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -43.79 152.15 0.46 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.596 0.712 . . . . 0.0 110.898 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 146.37 60.46 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 798' ' ' PRO . . . . . 0.577 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.8 Cg_endo -69.8 -167.55 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.685 2.257 . . . . 0.0 112.314 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 799' ' ' PHE . . . . . 0.552 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 1.1 p90 -154.62 170.27 21.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 14.7 m -101.95 127.96 48.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -139.88 126.12 20.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -49.17 140.18 9.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 803' ' ' THR . . . . . 0.561 HG22 ' N ' ' A' ' 804' ' ' GLU . 14.7 m -51.72 165.86 0.16 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.131 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 804' ' ' GLU . . . . . 0.561 ' N ' HG22 ' A' ' 803' ' ' THR . 13.3 mt-10 -94.4 109.06 20.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 39.98 49.01 2.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.846 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -43.16 -26.8 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.831 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -165.75 146.95 11.6 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.457 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 -37.79 8.86 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.731 2.287 . . . . 0.0 112.388 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 4.8 t 66.24 33.99 6.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.84 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 36.0 t -79.32 -56.07 4.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.479 179.991 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 2.4 m 43.05 48.34 5.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 0.0 110.857 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 5.0 t -70.5 132.27 45.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 69.86 91.65 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.48 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 5.4 t -66.35 104.13 1.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.951 0.405 . . . . 0.0 110.852 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 45.9 m -119.76 163.75 16.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.897 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 744' ' ' GLY . . . . . 0.474 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . 137.65 160.2 8.46 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.493 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 9.9 m -45.16 163.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 110.873 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 79.1 p -91.71 163.22 14.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.893 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -61.35 158.72 13.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 46.0 mt -111.52 150.84 42.76 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.59 0.71 . . . . 0.0 110.871 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 157.57 59.95 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.678 2.252 . . . . 0.0 112.362 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.47 148.81 51.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.9 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 2.0 tt -109.06 150.8 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.1 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -103.25 140.61 37.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.933 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 7.4 m120 57.0 43.95 23.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 174.55 -179.94 45.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.537 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 16.5 p90 -156.93 161.19 39.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 110.965 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -116.26 168.27 10.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 18.8 p -130.08 113.34 14.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 56.8 p -109.25 114.3 27.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.139 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 94.7 p -107.27 38.68 2.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.864 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -143.8 119.25 10.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 67.7 p -38.62 -51.11 1.64 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.172 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 762' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 764' ' ' VAL . 12.0 mm-40 -135.01 129.14 33.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 763' ' ' LEU . . . . . 0.656 HD13 ' HZ2' ' A' ' 793' ' ' TRP . 69.7 mt -58.87 101.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.922 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 764' ' ' VAL . . . . . 0.466 HG13 ' O ' ' A' ' 762' ' ' GLU . 34.5 m -112.27 -179.53 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.177 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -59.06 130.01 44.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.866 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 97.56 -35.25 4.6 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.507 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -52.72 145.13 12.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.819 0.342 . . . . 0.0 111.104 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -134.99 151.52 50.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.833 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 29.3 mt -118.44 143.22 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.141 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 98.5 m -104.98 124.03 48.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.143 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -96.95 128.87 44.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -124.62 145.11 49.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.912 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 100.0 m -124.12 174.28 7.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.89 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -60.78 158.28 33.54 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.607 0.717 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 112.84 3.19 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.66 2.24 . . . . 0.0 112.363 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 123.81 -16.28 7.84 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.509 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 777' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 802' ' ' LYS . 13.9 m-85 -104.01 178.66 4.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 0.0 110.939 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -137.9 155.93 48.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 779' ' ' ILE . . . . . 0.675 HG23 ' HB2' ' A' ' 798' ' ' PRO . 46.9 mt -91.01 133.7 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 780' ' ' VAL . . . . . 0.579 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 74.2 t -108.69 111.51 36.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.167 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 124.87 -143.63 14.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.504 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 3.5 m -94.05 101.18 13.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.914 0.387 . . . . 0.0 110.909 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.04 -47.97 76.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.888 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.644 ' C ' HD12 ' A' ' 785' ' ' LEU . 22.6 m -94.15 134.02 37.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.141 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 785' ' ' LEU . . . . . 0.644 HD12 ' C ' ' A' ' 784' ' ' THR . 7.9 mp -122.42 108.84 13.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.928 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 786' ' ' THR . . . . . 0.439 HG22 ' N ' ' A' ' 787' ' ' CYS . 23.0 m -97.1 156.8 16.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 787' ' ' CYS . . . . . 0.439 ' N ' HG22 ' A' ' 786' ' ' THR . 13.6 t -98.05 125.18 42.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -86.38 169.14 13.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.933 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 789' ' ' TRP . . . . . 0.442 ' CE2' ' OD1' ' A' ' 790' ' ' ASP . 5.9 p-90 -65.53 -8.49 19.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.938 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 790' ' ' ASP . . . . . 0.442 ' OD1' ' CE2' ' A' ' 789' ' ' TRP . 87.6 m-20 -100.93 23.29 10.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 791' ' ' LEU . . . . . 0.474 HD22 ' CA ' ' A' ' 744' ' ' GLY . 40.5 mt 50.26 42.75 26.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.902 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.6 t -134.7 149.89 50.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.85 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 793' ' ' TRP . . . . . 0.656 ' HZ2' HD13 ' A' ' 763' ' ' LEU . 94.3 m95 -86.02 144.53 27.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 794' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 793' ' ' TRP . 27.9 t -36.38 -40.77 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.838 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 1.7 t -172.29 -175.96 1.51 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.67 157.08 29.52 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.624 0.726 . . . . 0.0 110.832 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 797' ' ' PRO . . . . . 0.413 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.3 Cg_endo -69.83 141.11 44.07 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.667 2.244 . . . . 0.0 112.299 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 798' ' ' PRO . . . . . 0.675 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.7 Cg_endo -69.81 -176.76 1.61 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.647 2.231 . . . . 0.0 112.361 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 799' ' ' PHE . . . . . 0.579 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 6.6 p90 -153.27 169.96 21.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 3.0 m -101.75 125.88 48.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.888 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -137.82 120.08 15.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 802' ' ' LYS . . . . . 0.406 ' HB2' ' CE2' ' A' ' 777' ' ' TYR . 6.2 ttpm? -53.59 114.35 1.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 27.6 m -83.9 153.85 23.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 33.8 mp0 -64.66 146.08 55.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -148.06 148.13 30.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 60.2 p -67.03 122.48 17.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . 144.99 -160.98 28.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.504 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 97.34 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.683 2.255 . . . . 0.0 112.338 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 15.5 p -143.54 176.74 8.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.807 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 77.4 p -162.86 148.39 12.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.854 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.52 179.992 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 5.5 t -65.51 -58.66 5.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.35 . . . . 0.0 110.878 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 87.3 p -115.74 174.04 6.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.858 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -141.11 54.01 0.64 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.465 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 3.0 m -107.69 129.54 55.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.87 0.367 . . . . 0.0 110.854 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 15.9 m -122.74 31.07 6.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.845 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 744' ' ' GLY . . . . . 0.849 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . 48.66 -177.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.484 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 745' ' ' CYS . . . . . 0.405 ' SG ' ' C ' ' A' ' 791' ' ' LEU . 1.8 m -61.41 152.69 29.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.831 0.348 . . . . 0.0 110.854 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 2.9 m -73.81 166.85 22.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.811 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.39 152.21 38.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.884 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 15.1 mt -103.3 146.85 33.23 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.597 0.713 . . . . 0.0 110.909 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.7 162.65 41.22 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.716 2.278 . . . . 0.0 112.373 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.3 143.97 42.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 5.6 tt -100.69 151.11 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.126 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -94.18 140.49 29.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 28.9 t30 53.71 41.4 32.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -179.99 -176.92 47.75 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.488 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -153.13 159.09 42.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.833 0.349 . . . . 0.0 110.93 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.9 160.85 22.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 3.0 p -146.49 112.19 5.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.099 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 758' ' ' THR . . . . . 0.468 ' CG2' HD21 ' A' ' 763' ' ' LEU . 2.4 m -64.69 140.0 58.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.135 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 18.6 m -86.65 -58.14 2.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -81.21 134.58 35.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.882 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 88.6 m -41.87 -58.83 1.9 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -99.57 129.53 45.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.926 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 763' ' ' LEU . . . . . 0.468 HD21 ' CG2' ' A' ' 758' ' ' THR . 22.3 mt -71.81 69.0 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.899 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 35.6 m -103.51 158.87 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.133 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -41.83 122.72 2.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 112.25 -31.91 6.64 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.502 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -56.62 162.07 2.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.759 0.314 . . . . 0.0 111.144 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 768' ' ' ARG . . . . . 0.44 ' C ' HD13 ' A' ' 769' ' ' ILE . 5.7 ptp180 -131.2 146.86 52.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.871 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 769' ' ' ILE . . . . . 0.737 HD11 ' HH2' ' A' ' 793' ' ' TRP . 5.3 mm -113.14 145.83 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.125 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 6.7 m -111.73 149.21 31.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.199 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -130.74 134.68 47.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.933 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -133.45 126.83 32.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 84.9 m -108.75 174.36 5.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.17 158.05 38.81 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.601 0.715 . . . . 0.0 110.872 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 106.95 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.733 2.289 . . . . 0.0 112.378 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 126.56 -10.92 7.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.474 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -106.77 167.54 9.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.865 0.364 . . . . 0.0 110.938 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -128.14 156.86 42.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.861 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 779' ' ' ILE . . . . . 0.66 HG23 ' HB2' ' A' ' 798' ' ' PRO . 75.8 mt -99.49 134.67 37.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.151 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 780' ' ' VAL . . . . . 0.571 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 93.7 t -106.35 107.8 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.073 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 132.56 -132.59 6.68 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.488 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 2.9 m -109.99 110.37 21.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.879 0.371 . . . . 0.0 110.871 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -58.22 -51.71 68.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.814 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 23.7 m -96.89 123.57 40.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 785' ' ' LEU . . . . . 0.424 HD21 ' HA ' ' A' ' 797' ' ' PRO . 8.7 mp -106.99 113.46 26.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 26.3 m -101.32 144.59 29.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.146 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 36.5 t -93.35 140.18 29.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -95.26 166.73 11.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -52.98 -19.37 2.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.936 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -88.82 22.77 2.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.825 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 791' ' ' LEU . . . . . 0.849 HD22 ' HA2' ' A' ' 744' ' ' GLY . 18.6 mt 46.93 35.45 3.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.928 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 22.7 t -121.99 158.36 29.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.839 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 793' ' ' TRP . . . . . 0.737 ' HH2' HD11 ' A' ' 769' ' ' ILE . 95.6 m95 -96.05 139.37 32.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 794' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 793' ' ' TRP . 6.6 t -36.8 -47.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.871 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 6.1 m -170.16 174.38 5.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.827 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -50.53 155.31 1.88 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.614 0.721 . . . . 0.0 110.842 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 797' ' ' PRO . . . . . 0.424 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.7 Cg_endo -69.8 146.21 59.28 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.715 2.277 . . . . 0.0 112.313 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 798' ' ' PRO . . . . . 0.66 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.9 Cg_endo -69.74 -166.99 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.679 2.253 . . . . 0.0 112.353 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 799' ' ' PHE . . . . . 0.571 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.6 p90 -154.96 165.59 36.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 9.1 m -101.63 128.0 48.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.9 143.99 47.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 28.8 tttp -68.14 141.78 55.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 27.1 m -62.73 152.99 34.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.13 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -82.11 111.45 18.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.86 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -87.75 120.34 28.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 4.5 t -62.3 145.19 54.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . 97.1 179.66 34.17 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.51 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -21.19 33.59 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.637 2.225 . . . . 0.0 112.327 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 4.2 m -40.78 110.88 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.848 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 6.0 t -136.05 154.47 51.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.505 -179.972 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.437 -0.265 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 64.6 m -137.26 162.36 33.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 0.0 110.83 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 2.3 t -151.26 155.84 39.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.87 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -61.73 -128.43 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.485 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 22.9 t -53.22 150.01 6.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.868 0.366 . . . . 0.0 110.842 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 58.5 p -110.01 156.26 20.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 744' ' ' GLY . . . . . 0.501 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . 168.22 160.13 15.3 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 745' ' ' CYS . . . . . 0.451 ' HB3' ' CE2' ' A' ' 793' ' ' TRP . 1.8 m -44.84 154.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 0.0 110.863 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 17.7 m -64.53 137.4 57.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -55.58 155.34 5.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 748' ' ' LEU . . . . . 0.483 HD12 ' CD1' ' A' ' 769' ' ' ILE . 12.4 mt -119.02 145.49 38.14 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.64 0.733 . . . . 0.0 110.884 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -177.43 1.86 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.674 2.249 . . . . 0.0 112.366 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -88.28 148.3 24.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 751' ' ' ILE . . . . . 0.411 HG13 ' N ' ' A' ' 752' ' ' GLN . 2.3 tt -101.98 148.67 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.121 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 752' ' ' GLN . . . . . 0.411 ' N ' HG13 ' A' ' 751' ' ' ILE . 5.7 pt20 -86.54 142.35 28.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 3.0 m120 51.48 40.61 27.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -173.63 176.84 46.17 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.501 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 755' ' ' TRP . . . . . 0.469 ' CZ2' ' HG2' ' A' ' 772' ' ' GLN . 44.5 p90 -145.93 151.08 37.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.353 . . . . 0.0 110.897 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -118.98 153.38 34.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 23.3 p -123.29 152.38 41.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.155 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 38.4 p -125.61 167.09 15.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.156 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 75.4 m -103.29 127.07 50.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 760' ' ' HIS . . . . . 0.443 ' O ' ' N ' ' A' ' 762' ' ' GLU . 71.5 m-70 49.11 36.46 8.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 761' ' ' THR . . . . . 0.406 ' C ' ' O ' ' A' ' 760' ' ' HIS . 2.7 m 37.29 31.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.127 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 762' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 760' ' ' HIS . 14.2 mm-40 -146.24 119.74 9.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 38.0 mt -78.46 107.16 10.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.863 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.32 174.55 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.142 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -59.21 126.5 27.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 94.0 -17.01 59.62 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.513 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -60.61 140.16 57.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.782 0.325 . . . . 0.0 111.151 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 29.8 ptt85 -127.81 143.9 51.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 769' ' ' ILE . . . . . 0.483 ' CD1' HD12 ' A' ' 748' ' ' LEU . 94.8 mt -107.37 129.95 60.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.108 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 84.3 m -96.3 120.68 37.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.113 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -98.5 118.21 34.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.925 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 772' ' ' GLN . . . . . 0.469 ' HG2' ' CZ2' ' A' ' 755' ' ' TRP . 3.9 tp-100 -113.32 141.44 47.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 74.1 m -119.37 173.47 6.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.46 158.16 31.35 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.589 0.709 . . . . 0.0 110.867 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 106.77 1.73 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.652 2.235 . . . . 0.0 112.351 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 123.26 0.79 9.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.477 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 777' ' ' TYR . . . . . 0.456 ' CE2' ' HB2' ' A' ' 802' ' ' LYS . 23.9 m-85 -115.21 170.17 8.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.848 0.356 . . . . 0.0 110.974 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 778' ' ' ASP . . . . . 0.437 ' OD2' ' CG2' ' A' ' 803' ' ' THR . 45.1 m-20 -129.71 154.76 46.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 779' ' ' ILE . . . . . 0.624 HG23 ' HB2' ' A' ' 798' ' ' PRO . 72.8 mt -97.17 134.62 34.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.142 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 780' ' ' VAL . . . . . 0.561 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 59.8 t -105.61 109.4 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 126.94 -145.12 15.55 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.477 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 782' ' ' SER . . . . . 0.448 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 58.4 m -91.84 96.53 10.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.861 0.362 . . . . 0.0 110.865 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -46.77 -43.76 18.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.857 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.686 ' C ' HD12 ' A' ' 785' ' ' LEU . 6.2 m -106.34 141.24 37.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.168 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 785' ' ' LEU . . . . . 0.686 HD12 ' C ' ' A' ' 784' ' ' THR . 7.5 mp -126.33 110.13 13.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.937 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 7.0 m -94.43 152.39 18.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.109 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 13.8 t -93.15 118.8 31.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -71.98 179.47 3.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 3.2 m95 -71.11 -14.83 62.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -101.87 21.86 13.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.894 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 791' ' ' LEU . . . . . 0.501 HD22 ' HA2' ' A' ' 744' ' ' GLY . 69.3 mt 53.59 26.17 5.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.929 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 4.4 m -113.69 122.71 47.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 793' ' ' TRP . . . . . 0.451 ' CE2' ' HB3' ' A' ' 745' ' ' CYS . 91.6 m95 -61.97 136.07 57.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.918 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 1.4 t -38.38 -44.34 0.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.804 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 58.3 m -161.3 -179.6 7.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -65.17 157.34 77.48 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.588 0.708 . . . . 0.0 110.864 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 797' ' ' PRO . . . . . 0.538 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.3 Cg_endo -69.83 140.73 43.11 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.648 2.232 . . . . 0.0 112.293 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 798' ' ' PRO . . . . . 0.624 ' HB2' HG23 ' A' ' 779' ' ' ILE . 54.1 Cg_endo -69.71 -164.28 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.675 2.25 . . . . 0.0 112.405 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 799' ' ' PHE . . . . . 0.561 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 6.1 p90 -156.13 173.19 17.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 35.4 m -101.96 137.96 39.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -143.66 142.58 31.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 802' ' ' LYS . . . . . 0.456 ' HB2' ' CE2' ' A' ' 777' ' ' TYR . 4.8 ttpm? -83.37 126.14 32.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 803' ' ' THR . . . . . 0.437 ' CG2' ' OD2' ' A' ' 778' ' ' ASP . 42.2 p -49.87 140.33 12.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.103 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -65.25 123.88 20.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -85.98 139.96 30.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 10.1 m -98.06 122.45 41.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . 113.63 -158.79 14.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.522 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.72 -176.41 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.693 2.262 . . . . 0.0 112.392 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 38.8 t -153.23 141.48 20.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 70.9 p -93.99 132.87 38.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.499 179.981 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 9.8 m -46.6 132.15 10.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.839 0.352 . . . . 0.0 110.849 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 5.8 m -120.71 165.5 15.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.841 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -173.12 154.04 19.6 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.465 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 32.7 m -112.45 -51.14 2.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.892 0.377 . . . . 0.0 110.855 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 64.4 m -127.73 152.95 47.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.846 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 744' ' ' GLY . . . . . 0.561 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . -160.73 177.54 37.09 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.497 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.9 171.37 0.51 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.364 . . . . 0.0 110.843 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 3.4 t -90.38 167.34 12.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -75.4 132.23 40.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.56 152.26 60.07 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.628 0.728 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 167.5 24.37 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.662 2.241 . . . . 0.0 112.296 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -74.87 145.67 42.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.6 tt -100.72 146.52 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.115 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -91.8 130.48 37.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.937 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 61.99 44.34 8.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 179.99 -173.99 45.47 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.453 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 45.6 p90 -157.78 170.13 23.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.799 0.333 . . . . 0.0 110.971 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -118.96 165.55 13.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.917 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 58.6 p -136.25 119.84 17.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.144 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 25.9 p -128.12 148.52 50.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.172 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 47.1 m -93.15 -49.69 5.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -100.32 113.36 26.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.86 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 56.7 p -38.06 -47.36 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.135 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -82.6 124.71 30.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 31.7 mt -86.25 106.18 17.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 35.1 m -107.86 -175.0 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 765' ' ' ARG . . . . . 0.414 ' CD ' ' HA ' ' A' ' 789' ' ' TRP . 73.7 mtm180 -68.99 134.71 49.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 95.96 -20.56 49.41 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.49 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -60.02 152.94 22.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.809 0.338 . . . . 0.0 111.092 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.62 136.65 43.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.855 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 56.5 mt -114.48 135.99 52.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.118 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 51.8 m -107.67 122.34 46.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.151 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -97.12 126.01 41.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -123.53 135.12 53.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 20.8 m -117.72 173.07 6.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -61.18 159.62 28.06 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.586 0.708 . . . . 0.0 110.852 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 114.98 3.88 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.683 2.255 . . . . 0.0 112.324 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 125.13 -25.2 5.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.468 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -90.83 170.35 10.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 0.0 110.926 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -129.15 154.62 46.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 779' ' ' ILE . . . . . 0.405 HG23 ' HB2' ' A' ' 798' ' ' PRO . 10.9 mt -95.59 137.82 22.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 780' ' ' VAL . . . . . 0.565 ' HB ' ' CE1' ' A' ' 799' ' ' PHE . 58.3 t -114.45 110.38 31.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.128 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 128.33 -132.67 7.41 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.507 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.93 107.56 17.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 110.911 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.02 -34.94 63.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.657 ' C ' HD12 ' A' ' 785' ' ' LEU . 23.7 m -109.39 136.12 49.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.159 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 785' ' ' LEU . . . . . 0.657 HD12 ' C ' ' A' ' 784' ' ' THR . 10.1 mp -126.71 118.61 25.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.93 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 1.2 m -105.83 151.98 23.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.16 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 48.6 t -95.41 108.82 21.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.86 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -62.0 175.67 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 789' ' ' TRP . . . . . 0.414 ' HA ' ' CD ' ' A' ' 765' ' ' ARG . 23.7 p-90 -73.3 -8.22 54.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -98.95 20.37 13.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 791' ' ' LEU . . . . . 0.561 HD22 ' CA ' ' A' ' 744' ' ' GLY . 79.2 mt 54.28 32.9 17.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 73.6 m -131.34 135.65 47.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 793' ' ' TRP . . . . . 0.422 ' O ' ' C ' ' A' ' 794' ' ' SER . 93.4 m95 -73.85 136.66 43.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.919 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 794' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 793' ' ' TRP . 11.9 t -35.92 -47.06 0.5 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.829 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 58.5 p -159.12 165.43 33.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -53.78 157.86 3.69 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.617 0.722 . . . . 0.0 110.878 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 797' ' ' PRO . . . . . 0.492 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.5 Cg_endo -69.8 141.39 44.95 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.687 2.258 . . . . 0.0 112.342 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 798' ' ' PRO . . . . . 0.405 ' HB2' HG23 ' A' ' 779' ' ' ILE . 54.5 Cg_endo -69.7 -167.11 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 0.0 112.389 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 799' ' ' PHE . . . . . 0.565 ' CE1' ' HB ' ' A' ' 780' ' ' VAL . 8.1 p90 -153.33 169.19 23.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 2.8 m -103.33 122.31 44.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.874 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -122.51 147.94 45.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 20.1 tttp -80.21 128.24 33.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 70.8 p -56.81 162.71 2.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.139 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -143.8 148.68 35.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -94.27 -63.3 1.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.934 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 23.3 m -126.93 139.57 52.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.858 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -68.69 -175.8 11.05 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.467 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 102.43 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.688 2.258 . . . . 0.0 112.365 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 41.1 t -46.56 141.48 3.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.835 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 15.1 t -56.58 -46.63 80.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.841 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.503 -179.978 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 4.6 t -73.68 95.58 2.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.877 0.37 . . . . 0.0 110.878 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 2.7 m 49.89 43.64 25.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -116.29 62.06 0.39 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.475 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 55.4 p -52.25 140.51 21.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.883 0.373 . . . . 0.0 110.892 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 68.5 m -93.45 90.69 6.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.877 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 744' ' ' GLY . . . . . 0.467 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . -164.71 164.63 37.03 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.492 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 1.8 m -48.09 158.37 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.878 0.37 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 3.3 m -80.89 148.38 29.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -48.41 159.46 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.879 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 748' ' ' LEU . . . . . 0.541 HD21 ' CD1' ' A' ' 793' ' ' TRP . 92.2 mt -118.24 146.72 40.06 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.662 0.744 . . . . 0.0 110.875 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 139.27 39.7 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.68 2.253 . . . . 0.0 112.31 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -46.81 156.68 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.84 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 751' ' ' ILE . . . . . 0.623 HD11 ' SG ' ' A' ' 800' ' ' CYS . 1.6 tt -102.04 139.85 22.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.114 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -83.96 130.85 34.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 55.45 45.02 26.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 177.94 -170.76 43.16 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.491 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 755' ' ' TRP . . . . . 0.45 ' C ' ' CD1' ' A' ' 755' ' ' TRP . 1.6 p90 -153.0 173.01 15.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.874 0.369 . . . . 0.0 110.9 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -135.07 172.0 13.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 3.4 t -164.59 149.66 9.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.138 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 758' ' ' THR . . . . . 0.433 HG22 ' CD1' ' A' ' 769' ' ' ILE . 61.2 p -119.42 143.02 47.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.134 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 27.2 t -82.66 -48.14 11.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -61.37 163.42 6.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.865 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 28.0 m -67.67 -45.87 74.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -133.1 165.68 24.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 74.3 mt -75.76 83.28 2.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 28.9 m -113.24 162.17 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.076 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 57.7 mtm-85 -40.94 145.27 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.927 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 82.38 -36.61 2.59 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.491 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -47.02 147.52 1.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.778 0.323 . . . . 0.0 111.076 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -124.85 164.67 19.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 769' ' ' ILE . . . . . 0.433 ' CD1' HG22 ' A' ' 758' ' ' THR . 35.1 mm -118.12 140.3 41.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.123 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 90.8 m -109.93 125.51 52.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.072 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 771' ' ' TYR . . . . . 0.553 ' CE2' ' HD2' ' A' ' 798' ' ' PRO . 24.6 m-85 -107.69 142.86 37.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.95 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -146.91 123.58 11.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 63.7 m -108.89 174.51 5.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.35 161.51 13.46 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.655 0.74 . . . . 0.0 110.859 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 120.57 7.34 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.718 2.279 . . . . 0.0 112.287 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 118.84 -29.09 6.41 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.493 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 777' ' ' TYR . . . . . 0.563 ' CE2' ' HB2' ' A' ' 802' ' ' LYS . 28.9 m-85 -89.94 179.46 5.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.918 0.389 . . . . 0.0 110.926 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -142.3 154.57 44.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.847 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 779' ' ' ILE . . . . . 0.622 HG23 ' HB2' ' A' ' 798' ' ' PRO . 75.9 mt -87.21 135.22 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.184 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 780' ' ' VAL . . . . . 0.569 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 66.5 t -103.06 105.0 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 126.03 -129.22 6.69 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.486 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 1.1 t -114.46 107.68 15.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.884 0.374 . . . . 0.0 110.86 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -55.19 -36.92 66.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.65 ' C ' HD12 ' A' ' 785' ' ' LEU . 33.3 m -101.27 139.39 37.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.139 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 785' ' ' LEU . . . . . 0.65 HD12 ' C ' ' A' ' 784' ' ' THR . 11.2 mp -130.37 111.81 12.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.943 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 11.1 m -90.71 149.96 21.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.134 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 9.3 t -93.23 107.48 19.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -57.79 -179.18 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.953 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 41.3 p-90 -72.44 -25.48 61.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.67 27.79 1.45 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.862 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 791' ' ' LEU . . . . . 0.467 HD22 ' HA2' ' A' ' 744' ' ' GLY . 20.1 mt 49.67 40.83 20.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.8 t -130.98 147.14 52.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 793' ' ' TRP . . . . . 0.541 ' CD1' HD21 ' A' ' 748' ' ' LEU . 83.3 m95 -80.87 134.98 35.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.941 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 794' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 793' ' ' TRP . 2.3 m -34.74 -47.34 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.824 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 79.4 p -159.98 165.41 32.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.831 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -44.6 152.96 0.49 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.609 0.719 . . . . 0.0 110.841 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 797' ' ' PRO . . . . . 0.6 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.6 Cg_endo -69.76 146.69 60.94 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.661 2.241 . . . . 0.0 112.354 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 798' ' ' PRO . . . . . 0.622 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.6 Cg_endo -69.71 -169.31 0.32 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.687 2.258 . . . . 0.0 112.392 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 799' ' ' PHE . . . . . 0.569 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 4.9 p90 -157.76 172.74 17.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.875 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 800' ' ' CYS . . . . . 0.623 ' SG ' HD11 ' A' ' 751' ' ' ILE . 7.2 m -101.96 136.14 42.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -146.71 135.7 22.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 802' ' ' LYS . . . . . 0.563 ' HB2' ' CE2' ' A' ' 777' ' ' TYR . 44.5 tttm -67.56 118.28 10.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.944 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 22.3 p -85.72 164.68 17.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.152 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -47.83 138.71 8.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -86.72 -24.61 25.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 11.2 t 49.17 49.18 20.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -98.21 -163.26 30.79 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.498 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 -13.38 34.56 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.656 2.237 . . . . 0.0 112.339 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 13.7 t -86.92 101.34 13.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 810' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 811' ' ' GLY . 3.8 m -105.84 146.2 30.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 811' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 810' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.495 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 4.5 t -69.5 88.35 0.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 0.0 110.823 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 39.0 t -118.32 147.8 43.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 145.28 125.87 1.81 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.512 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 79.1 p -88.06 -44.23 11.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.88 0.371 . . . . 0.0 110.864 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 6.1 m -53.22 152.93 4.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.88 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 744' ' ' GLY . . . . . 0.451 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . 171.18 145.17 4.69 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.501 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 3.9 m -40.54 154.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 110.895 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 4.4 m -75.9 147.38 39.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.22 117.89 6.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.84 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 748' ' ' LEU . . . . . 0.427 HD21 ' CD1' ' A' ' 793' ' ' TRP . 10.2 mt -70.62 149.34 95.4 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.598 0.713 . . . . 0.0 110.895 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 159.92 51.61 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.666 2.244 . . . . 0.0 112.342 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.08 149.95 43.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.7 tt -100.65 148.54 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.121 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -93.41 123.42 36.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.945 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 70.08 41.68 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.883 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 177.54 -174.24 46.77 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.494 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 3.2 p90 -151.35 166.11 32.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.835 0.35 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.24 156.2 43.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 49.2 p -133.33 125.44 29.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 73.7 p -81.34 171.09 15.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 47.6 m -100.22 -66.6 0.9 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.867 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -98.6 171.88 7.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.839 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 2.9 t -72.33 -3.54 24.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.153 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 762' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 764' ' ' VAL . 18.2 mt-10 -144.48 124.81 13.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.911 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 65.8 mt -64.97 74.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 764' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 762' ' ' GLU . 24.0 m -87.89 162.13 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 765' ' ' ARG . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 765' ' ' ARG . 25.9 mtm105 -51.75 132.88 31.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 99.52 -25.4 28.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.461 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -62.81 131.52 49.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 0.0 111.102 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 19.6 ptt-85 -111.23 147.47 34.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 8.9 mm -104.13 139.98 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.121 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 22.8 m -104.69 119.72 39.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.142 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -104.19 130.45 51.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -135.41 132.48 37.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 39.9 m -112.56 171.81 7.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -60.48 160.63 17.38 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.629 0.728 . . . . 0.0 110.865 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 107.98 1.99 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.663 2.242 . . . . 0.0 112.359 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 133.43 -24.42 3.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.436 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -92.72 170.73 9.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.876 0.37 . . . . 0.0 110.948 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -130.86 155.63 46.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.852 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 779' ' ' ILE . . . . . 0.438 HG23 ' HB2' ' A' ' 798' ' ' PRO . 11.5 mt -91.68 141.62 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.165 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 780' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 58.4 t -116.15 106.6 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 124.61 -126.38 6.04 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 782' ' ' SER . . . . . 0.5 ' O ' HD11 ' A' ' 785' ' ' LEU . 1.3 t -113.52 108.09 16.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.916 0.389 . . . . 0.0 110.871 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.7 -33.87 66.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.904 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.617 ' C ' HD12 ' A' ' 785' ' ' LEU . 9.9 m -111.61 129.22 56.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.123 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 785' ' ' LEU . . . . . 0.617 HD12 ' C ' ' A' ' 784' ' ' THR . 8.8 mp -121.45 118.81 30.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.898 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 51.8 m -96.65 152.59 18.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.087 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 20.0 t -95.63 112.05 23.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -65.41 170.97 4.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.949 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -69.36 -6.58 30.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -105.95 24.28 12.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.844 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 791' ' ' LEU . . . . . 0.451 HD22 ' CA ' ' A' ' 744' ' ' GLY . 34.5 mt 50.5 33.52 8.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.887 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 6.8 m -128.31 123.13 33.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 793' ' ' TRP . . . . . 0.429 ' O ' ' C ' ' A' ' 794' ' ' SER . 86.9 m95 -66.17 137.2 56.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.958 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 794' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 793' ' ' TRP . 23.0 t -35.67 -50.56 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.814 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 38.8 p -154.96 165.17 37.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.866 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -51.1 156.74 1.69 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.568 0.699 . . . . 0.0 110.884 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 797' ' ' PRO . . . . . 0.549 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.5 Cg_endo -69.77 141.81 46.2 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.663 2.242 . . . . 0.0 112.343 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 798' ' ' PRO . . . . . 0.438 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.6 Cg_endo -69.79 -164.07 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.679 2.252 . . . . 0.0 112.321 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 799' ' ' PHE . . . . . 0.466 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 6.7 p90 -158.56 172.28 18.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 2.7 m -101.7 138.36 38.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -146.72 150.04 34.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -65.36 119.53 11.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 10.1 m -65.13 147.77 52.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.164 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -105.45 136.34 45.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -123.57 -54.0 1.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 25.0 p -111.57 162.29 15.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -78.76 146.18 29.53 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.473 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 119.0 6.02 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.66 2.24 . . . . 0.0 112.377 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 43.5 t -97.13 78.8 2.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.821 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 9.5 t -127.98 178.13 6.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.907 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.447 179.948 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 66.2 m -68.08 172.99 4.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.924 0.392 . . . . 0.0 110.841 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 3.5 m -125.5 104.37 8.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.834 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 57.01 49.69 69.75 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.483 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 4.4 m -93.8 160.71 14.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.868 0.366 . . . . 0.0 110.873 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 92.0 p -97.54 102.61 14.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.846 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 744' ' ' GLY . . . . . 0.489 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . 172.96 140.34 3.12 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.475 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 5.1 m -40.55 155.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.858 0.361 . . . . 0.0 110.867 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 2.8 m -78.5 133.45 37.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -44.53 140.62 2.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 748' ' ' LEU . . . . . 0.553 HD23 ' CD1' ' A' ' 769' ' ' ILE . 4.0 mm? -76.47 148.18 79.86 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.598 0.713 . . . . 0.0 110.932 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.63 168.74 20.51 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.677 2.251 . . . . 0.0 112.38 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -74.31 135.75 42.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 751' ' ' ILE . . . . . 0.635 HD11 ' SG ' ' A' ' 800' ' ' CYS . 1.4 tt -108.05 141.78 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.15 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -83.1 146.84 28.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.939 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 42.44 48.67 4.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 176.74 172.56 41.5 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.477 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 45.5 p90 -153.88 152.55 30.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.81 0.338 . . . . 0.0 110.901 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 756' ' ' LYS . . . . . 0.483 ' O ' HG23 ' A' ' 757' ' ' THR . 7.7 ptpp? -109.42 164.26 12.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 757' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 756' ' ' LYS . 0.9 OUTLIER -159.45 153.18 22.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.098 179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -157.32 131.9 8.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.107 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 4.1 t -56.1 -63.26 1.24 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.884 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -54.6 101.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.831 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 45.2 m -52.65 -56.68 13.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.149 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -77.18 105.87 8.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 65.3 mt -58.16 94.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.942 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 29.3 m -120.62 174.06 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 49.6 mtm180 -46.78 133.97 10.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.92 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 766' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 767' ' ' ALA . . . 91.48 -34.37 4.36 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.515 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 767' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 766' ' ' GLY . . . -38.02 131.8 1.05 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 0.0 111.027 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 768' ' ' ARG . . . . . 0.551 ' HG2' HG23 ' A' ' 784' ' ' THR . 7.3 tmm_? -117.04 130.86 56.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.872 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 769' ' ' ILE . . . . . 0.553 ' CD1' HD23 ' A' ' 748' ' ' LEU . 56.9 mt -112.64 141.09 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.18 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 5.7 t -111.53 152.9 26.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.167 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -120.49 116.95 26.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.913 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -110.83 124.43 52.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.942 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 77.4 m -109.21 174.22 5.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -60.43 153.08 62.03 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.665 0.745 . . . . 0.0 110.856 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 93.97 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.708 2.272 . . . . 0.0 112.357 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 140.78 -9.82 2.85 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.535 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -100.91 176.31 5.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.885 0.374 . . . . 0.0 110.947 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -128.57 159.53 35.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.865 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 4.4 mt -104.44 143.34 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 780' ' ' VAL . . . . . 0.571 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 86.4 t -124.04 108.93 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.095 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 128.42 -135.82 8.78 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.493 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 3.0 m -107.29 98.99 8.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.371 . . . . 0.0 110.908 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.57 -48.8 57.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.857 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.667 ' C ' HD12 ' A' ' 785' ' ' LEU . 87.5 m -95.42 135.54 36.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.15 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 785' ' ' LEU . . . . . 0.667 HD12 ' C ' ' A' ' 784' ' ' THR . 7.6 mp -122.19 122.35 38.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.96 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 8.1 m -109.5 150.62 27.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.154 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 6.6 t -95.06 120.44 35.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -81.67 -176.69 6.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.938 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -68.72 -16.87 63.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.8 16.14 16.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.862 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 791' ' ' LEU . . . . . 0.489 HD22 ' CA ' ' A' ' 744' ' ' GLY . 68.4 mt 53.99 25.13 5.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.946 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 44.0 m -115.35 131.38 56.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 793' ' ' TRP . . . . . 0.416 ' CE2' HD21 ' A' ' 748' ' ' LEU . 83.5 m95 -63.05 137.84 58.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 794' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 793' ' ' TRP . 9.4 t -37.87 -47.2 1.02 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 68.0 m -156.74 161.99 39.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.866 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -46.4 158.97 0.36 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.59 0.709 . . . . 0.0 110.854 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 140.74 43.08 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.673 2.249 . . . . 0.0 112.293 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -169.77 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.671 2.247 . . . . 0.0 112.37 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 799' ' ' PHE . . . . . 0.571 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 4.1 p90 -159.29 167.41 29.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 800' ' ' CYS . . . . . 0.635 ' SG ' HD11 ' A' ' 751' ' ' ILE . 3.0 m -103.55 138.51 40.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -141.3 112.79 7.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -44.96 132.61 6.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.908 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 74.4 p -80.21 172.67 13.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.117 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -133.77 121.05 21.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 805' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 806' ' ' SER . 11.5 pt-20 -100.96 -43.69 5.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 806' ' ' SER . . . . . 0.41 ' N ' ' HG3' ' A' ' 805' ' ' GLU . 50.5 m -159.16 164.98 34.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.841 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -170.72 -97.63 0.11 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.456 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 120.81 7.54 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.718 2.279 . . . . 0.0 112.32 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 3.7 m -92.93 -48.22 6.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.832 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 4.0 m -110.25 97.6 7.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.856 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.524 179.975 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.484 -0.247 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 87.7 p -103.8 -13.32 16.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.903 0.382 . . . . 0.0 110.899 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 7.9 t -120.57 154.19 35.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.899 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -131.9 -113.35 1.5 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.461 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 84.7 p -81.33 114.88 20.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.95 0.405 . . . . 0.0 110.838 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 24.0 m -163.22 129.6 3.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.855 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 744' ' ' GLY . . . . . 0.556 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . 159.51 -167.77 35.22 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.489 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 3.6 m -45.39 152.22 0.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.881 0.372 . . . . 0.0 110.859 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 68.4 m -75.91 146.24 39.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -56.26 130.31 43.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 12.4 mt -79.45 149.23 71.64 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.606 0.717 . . . . 0.0 110.895 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 165.1 32.16 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.726 2.284 . . . . 0.0 112.312 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -73.67 144.52 45.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 6.7 tt -100.57 151.86 5.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.127 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -97.45 124.44 41.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 67.17 39.41 3.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -173.41 177.54 45.75 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.465 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -158.34 156.72 31.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.815 0.34 . . . . 0.0 110.935 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -98.24 165.14 12.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 81.0 p -124.65 40.61 3.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.123 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 758' ' ' THR . . . . . 0.818 HG23 ' CE1' ' A' ' 760' ' ' HIS . 47.7 m -57.13 102.81 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.121 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 83.2 p -82.75 -1.43 51.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.846 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 760' ' ' HIS . . . . . 0.818 ' CE1' HG23 ' A' ' 758' ' ' THR . 17.8 p-80 -107.85 122.3 46.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 82.5 p -62.61 -54.58 37.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.122 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.39 119.17 38.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 10.5 mt -64.34 107.94 1.47 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.914 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 27.7 m -112.77 155.78 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.122 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -48.84 116.09 1.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 112.61 -26.38 10.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.509 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -45.85 129.07 9.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.774 0.321 . . . . 0.0 111.147 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -115.17 120.79 40.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.861 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 52.3 mt -102.18 150.33 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.129 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 50.1 m -124.06 128.09 48.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.147 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -98.56 136.92 37.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -129.7 129.95 44.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 35.0 m -110.42 173.4 6.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.78 161.14 23.0 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.575 0.703 . . . . 0.0 110.84 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 117.5 5.12 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.656 2.237 . . . . 0.0 112.315 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 121.92 -22.52 7.62 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.479 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -96.55 172.83 7.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.877 0.37 . . . . 0.0 110.935 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -137.47 149.79 47.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.836 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 779' ' ' ILE . . . . . 0.668 HG23 ' HB2' ' A' ' 798' ' ' PRO . 66.8 mt -88.11 134.26 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.118 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 780' ' ' VAL . . . . . 0.565 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 63.6 t -108.25 108.23 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.12 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 124.45 -156.56 18.56 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.48 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 782' ' ' SER . . . . . 0.479 ' O ' HD11 ' A' ' 785' ' ' LEU . 58.2 m -76.87 95.44 4.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.868 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -49.36 -55.2 13.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.861 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.76 ' C ' HD12 ' A' ' 785' ' ' LEU . 87.4 m -92.27 142.19 27.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.076 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 785' ' ' LEU . . . . . 0.76 HD12 ' C ' ' A' ' 784' ' ' THR . 8.2 mp -128.04 143.09 51.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 55.8 m -128.42 151.99 48.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.144 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 14.4 t -94.6 107.08 19.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -61.15 -179.95 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -69.61 -20.27 63.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.871 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -91.92 23.71 3.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.866 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 791' ' ' LEU . . . . . 0.556 HD22 ' HA2' ' A' ' 744' ' ' GLY . 39.3 mt 51.02 29.55 4.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.8 t -117.9 147.34 43.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.825 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 793' ' ' TRP . . . . . 0.432 ' O ' ' C ' ' A' ' 794' ' ' SER . 95.0 m95 -83.78 134.63 34.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.881 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 794' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 793' ' ' TRP . 2.3 t -34.47 -50.51 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 97.7 p -162.07 168.45 22.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.836 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.21 153.14 0.95 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.619 0.723 . . . . 0.0 110.822 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 797' ' ' PRO . . . . . 0.423 ' HA ' HD21 ' A' ' 785' ' ' LEU . 54.0 Cg_endo -69.74 148.07 64.37 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.707 2.271 . . . . 0.0 112.345 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 798' ' ' PRO . . . . . 0.668 ' HB2' HG23 ' A' ' 779' ' ' ILE . 54.3 Cg_endo -69.71 -167.77 0.24 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.699 2.266 . . . . 0.0 112.339 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 799' ' ' PHE . . . . . 0.565 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 1.6 p90 -157.67 164.61 37.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 5.4 m -102.93 113.49 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -126.6 126.13 43.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -57.76 122.47 12.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 57.0 m -85.38 146.77 26.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.102 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -42.26 161.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.903 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.33 90.4 8.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.902 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 1.4 t -40.34 113.97 0.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . 148.28 -167.48 29.03 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.49 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 87.66 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.627 2.218 . . . . 0.0 112.359 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 2.9 t -100.16 86.09 3.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 53.4 p -70.15 166.92 18.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.865 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.498 -179.998 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 1.9 t -54.24 128.63 32.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 0.0 110.871 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 15.7 m -65.37 127.69 32.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.823 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 74.29 158.52 5.92 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 11.2 t -132.91 -45.07 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 0.0 110.876 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 743' ' ' SER . . . . . 0.85 ' O ' HG12 ' A' ' 764' ' ' VAL . 96.8 p -90.82 161.24 15.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . 178.84 158.11 20.69 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.484 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 7.1 m -48.8 152.63 0.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.809 0.337 . . . . 0.0 110.879 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 32.4 m -72.96 156.69 38.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.817 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.93 131.96 45.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.831 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 748' ' ' LEU . . . . . 0.448 HD12 HD13 ' A' ' 769' ' ' ILE . 12.2 mt -79.93 148.66 68.83 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.566 0.698 . . . . 0.0 110.928 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 175.47 8.01 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.705 2.27 . . . . 0.0 112.36 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -77.93 149.41 34.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 2.0 tt -106.52 145.76 13.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.129 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -89.8 132.27 35.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 4.7 m120 59.92 44.59 13.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.854 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 178.17 179.72 48.24 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.488 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 755' ' ' TRP . . . . . 0.483 ' CZ2' ' HG2' ' A' ' 772' ' ' GLN . 19.0 p90 -156.06 168.56 26.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.834 0.35 . . . . 0.0 110.94 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.91 165.67 14.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.91 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 51.4 p -146.25 134.62 21.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.112 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 758' ' ' THR . . . . . 0.41 ' CG2' HG12 ' A' ' 769' ' ' ILE . 80.7 p -139.61 148.19 42.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.159 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 10.1 m -96.9 -46.82 6.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -69.92 177.89 2.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 90.7 m -113.03 -49.96 2.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.162 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -80.15 128.46 33.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 55.8 mt -84.28 46.76 1.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 764' ' ' VAL . . . . . 0.85 HG12 ' O ' ' A' ' 743' ' ' SER . 23.7 m -84.99 -175.92 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.154 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -53.35 130.68 35.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 103.12 -32.96 6.99 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -50.48 125.14 12.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.755 0.312 . . . . 0.0 111.144 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 768' ' ' ARG . . . . . 0.452 ' HG2' ' CG2' ' A' ' 784' ' ' THR . 8.9 ttp-105 -116.52 145.56 43.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.862 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 769' ' ' ILE . . . . . 0.448 HD13 HD12 ' A' ' 748' ' ' LEU . 39.4 mt -123.89 140.45 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.11 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 18.7 m -108.5 123.01 48.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.147 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -99.67 121.37 41.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.911 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 772' ' ' GLN . . . . . 0.483 ' HG2' ' CZ2' ' A' ' 755' ' ' TRP . 4.3 tp-100 -118.09 143.54 46.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.857 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 73.6 m -124.36 171.1 10.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -62.06 159.68 35.9 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.578 0.704 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 119.66 6.57 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.725 2.283 . . . . 0.0 112.311 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 117.77 -20.21 10.97 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.481 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -96.3 179.31 5.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.882 0.372 . . . . 0.0 110.953 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -141.92 150.41 41.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.847 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 5.6 mt -87.58 144.96 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 780' ' ' VAL . . . . . 0.56 ' HB ' ' CE1' ' A' ' 799' ' ' PHE . 75.3 t -120.69 106.14 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.125 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 126.65 -132.62 7.77 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 3.0 m -101.75 88.34 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.888 0.375 . . . . 0.0 110.891 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -41.65 -33.73 0.51 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.875 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.478 ' C ' HD12 ' A' ' 785' ' ' LEU . 16.7 m -114.7 142.8 46.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 785' ' ' LEU . . . . . 0.88 HD11 ' HD3' ' A' ' 798' ' ' PRO . 9.6 mp -126.64 144.92 50.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 1.9 m -138.18 157.43 46.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.199 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 8.1 t -92.62 118.12 30.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.828 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -77.34 171.85 14.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 1.6 m-90 -59.52 -12.9 7.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -98.0 25.1 6.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 90.3 mt 48.08 25.76 0.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.4 t -121.35 147.34 45.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.84 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 793' ' ' TRP . . . . . 0.447 ' O ' ' C ' ' A' ' 794' ' ' SER . 98.0 m95 -77.79 141.15 39.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.958 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 794' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 793' ' ' TRP . 36.4 t -34.52 -46.41 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 19.4 p -173.11 170.72 4.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.12 151.54 0.2 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.593 0.711 . . . . 0.0 110.862 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 797' ' ' PRO . . . . . 0.466 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.8 Cg_endo -69.76 143.95 52.46 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.626 2.218 . . . . 0.0 112.367 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 798' ' ' PRO . . . . . 0.88 ' HD3' HD11 ' A' ' 785' ' ' LEU . 54.0 Cg_endo -69.75 177.51 5.5 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.696 2.264 . . . . 0.0 112.331 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 799' ' ' PHE . . . . . 0.56 ' CE1' ' HB ' ' A' ' 780' ' ' VAL . 10.0 p90 -149.55 172.55 14.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 12.6 m -102.79 129.51 49.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -129.68 129.66 44.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -59.81 136.73 58.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.896 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 5.3 t -65.17 168.89 6.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.133 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -104.81 164.39 11.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.928 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -147.39 130.81 16.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 3.0 t -93.04 116.41 29.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.855 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . 137.54 147.17 5.21 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.511 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 179.17 3.89 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.656 2.238 . . . . 0.0 112.364 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 85.0 p -113.05 122.64 48.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.871 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 4.0 m -112.32 -54.79 2.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.857 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.462 179.997 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 17.4 m -140.54 176.49 8.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 110.836 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 47.1 p -44.05 -55.11 4.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.829 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 135.95 47.59 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.506 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 55.9 p -93.1 144.37 25.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.868 0.366 . . . . 0.0 110.868 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 743' ' ' SER . . . . . 0.73 ' O ' HD13 ' A' ' 791' ' ' LEU . 66.5 m -141.38 120.22 12.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.843 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 744' ' ' GLY . . . . . 0.73 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . -92.79 -150.02 25.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.486 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 1.8 m -48.29 171.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.348 . . . . 0.0 110.885 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 56.9 p -100.55 140.7 34.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -46.25 144.01 2.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 16.3 mt -94.85 151.09 38.75 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.619 0.723 . . . . 0.0 110.94 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 151.45 68.99 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.67 2.246 . . . . 0.0 112.349 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -62.97 143.32 57.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 6.7 tt -100.54 153.24 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -97.39 128.42 44.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 61.92 41.3 11.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -173.46 176.21 46.12 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.458 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -152.22 170.52 19.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.827 0.346 . . . . 0.0 110.931 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 756' ' ' LYS . . . . . 0.766 ' HE3' HG21 ' A' ' 769' ' ' ILE . 9.9 ptmt -130.51 168.43 17.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 40.1 p -126.06 142.91 51.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.129 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 59.3 p -125.82 133.76 51.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.136 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 1.1 t -96.34 -55.53 2.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -81.64 131.96 35.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.855 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 761' ' ' THR . . . . . 0.483 HG23 ' N ' ' A' ' 762' ' ' GLU . 8.9 t -43.38 -44.37 5.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.115 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 762' ' ' GLU . . . . . 0.483 ' N ' HG23 ' A' ' 761' ' ' THR . 68.7 mm-40 -118.87 142.99 47.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.92 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 763' ' ' LEU . . . . . 0.554 HD21 HD11 ' A' ' 769' ' ' ILE . 77.6 mt -67.79 93.69 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.929 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 29.4 m -105.55 154.94 6.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.098 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -43.43 124.79 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 105.23 -25.22 25.65 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.485 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -53.88 137.9 37.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 111.084 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -121.95 130.47 53.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 769' ' ' ILE . . . . . 0.766 HG21 ' HE3' ' A' ' 756' ' ' LYS . 69.1 mt -110.68 131.93 60.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 31.1 m -99.01 130.78 45.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.147 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -98.57 120.19 38.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.937 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -117.83 124.21 47.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.917 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 72.1 m -107.55 173.39 6.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.66 157.49 37.62 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.6 0.714 . . . . 0.0 110.888 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 111.3 2.78 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.653 2.236 . . . . 0.0 112.371 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 125.13 -19.84 6.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.473 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -97.75 168.52 10.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.863 0.364 . . . . 0.0 110.932 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -125.72 162.93 23.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.869 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 779' ' ' ILE . . . . . 0.591 HG23 ' HB2' ' A' ' 798' ' ' PRO . 65.4 mt -103.8 135.13 42.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 780' ' ' VAL . . . . . 0.538 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 61.7 t -112.34 107.52 23.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.12 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 127.99 -150.32 18.35 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.449 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 782' ' ' SER . . . . . 0.418 ' O ' HD11 ' A' ' 785' ' ' LEU . 5.2 p -81.28 105.29 12.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.857 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.66 -50.48 73.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 30.7 m -102.47 121.24 41.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.174 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 785' ' ' LEU . . . . . 0.474 HD21 ' HA ' ' A' ' 797' ' ' PRO . 7.8 mp -106.91 148.68 28.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 37.8 m -137.77 153.03 49.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.116 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 12.4 t -93.94 115.91 28.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.912 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -71.86 -177.51 2.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.882 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 53.5 p-90 -71.42 -16.31 62.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.885 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -92.34 23.68 3.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.833 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 791' ' ' LEU . . . . . 0.73 HD13 ' O ' ' A' ' 743' ' ' SER . 32.3 mt 48.63 37.5 9.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.6 t -134.47 147.57 50.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.846 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 793' ' ' TRP . . . . . 0.44 ' O ' ' C ' ' A' ' 794' ' ' SER . 88.7 m95 -82.44 141.67 32.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.936 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 794' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 793' ' ' TRP . 1.3 t -35.41 -45.49 0.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.884 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 22.6 t -171.68 171.55 5.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -47.56 150.6 1.68 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.647 0.737 . . . . 0.0 110.833 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 797' ' ' PRO . . . . . 0.474 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.0 Cg_endo -69.8 149.17 66.25 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.685 2.257 . . . . 0.0 112.285 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 798' ' ' PRO . . . . . 0.591 ' HB2' HG23 ' A' ' 779' ' ' ILE . 54.1 Cg_endo -69.83 -171.79 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.678 2.252 . . . . 0.0 112.355 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 799' ' ' PHE . . . . . 0.538 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 3.2 p90 -147.22 167.71 23.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.912 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 3.9 m -102.05 119.18 38.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -123.32 132.59 54.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -58.75 137.8 57.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 22.1 m -95.96 144.92 25.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.139 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 804' ' ' GLU . . . . . 0.431 ' OE2' ' C ' ' A' ' 805' ' ' GLU . 2.2 tm-20 -140.27 129.64 23.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 805' ' ' GLU . . . . . 0.431 ' C ' ' OE2' ' A' ' 804' ' ' GLU . 0.0 OUTLIER -105.84 115.89 31.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.93 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 69.2 p -118.31 100.81 7.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . 76.58 148.86 2.76 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.479 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -45.35 1.61 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.65 2.234 . . . . 0.0 112.348 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 58.9 m -134.51 140.8 46.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.831 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 16.1 m -159.78 150.33 19.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.851 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.472 -179.994 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 3.0 m -46.76 170.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 110.895 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 70.4 m -97.35 138.4 34.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.865 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.26 123.94 5.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.857 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 748' ' ' LEU . . . . . 0.485 HD13 ' OH ' ' A' ' 771' ' ' TYR . 24.2 mt -69.42 144.1 94.1 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.611 0.719 . . . . 0.0 110.873 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 143.74 51.8 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.693 2.262 . . . . 0.0 112.325 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -52.12 133.55 33.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 751' ' ' ILE . . . . . 0.498 HG23 ' O ' ' A' ' 754' ' ' GLY . 1.5 tt -100.77 143.78 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.138 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 752' ' ' GLN . . . . . 0.412 ' N ' HG13 ' A' ' 751' ' ' ILE . 26.8 pt20 -82.49 136.39 34.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 5.8 m120 58.71 37.4 25.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 754' ' ' GLY . . . . . 0.498 ' O ' HG23 ' A' ' 751' ' ' ILE . . . -178.23 166.45 36.47 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.474 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -147.48 150.46 34.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.817 0.341 . . . . 0.0 110.912 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -91.54 148.87 21.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 39.5 p . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 179.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 55.9 mt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.863 0.364 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.09 170.59 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.119 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 40.8 mtt85 -53.91 132.69 42.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 94.24 -26.17 18.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.48 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -45.99 142.62 2.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.799 0.333 . . . . 0.0 111.084 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 768' ' ' ARG . . . . . 0.528 ' HD3' HG21 ' A' ' 784' ' ' THR . 15.6 ttm-85 -119.72 122.88 42.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 769' ' ' ILE . . . . . 0.626 ' CG1' ' CH2' ' A' ' 793' ' ' TRP . 37.3 mm -99.87 143.45 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.077 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 12.0 m -121.11 125.99 48.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.131 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 771' ' ' TYR . . . . . 0.485 ' OH ' HD13 ' A' ' 748' ' ' LEU . 35.0 m-85 -101.66 121.54 42.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -122.45 130.29 52.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.922 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 74.9 m -108.57 174.16 6.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -60.75 159.72 24.14 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.606 0.717 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 114.51 3.73 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.638 2.225 . . . . 0.0 112.332 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 122.01 -22.2 7.66 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.461 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -94.38 174.39 7.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.896 0.379 . . . . 0.0 110.909 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -131.87 155.36 47.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.842 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 779' ' ' ILE . . . . . 0.4 HG23 ' HB2' ' A' ' 798' ' ' PRO . 7.4 mt -97.39 141.0 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 780' ' ' VAL . . . . . 0.428 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 61.0 t -114.1 109.47 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.093 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 125.91 -131.06 7.39 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.481 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 782' ' ' SER . . . . . 0.406 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 1.5 t -107.9 108.52 19.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.852 0.358 . . . . 0.0 110.86 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.45 -31.15 67.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.595 ' C ' HD12 ' A' ' 785' ' ' LEU . 20.8 m -115.49 131.38 56.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.122 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 785' ' ' LEU . . . . . 0.595 HD12 ' C ' ' A' ' 784' ' ' THR . 10.4 mp -123.74 127.65 48.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . 0.496 HG22 ' N ' ' A' ' 787' ' ' CYS . 26.6 m -107.78 159.61 16.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.144 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 787' ' ' CYS . . . . . 0.496 ' N ' HG22 ' A' ' 786' ' ' THR . 6.5 t -94.47 119.09 32.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -73.62 176.76 5.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -73.39 -7.74 52.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -100.94 12.94 36.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 66.6 mt 61.78 26.92 16.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 14.8 m -130.39 127.35 39.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.873 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 793' ' ' TRP . . . . . 0.626 ' CH2' ' CG1' ' A' ' 769' ' ' ILE . 73.6 m95 -58.38 140.64 53.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.946 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 793' ' ' TRP . 28.8 t -37.13 -47.98 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.837 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 37.4 m -154.75 167.04 31.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.841 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -51.63 155.8 2.59 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.63 0.729 . . . . 0.0 110.842 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . 0.448 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.5 Cg_endo -69.78 145.32 56.68 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.677 2.251 . . . . 0.0 112.329 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 798' ' ' PRO . . . . . 0.4 ' HB2' HG23 ' A' ' 779' ' ' ILE . 54.0 Cg_endo -69.85 -165.28 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.659 2.239 . . . . 0.0 112.348 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 799' ' ' PHE . . . . . 0.428 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.7 p90 -153.67 170.5 20.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.911 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 8.4 m -101.94 135.01 44.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.909 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -130.36 143.04 50.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 744' ' ' GLY . . . . . 0.482 ' CA ' ' O ' ' A' ' 763' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 745' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 763' ' ' LEU . 7.5 m -44.86 150.56 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.847 0.356 . . . . 0.0 110.832 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 16.4 m -71.56 147.91 47.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.825 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -60.69 137.34 58.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.906 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 748' ' ' LEU . . . . . 0.531 HD13 ' OH ' ' A' ' 771' ' ' TYR . 12.4 mt -97.0 144.28 27.58 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.631 0.729 . . . . 0.0 110.884 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 163.57 37.82 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.716 2.277 . . . . 0.0 112.361 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -62.32 149.0 43.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.89 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.0 tt -103.08 148.61 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.129 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -85.22 135.28 34.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 5.7 m120 53.92 46.6 25.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 754' ' ' GLY . . . . . 0.465 ' CA ' ' O ' ' A' ' 772' ' ' GLN . . . 175.98 -169.15 41.72 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.462 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 15.0 p90 -156.54 171.78 19.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.816 0.341 . . . . 0.0 110.961 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 17.7 pttm -134.74 159.92 39.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.87 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 77.3 p . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 763' ' ' LEU . . . . . 0.482 ' O ' ' CA ' ' A' ' 744' ' ' GLY . 21.9 mt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.844 0.354 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 26.9 m -108.38 175.24 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.155 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -41.88 136.63 1.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.861 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 88.1 -29.88 5.37 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.459 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -54.1 130.91 39.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.81 0.338 . . . . 0.0 111.143 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -121.51 150.06 42.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 769' ' ' ILE . . . . . 0.462 HD11 HD22 ' A' ' 763' ' ' LEU . 6.8 mm -115.57 132.4 65.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.174 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 79.0 m -103.46 116.22 31.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.177 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 771' ' ' TYR . . . . . 0.531 ' OH ' HD13 ' A' ' 748' ' ' LEU . 38.9 m-85 -98.54 127.36 44.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.926 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 772' ' ' GLN . . . . . 0.465 ' O ' ' CA ' ' A' ' 754' ' ' GLY . 22.9 tp60 -122.5 137.84 54.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.896 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 64.9 m -115.83 172.05 7.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -60.57 157.06 39.43 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.625 0.726 . . . . 0.0 110.823 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.77 119.1 6.1 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.659 2.239 . . . . 0.0 112.31 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 117.96 -15.06 12.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.452 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -100.12 176.48 5.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 0.0 110.924 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -133.57 157.79 44.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 4.6 mt -97.96 139.29 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.122 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 780' ' ' VAL . . . . . 0.573 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 65.2 t -115.75 113.66 43.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.14 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 116.15 -143.01 17.92 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.535 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 12.6 m -97.99 103.13 15.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.873 0.368 . . . . 0.0 110.823 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -57.8 -52.99 63.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.878 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.844 ' C ' HD12 ' A' ' 785' ' ' LEU . 44.6 m -86.06 141.93 29.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.13 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 785' ' ' LEU . . . . . 0.844 HD12 ' C ' ' A' ' 784' ' ' THR . 7.6 mp -132.03 113.07 12.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.915 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . 0.414 HG22 ' N ' ' A' ' 787' ' ' CYS . 27.2 m -96.6 154.88 17.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.104 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 787' ' ' CYS . . . . . 0.414 ' N ' HG22 ' A' ' 786' ' ' THR . 4.3 t -95.66 109.56 21.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -61.5 -176.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -69.99 -26.8 64.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.947 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -86.85 20.86 2.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 791' ' ' LEU . . . . . 0.427 HD22 ' HA2' ' A' ' 744' ' ' GLY . 57.5 mt 51.92 44.64 29.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 30.1 t -130.5 156.11 45.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 793' ' ' TRP . . . . . 0.418 ' CD1' HD21 ' A' ' 748' ' ' LEU . 73.8 m95 -84.54 133.07 34.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 40.3 t -37.27 -48.83 0.91 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 8.6 t -157.9 174.62 14.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.801 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.98 156.51 3.45 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.612 0.72 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . 0.464 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.8 Cg_endo -69.72 145.37 57.16 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.654 2.236 . . . . 0.0 112.356 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -167.5 0.23 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.689 2.259 . . . . 0.0 112.354 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 799' ' ' PHE . . . . . 0.573 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 1.3 p90 -159.79 164.2 33.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 3.5 m -101.76 133.15 46.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -145.78 140.44 27.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.889 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 744' ' ' GLY . . . . . 0.751 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 57.3 m -53.99 152.22 6.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.822 0.344 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 22.9 t -90.48 165.19 13.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.862 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -59.59 159.09 8.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.876 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 13.7 mt -110.29 149.0 39.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.629 0.728 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 146.08 59.19 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.71 2.273 . . . . 0.0 112.358 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -54.96 141.12 35.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.907 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 751' ' ' ILE . . . . . 0.421 HG13 ' N ' ' A' ' 752' ' ' GLN . 1.9 tt -103.82 146.49 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.077 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 752' ' ' GLN . . . . . 0.421 ' N ' HG13 ' A' ' 751' ' ' ILE . 21.1 mt-30 -87.15 136.7 32.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.921 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 60.5 47.33 8.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 169.79 170.57 34.39 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.5 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 17.5 p90 -148.39 152.75 37.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.829 0.347 . . . . 0.0 110.93 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -96.71 168.94 10.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 757' ' ' THR . 5.0 t . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.147 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.86 0.362 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 31.6 m -125.65 172.09 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -47.52 128.17 12.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 98.92 -18.77 56.36 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.485 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -56.94 132.27 52.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.743 0.306 . . . . 0.0 111.09 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 768' ' ' ARG . . . . . 0.42 ' HD2' ' C ' ' A' ' 768' ' ' ARG . 3.9 tmm_? -128.13 132.78 48.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.881 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 63.7 mt -113.59 144.09 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.167 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 87.3 m -110.41 131.94 54.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.113 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -103.96 118.21 36.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -110.29 136.39 49.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.937 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 83.8 m -115.83 171.87 7.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -60.99 159.53 26.85 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.588 0.709 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 122.02 8.69 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.674 2.25 . . . . 0.0 112.337 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 113.76 -22.3 14.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.453 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 777' ' ' TYR . . . . . 0.4 ' CE2' ' HB2' ' A' ' 802' ' ' LYS . 18.6 m-85 -86.5 178.56 7.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.912 0.387 . . . . 0.0 110.902 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.75 135.33 26.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.866 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 3.6 mt -74.54 150.42 7.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 780' ' ' VAL . . . . . 0.566 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 89.6 t -128.49 108.82 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.094 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 123.67 -134.02 9.13 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.488 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 43.7 m -105.22 98.81 8.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.883 0.373 . . . . 0.0 110.879 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.72 -39.21 76.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.827 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.801 ' C ' HD12 ' A' ' 785' ' ' LEU . 25.8 m -93.18 141.75 28.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.16 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 785' ' ' LEU . . . . . 0.801 HD12 ' C ' ' A' ' 784' ' ' THR . 9.4 mp -133.5 119.09 19.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 1.2 m -114.93 153.88 29.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.08 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 3.2 t -92.44 121.77 34.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.849 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -86.48 173.85 9.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 5.1 p90 -55.32 -17.07 4.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.927 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -94.13 23.05 5.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.82 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 791' ' ' LEU . . . . . 0.751 HD22 ' HA2' ' A' ' 744' ' ' GLY . 23.1 mt 45.38 24.98 0.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.949 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.4 t -117.14 150.44 38.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 793' ' ' TRP . . . . . 0.404 ' O ' ' C ' ' A' ' 794' ' ' SER . 86.3 m95 -77.08 142.99 39.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.935 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 793' ' ' TRP . 40.5 t -37.66 -42.85 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.828 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 5.1 t -171.3 173.19 4.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -46.43 154.54 0.64 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.632 0.73 . . . . 0.0 110.884 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 145.79 58.7 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.695 2.263 . . . . 0.0 112.369 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 798' ' ' PRO . . . . . 0.467 ' HD3' HD11 ' A' ' 785' ' ' LEU . 54.3 Cg_endo -69.75 177.86 5.15 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.678 2.252 . . . . 0.0 112.39 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 799' ' ' PHE . . . . . 0.566 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 0.8 OUTLIER -142.95 166.64 24.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 11.9 m -102.48 124.48 48.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -118.75 133.09 56.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 802' ' ' LYS . . . . . 0.4 ' HB2' ' CE2' ' A' ' 777' ' ' TYR . 32.0 tttt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 744' ' ' GLY . . . . . 0.426 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 1.8 m -59.04 162.14 4.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.867 0.365 . . . . 0.0 110.869 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 23.5 p -92.08 144.74 25.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -38.27 150.13 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.866 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 14.8 mt -106.46 151.95 40.48 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.651 0.739 . . . . 0.0 110.925 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 141.29 44.57 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.657 2.238 . . . . 0.0 112.364 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -54.0 145.59 16.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 751' ' ' ILE . . . . . 0.422 HG13 ' N ' ' A' ' 752' ' ' GLN . 2.1 tt -100.95 147.73 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.111 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 752' ' ' GLN . . . . . 0.422 ' N ' HG13 ' A' ' 751' ' ' ILE . 40.8 mt-30 -90.83 139.51 30.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 50.41 41.64 25.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -177.37 -173.62 43.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.504 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -157.4 159.41 37.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.784 0.326 . . . . 0.0 110.949 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 756' ' ' LYS . . . . . 0.41 ' C ' ' HD2' ' A' ' 756' ' ' LYS . 0.0 OUTLIER -118.62 152.44 36.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.939 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 55.7 p . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.19 179.946 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 86.0 mt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.861 0.362 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' A' ' 765' ' ' ARG . 28.3 m -101.55 156.75 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 765' ' ' ARG . 25.4 mtm105 -34.73 139.52 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 87.75 -25.6 8.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -57.11 139.9 51.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.787 0.327 . . . . 0.0 111.095 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -115.08 157.36 23.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.904 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 34.0 mm -114.27 140.19 36.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.144 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 89.1 m -113.52 119.5 37.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.181 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -97.68 121.67 39.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -121.34 124.7 45.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.93 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 62.9 m -110.51 174.35 5.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.46 157.48 35.69 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.592 0.711 . . . . 0.0 110.882 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 106.99 1.77 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.671 2.247 . . . . 0.0 112.337 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 131.87 -15.03 5.17 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.461 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -104.4 169.88 8.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.882 0.373 . . . . 0.0 110.919 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.12 160.78 30.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 8.7 mt -96.71 139.34 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.114 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 780' ' ' VAL . . . . . 0.516 ' HB ' ' CE1' ' A' ' 799' ' ' PHE . 72.0 t -114.0 106.43 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 125.82 -149.62 17.32 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.506 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 782' ' ' SER . . . . . 0.476 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 93.0 p -82.03 103.02 11.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.885 0.374 . . . . 0.0 110.842 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -57.14 -44.56 83.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 31.4 m -105.98 124.29 49.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.152 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 785' ' ' LEU . . . . . 0.476 ' CD1' ' O ' ' A' ' 782' ' ' SER . 10.7 mp -113.45 120.0 39.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.923 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 26.0 m -107.41 154.03 21.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.174 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 6.6 t -94.46 125.1 38.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.835 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -75.91 177.04 7.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 2.2 p90 -69.76 -19.06 63.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.964 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . 0.421 ' O ' ' CG ' ' A' ' 790' ' ' ASP . 23.2 t0 -96.24 23.65 6.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 791' ' ' LEU . . . . . 0.426 HD22 ' CA ' ' A' ' 744' ' ' GLY . 15.8 mt 51.21 35.8 14.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.91 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 49.4 m -120.77 135.56 55.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 793' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -72.22 147.11 46.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 5.0 t -48.54 -41.64 30.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.859 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 1.3 t -175.06 -178.72 1.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -54.32 147.06 29.21 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.599 0.714 . . . . 0.0 110.846 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 142.98 49.51 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.648 2.232 . . . . 0.0 112.349 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -164.73 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.695 2.263 . . . . 0.0 112.36 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 799' ' ' PHE . . . . . 0.516 ' CE1' ' HB ' ' A' ' 780' ' ' VAL . 18.6 p90 -161.9 173.95 13.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.882 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 800' ' ' CYS . . . . . 0.407 ' SG ' HD11 ' A' ' 751' ' ' ILE . 3.4 m -103.07 136.14 43.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.913 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -146.99 131.53 17.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.925 179.908 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 744' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 745' ' ' CYS . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 745' ' ' CYS . . . . . 0.413 ' HB3' ' CE2' ' A' ' 793' ' ' TRP . 9.8 m -37.51 152.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 0.0 110.893 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 60.8 p -84.7 155.69 21.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -62.42 142.66 57.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 58.7 mt -90.43 149.4 40.91 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.624 0.726 . . . . 0.0 110.927 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 134.2 27.38 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.693 2.262 . . . . 0.0 112.347 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -42.35 146.63 0.31 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.911 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 751' ' ' ILE . . . . . 0.487 HD11 ' SG ' ' A' ' 800' ' ' CYS . 2.7 tt -102.91 148.86 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -88.18 137.98 31.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 18.0 t30 51.97 43.15 30.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 754' ' ' GLY . . . . . 0.449 ' O ' HG23 ' A' ' 751' ' ' ILE . . . 178.08 176.62 46.19 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.477 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -149.31 179.03 8.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.805 0.336 . . . . 0.0 110.956 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.54 172.09 13.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.897 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 20.4 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 179.96 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.894 0.378 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.89 152.43 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.083 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -41.22 131.16 2.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 98.76 -23.45 36.28 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -58.7 147.5 32.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.82 0.343 . . . . 0.0 111.047 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -135.46 145.09 46.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 25.3 mt -120.0 142.96 33.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.148 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 3.5 t -109.4 153.47 23.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 771' ' ' TYR . . . . . 0.431 ' HD2' HD13 ' A' ' 751' ' ' ILE . 25.4 m-85 -119.41 129.6 54.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.913 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -125.8 122.4 36.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.96 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 60.2 m -106.55 174.07 6.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.5 158.98 26.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.642 0.734 . . . . 0.0 110.876 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 111.18 2.74 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.701 2.268 . . . . 0.0 112.332 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 126.98 -14.68 6.61 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.49 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -104.72 173.28 6.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.889 0.376 . . . . 0.0 110.96 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -134.6 147.75 50.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.837 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 779' ' ' ILE . . . . . 0.426 HD11 ' O ' ' A' ' 771' ' ' TYR . 24.1 mt -82.96 144.87 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.141 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 780' ' ' VAL . . . . . 0.557 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 58.3 t -118.15 105.87 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.162 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 125.11 -150.46 17.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.507 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 782' ' ' SER . . . . . 0.528 ' O ' HD11 ' A' ' 785' ' ' LEU . 43.7 m -85.2 106.73 16.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 0.0 110.832 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -57.27 -49.16 76.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.855 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.544 ' C ' HD12 ' A' ' 785' ' ' LEU . 21.0 m -102.12 126.79 49.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 785' ' ' LEU . . . . . 0.57 HD21 ' HA ' ' A' ' 797' ' ' PRO . 7.0 mp -113.61 111.01 21.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . 0.497 HG22 ' N ' ' A' ' 787' ' ' CYS . 32.6 m -94.37 159.4 15.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.163 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 787' ' ' CYS . . . . . 0.497 ' N ' HG22 ' A' ' 786' ' ' THR . 7.0 t -96.93 117.59 31.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -75.5 175.37 8.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 11.6 p-90 -62.15 -21.87 65.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -88.98 20.61 3.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.884 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 23.3 mt 51.2 31.85 7.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 36.1 t -121.97 153.83 38.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 793' ' ' TRP . . . . . 0.439 ' O ' ' C ' ' A' ' 794' ' ' SER . 88.6 m95 -83.99 140.73 31.7 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 793' ' ' TRP . 8.5 t -34.55 -44.83 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 8.6 t -173.03 173.03 3.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -44.93 151.04 0.67 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.586 0.708 . . . . 0.0 110.856 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . 0.57 ' HA ' HD21 ' A' ' 785' ' ' LEU . 54.2 Cg_endo -69.75 147.82 63.78 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.678 2.252 . . . . 0.0 112.39 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 798' ' ' PRO . . . . . 0.408 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.8 Cg_endo -69.74 -163.87 0.12 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.697 2.265 . . . . 0.0 112.385 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 799' ' ' PHE . . . . . 0.557 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 3.9 p90 -160.6 170.24 21.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 800' ' ' CYS . . . . . 0.487 ' SG ' HD11 ' A' ' 751' ' ' ILE . 19.9 m -104.21 119.41 38.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.876 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -128.19 126.16 40.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.986 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 745' ' ' CYS . . . . . 0.506 ' HB3' ' CE2' ' A' ' 793' ' ' TRP . 1.8 m -40.23 152.91 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.841 0.353 . . . . 0.0 110.886 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 27.1 m -79.79 140.46 36.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.82 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -44.11 141.0 1.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.867 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 43.7 mt -93.08 148.59 36.0 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.595 0.712 . . . . 0.0 110.932 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -174.09 0.84 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.697 2.265 . . . . 0.0 112.339 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -95.24 143.27 26.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 751' ' ' ILE . . . . . 0.485 HD11 ' SG ' ' A' ' 800' ' ' CYS . 3.0 tt -100.72 144.37 12.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.077 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 19.7 mp0 -78.17 132.09 37.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.912 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 55.59 40.22 31.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 754' ' ' GLY . . . . . 0.46 ' C ' HG23 ' A' ' 751' ' ' ILE . . . -174.26 176.4 46.64 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.513 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 32.6 p90 -157.24 161.59 39.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.799 0.333 . . . . 0.0 110.916 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -108.84 159.01 17.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.902 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 56.5 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.143 179.951 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 763' ' ' LEU . . . . . 0.476 HD22 HD11 ' A' ' 769' ' ' ILE . 78.4 mt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.801 0.334 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 34.4 m -96.4 159.91 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . 0.559 ' NE ' HD21 ' A' ' 791' ' ' LEU . 6.1 ptp180 -45.65 132.95 8.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 101.94 -39.99 2.57 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.485 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -46.77 157.58 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 111.114 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 768' ' ' ARG . . . . . 0.52 ' O ' HD13 ' A' ' 769' ' ' ILE . 72.4 mtt180 -123.99 172.93 8.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 769' ' ' ILE . . . . . 0.52 HD13 ' O ' ' A' ' 768' ' ' ARG . 8.2 mm -143.12 134.08 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 17.1 m -100.6 113.67 26.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.129 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 771' ' ' TYR . . . . . 0.737 ' HE2' HD22 ' A' ' 785' ' ' LEU . 22.7 m-85 -96.79 124.24 40.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.918 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -126.79 137.57 53.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 75.2 m -115.2 174.19 6.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.904 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -60.54 157.47 36.44 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.636 0.732 . . . . 0.0 110.829 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 112.93 3.21 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.665 2.243 . . . . 0.0 112.365 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 124.84 -22.23 6.47 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.484 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -95.32 178.24 5.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.896 0.379 . . . . 0.0 110.868 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -136.67 156.42 48.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.876 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 779' ' ' ILE . . . . . 0.702 HG23 ' HB2' ' A' ' 798' ' ' PRO . 74.3 mt -98.69 135.26 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.14 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 780' ' ' VAL . . . . . 0.576 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 61.8 t -112.16 106.77 21.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.136 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 128.0 -149.0 17.97 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.448 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 21.9 m -83.06 107.47 15.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.866 0.365 . . . . 0.0 110.849 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.25 -46.17 90.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 25.6 m -101.93 122.11 43.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 785' ' ' LEU . . . . . 0.737 HD22 ' HE2' ' A' ' 771' ' ' TYR . 9.8 mp -103.3 114.46 28.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 10.1 m -107.92 147.27 31.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.136 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 8.8 t -92.51 137.55 32.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.847 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -87.97 169.4 12.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -56.0 -25.09 42.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -86.75 21.2 2.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.836 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 791' ' ' LEU . . . . . 0.559 HD21 ' NE ' ' A' ' 765' ' ' ARG . 7.4 mt 51.22 37.47 18.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 90.4 p -122.38 136.41 54.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.825 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 793' ' ' TRP . . . . . 0.506 ' CE2' ' HB3' ' A' ' 745' ' ' CYS . 97.1 m95 -67.9 140.53 56.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.928 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 1.5 t -42.73 -48.62 5.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.899 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 8.4 t -168.78 173.82 6.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.855 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.97 151.16 4.72 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.576 0.703 . . . . 0.0 110.851 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . 0.522 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.7 Cg_endo -69.81 144.49 53.96 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.67 2.246 . . . . 0.0 112.345 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 798' ' ' PRO . . . . . 0.702 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.6 Cg_endo -69.7 -175.25 1.08 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.715 2.277 . . . . 0.0 112.332 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 799' ' ' PHE . . . . . 0.576 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.4 p90 -145.27 165.4 28.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 800' ' ' CYS . . . . . 0.485 ' SG ' HD11 ' A' ' 751' ' ' ILE . 2.6 m -103.75 128.26 51.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -129.83 151.0 50.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 802' ' ' LYS . . . . . 0.42 ' HD2' ' C ' ' A' ' 802' ' ' LYS . 1.6 tmmm? . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 744' ' ' GLY . . . . . 0.409 ' CA ' ' HA ' ' A' ' 764' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 9.1 m -78.98 155.03 29.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.817 0.342 . . . . 0.0 110.918 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 77.5 p -73.24 149.45 42.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.862 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -54.09 163.09 0.84 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 11.7 mt -115.27 148.17 40.17 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.574 0.702 . . . . 0.0 110.932 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 144.28 53.42 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.726 2.284 . . . . 0.0 112.319 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -54.23 147.44 13.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 751' ' ' ILE . . . . . 0.405 HG13 ' N ' ' A' ' 752' ' ' GLN . 1.5 tt -105.17 144.1 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.093 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 752' ' ' GLN . . . . . 0.405 ' N ' HG13 ' A' ' 751' ' ' ILE . 23.2 mt-30 -89.04 145.47 25.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 47.3 47.9 16.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 179.96 179.96 48.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.461 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 47.3 p90 -154.96 154.23 32.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.839 0.352 . . . . 0.0 110.888 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -124.55 159.43 30.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.922 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 76.3 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.096 -179.981 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 763' ' ' LEU . . . . . 0.614 HD22 HD11 ' A' ' 769' ' ' ILE . 7.8 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.815 0.34 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 765' ' ' ARG . 33.1 m -86.11 175.68 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.12 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 764' ' ' VAL . 88.2 mtm180 -36.54 137.82 0.27 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 90.25 -31.55 5.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.486 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -50.54 125.5 13.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.737 0.304 . . . . 0.0 111.116 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -119.41 140.87 49.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.867 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 769' ' ' ILE . . . . . 0.614 HD11 HD22 ' A' ' 763' ' ' LEU . 68.1 mt -121.92 142.0 40.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.121 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 6.2 t -107.21 154.27 21.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.167 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 771' ' ' TYR . . . . . 0.468 ' HE2' HD22 ' A' ' 785' ' ' LEU . 47.3 m-85 -124.81 120.05 30.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -119.25 128.22 53.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.918 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 69.1 m -109.8 173.54 6.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -60.45 159.03 26.0 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.588 0.709 . . . . 0.0 110.858 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 121.12 7.81 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.711 2.274 . . . . 0.0 112.337 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 104.71 11.12 31.41 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -116.99 172.24 7.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.905 0.383 . . . . 0.0 110.881 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -126.95 155.17 43.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.848 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 5.3 mt -103.32 138.39 27.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.138 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 780' ' ' VAL . . . . . 0.564 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 56.3 t -114.51 107.98 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 129.53 -134.03 7.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.473 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 782' ' ' SER . . . . . 0.527 ' O ' HD11 ' A' ' 785' ' ' LEU . 1.6 t -109.82 109.86 20.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.862 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -57.44 -37.33 72.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.845 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.723 ' C ' HD12 ' A' ' 785' ' ' LEU . 16.7 m -108.84 134.28 51.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 785' ' ' LEU . . . . . 0.723 HD12 ' C ' ' A' ' 784' ' ' THR . 8.7 mp -127.11 120.31 28.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . 0.478 HG22 ' N ' ' A' ' 787' ' ' CYS . 16.6 m -111.07 160.79 16.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.107 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 787' ' ' CYS . . . . . 0.478 ' N ' HG22 ' A' ' 786' ' ' THR . 16.5 t -94.46 135.39 35.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -91.62 177.56 6.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 3.0 p90 -73.03 -3.55 26.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -107.44 17.37 22.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.897 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 31.7 mt 57.6 28.66 15.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.8 t -123.24 148.65 45.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 793' ' ' TRP . . . . . 0.431 ' O ' ' C ' ' A' ' 794' ' ' SER . 95.9 m95 -85.51 137.98 32.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.93 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 793' ' ' TRP . 37.9 t -34.8 -50.27 0.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.838 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 45.5 m -164.24 152.83 13.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -37.84 153.53 0.13 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.635 0.731 . . . . 0.0 110.863 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . 0.568 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.4 Cg_endo -69.83 145.84 57.94 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.676 2.251 . . . . 0.0 112.329 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -164.91 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.666 2.244 . . . . 0.0 112.397 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 799' ' ' PHE . . . . . 0.564 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.6 p90 -154.78 169.1 24.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.854 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 4.0 m -104.97 121.11 43.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.872 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -129.63 121.68 27.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 30.6 tttm . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 179.966 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 2.0 m -59.75 154.77 17.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.862 0.363 . . . . 0.0 110.848 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 84.8 p -71.27 141.01 50.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -46.15 144.36 1.99 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.88 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 748' ' ' LEU . . . . . 0.443 HD13 ' OH ' ' A' ' 771' ' ' TYR . 35.0 mt -92.11 144.93 29.88 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.597 0.713 . . . . 0.0 110.911 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 156.73 62.6 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.624 2.216 . . . . 0.0 112.325 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.32 147.03 53.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 751' ' ' ILE . . . . . 0.442 HD11 ' SG ' ' A' ' 800' ' ' CYS . 3.0 tt -102.66 149.66 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.16 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -90.77 141.75 28.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 46.16 49.73 12.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 177.82 -173.67 46.23 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.45 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 755' ' ' TRP . . . . . 0.444 ' NE1' ' HB2' ' A' ' 772' ' ' GLN . 15.4 p90 -154.94 -177.94 6.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.852 0.358 . . . . 0.0 110.896 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.67 165.82 25.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 -179.964 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 763' ' ' LEU . . . . . 0.815 HD21 HD11 ' A' ' 769' ' ' ILE . 37.8 mt . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.857 0.361 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . 0.513 ' H ' ' HB2' ' A' ' 767' ' ' ALA . 34.9 m -132.99 177.47 7.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -52.78 108.11 0.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 103.32 10.41 36.31 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.458 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . 0.513 ' HB2' ' H ' ' A' ' 764' ' ' VAL . . . -65.63 140.24 58.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.793 0.33 . . . . 0.0 111.105 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 768' ' ' ARG . . . . . 0.403 ' HG3' ' CG2' ' A' ' 784' ' ' THR . 36.5 ttm180 -130.22 119.56 23.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.904 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 769' ' ' ILE . . . . . 0.815 HD11 HD21 ' A' ' 763' ' ' LEU . 68.8 mt -116.53 144.9 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.136 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 19.1 m -110.0 143.85 39.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.132 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 771' ' ' TYR . . . . . 0.443 ' OH ' HD13 ' A' ' 748' ' ' LEU . 52.1 m-85 -113.18 121.99 46.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.889 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 772' ' ' GLN . . . . . 0.444 ' HB2' ' NE1' ' A' ' 755' ' ' TRP . 22.1 mp0 -110.28 137.43 48.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.942 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 77.5 m -114.59 171.89 7.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.871 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 774' ' ' ASP . . . . . 0.456 ' HB2' ' CD1' ' A' ' 777' ' ' TYR . 0.3 OUTLIER -64.01 154.49 81.71 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.605 0.717 . . . . 0.0 110.832 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 96.03 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.679 2.253 . . . . 0.0 112.368 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 139.32 -5.53 2.96 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.465 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 777' ' ' TYR . . . . . 0.456 ' CD1' ' HB2' ' A' ' 774' ' ' ASP . 18.8 m-85 -106.23 179.26 4.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.868 0.366 . . . . 0.0 110.953 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -134.61 146.08 49.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 779' ' ' ILE . . . . . 0.402 HG23 ' HB2' ' A' ' 798' ' ' PRO . 11.0 mt -91.2 142.13 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.158 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 780' ' ' VAL . . . . . 0.578 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 50.9 t -120.83 108.64 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.111 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 127.21 -134.75 8.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 782' ' ' SER . . . . . 0.546 ' O ' HD11 ' A' ' 785' ' ' LEU . 1.3 t -106.84 112.22 25.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.831 0.348 . . . . 0.0 110.877 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -61.17 -36.88 81.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.872 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.532 ' C ' HD12 ' A' ' 785' ' ' LEU . 15.4 m -110.32 123.55 50.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.136 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 785' ' ' LEU . . . . . 0.751 HD21 ' HA ' ' A' ' 797' ' ' PRO . 7.3 mp -115.06 122.25 45.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.945 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . 0.43 HG22 ' N ' ' A' ' 787' ' ' CYS . 20.4 m -107.01 156.82 18.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.132 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 787' ' ' CYS . . . . . 0.43 ' N ' HG22 ' A' ' 786' ' ' THR . 41.4 t -95.81 109.96 22.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.895 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -61.38 168.08 2.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -62.61 -17.77 60.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -94.02 19.91 8.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.848 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 80.5 mt 54.14 37.45 27.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 13.4 m -132.4 123.26 26.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 793' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -58.09 133.45 55.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 15.2 t -37.27 -42.62 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 37.9 m -164.31 164.17 22.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.58 154.77 4.33 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.597 0.713 . . . . 0.0 110.858 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . 0.751 ' HA ' HD21 ' A' ' 785' ' ' LEU . 54.1 Cg_endo -69.77 144.82 55.21 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.656 2.237 . . . . 0.0 112.339 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 798' ' ' PRO . . . . . 0.402 ' HB2' HG23 ' A' ' 779' ' ' ILE . 54.1 Cg_endo -69.75 -164.19 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.68 2.253 . . . . 0.0 112.324 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 799' ' ' PHE . . . . . 0.578 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.9 p90 -156.71 165.52 36.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.882 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 800' ' ' CYS . . . . . 0.442 ' SG ' HD11 ' A' ' 751' ' ' ILE . 3.8 m -102.24 117.51 34.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -117.68 134.47 54.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.935 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 64.0 tttt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 744' ' ' GLY . . . . . 0.431 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 3.6 m -60.72 161.25 8.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.86 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 67.4 m -74.84 141.92 44.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -48.86 155.45 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 69.9 mt -105.1 149.05 37.19 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.635 0.731 . . . . 0.0 110.933 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 164.59 33.96 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.684 2.256 . . . . 0.0 112.329 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -73.89 142.08 46.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 751' ' ' ILE . . . . . 0.699 HD11 ' SG ' ' A' ' 800' ' ' CYS . 3.5 tt -100.74 150.09 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -94.85 141.44 28.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 9.2 m120 54.29 43.34 30.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.856 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 754' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 751' ' ' ILE . . . 167.67 -179.75 40.88 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.471 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -154.35 164.75 38.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.878 0.37 . . . . 0.0 110.914 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -101.38 156.69 17.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 45.3 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.127 179.974 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 69.4 mt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.844 0.354 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 24.9 m -131.14 -179.09 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -60.2 127.63 32.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 95.67 -21.41 44.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.477 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -52.89 141.85 20.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.75 0.309 . . . . 0.0 111.094 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -123.01 140.88 52.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.897 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 769' ' ' ILE . . . . . 0.436 ' CG1' ' CH2' ' A' ' 793' ' ' TRP . 18.5 mm -106.32 148.84 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.162 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 95.6 m -121.04 113.56 20.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.148 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -97.39 124.16 41.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.969 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 43.5 tp60 -127.06 140.95 51.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.948 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 38.9 m -118.3 171.77 7.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.49 159.5 23.7 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.553 0.692 . . . . 0.0 110.888 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 104.29 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.678 2.252 . . . . 0.0 112.357 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 137.28 -19.1 3.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.494 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -100.59 177.04 5.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.0 110.887 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -136.08 151.04 49.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.824 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 3.4 mt -88.81 137.5 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.107 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 780' ' ' VAL . . . . . 0.573 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 65.7 t -115.74 107.32 22.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.155 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 127.73 -140.57 11.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.497 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 782' ' ' SER . . . . . 0.596 ' O ' HD11 ' A' ' 785' ' ' LEU . 3.8 m -105.56 102.23 11.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.879 0.371 . . . . 0.0 110.889 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.58 -53.25 59.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.895 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.714 ' C ' HD12 ' A' ' 785' ' ' LEU . 33.0 m -83.47 132.8 34.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.132 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 785' ' ' LEU . . . . . 0.714 HD12 ' C ' ' A' ' 784' ' ' THR . 9.1 mp -127.03 125.37 41.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 1.8 m -106.36 148.13 28.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.139 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 21.4 t -93.87 115.23 27.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.905 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -71.0 169.58 14.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 789' ' ' TRP . . . . . 0.458 ' CE3' ' O ' ' A' ' 789' ' ' TRP . 10.3 p-90 -66.73 -7.37 20.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -100.58 15.77 26.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.875 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 791' ' ' LEU . . . . . 0.431 HD22 ' CA ' ' A' ' 744' ' ' GLY . 82.5 mt 56.25 31.31 18.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 38.3 m -126.58 128.88 47.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 793' ' ' TRP . . . . . 0.449 ' CE3' ' HB3' ' A' ' 785' ' ' LEU . 98.6 m95 -59.53 137.74 57.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 9.3 t -48.17 -39.48 20.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 78.1 p -155.46 167.73 29.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.59 156.54 32.06 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.59 0.709 . . . . 0.0 110.86 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . 0.427 ' HA ' HD21 ' A' ' 785' ' ' LEU . 54.3 Cg_endo -69.74 141.15 44.53 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.665 2.243 . . . . 0.0 112.403 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -168.15 0.26 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.69 2.26 . . . . 0.0 112.382 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 799' ' ' PHE . . . . . 0.573 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 9.1 p90 -160.0 170.87 20.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.85 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 800' ' ' CYS . . . . . 0.699 ' SG ' HD11 ' A' ' 751' ' ' ILE . 12.0 m -102.52 145.8 29.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.875 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -148.02 134.13 19.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.871 179.97 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 744' ' ' GLY . . . . . 0.415 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 2.2 m -47.72 154.25 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.847 0.356 . . . . 0.0 110.913 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 41.6 m -69.58 150.82 46.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -72.78 139.29 46.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.891 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 9.6 mt -94.31 146.63 31.9 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.671 0.748 . . . . 0.0 110.867 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -179.78 3.14 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.678 2.252 . . . . 0.0 112.379 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -79.75 142.93 34.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.2 tt -101.16 149.25 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.127 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -94.17 137.75 32.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 62.84 36.83 12.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.922 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 174.4 -177.42 46.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.498 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 755' ' ' TRP . . . . . 0.418 ' CD1' ' C ' ' A' ' 755' ' ' TRP . 2.4 p90 -156.02 169.36 24.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.858 0.361 . . . . 0.0 110.885 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -118.68 161.93 19.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 24.4 p . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.119 -179.974 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 16.6 mt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.9 0.381 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 27.2 m -111.16 176.01 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.105 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -48.27 138.07 10.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 88.16 -30.74 5.02 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.465 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -40.08 129.07 2.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 34.3 mtt85 -122.0 127.37 50.21 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.846 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 59.1 mt -104.85 148.87 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.141 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 55.7 m -118.31 125.53 50.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.177 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -96.74 132.89 41.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.955 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -126.0 121.89 34.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.973 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 82.9 m -103.86 174.45 5.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.84 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -60.42 156.91 38.7 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.592 0.71 . . . . 0.0 110.899 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 109.93 2.43 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.67 2.247 . . . . 0.0 112.41 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 127.64 -13.07 6.54 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.502 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -105.07 179.03 4.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.879 0.371 . . . . 0.0 110.937 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -139.91 152.06 46.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.825 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 779' ' ' ILE . . . . . 0.577 HG23 ' HB2' ' A' ' 798' ' ' PRO . 57.0 mt -89.67 135.55 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.193 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 780' ' ' VAL . . . . . 0.552 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 60.5 t -108.62 106.68 21.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 126.5 -147.68 16.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.484 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 54.1 p -84.62 103.05 13.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.0 110.874 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.8 -34.21 74.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 98.0 m -112.12 121.97 46.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 785' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.64 135.84 48.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 2.3 m -119.46 150.61 39.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 17.4 t -94.9 107.81 19.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -63.66 162.39 13.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -58.05 -17.04 15.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.38 20.32 12.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 791' ' ' LEU . . . . . 0.415 HD22 ' HA2' ' A' ' 744' ' ' GLY . 74.3 mt 55.16 25.0 6.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.938 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 19.9 m -109.56 125.86 52.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 793' ' ' TRP . . . . . 0.416 ' O ' ' C ' ' A' ' 794' ' ' SER . 75.7 m95 -67.13 135.74 54.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 793' ' ' TRP . 4.3 t -36.93 -44.1 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 10.9 m -173.06 167.06 4.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.832 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -43.79 152.15 0.46 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.596 0.712 . . . . 0.0 110.898 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 146.37 60.46 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 798' ' ' PRO . . . . . 0.577 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.8 Cg_endo -69.8 -167.55 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.685 2.257 . . . . 0.0 112.314 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 799' ' ' PHE . . . . . 0.552 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 1.1 p90 -154.62 170.27 21.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 14.7 m -101.95 127.96 48.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -139.88 126.12 20.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 12.9 tttt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 -179.994 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 744' ' ' GLY . . . . . 0.474 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 9.9 m -45.16 163.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 110.873 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 79.1 p -91.71 163.22 14.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.893 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -61.35 158.72 13.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 46.0 mt -111.52 150.84 42.76 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.59 0.71 . . . . 0.0 110.871 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 157.57 59.95 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.678 2.252 . . . . 0.0 112.362 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.47 148.81 51.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.9 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 2.0 tt -109.06 150.8 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.1 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -103.25 140.61 37.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.933 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 7.4 m120 57.0 43.95 23.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 174.55 -179.94 45.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.537 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 16.5 p90 -156.93 161.19 39.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 110.965 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -116.26 168.27 10.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 179.984 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 763' ' ' LEU . . . . . 0.656 HD13 ' HZ2' ' A' ' 793' ' ' TRP . 69.7 mt . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.84 0.352 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 34.5 m -112.27 -179.53 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.177 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -59.06 130.01 44.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.866 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 97.56 -35.25 4.6 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.507 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -52.72 145.13 12.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.819 0.342 . . . . 0.0 111.104 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -134.99 151.52 50.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.833 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 29.3 mt -118.44 143.22 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.141 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 98.5 m -104.98 124.03 48.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.143 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -96.95 128.87 44.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -124.62 145.11 49.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.912 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 100.0 m -124.12 174.28 7.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.89 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -60.78 158.28 33.54 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.607 0.717 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 112.84 3.19 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.66 2.24 . . . . 0.0 112.363 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 123.81 -16.28 7.84 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.509 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 777' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 802' ' ' LYS . 13.9 m-85 -104.01 178.66 4.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 0.0 110.939 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -137.9 155.93 48.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 779' ' ' ILE . . . . . 0.675 HG23 ' HB2' ' A' ' 798' ' ' PRO . 46.9 mt -91.01 133.7 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 780' ' ' VAL . . . . . 0.579 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 74.2 t -108.69 111.51 36.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.167 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 124.87 -143.63 14.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.504 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 3.5 m -94.05 101.18 13.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.914 0.387 . . . . 0.0 110.909 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.04 -47.97 76.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.888 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.644 ' C ' HD12 ' A' ' 785' ' ' LEU . 22.6 m -94.15 134.02 37.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.141 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 785' ' ' LEU . . . . . 0.644 HD12 ' C ' ' A' ' 784' ' ' THR . 7.9 mp -122.42 108.84 13.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.928 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . 0.439 HG22 ' N ' ' A' ' 787' ' ' CYS . 23.0 m -97.1 156.8 16.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 787' ' ' CYS . . . . . 0.439 ' N ' HG22 ' A' ' 786' ' ' THR . 13.6 t -98.05 125.18 42.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -86.38 169.14 13.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.933 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 789' ' ' TRP . . . . . 0.442 ' CE2' ' OD1' ' A' ' 790' ' ' ASP . 5.9 p-90 -65.53 -8.49 19.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.938 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . 0.442 ' OD1' ' CE2' ' A' ' 789' ' ' TRP . 87.6 m-20 -100.93 23.29 10.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 791' ' ' LEU . . . . . 0.474 HD22 ' CA ' ' A' ' 744' ' ' GLY . 40.5 mt 50.26 42.75 26.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.902 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.6 t -134.7 149.89 50.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.85 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 793' ' ' TRP . . . . . 0.656 ' HZ2' HD13 ' A' ' 763' ' ' LEU . 94.3 m95 -86.02 144.53 27.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 793' ' ' TRP . 27.9 t -36.38 -40.77 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.838 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 1.7 t -172.29 -175.96 1.51 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.67 157.08 29.52 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.624 0.726 . . . . 0.0 110.832 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . 0.413 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.3 Cg_endo -69.83 141.11 44.07 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.667 2.244 . . . . 0.0 112.299 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 798' ' ' PRO . . . . . 0.675 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.7 Cg_endo -69.81 -176.76 1.61 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.647 2.231 . . . . 0.0 112.361 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 799' ' ' PHE . . . . . 0.579 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 6.6 p90 -153.27 169.96 21.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 3.0 m -101.75 125.88 48.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.888 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -137.82 120.08 15.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 802' ' ' LYS . . . . . 0.406 ' HB2' ' CE2' ' A' ' 777' ' ' TYR . 6.2 ttpm? . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 744' ' ' GLY . . . . . 0.849 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 745' ' ' CYS . . . . . 0.405 ' SG ' ' C ' ' A' ' 791' ' ' LEU . 1.8 m -61.41 152.69 29.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.831 0.348 . . . . 0.0 110.854 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 2.9 m -73.81 166.85 22.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.811 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.39 152.21 38.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.884 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 15.1 mt -103.3 146.85 33.23 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.597 0.713 . . . . 0.0 110.909 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.7 162.65 41.22 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.716 2.278 . . . . 0.0 112.373 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.3 143.97 42.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 5.6 tt -100.69 151.11 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.126 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -94.18 140.49 29.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 28.9 t30 53.71 41.4 32.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -179.99 -176.92 47.75 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.488 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -153.13 159.09 42.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.833 0.349 . . . . 0.0 110.93 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.9 160.85 22.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 3.0 p . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.099 -179.97 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 22.3 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.85 0.357 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 35.6 m -103.51 158.87 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.133 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -41.83 122.72 2.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 112.25 -31.91 6.64 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.502 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -56.62 162.07 2.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.759 0.314 . . . . 0.0 111.144 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 768' ' ' ARG . . . . . 0.44 ' C ' HD13 ' A' ' 769' ' ' ILE . 5.7 ptp180 -131.2 146.86 52.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.871 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 769' ' ' ILE . . . . . 0.737 HD11 ' HH2' ' A' ' 793' ' ' TRP . 5.3 mm -113.14 145.83 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.125 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 6.7 m -111.73 149.21 31.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.199 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -130.74 134.68 47.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.933 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -133.45 126.83 32.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 84.9 m -108.75 174.36 5.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.17 158.05 38.81 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.601 0.715 . . . . 0.0 110.872 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 106.95 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.733 2.289 . . . . 0.0 112.378 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 126.56 -10.92 7.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.474 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -106.77 167.54 9.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.865 0.364 . . . . 0.0 110.938 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -128.14 156.86 42.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.861 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 779' ' ' ILE . . . . . 0.66 HG23 ' HB2' ' A' ' 798' ' ' PRO . 75.8 mt -99.49 134.67 37.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.151 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 780' ' ' VAL . . . . . 0.571 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 93.7 t -106.35 107.8 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.073 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 132.56 -132.59 6.68 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.488 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 2.9 m -109.99 110.37 21.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.879 0.371 . . . . 0.0 110.871 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -58.22 -51.71 68.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.814 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 23.7 m -96.89 123.57 40.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 785' ' ' LEU . . . . . 0.424 HD21 ' HA ' ' A' ' 797' ' ' PRO . 8.7 mp -106.99 113.46 26.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 26.3 m -101.32 144.59 29.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.146 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 36.5 t -93.35 140.18 29.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -95.26 166.73 11.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -52.98 -19.37 2.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.936 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -88.82 22.77 2.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.825 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 791' ' ' LEU . . . . . 0.849 HD22 ' HA2' ' A' ' 744' ' ' GLY . 18.6 mt 46.93 35.45 3.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.928 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 22.7 t -121.99 158.36 29.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.839 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 793' ' ' TRP . . . . . 0.737 ' HH2' HD11 ' A' ' 769' ' ' ILE . 95.6 m95 -96.05 139.37 32.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 793' ' ' TRP . 6.6 t -36.8 -47.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.871 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 6.1 m -170.16 174.38 5.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.827 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -50.53 155.31 1.88 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.614 0.721 . . . . 0.0 110.842 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . 0.424 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.7 Cg_endo -69.8 146.21 59.28 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.715 2.277 . . . . 0.0 112.313 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 798' ' ' PRO . . . . . 0.66 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.9 Cg_endo -69.74 -166.99 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.679 2.253 . . . . 0.0 112.353 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 799' ' ' PHE . . . . . 0.571 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.6 p90 -154.96 165.59 36.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 9.1 m -101.63 128.0 48.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.9 143.99 47.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 28.8 tttp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.928 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 744' ' ' GLY . . . . . 0.501 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 745' ' ' CYS . . . . . 0.451 ' HB3' ' CE2' ' A' ' 793' ' ' TRP . 1.8 m -44.84 154.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 0.0 110.863 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 17.7 m -64.53 137.4 57.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -55.58 155.34 5.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 748' ' ' LEU . . . . . 0.483 HD12 ' CD1' ' A' ' 769' ' ' ILE . 12.4 mt -119.02 145.49 38.14 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.64 0.733 . . . . 0.0 110.884 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -177.43 1.86 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.674 2.249 . . . . 0.0 112.366 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -88.28 148.3 24.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 751' ' ' ILE . . . . . 0.411 HG13 ' N ' ' A' ' 752' ' ' GLN . 2.3 tt -101.98 148.67 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.121 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 752' ' ' GLN . . . . . 0.411 ' N ' HG13 ' A' ' 751' ' ' ILE . 5.7 pt20 -86.54 142.35 28.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 3.0 m120 51.48 40.61 27.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -173.63 176.84 46.17 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.501 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 755' ' ' TRP . . . . . 0.469 ' CZ2' ' HG2' ' A' ' 772' ' ' GLN . 44.5 p90 -145.93 151.08 37.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.353 . . . . 0.0 110.897 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -118.98 153.38 34.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 23.3 p . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.155 179.962 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 38.0 mt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.841 0.353 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.32 174.55 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.142 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -59.21 126.5 27.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 94.0 -17.01 59.62 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.513 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -60.61 140.16 57.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.782 0.325 . . . . 0.0 111.151 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 29.8 ptt85 -127.81 143.9 51.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 769' ' ' ILE . . . . . 0.483 ' CD1' HD12 ' A' ' 748' ' ' LEU . 94.8 mt -107.37 129.95 60.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.108 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 84.3 m -96.3 120.68 37.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.113 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -98.5 118.21 34.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.925 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 772' ' ' GLN . . . . . 0.469 ' HG2' ' CZ2' ' A' ' 755' ' ' TRP . 3.9 tp-100 -113.32 141.44 47.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 74.1 m -119.37 173.47 6.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.46 158.16 31.35 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.589 0.709 . . . . 0.0 110.867 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 106.77 1.73 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.652 2.235 . . . . 0.0 112.351 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 123.26 0.79 9.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.477 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 777' ' ' TYR . . . . . 0.456 ' CE2' ' HB2' ' A' ' 802' ' ' LYS . 23.9 m-85 -115.21 170.17 8.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.848 0.356 . . . . 0.0 110.974 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -129.71 154.76 46.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 779' ' ' ILE . . . . . 0.624 HG23 ' HB2' ' A' ' 798' ' ' PRO . 72.8 mt -97.17 134.62 34.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.142 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 780' ' ' VAL . . . . . 0.561 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 59.8 t -105.61 109.4 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 126.94 -145.12 15.55 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.477 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 782' ' ' SER . . . . . 0.448 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 58.4 m -91.84 96.53 10.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.861 0.362 . . . . 0.0 110.865 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -46.77 -43.76 18.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.857 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.686 ' C ' HD12 ' A' ' 785' ' ' LEU . 6.2 m -106.34 141.24 37.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.168 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 785' ' ' LEU . . . . . 0.686 HD12 ' C ' ' A' ' 784' ' ' THR . 7.5 mp -126.33 110.13 13.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.937 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 7.0 m -94.43 152.39 18.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.109 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 13.8 t -93.15 118.8 31.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -71.98 179.47 3.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 3.2 m95 -71.11 -14.83 62.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -101.87 21.86 13.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.894 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 791' ' ' LEU . . . . . 0.501 HD22 ' HA2' ' A' ' 744' ' ' GLY . 69.3 mt 53.59 26.17 5.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.929 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 4.4 m -113.69 122.71 47.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 793' ' ' TRP . . . . . 0.451 ' CE2' ' HB3' ' A' ' 745' ' ' CYS . 91.6 m95 -61.97 136.07 57.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.918 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 1.4 t -38.38 -44.34 0.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.804 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 58.3 m -161.3 -179.6 7.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -65.17 157.34 77.48 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.588 0.708 . . . . 0.0 110.864 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . 0.538 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.3 Cg_endo -69.83 140.73 43.11 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.648 2.232 . . . . 0.0 112.293 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 798' ' ' PRO . . . . . 0.624 ' HB2' HG23 ' A' ' 779' ' ' ILE . 54.1 Cg_endo -69.71 -164.28 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.675 2.25 . . . . 0.0 112.405 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 799' ' ' PHE . . . . . 0.561 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 6.1 p90 -156.13 173.19 17.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 35.4 m -101.96 137.96 39.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -143.66 142.58 31.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 802' ' ' LYS . . . . . 0.456 ' HB2' ' CE2' ' A' ' 777' ' ' TYR . 4.8 ttpm? . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 744' ' ' GLY . . . . . 0.561 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.9 171.37 0.51 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.364 . . . . 0.0 110.843 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 3.4 t -90.38 167.34 12.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -75.4 132.23 40.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.56 152.26 60.07 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.628 0.728 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 167.5 24.37 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.662 2.241 . . . . 0.0 112.296 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -74.87 145.67 42.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.6 tt -100.72 146.52 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.115 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -91.8 130.48 37.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.937 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 61.99 44.34 8.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 179.99 -173.99 45.47 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.453 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 45.6 p90 -157.78 170.13 23.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.799 0.333 . . . . 0.0 110.971 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -118.96 165.55 13.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.917 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 58.6 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.144 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 31.7 mt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.836 0.35 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 35.1 m -107.86 -175.0 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . 0.414 ' CD ' ' HA ' ' A' ' 789' ' ' TRP . 73.7 mtm180 -68.99 134.71 49.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 95.96 -20.56 49.41 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.49 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -60.02 152.94 22.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.809 0.338 . . . . 0.0 111.092 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.62 136.65 43.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.855 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 56.5 mt -114.48 135.99 52.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.118 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 51.8 m -107.67 122.34 46.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.151 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -97.12 126.01 41.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -123.53 135.12 53.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 20.8 m -117.72 173.07 6.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -61.18 159.62 28.06 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.586 0.708 . . . . 0.0 110.852 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 114.98 3.88 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.683 2.255 . . . . 0.0 112.324 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 125.13 -25.2 5.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.468 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -90.83 170.35 10.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 0.0 110.926 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -129.15 154.62 46.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 779' ' ' ILE . . . . . 0.405 HG23 ' HB2' ' A' ' 798' ' ' PRO . 10.9 mt -95.59 137.82 22.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 780' ' ' VAL . . . . . 0.565 ' HB ' ' CE1' ' A' ' 799' ' ' PHE . 58.3 t -114.45 110.38 31.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.128 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 128.33 -132.67 7.41 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.507 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.93 107.56 17.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 110.911 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.02 -34.94 63.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.657 ' C ' HD12 ' A' ' 785' ' ' LEU . 23.7 m -109.39 136.12 49.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.159 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 785' ' ' LEU . . . . . 0.657 HD12 ' C ' ' A' ' 784' ' ' THR . 10.1 mp -126.71 118.61 25.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.93 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 1.2 m -105.83 151.98 23.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.16 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 48.6 t -95.41 108.82 21.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.86 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -62.0 175.67 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 789' ' ' TRP . . . . . 0.414 ' HA ' ' CD ' ' A' ' 765' ' ' ARG . 23.7 p-90 -73.3 -8.22 54.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -98.95 20.37 13.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 791' ' ' LEU . . . . . 0.561 HD22 ' CA ' ' A' ' 744' ' ' GLY . 79.2 mt 54.28 32.9 17.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 73.6 m -131.34 135.65 47.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 793' ' ' TRP . . . . . 0.422 ' O ' ' C ' ' A' ' 794' ' ' SER . 93.4 m95 -73.85 136.66 43.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.919 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 793' ' ' TRP . 11.9 t -35.92 -47.06 0.5 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.829 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 58.5 p -159.12 165.43 33.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -53.78 157.86 3.69 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.617 0.722 . . . . 0.0 110.878 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . 0.492 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.5 Cg_endo -69.8 141.39 44.95 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.687 2.258 . . . . 0.0 112.342 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 798' ' ' PRO . . . . . 0.405 ' HB2' HG23 ' A' ' 779' ' ' ILE . 54.5 Cg_endo -69.7 -167.11 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 0.0 112.389 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 799' ' ' PHE . . . . . 0.565 ' CE1' ' HB ' ' A' ' 780' ' ' VAL . 8.1 p90 -153.33 169.19 23.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 2.8 m -103.33 122.31 44.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.874 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -122.51 147.94 45.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 20.1 tttp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 -179.98 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 744' ' ' GLY . . . . . 0.467 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 1.8 m -48.09 158.37 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.878 0.37 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 3.3 m -80.89 148.38 29.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -48.41 159.46 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.879 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 748' ' ' LEU . . . . . 0.541 HD21 ' CD1' ' A' ' 793' ' ' TRP . 92.2 mt -118.24 146.72 40.06 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.662 0.744 . . . . 0.0 110.875 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 139.27 39.7 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.68 2.253 . . . . 0.0 112.31 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -46.81 156.68 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.84 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 751' ' ' ILE . . . . . 0.623 HD11 ' SG ' ' A' ' 800' ' ' CYS . 1.6 tt -102.04 139.85 22.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.114 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -83.96 130.85 34.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 5.6 t30 55.45 45.02 26.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 177.94 -170.76 43.16 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.491 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 755' ' ' TRP . . . . . 0.45 ' C ' ' CD1' ' A' ' 755' ' ' TRP . 1.6 p90 -153.0 173.01 15.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.874 0.369 . . . . 0.0 110.9 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -135.07 172.0 13.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.138 -179.987 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 74.3 mt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.887 0.375 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 28.9 m -113.24 162.17 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.076 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 57.7 mtm-85 -40.94 145.27 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.927 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 82.38 -36.61 2.59 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.491 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -47.02 147.52 1.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.778 0.323 . . . . 0.0 111.076 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -124.85 164.67 19.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 35.1 mm -118.12 140.3 41.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.123 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 90.8 m -109.93 125.51 52.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.072 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 771' ' ' TYR . . . . . 0.553 ' CE2' ' HD2' ' A' ' 798' ' ' PRO . 24.6 m-85 -107.69 142.86 37.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.95 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -146.91 123.58 11.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 63.7 m -108.89 174.51 5.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.35 161.51 13.46 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.655 0.74 . . . . 0.0 110.859 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 120.57 7.34 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.718 2.279 . . . . 0.0 112.287 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 118.84 -29.09 6.41 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.493 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 777' ' ' TYR . . . . . 0.563 ' CE2' ' HB2' ' A' ' 802' ' ' LYS . 28.9 m-85 -89.94 179.46 5.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.918 0.389 . . . . 0.0 110.926 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -142.3 154.57 44.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.847 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 779' ' ' ILE . . . . . 0.622 HG23 ' HB2' ' A' ' 798' ' ' PRO . 75.9 mt -87.21 135.22 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.184 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 780' ' ' VAL . . . . . 0.569 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 66.5 t -103.06 105.0 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 126.03 -129.22 6.69 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.486 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 1.1 t -114.46 107.68 15.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.884 0.374 . . . . 0.0 110.86 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -55.19 -36.92 66.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.65 ' C ' HD12 ' A' ' 785' ' ' LEU . 33.3 m -101.27 139.39 37.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.139 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 785' ' ' LEU . . . . . 0.65 HD12 ' C ' ' A' ' 784' ' ' THR . 11.2 mp -130.37 111.81 12.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.943 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 11.1 m -90.71 149.96 21.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.134 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 9.3 t -93.23 107.48 19.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -57.79 -179.18 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.953 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 41.3 p-90 -72.44 -25.48 61.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.67 27.79 1.45 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.862 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 791' ' ' LEU . . . . . 0.467 HD22 ' HA2' ' A' ' 744' ' ' GLY . 20.1 mt 49.67 40.83 20.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.8 t -130.98 147.14 52.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 793' ' ' TRP . . . . . 0.541 ' CD1' HD21 ' A' ' 748' ' ' LEU . 83.3 m95 -80.87 134.98 35.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.941 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 793' ' ' TRP . 2.3 m -34.74 -47.34 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.824 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 79.4 p -159.98 165.41 32.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.831 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -44.6 152.96 0.49 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.609 0.719 . . . . 0.0 110.841 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . 0.6 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.6 Cg_endo -69.76 146.69 60.94 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.661 2.241 . . . . 0.0 112.354 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 798' ' ' PRO . . . . . 0.622 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.6 Cg_endo -69.71 -169.31 0.32 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.687 2.258 . . . . 0.0 112.392 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 799' ' ' PHE . . . . . 0.569 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 4.9 p90 -157.76 172.74 17.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.875 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 800' ' ' CYS . . . . . 0.623 ' SG ' HD11 ' A' ' 751' ' ' ILE . 7.2 m -101.96 136.14 42.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -146.71 135.7 22.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 802' ' ' LYS . . . . . 0.563 ' HB2' ' CE2' ' A' ' 777' ' ' TYR . 44.5 tttm . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.944 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 744' ' ' GLY . . . . . 0.451 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 3.9 m -40.54 154.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 110.895 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 4.4 m -75.9 147.38 39.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.22 117.89 6.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.84 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 748' ' ' LEU . . . . . 0.427 HD21 ' CD1' ' A' ' 793' ' ' TRP . 10.2 mt -70.62 149.34 95.4 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.598 0.713 . . . . 0.0 110.895 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 159.92 51.61 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.666 2.244 . . . . 0.0 112.342 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.08 149.95 43.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.7 tt -100.65 148.54 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.121 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -93.41 123.42 36.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.945 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 70.08 41.68 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.883 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 177.54 -174.24 46.77 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.494 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 3.2 p90 -151.35 166.11 32.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.835 0.35 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.24 156.2 43.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 49.2 p . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 179.981 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 65.8 mt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.844 0.354 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 24.0 m -87.89 162.13 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 765' ' ' ARG . 25.9 mtm105 -51.75 132.88 31.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 99.52 -25.4 28.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.461 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -62.81 131.52 49.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 0.0 111.102 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 19.6 ptt-85 -111.23 147.47 34.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 8.9 mm -104.13 139.98 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.121 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 22.8 m -104.69 119.72 39.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.142 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -104.19 130.45 51.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -135.41 132.48 37.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 39.9 m -112.56 171.81 7.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -60.48 160.63 17.38 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.629 0.728 . . . . 0.0 110.865 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 107.98 1.99 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.663 2.242 . . . . 0.0 112.359 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 133.43 -24.42 3.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.436 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -92.72 170.73 9.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.876 0.37 . . . . 0.0 110.948 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -130.86 155.63 46.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.852 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 779' ' ' ILE . . . . . 0.438 HG23 ' HB2' ' A' ' 798' ' ' PRO . 11.5 mt -91.68 141.62 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.165 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 780' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 58.4 t -116.15 106.6 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 124.61 -126.38 6.04 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 782' ' ' SER . . . . . 0.5 ' O ' HD11 ' A' ' 785' ' ' LEU . 1.3 t -113.52 108.09 16.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.916 0.389 . . . . 0.0 110.871 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.7 -33.87 66.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.904 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.617 ' C ' HD12 ' A' ' 785' ' ' LEU . 9.9 m -111.61 129.22 56.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.123 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 785' ' ' LEU . . . . . 0.617 HD12 ' C ' ' A' ' 784' ' ' THR . 8.8 mp -121.45 118.81 30.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.898 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 51.8 m -96.65 152.59 18.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.087 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 20.0 t -95.63 112.05 23.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -65.41 170.97 4.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.949 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -69.36 -6.58 30.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -105.95 24.28 12.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.844 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 791' ' ' LEU . . . . . 0.451 HD22 ' CA ' ' A' ' 744' ' ' GLY . 34.5 mt 50.5 33.52 8.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.887 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 6.8 m -128.31 123.13 33.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 793' ' ' TRP . . . . . 0.429 ' O ' ' C ' ' A' ' 794' ' ' SER . 86.9 m95 -66.17 137.2 56.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.958 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 793' ' ' TRP . 23.0 t -35.67 -50.56 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.814 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 38.8 p -154.96 165.17 37.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.866 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -51.1 156.74 1.69 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.568 0.699 . . . . 0.0 110.884 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . 0.549 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.5 Cg_endo -69.77 141.81 46.2 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.663 2.242 . . . . 0.0 112.343 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 798' ' ' PRO . . . . . 0.438 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.6 Cg_endo -69.79 -164.07 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.679 2.252 . . . . 0.0 112.321 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 799' ' ' PHE . . . . . 0.466 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 6.7 p90 -158.56 172.28 18.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 2.7 m -101.7 138.36 38.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -146.72 150.04 34.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 5.3 tttm . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 179.971 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 744' ' ' GLY . . . . . 0.489 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 5.1 m -40.55 155.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.858 0.361 . . . . 0.0 110.867 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 2.8 m -78.5 133.45 37.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -44.53 140.62 2.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 748' ' ' LEU . . . . . 0.553 HD23 ' CD1' ' A' ' 769' ' ' ILE . 4.0 mm? -76.47 148.18 79.86 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.598 0.713 . . . . 0.0 110.932 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.63 168.74 20.51 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.677 2.251 . . . . 0.0 112.38 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -74.31 135.75 42.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 751' ' ' ILE . . . . . 0.635 HD11 ' SG ' ' A' ' 800' ' ' CYS . 1.4 tt -108.05 141.78 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.15 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -83.1 146.84 28.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.939 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 42.44 48.67 4.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 176.74 172.56 41.5 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.477 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 45.5 p90 -153.88 152.55 30.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.81 0.338 . . . . 0.0 110.901 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 756' ' ' LYS . . . . . 0.483 ' O ' HG23 ' A' ' 757' ' ' THR . 7.7 ptpp? -109.42 164.26 12.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 756' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.098 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 65.3 mt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.853 0.359 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 29.3 m -120.62 174.06 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 49.6 mtm180 -46.78 133.97 10.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.92 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 767' ' ' ALA . . . 91.48 -34.37 4.36 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.515 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 766' ' ' GLY . . . -38.02 131.8 1.05 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 0.0 111.027 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 768' ' ' ARG . . . . . 0.551 ' HG2' HG23 ' A' ' 784' ' ' THR . 7.3 tmm_? -117.04 130.86 56.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.872 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 769' ' ' ILE . . . . . 0.553 ' CD1' HD23 ' A' ' 748' ' ' LEU . 56.9 mt -112.64 141.09 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.18 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 5.7 t -111.53 152.9 26.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.167 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -120.49 116.95 26.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.913 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -110.83 124.43 52.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.942 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 77.4 m -109.21 174.22 5.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -60.43 153.08 62.03 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.665 0.745 . . . . 0.0 110.856 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 93.97 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.708 2.272 . . . . 0.0 112.357 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 140.78 -9.82 2.85 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.535 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -100.91 176.31 5.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.885 0.374 . . . . 0.0 110.947 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -128.57 159.53 35.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.865 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 4.4 mt -104.44 143.34 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 780' ' ' VAL . . . . . 0.571 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 86.4 t -124.04 108.93 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.095 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 128.42 -135.82 8.78 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.493 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 3.0 m -107.29 98.99 8.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.371 . . . . 0.0 110.908 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.57 -48.8 57.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.857 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.667 ' C ' HD12 ' A' ' 785' ' ' LEU . 87.5 m -95.42 135.54 36.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.15 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 785' ' ' LEU . . . . . 0.667 HD12 ' C ' ' A' ' 784' ' ' THR . 7.6 mp -122.19 122.35 38.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.96 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 8.1 m -109.5 150.62 27.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.154 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 6.6 t -95.06 120.44 35.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -81.67 -176.69 6.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.938 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -68.72 -16.87 63.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.8 16.14 16.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.862 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 791' ' ' LEU . . . . . 0.489 HD22 ' CA ' ' A' ' 744' ' ' GLY . 68.4 mt 53.99 25.13 5.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.946 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 44.0 m -115.35 131.38 56.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 793' ' ' TRP . . . . . 0.416 ' CE2' HD21 ' A' ' 748' ' ' LEU . 83.5 m95 -63.05 137.84 58.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 793' ' ' TRP . 9.4 t -37.87 -47.2 1.02 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 68.0 m -156.74 161.99 39.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.866 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -46.4 158.97 0.36 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.59 0.709 . . . . 0.0 110.854 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 140.74 43.08 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.673 2.249 . . . . 0.0 112.293 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -169.77 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.671 2.247 . . . . 0.0 112.37 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 799' ' ' PHE . . . . . 0.571 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 4.1 p90 -159.29 167.41 29.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 800' ' ' CYS . . . . . 0.635 ' SG ' HD11 ' A' ' 751' ' ' ILE . 3.0 m -103.55 138.51 40.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -141.3 112.79 7.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 24.4 tttt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.908 179.992 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 744' ' ' GLY . . . . . 0.556 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 3.6 m -45.39 152.22 0.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.881 0.372 . . . . 0.0 110.859 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 68.4 m -75.91 146.24 39.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -56.26 130.31 43.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 12.4 mt -79.45 149.23 71.64 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.606 0.717 . . . . 0.0 110.895 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 165.1 32.16 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.726 2.284 . . . . 0.0 112.312 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -73.67 144.52 45.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 6.7 tt -100.57 151.86 5.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.127 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -97.45 124.44 41.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 67.17 39.41 3.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -173.41 177.54 45.75 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.465 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -158.34 156.72 31.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.815 0.34 . . . . 0.0 110.935 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -98.24 165.14 12.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 81.0 p . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.123 -179.995 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.824 0.345 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 27.7 m -112.77 155.78 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.122 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -48.84 116.09 1.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 112.61 -26.38 10.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.509 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -45.85 129.07 9.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.774 0.321 . . . . 0.0 111.147 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -115.17 120.79 40.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.861 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 52.3 mt -102.18 150.33 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.129 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 50.1 m -124.06 128.09 48.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.147 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -98.56 136.92 37.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -129.7 129.95 44.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 35.0 m -110.42 173.4 6.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.78 161.14 23.0 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.575 0.703 . . . . 0.0 110.84 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 117.5 5.12 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.656 2.237 . . . . 0.0 112.315 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 121.92 -22.52 7.62 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.479 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -96.55 172.83 7.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.877 0.37 . . . . 0.0 110.935 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -137.47 149.79 47.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.836 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 779' ' ' ILE . . . . . 0.668 HG23 ' HB2' ' A' ' 798' ' ' PRO . 66.8 mt -88.11 134.26 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.118 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 780' ' ' VAL . . . . . 0.565 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 63.6 t -108.25 108.23 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.12 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 124.45 -156.56 18.56 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.48 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 782' ' ' SER . . . . . 0.479 ' O ' HD11 ' A' ' 785' ' ' LEU . 58.2 m -76.87 95.44 4.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.868 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -49.36 -55.2 13.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.861 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.76 ' C ' HD12 ' A' ' 785' ' ' LEU . 87.4 m -92.27 142.19 27.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.076 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 785' ' ' LEU . . . . . 0.76 HD12 ' C ' ' A' ' 784' ' ' THR . 8.2 mp -128.04 143.09 51.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 55.8 m -128.42 151.99 48.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.144 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 14.4 t -94.6 107.08 19.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -61.15 -179.95 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -69.61 -20.27 63.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.871 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -91.92 23.71 3.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.866 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 791' ' ' LEU . . . . . 0.556 HD22 ' HA2' ' A' ' 744' ' ' GLY . 39.3 mt 51.02 29.55 4.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.8 t -117.9 147.34 43.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.825 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 793' ' ' TRP . . . . . 0.432 ' O ' ' C ' ' A' ' 794' ' ' SER . 95.0 m95 -83.78 134.63 34.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.881 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 793' ' ' TRP . 2.3 t -34.47 -50.51 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 97.7 p -162.07 168.45 22.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.836 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.21 153.14 0.95 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.619 0.723 . . . . 0.0 110.822 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . 0.423 ' HA ' HD21 ' A' ' 785' ' ' LEU . 54.0 Cg_endo -69.74 148.07 64.37 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.707 2.271 . . . . 0.0 112.345 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 798' ' ' PRO . . . . . 0.668 ' HB2' HG23 ' A' ' 779' ' ' ILE . 54.3 Cg_endo -69.71 -167.77 0.24 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.699 2.266 . . . . 0.0 112.339 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 799' ' ' PHE . . . . . 0.565 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 1.6 p90 -157.67 164.61 37.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 5.4 m -102.93 113.49 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -126.6 126.13 43.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.971 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 7.1 m -48.8 152.63 0.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.809 0.337 . . . . 0.0 110.879 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 32.4 m -72.96 156.69 38.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.817 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.93 131.96 45.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.831 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 748' ' ' LEU . . . . . 0.448 HD12 HD13 ' A' ' 769' ' ' ILE . 12.2 mt -79.93 148.66 68.83 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.566 0.698 . . . . 0.0 110.928 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 175.47 8.01 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.705 2.27 . . . . 0.0 112.36 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -77.93 149.41 34.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 2.0 tt -106.52 145.76 13.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.129 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -89.8 132.27 35.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 4.7 m120 59.92 44.59 13.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.854 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 178.17 179.72 48.24 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.488 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 755' ' ' TRP . . . . . 0.483 ' CZ2' ' HG2' ' A' ' 772' ' ' GLN . 19.0 p90 -156.06 168.56 26.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.834 0.35 . . . . 0.0 110.94 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.91 165.67 14.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.91 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 51.4 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.112 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 55.8 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.866 0.365 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 23.7 m -84.99 -175.92 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.154 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -53.35 130.68 35.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 103.12 -32.96 6.99 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -50.48 125.14 12.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.755 0.312 . . . . 0.0 111.144 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 768' ' ' ARG . . . . . 0.452 ' HG2' ' CG2' ' A' ' 784' ' ' THR . 8.9 ttp-105 -116.52 145.56 43.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.862 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 769' ' ' ILE . . . . . 0.448 HD13 HD12 ' A' ' 748' ' ' LEU . 39.4 mt -123.89 140.45 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.11 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 18.7 m -108.5 123.01 48.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.147 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -99.67 121.37 41.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.911 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 772' ' ' GLN . . . . . 0.483 ' HG2' ' CZ2' ' A' ' 755' ' ' TRP . 4.3 tp-100 -118.09 143.54 46.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.857 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 73.6 m -124.36 171.1 10.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -62.06 159.68 35.9 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.578 0.704 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 119.66 6.57 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.725 2.283 . . . . 0.0 112.311 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 117.77 -20.21 10.97 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.481 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -96.3 179.31 5.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.882 0.372 . . . . 0.0 110.953 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -141.92 150.41 41.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.847 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 5.6 mt -87.58 144.96 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 780' ' ' VAL . . . . . 0.56 ' HB ' ' CE1' ' A' ' 799' ' ' PHE . 75.3 t -120.69 106.14 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.125 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 126.65 -132.62 7.77 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 3.0 m -101.75 88.34 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.888 0.375 . . . . 0.0 110.891 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -41.65 -33.73 0.51 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.875 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.478 ' C ' HD12 ' A' ' 785' ' ' LEU . 16.7 m -114.7 142.8 46.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 785' ' ' LEU . . . . . 0.88 HD11 ' HD3' ' A' ' 798' ' ' PRO . 9.6 mp -126.64 144.92 50.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 1.9 m -138.18 157.43 46.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.199 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 8.1 t -92.62 118.12 30.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.828 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -77.34 171.85 14.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 1.6 m-90 -59.52 -12.9 7.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -98.0 25.1 6.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 90.3 mt 48.08 25.76 0.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.4 t -121.35 147.34 45.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.84 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 793' ' ' TRP . . . . . 0.447 ' O ' ' C ' ' A' ' 794' ' ' SER . 98.0 m95 -77.79 141.15 39.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.958 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 793' ' ' TRP . 36.4 t -34.52 -46.41 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 19.4 p -173.11 170.72 4.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.12 151.54 0.2 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.593 0.711 . . . . 0.0 110.862 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . 0.466 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.8 Cg_endo -69.76 143.95 52.46 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.626 2.218 . . . . 0.0 112.367 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 798' ' ' PRO . . . . . 0.88 ' HD3' HD11 ' A' ' 785' ' ' LEU . 54.0 Cg_endo -69.75 177.51 5.5 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.696 2.264 . . . . 0.0 112.331 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 799' ' ' PHE . . . . . 0.56 ' CE1' ' HB ' ' A' ' 780' ' ' VAL . 10.0 p90 -149.55 172.55 14.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 12.6 m -102.79 129.51 49.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -129.68 129.66 44.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.896 179.95 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 744' ' ' GLY . . . . . 0.73 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 1.8 m -48.29 171.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.348 . . . . 0.0 110.885 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 56.9 p -100.55 140.7 34.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -46.25 144.01 2.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 16.3 mt -94.85 151.09 38.75 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.619 0.723 . . . . 0.0 110.94 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 151.45 68.99 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.67 2.246 . . . . 0.0 112.349 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -62.97 143.32 57.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 6.7 tt -100.54 153.24 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -97.39 128.42 44.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 61.92 41.3 11.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -173.46 176.21 46.12 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.458 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -152.22 170.52 19.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.827 0.346 . . . . 0.0 110.931 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 756' ' ' LYS . . . . . 0.766 ' HE3' HG21 ' A' ' 769' ' ' ILE . 9.9 ptmt -130.51 168.43 17.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 40.1 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.129 -179.995 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 763' ' ' LEU . . . . . 0.554 HD21 HD11 ' A' ' 769' ' ' ILE . 77.6 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.901 0.382 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 29.4 m -105.55 154.94 6.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.098 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -43.43 124.79 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 105.23 -25.22 25.65 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.485 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -53.88 137.9 37.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 111.084 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -121.95 130.47 53.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 769' ' ' ILE . . . . . 0.766 HG21 ' HE3' ' A' ' 756' ' ' LYS . 69.1 mt -110.68 131.93 60.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 31.1 m -99.01 130.78 45.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.147 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -98.57 120.19 38.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.937 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -117.83 124.21 47.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.917 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 72.1 m -107.55 173.39 6.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.66 157.49 37.62 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.6 0.714 . . . . 0.0 110.888 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 111.3 2.78 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.653 2.236 . . . . 0.0 112.371 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 125.13 -19.84 6.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.473 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -97.75 168.52 10.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.863 0.364 . . . . 0.0 110.932 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -125.72 162.93 23.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.869 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 779' ' ' ILE . . . . . 0.591 HG23 ' HB2' ' A' ' 798' ' ' PRO . 65.4 mt -103.8 135.13 42.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 780' ' ' VAL . . . . . 0.538 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 61.7 t -112.34 107.52 23.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.12 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 127.99 -150.32 18.35 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.449 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 782' ' ' SER . . . . . 0.418 ' O ' HD11 ' A' ' 785' ' ' LEU . 5.2 p -81.28 105.29 12.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.857 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.66 -50.48 73.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 30.7 m -102.47 121.24 41.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.174 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 785' ' ' LEU . . . . . 0.474 HD21 ' HA ' ' A' ' 797' ' ' PRO . 7.8 mp -106.91 148.68 28.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 37.8 m -137.77 153.03 49.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.116 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 12.4 t -93.94 115.91 28.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.912 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -71.86 -177.51 2.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.882 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 53.5 p-90 -71.42 -16.31 62.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.885 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -92.34 23.68 3.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.833 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 791' ' ' LEU . . . . . 0.73 HD22 ' HA2' ' A' ' 744' ' ' GLY . 32.3 mt 48.63 37.5 9.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.6 t -134.47 147.57 50.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.846 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 793' ' ' TRP . . . . . 0.44 ' O ' ' C ' ' A' ' 794' ' ' SER . 88.7 m95 -82.44 141.67 32.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.936 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 793' ' ' TRP . 1.3 t -35.41 -45.49 0.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.884 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 22.6 t -171.68 171.55 5.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -47.56 150.6 1.68 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.647 0.737 . . . . 0.0 110.833 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . 0.474 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.0 Cg_endo -69.8 149.17 66.25 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.685 2.257 . . . . 0.0 112.285 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 798' ' ' PRO . . . . . 0.591 ' HB2' HG23 ' A' ' 779' ' ' ILE . 54.1 Cg_endo -69.83 -171.79 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.678 2.252 . . . . 0.0 112.355 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 799' ' ' PHE . . . . . 0.538 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 3.2 p90 -147.22 167.71 23.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.912 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 3.9 m -102.05 119.18 38.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -123.32 132.59 54.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 24.3 tttp . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 15.3 t -107.91 88.16 2.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.914 0.387 . . . . 0.0 110.833 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 52.0 m -155.55 134.96 12.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.817 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -111.98 -107.25 2.91 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.533 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 3.9 t 64.76 41.54 5.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.905 0.383 . . . . 0.0 110.887 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 73.4 m -122.65 133.34 54.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.852 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . 171.65 142.8 3.82 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.504 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 3.0 m -46.76 170.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 110.895 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 70.4 m -97.35 138.4 34.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.865 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.26 123.94 5.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.857 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 748' ' ' LEU . . . . . 0.485 HD13 ' OH ' ' A' ' 771' ' ' TYR . 24.2 mt -69.42 144.1 94.1 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.611 0.719 . . . . 0.0 110.873 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 143.74 51.8 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.693 2.262 . . . . 0.0 112.325 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -52.12 133.55 33.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . 0.498 HG23 ' O ' ' A' ' 754' ' ' GLY . 1.5 tt -100.77 143.78 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.138 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 752' ' ' GLN . . . . . 0.412 ' N ' HG13 ' A' ' 751' ' ' ILE . 26.8 pt20 -82.49 136.39 34.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 5.8 m120 58.71 37.4 25.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . 0.498 ' O ' HG23 ' A' ' 751' ' ' ILE . . . -178.23 166.45 36.47 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.474 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -147.48 150.46 34.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.817 0.341 . . . . 0.0 110.912 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -91.54 148.87 21.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 39.5 p -139.92 113.37 8.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.09 145.12 51.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.133 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 24.0 t -64.09 -63.48 1.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -80.78 125.94 30.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.822 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 95.1 m -63.83 -55.29 24.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.173 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -66.81 111.71 3.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 55.9 mt -65.81 111.14 3.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.944 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.09 170.59 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.119 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 40.8 mtt85 -53.91 132.69 42.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 94.24 -26.17 18.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.48 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -45.99 142.62 2.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.799 0.333 . . . . 0.0 111.084 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 768' ' ' ARG . . . . . 0.528 ' HD3' HG21 ' A' ' 784' ' ' THR . 15.6 ttm-85 -119.72 122.88 42.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 769' ' ' ILE . . . . . 0.626 ' CG1' ' CH2' ' A' ' 793' ' ' TRP . 37.3 mm -99.87 143.45 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.077 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 12.0 m -121.11 125.99 48.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.131 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 771' ' ' TYR . . . . . 0.485 ' OH ' HD13 ' A' ' 748' ' ' LEU . 35.0 m-85 -101.66 121.54 42.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -122.45 130.29 52.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.922 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 74.9 m -108.57 174.16 6.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -60.75 159.72 24.14 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.606 0.717 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 114.51 3.73 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.638 2.225 . . . . 0.0 112.332 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 122.01 -22.2 7.66 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.461 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -94.38 174.39 7.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.896 0.379 . . . . 0.0 110.909 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -131.87 155.36 47.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.842 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 779' ' ' ILE . . . . . 0.4 HG23 ' HB2' ' A' ' 798' ' ' PRO . 7.4 mt -97.39 141.0 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 780' ' ' VAL . . . . . 0.428 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 61.0 t -114.1 109.47 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.093 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 125.91 -131.06 7.39 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.481 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 782' ' ' SER . . . . . 0.406 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 1.5 t -107.9 108.52 19.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.852 0.358 . . . . 0.0 110.86 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.45 -31.15 67.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.595 ' C ' HD12 ' A' ' 785' ' ' LEU . 20.8 m -115.49 131.38 56.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.122 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 785' ' ' LEU . . . . . 0.595 HD12 ' C ' ' A' ' 784' ' ' THR . 10.4 mp -123.74 127.65 48.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . 0.496 HG22 ' N ' ' A' ' 787' ' ' CYS . 26.6 m -107.78 159.61 16.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.144 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 787' ' ' CYS . . . . . 0.496 ' N ' HG22 ' A' ' 786' ' ' THR . 6.5 t -94.47 119.09 32.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -73.62 176.76 5.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -73.39 -7.74 52.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -100.94 12.94 36.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 66.6 mt 61.78 26.92 16.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 14.8 m -130.39 127.35 39.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.873 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 793' ' ' TRP . . . . . 0.626 ' CH2' ' CG1' ' A' ' 769' ' ' ILE . 73.6 m95 -58.38 140.64 53.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.946 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 793' ' ' TRP . 28.8 t -37.13 -47.98 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.837 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 37.4 m -154.75 167.04 31.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.841 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -51.63 155.8 2.59 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.63 0.729 . . . . 0.0 110.842 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . 0.448 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.5 Cg_endo -69.78 145.32 56.68 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.677 2.251 . . . . 0.0 112.329 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 798' ' ' PRO . . . . . 0.4 ' HB2' HG23 ' A' ' 779' ' ' ILE . 54.0 Cg_endo -69.85 -165.28 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.659 2.239 . . . . 0.0 112.348 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 799' ' ' PHE . . . . . 0.428 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.7 p90 -153.67 170.5 20.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.911 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 8.4 m -101.94 135.01 44.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.909 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -130.36 143.04 50.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 802' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 803' ' ' THR . 0.4 OUTLIER -81.28 139.18 35.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 803' ' ' THR . . . . . 0.426 ' N ' ' HD2' ' A' ' 802' ' ' LYS . 84.7 m -100.05 148.93 24.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.2 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -68.87 89.03 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.862 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -147.9 146.98 29.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 70.5 p -131.18 110.61 11.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.847 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . 83.96 159.15 28.57 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.519 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -32.66 18.19 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.713 2.275 . . . . 0.0 112.302 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 16.1 m -115.17 133.88 55.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.86 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 50.3 p -43.66 -57.6 3.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.506 -179.967 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 5.9 t -63.19 -52.19 63.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.941 0.4 . . . . 0.0 110.853 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 89.7 p -83.94 41.5 0.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.887 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 102.73 111.53 3.54 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.531 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 8.7 t -67.26 -51.92 47.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.889 0.376 . . . . 0.0 110.847 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 743' ' ' SER . . . . . 0.468 ' O ' HG12 ' A' ' 764' ' ' VAL . 2.2 m 40.76 44.43 1.88 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.84 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 744' ' ' GLY . . . . . 0.482 ' CA ' ' O ' ' A' ' 763' ' ' LEU . . . -176.15 153.8 15.45 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.499 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 745' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 763' ' ' LEU . 7.5 m -44.86 150.56 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.847 0.356 . . . . 0.0 110.832 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 16.4 m -71.56 147.91 47.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.825 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -60.69 137.34 58.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.906 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 748' ' ' LEU . . . . . 0.531 HD13 ' OH ' ' A' ' 771' ' ' TYR . 12.4 mt -97.0 144.28 27.58 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.631 0.729 . . . . 0.0 110.884 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 163.57 37.82 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.716 2.277 . . . . 0.0 112.361 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -62.32 149.0 43.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.89 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.0 tt -103.08 148.61 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.129 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -85.22 135.28 34.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 5.7 m120 53.92 46.6 25.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . 0.465 ' CA ' ' O ' ' A' ' 772' ' ' GLN . . . 175.98 -169.15 41.72 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.462 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 15.0 p90 -156.54 171.78 19.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.816 0.341 . . . . 0.0 110.961 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 17.7 pttm -134.74 159.92 39.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.87 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 77.3 p -133.49 175.19 9.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 70.7 p -137.87 114.07 10.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.161 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 11.9 t -63.43 -58.24 7.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.85 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -88.02 155.26 19.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.815 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 42.2 p -55.08 -50.83 68.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.107 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.92 141.03 46.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.87 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 763' ' ' LEU . . . . . 0.482 ' O ' ' CA ' ' A' ' 744' ' ' GLY . 21.9 mt -69.47 75.96 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.941 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 743' ' ' SER . 26.9 m -108.38 175.24 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.155 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -41.88 136.63 1.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.861 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 88.1 -29.88 5.37 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.459 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -54.1 130.91 39.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.81 0.338 . . . . 0.0 111.143 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -121.51 150.06 42.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 769' ' ' ILE . . . . . 0.462 HD11 HD22 ' A' ' 763' ' ' LEU . 6.8 mm -115.57 132.4 65.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.174 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 79.0 m -103.46 116.22 31.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.177 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 771' ' ' TYR . . . . . 0.531 ' OH ' HD13 ' A' ' 748' ' ' LEU . 38.9 m-85 -98.54 127.36 44.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.926 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 772' ' ' GLN . . . . . 0.465 ' O ' ' CA ' ' A' ' 754' ' ' GLY . 22.9 tp60 -122.5 137.84 54.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.896 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 64.9 m -115.83 172.05 7.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -60.57 157.06 39.43 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.625 0.726 . . . . 0.0 110.823 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.77 119.1 6.1 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.659 2.239 . . . . 0.0 112.31 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 117.96 -15.06 12.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.452 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -100.12 176.48 5.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 0.0 110.924 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -133.57 157.79 44.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 4.6 mt -97.96 139.29 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.122 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 780' ' ' VAL . . . . . 0.573 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 65.2 t -115.75 113.66 43.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.14 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 116.15 -143.01 17.92 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.535 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 12.6 m -97.99 103.13 15.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.873 0.368 . . . . 0.0 110.823 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -57.8 -52.99 63.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.878 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.844 ' C ' HD12 ' A' ' 785' ' ' LEU . 44.6 m -86.06 141.93 29.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.13 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 785' ' ' LEU . . . . . 0.844 HD12 ' C ' ' A' ' 784' ' ' THR . 7.6 mp -132.03 113.07 12.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.915 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . 0.414 HG22 ' N ' ' A' ' 787' ' ' CYS . 27.2 m -96.6 154.88 17.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.104 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 787' ' ' CYS . . . . . 0.414 ' N ' HG22 ' A' ' 786' ' ' THR . 4.3 t -95.66 109.56 21.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -61.5 -176.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -69.99 -26.8 64.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.947 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -86.85 20.86 2.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 791' ' ' LEU . . . . . 0.427 HD22 ' HA2' ' A' ' 744' ' ' GLY . 57.5 mt 51.92 44.64 29.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 30.1 t -130.5 156.11 45.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 793' ' ' TRP . . . . . 0.418 ' CD1' HD21 ' A' ' 748' ' ' LEU . 73.8 m95 -84.54 133.07 34.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 40.3 t -37.27 -48.83 0.91 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 8.6 t -157.9 174.62 14.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.801 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.98 156.51 3.45 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.612 0.72 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . 0.464 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.8 Cg_endo -69.72 145.37 57.16 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.654 2.236 . . . . 0.0 112.356 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -167.5 0.23 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.689 2.259 . . . . 0.0 112.354 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 799' ' ' PHE . . . . . 0.573 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 1.3 p90 -159.79 164.2 33.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 3.5 m -101.76 133.15 46.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -145.78 140.44 27.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.889 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.55 132.74 54.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 4.6 m -53.03 144.08 15.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.145 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 804' ' ' GLU . . . . . 0.443 ' CD ' ' O ' ' A' ' 804' ' ' GLU . 1.8 pp20? -104.18 36.67 2.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.941 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -75.08 159.22 31.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.918 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 22.8 t -108.93 118.22 36.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.86 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -128.46 -160.51 10.38 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.509 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -1.17 7.98 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.741 2.294 . . . . 0.0 112.305 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 10.6 m -126.25 115.02 19.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.841 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 10.7 t -59.19 114.04 2.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.891 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.506 -179.94 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.388 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 8.2 t -141.08 121.46 14.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.827 0.346 . . . . 0.0 110.895 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 3.7 m 48.65 43.71 20.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.843 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 73.04 110.09 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.468 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 78.1 p -76.23 -30.28 57.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 110.841 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 51.9 m -122.41 101.83 7.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.859 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 744' ' ' GLY . . . . . 0.751 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . 129.1 164.29 11.45 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 57.3 m -53.99 152.22 6.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.822 0.344 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 22.9 t -90.48 165.19 13.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.862 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -59.59 159.09 8.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.876 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 13.7 mt -110.29 149.0 39.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.629 0.728 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 146.08 59.19 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.71 2.273 . . . . 0.0 112.358 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -54.96 141.12 35.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.907 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . 0.421 HG13 ' N ' ' A' ' 752' ' ' GLN . 1.9 tt -103.82 146.49 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.077 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 752' ' ' GLN . . . . . 0.421 ' N ' HG13 ' A' ' 751' ' ' ILE . 21.1 mt-30 -87.15 136.7 32.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.921 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 60.5 47.33 8.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 169.79 170.57 34.39 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.5 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 17.5 p90 -148.39 152.75 37.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.829 0.347 . . . . 0.0 110.93 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -96.71 168.94 10.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 757' ' ' THR . 5.0 t -161.14 119.66 2.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.147 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 3.9 t -146.19 133.3 20.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.172 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 4.5 m -92.96 47.03 1.25 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.849 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -124.5 97.66 5.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.888 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 24.0 p -43.99 -48.54 8.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -122.11 119.8 32.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 82.5 mt -59.17 102.18 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.901 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 31.6 m -125.65 172.09 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -47.52 128.17 12.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 98.92 -18.77 56.36 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.485 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -56.94 132.27 52.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.743 0.306 . . . . 0.0 111.09 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 768' ' ' ARG . . . . . 0.42 ' HD2' ' C ' ' A' ' 768' ' ' ARG . 3.9 tmm_? -128.13 132.78 48.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.881 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 63.7 mt -113.59 144.09 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.167 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 87.3 m -110.41 131.94 54.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.113 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -103.96 118.21 36.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -110.29 136.39 49.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.937 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 83.8 m -115.83 171.87 7.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -60.99 159.53 26.85 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.588 0.709 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 122.02 8.69 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.674 2.25 . . . . 0.0 112.337 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 113.76 -22.3 14.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.453 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 777' ' ' TYR . . . . . 0.4 ' CE2' ' HB2' ' A' ' 802' ' ' LYS . 18.6 m-85 -86.5 178.56 7.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.912 0.387 . . . . 0.0 110.902 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.75 135.33 26.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.866 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 3.6 mt -74.54 150.42 7.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 780' ' ' VAL . . . . . 0.566 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 89.6 t -128.49 108.82 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.094 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 123.67 -134.02 9.13 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.488 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 43.7 m -105.22 98.81 8.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.883 0.373 . . . . 0.0 110.879 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.72 -39.21 76.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.827 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.801 ' C ' HD12 ' A' ' 785' ' ' LEU . 25.8 m -93.18 141.75 28.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.16 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 785' ' ' LEU . . . . . 0.801 HD12 ' C ' ' A' ' 784' ' ' THR . 9.4 mp -133.5 119.09 19.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 1.2 m -114.93 153.88 29.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.08 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 3.2 t -92.44 121.77 34.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.849 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -86.48 173.85 9.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 5.1 p90 -55.32 -17.07 4.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.927 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -94.13 23.05 5.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.82 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 791' ' ' LEU . . . . . 0.751 HD22 ' HA2' ' A' ' 744' ' ' GLY . 23.1 mt 45.38 24.98 0.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.949 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.4 t -117.14 150.44 38.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 793' ' ' TRP . . . . . 0.404 ' O ' ' C ' ' A' ' 794' ' ' SER . 86.3 m95 -77.08 142.99 39.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.935 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 793' ' ' TRP . 40.5 t -37.66 -42.85 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.828 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 5.1 t -171.3 173.19 4.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -46.43 154.54 0.64 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.632 0.73 . . . . 0.0 110.884 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 145.79 58.7 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.695 2.263 . . . . 0.0 112.369 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 798' ' ' PRO . . . . . 0.467 ' HD3' HD11 ' A' ' 785' ' ' LEU . 54.3 Cg_endo -69.75 177.86 5.15 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.678 2.252 . . . . 0.0 112.39 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 799' ' ' PHE . . . . . 0.566 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 0.8 OUTLIER -142.95 166.64 24.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 11.9 m -102.48 124.48 48.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -118.75 133.09 56.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 802' ' ' LYS . . . . . 0.4 ' HB2' ' CE2' ' A' ' 777' ' ' TYR . 32.0 tttt -73.88 145.56 44.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 32.7 p -60.16 141.01 56.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.154 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -83.62 88.15 7.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -53.43 -61.44 2.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.932 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 1.7 t -106.09 -51.31 3.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . 70.74 -158.76 53.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.492 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 810' ' ' SER . 53.7 Cg_endo -69.73 -13.82 35.28 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.714 2.276 . . . . 0.0 112.311 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 7.8 t -54.2 87.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 810' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 808' ' ' PRO . 87.0 p -95.08 139.17 31.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.553 -179.973 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 4.7 m -49.52 130.66 20.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 110.868 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 15.3 t -89.61 55.45 3.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 157.09 81.35 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.44 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 84.0 p -136.06 139.04 42.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.9 0.381 . . . . 0.0 110.849 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 19.0 m -135.32 161.03 36.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.925 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 744' ' ' GLY . . . . . 0.426 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . 136.17 -169.9 23.47 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.49 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 1.8 m -59.04 162.14 4.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.867 0.365 . . . . 0.0 110.869 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 23.5 p -92.08 144.74 25.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -38.27 150.13 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.866 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 14.8 mt -106.46 151.95 40.48 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.651 0.739 . . . . 0.0 110.925 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 141.29 44.57 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.657 2.238 . . . . 0.0 112.364 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -54.0 145.59 16.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . 0.422 HG13 ' N ' ' A' ' 752' ' ' GLN . 2.1 tt -100.95 147.73 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.111 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 752' ' ' GLN . . . . . 0.422 ' N ' HG13 ' A' ' 751' ' ' ILE . 40.8 mt-30 -90.83 139.51 30.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 50.41 41.64 25.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -177.37 -173.62 43.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.504 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -157.4 159.41 37.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.784 0.326 . . . . 0.0 110.949 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . 0.41 ' C ' ' HD2' ' A' ' 756' ' ' LYS . 0.0 OUTLIER -118.62 152.44 36.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.939 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 55.7 p -138.65 136.67 36.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.19 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . 0.681 HG21 HD21 ' A' ' 763' ' ' LEU . 71.2 p -100.31 149.7 23.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.16 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 2.0 t -106.31 42.98 1.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.842 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -163.4 165.58 23.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 34.9 m -71.51 -43.72 65.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.124 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 764' ' ' VAL . 3.0 tm-20 -133.78 138.45 45.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 763' ' ' LEU . . . . . 0.681 HD21 HG21 ' A' ' 758' ' ' THR . 86.0 mt -62.71 74.86 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.959 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' A' ' 762' ' ' GLU . 28.3 m -101.55 156.75 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 765' ' ' ARG . 25.4 mtm105 -34.73 139.52 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 87.75 -25.6 8.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -57.11 139.9 51.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.787 0.327 . . . . 0.0 111.095 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -115.08 157.36 23.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.904 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 769' ' ' ILE . . . . . 0.492 ' CD1' HG22 ' A' ' 758' ' ' THR . 34.0 mm -114.27 140.19 36.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.144 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 89.1 m -113.52 119.5 37.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.181 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -97.68 121.67 39.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -121.34 124.7 45.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.93 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 62.9 m -110.51 174.35 5.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.46 157.48 35.69 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.592 0.711 . . . . 0.0 110.882 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 106.99 1.77 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.671 2.247 . . . . 0.0 112.337 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 131.87 -15.03 5.17 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.461 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -104.4 169.88 8.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.882 0.373 . . . . 0.0 110.919 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.12 160.78 30.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 8.7 mt -96.71 139.34 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.114 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 780' ' ' VAL . . . . . 0.516 ' HB ' ' CE1' ' A' ' 799' ' ' PHE . 72.0 t -114.0 106.43 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 125.82 -149.62 17.32 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.506 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 782' ' ' SER . . . . . 0.476 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 93.0 p -82.03 103.02 11.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.885 0.374 . . . . 0.0 110.842 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -57.14 -44.56 83.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 31.4 m -105.98 124.29 49.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.152 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 785' ' ' LEU . . . . . 0.476 ' CD1' ' O ' ' A' ' 782' ' ' SER . 10.7 mp -113.45 120.0 39.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.923 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 26.0 m -107.41 154.03 21.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.174 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 6.6 t -94.46 125.1 38.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.835 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -75.91 177.04 7.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 2.2 p90 -69.76 -19.06 63.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.964 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . 0.421 ' O ' ' CG ' ' A' ' 790' ' ' ASP . 23.2 t0 -96.24 23.65 6.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 791' ' ' LEU . . . . . 0.426 HD22 ' CA ' ' A' ' 744' ' ' GLY . 15.8 mt 51.21 35.8 14.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.91 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 49.4 m -120.77 135.56 55.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 793' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -72.22 147.11 46.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 5.0 t -48.54 -41.64 30.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.859 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 1.3 t -175.06 -178.72 1.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -54.32 147.06 29.21 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.599 0.714 . . . . 0.0 110.846 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 142.98 49.51 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.648 2.232 . . . . 0.0 112.349 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -164.73 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.695 2.263 . . . . 0.0 112.36 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 799' ' ' PHE . . . . . 0.516 ' CE1' ' HB ' ' A' ' 780' ' ' VAL . 18.6 p90 -161.9 173.95 13.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.882 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 800' ' ' CYS . . . . . 0.407 ' SG ' HD11 ' A' ' 751' ' ' ILE . 3.4 m -103.07 136.14 43.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.913 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -146.99 131.53 17.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -50.84 124.85 12.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.925 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 25.1 m -60.16 144.13 50.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.19 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 804' ' ' GLU . . . . . 0.435 ' CD ' ' O ' ' A' ' 804' ' ' GLU . 0.1 OUTLIER -83.34 42.03 0.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -56.13 -58.48 7.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.829 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 8.4 t -96.23 95.61 8.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.847 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -133.32 -158.77 8.85 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.51 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -179.12 2.7 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.682 2.254 . . . . 0.0 112.322 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 22.0 p -134.07 155.33 50.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.897 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 3.2 m -156.83 105.93 2.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.887 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.466 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 3.3 t -82.23 141.63 32.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.887 0.375 . . . . 0.0 110.866 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 78.1 p -109.75 -27.19 9.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.826 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -100.6 178.5 28.79 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.482 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 40.6 t -137.7 135.5 36.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.831 0.348 . . . . 0.0 110.881 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 23.7 m -51.91 168.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 744' ' ' GLY . . . . . 0.675 ' H ' HD13 ' A' ' 791' ' ' LEU . . . 104.4 149.41 19.75 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.524 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 745' ' ' CYS . . . . . 0.413 ' HB3' ' CE2' ' A' ' 793' ' ' TRP . 9.8 m -37.51 152.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 0.0 110.893 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 60.8 p -84.7 155.69 21.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -62.42 142.66 57.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 58.7 mt -90.43 149.4 40.91 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.624 0.726 . . . . 0.0 110.927 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 134.2 27.38 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.693 2.262 . . . . 0.0 112.347 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -42.35 146.63 0.31 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.911 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . 0.487 HD11 ' SG ' ' A' ' 800' ' ' CYS . 2.7 tt -102.91 148.86 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -88.18 137.98 31.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 18.0 t30 51.97 43.15 30.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . 0.449 ' O ' HG23 ' A' ' 751' ' ' ILE . . . 178.08 176.62 46.19 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.477 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -149.31 179.03 8.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.805 0.336 . . . . 0.0 110.956 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.54 172.09 13.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.897 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 20.4 p -154.28 106.18 2.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 26.7 m -58.32 153.69 14.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.173 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 12.2 t -78.68 -48.53 14.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.849 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -108.33 147.82 30.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.897 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 95.6 m -53.44 -55.25 26.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . 0.434 ' O ' HG13 ' A' ' 764' ' ' VAL . 3.8 mm-40 -97.23 120.92 38.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 94.3 mt -54.92 101.53 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.965 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 762' ' ' GLU . 29.2 m -124.89 152.43 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.083 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -41.22 131.16 2.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 98.76 -23.45 36.28 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -58.7 147.5 32.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.82 0.343 . . . . 0.0 111.047 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -135.46 145.09 46.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 25.3 mt -120.0 142.96 33.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.148 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 3.5 t -109.4 153.47 23.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 771' ' ' TYR . . . . . 0.431 ' HD2' HD13 ' A' ' 751' ' ' ILE . 25.4 m-85 -119.41 129.6 54.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.913 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -125.8 122.4 36.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.96 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 60.2 m -106.55 174.07 6.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.5 158.98 26.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.642 0.734 . . . . 0.0 110.876 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 111.18 2.74 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.701 2.268 . . . . 0.0 112.332 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 126.98 -14.68 6.61 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.49 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -104.72 173.28 6.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.889 0.376 . . . . 0.0 110.96 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -134.6 147.75 50.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.837 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 779' ' ' ILE . . . . . 0.426 HD11 ' O ' ' A' ' 771' ' ' TYR . 24.1 mt -82.96 144.87 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.141 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 780' ' ' VAL . . . . . 0.557 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 58.3 t -118.15 105.87 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.162 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 125.11 -150.46 17.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.507 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 782' ' ' SER . . . . . 0.528 ' O ' HD11 ' A' ' 785' ' ' LEU . 43.7 m -85.2 106.73 16.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 0.0 110.832 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -57.27 -49.16 76.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.855 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.544 ' C ' HD12 ' A' ' 785' ' ' LEU . 21.0 m -102.12 126.79 49.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 785' ' ' LEU . . . . . 0.57 HD21 ' HA ' ' A' ' 797' ' ' PRO . 7.0 mp -113.61 111.01 21.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . 0.497 HG22 ' N ' ' A' ' 787' ' ' CYS . 32.6 m -94.37 159.4 15.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.163 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 787' ' ' CYS . . . . . 0.497 ' N ' HG22 ' A' ' 786' ' ' THR . 7.0 t -96.93 117.59 31.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -75.5 175.37 8.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 11.6 p-90 -62.15 -21.87 65.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -88.98 20.61 3.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.884 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 791' ' ' LEU . . . . . 0.675 HD13 ' H ' ' A' ' 744' ' ' GLY . 23.3 mt 51.2 31.85 7.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 36.1 t -121.97 153.83 38.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 793' ' ' TRP . . . . . 0.439 ' O ' ' C ' ' A' ' 794' ' ' SER . 88.6 m95 -83.99 140.73 31.7 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 793' ' ' TRP . 8.5 t -34.55 -44.83 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 8.6 t -173.03 173.03 3.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -44.93 151.04 0.67 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.586 0.708 . . . . 0.0 110.856 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . 0.57 ' HA ' HD21 ' A' ' 785' ' ' LEU . 54.2 Cg_endo -69.75 147.82 63.78 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.678 2.252 . . . . 0.0 112.39 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 798' ' ' PRO . . . . . 0.408 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.8 Cg_endo -69.74 -163.87 0.12 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.697 2.265 . . . . 0.0 112.385 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 799' ' ' PHE . . . . . 0.557 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 3.9 p90 -160.6 170.24 21.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 800' ' ' CYS . . . . . 0.487 ' SG ' HD11 ' A' ' 751' ' ' ILE . 19.9 m -104.21 119.41 38.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.876 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -128.19 126.16 40.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -51.42 141.69 15.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 80.8 p -39.92 144.21 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.103 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -98.01 129.35 44.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.855 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -90.9 58.07 3.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.877 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 4.0 m -99.16 147.88 24.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.847 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . 135.56 -97.65 0.28 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.481 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -25.98 28.32 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.637 2.225 . . . . 0.0 112.36 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 35.7 t -49.87 141.9 9.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.866 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 38.9 t -126.82 116.49 20.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.861 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.477 179.994 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 71.0 p -74.56 99.65 3.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.908 0.385 . . . . 0.0 110.832 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 20.1 m -75.23 117.38 16.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.887 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -90.14 49.75 3.3 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.465 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 27.5 t -95.57 121.9 37.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.368 . . . . 0.0 110.877 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 44.0 m -142.52 162.33 35.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.846 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 744' ' ' GLY . . . . . 0.407 ' H ' HD13 ' A' ' 791' ' ' LEU . . . 129.83 164.38 11.37 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.489 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 745' ' ' CYS . . . . . 0.506 ' HB3' ' CE2' ' A' ' 793' ' ' TRP . 1.8 m -40.23 152.91 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.841 0.353 . . . . 0.0 110.886 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 27.1 m -79.79 140.46 36.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.82 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -44.11 141.0 1.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.867 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 43.7 mt -93.08 148.59 36.0 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.595 0.712 . . . . 0.0 110.932 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -174.09 0.84 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.697 2.265 . . . . 0.0 112.339 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -95.24 143.27 26.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . 0.485 HD11 ' SG ' ' A' ' 800' ' ' CYS . 3.0 tt -100.72 144.37 12.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.077 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 19.7 mp0 -78.17 132.09 37.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.912 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 55.59 40.22 31.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . 0.46 ' C ' HG23 ' A' ' 751' ' ' ILE . . . -174.26 176.4 46.64 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.513 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 32.6 p90 -157.24 161.59 39.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.799 0.333 . . . . 0.0 110.916 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -108.84 159.01 17.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.902 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 56.5 p -148.62 120.3 8.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.143 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 4.5 t -134.74 131.38 37.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 89.7 p -67.34 -42.1 84.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -70.91 129.86 40.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 88.1 m -73.37 -66.85 0.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.108 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -72.94 107.94 5.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.908 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 763' ' ' LEU . . . . . 0.476 HD22 HD11 ' A' ' 769' ' ' ILE . 78.4 mt -64.41 82.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 34.4 m -96.4 159.91 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . 0.559 ' NE ' HD21 ' A' ' 791' ' ' LEU . 6.1 ptp180 -45.65 132.95 8.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 101.94 -39.99 2.57 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.485 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -46.77 157.58 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 111.114 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 768' ' ' ARG . . . . . 0.52 ' O ' HD13 ' A' ' 769' ' ' ILE . 72.4 mtt180 -123.99 172.93 8.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 769' ' ' ILE . . . . . 0.52 HD13 ' O ' ' A' ' 768' ' ' ARG . 8.2 mm -143.12 134.08 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 17.1 m -100.6 113.67 26.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.129 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 771' ' ' TYR . . . . . 0.737 ' HE2' HD22 ' A' ' 785' ' ' LEU . 22.7 m-85 -96.79 124.24 40.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.918 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -126.79 137.57 53.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 75.2 m -115.2 174.19 6.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.904 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -60.54 157.47 36.44 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.636 0.732 . . . . 0.0 110.829 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 112.93 3.21 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.665 2.243 . . . . 0.0 112.365 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 124.84 -22.23 6.47 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.484 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -95.32 178.24 5.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.896 0.379 . . . . 0.0 110.868 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -136.67 156.42 48.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.876 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 779' ' ' ILE . . . . . 0.702 HG23 ' HB2' ' A' ' 798' ' ' PRO . 74.3 mt -98.69 135.26 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.14 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 780' ' ' VAL . . . . . 0.576 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 61.8 t -112.16 106.77 21.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.136 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 128.0 -149.0 17.97 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.448 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 21.9 m -83.06 107.47 15.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.866 0.365 . . . . 0.0 110.849 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.25 -46.17 90.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 25.6 m -101.93 122.11 43.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 785' ' ' LEU . . . . . 0.737 HD22 ' HE2' ' A' ' 771' ' ' TYR . 9.8 mp -103.3 114.46 28.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 10.1 m -107.92 147.27 31.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.136 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 8.8 t -92.51 137.55 32.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.847 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -87.97 169.4 12.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -56.0 -25.09 42.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -86.75 21.2 2.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.836 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 791' ' ' LEU . . . . . 0.559 HD21 ' NE ' ' A' ' 765' ' ' ARG . 7.4 mt 51.22 37.47 18.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 90.4 p -122.38 136.41 54.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.825 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 793' ' ' TRP . . . . . 0.506 ' CE2' ' HB3' ' A' ' 745' ' ' CYS . 97.1 m95 -67.9 140.53 56.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.928 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 1.5 t -42.73 -48.62 5.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.899 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 8.4 t -168.78 173.82 6.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.855 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.97 151.16 4.72 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.576 0.703 . . . . 0.0 110.851 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . 0.522 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.7 Cg_endo -69.81 144.49 53.96 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.67 2.246 . . . . 0.0 112.345 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 798' ' ' PRO . . . . . 0.702 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.6 Cg_endo -69.7 -175.25 1.08 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.715 2.277 . . . . 0.0 112.332 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 799' ' ' PHE . . . . . 0.576 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.4 p90 -145.27 165.4 28.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 800' ' ' CYS . . . . . 0.485 ' SG ' HD11 ' A' ' 751' ' ' ILE . 2.6 m -103.75 128.26 51.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -129.83 151.0 50.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 802' ' ' LYS . . . . . 0.42 ' HD2' ' C ' ' A' ' 802' ' ' LYS . 1.6 tmmm? -73.85 135.95 43.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 36.7 p -94.87 134.76 37.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.121 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -82.52 124.89 30.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -122.57 86.52 2.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 3.1 t 59.2 44.46 15.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.912 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -153.02 146.04 14.12 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.515 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 177.17 5.85 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.639 2.226 . . . . 0.0 112.36 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 80.2 p -153.91 165.33 36.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.855 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 35.6 p -128.13 123.91 35.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.248 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.464 -179.987 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 2.5 t -64.43 114.75 4.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.894 0.378 . . . . 0.0 110.884 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 19.6 t 66.49 41.05 3.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.873 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -94.02 -58.65 1.22 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.513 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 80.1 p -172.0 121.43 0.47 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.854 0.359 . . . . 0.0 110.871 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 5.8 m -93.35 30.98 1.57 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.846 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 744' ' ' GLY . . . . . 0.409 ' CA ' ' HA ' ' A' ' 764' ' ' VAL . . . 52.78 -163.81 1.94 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.474 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 9.1 m -78.98 155.03 29.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.817 0.342 . . . . 0.0 110.918 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 77.5 p -73.24 149.45 42.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.862 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -54.09 163.09 0.84 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 11.7 mt -115.27 148.17 40.17 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.574 0.702 . . . . 0.0 110.932 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 144.28 53.42 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.726 2.284 . . . . 0.0 112.319 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -54.23 147.44 13.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . 0.405 HG13 ' N ' ' A' ' 752' ' ' GLN . 1.5 tt -105.17 144.1 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.093 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 752' ' ' GLN . . . . . 0.405 ' N ' HG13 ' A' ' 751' ' ' ILE . 23.2 mt-30 -89.04 145.47 25.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 47.3 47.9 16.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 179.96 179.96 48.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.461 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 47.3 p90 -154.96 154.23 32.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.839 0.352 . . . . 0.0 110.888 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -124.55 159.43 30.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.922 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 76.3 p -143.43 148.03 35.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.096 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . 0.412 HG21 HD21 ' A' ' 763' ' ' LEU . 10.2 t -169.09 135.18 1.68 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.147 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 15.7 m -121.86 79.07 1.53 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.844 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 760' ' ' HIS . . . . . 0.46 ' CD2' ' HA ' ' A' ' 767' ' ' ALA . 25.6 m80 -132.04 -179.54 5.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.849 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 761' ' ' THR . . . . . 0.542 ' O ' HG13 ' A' ' 764' ' ' VAL . 65.8 p -103.22 106.79 17.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.151 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 763' ' ' LEU . 16.0 mt-10 55.06 36.92 28.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 763' ' ' LEU . . . . . 0.614 HD22 HD11 ' A' ' 769' ' ' ILE . 7.8 mt 33.27 53.56 0.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.927 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 761' ' ' THR . 33.1 m -86.11 175.68 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.12 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 764' ' ' VAL . 88.2 mtm180 -36.54 137.82 0.27 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 90.25 -31.55 5.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.486 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . 0.46 ' HA ' ' CD2' ' A' ' 760' ' ' HIS . . . -50.54 125.5 13.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.737 0.304 . . . . 0.0 111.116 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -119.41 140.87 49.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.867 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 769' ' ' ILE . . . . . 0.614 HD11 HD22 ' A' ' 763' ' ' LEU . 68.1 mt -121.92 142.0 40.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.121 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 6.2 t -107.21 154.27 21.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.167 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 771' ' ' TYR . . . . . 0.468 ' HE2' HD22 ' A' ' 785' ' ' LEU . 47.3 m-85 -124.81 120.05 30.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -119.25 128.22 53.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.918 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 69.1 m -109.8 173.54 6.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -60.45 159.03 26.0 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.588 0.709 . . . . 0.0 110.858 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 121.12 7.81 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.711 2.274 . . . . 0.0 112.337 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 104.71 11.12 31.41 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -116.99 172.24 7.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.905 0.383 . . . . 0.0 110.881 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -126.95 155.17 43.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.848 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 5.3 mt -103.32 138.39 27.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.138 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 780' ' ' VAL . . . . . 0.564 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 56.3 t -114.51 107.98 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 129.53 -134.03 7.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.473 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 782' ' ' SER . . . . . 0.527 ' O ' HD11 ' A' ' 785' ' ' LEU . 1.6 t -109.82 109.86 20.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.862 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -57.44 -37.33 72.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.845 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.723 ' C ' HD12 ' A' ' 785' ' ' LEU . 16.7 m -108.84 134.28 51.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 785' ' ' LEU . . . . . 0.723 HD12 ' C ' ' A' ' 784' ' ' THR . 8.7 mp -127.11 120.31 28.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . 0.478 HG22 ' N ' ' A' ' 787' ' ' CYS . 16.6 m -111.07 160.79 16.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.107 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 787' ' ' CYS . . . . . 0.478 ' N ' HG22 ' A' ' 786' ' ' THR . 16.5 t -94.46 135.39 35.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -91.62 177.56 6.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 3.0 p90 -73.03 -3.55 26.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -107.44 17.37 22.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.897 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 31.7 mt 57.6 28.66 15.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.8 t -123.24 148.65 45.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 793' ' ' TRP . . . . . 0.431 ' O ' ' C ' ' A' ' 794' ' ' SER . 95.9 m95 -85.51 137.98 32.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.93 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 793' ' ' TRP . 37.9 t -34.8 -50.27 0.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.838 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 45.5 m -164.24 152.83 13.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -37.84 153.53 0.13 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.635 0.731 . . . . 0.0 110.863 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . 0.568 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.4 Cg_endo -69.83 145.84 57.94 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.676 2.251 . . . . 0.0 112.329 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -164.91 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.666 2.244 . . . . 0.0 112.397 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 799' ' ' PHE . . . . . 0.564 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.6 p90 -154.78 169.1 24.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.854 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 4.0 m -104.97 121.11 43.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.872 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -129.63 121.68 27.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -52.24 121.13 6.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 77.4 p -50.8 158.31 0.68 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.15 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -71.73 136.18 47.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -78.7 124.47 28.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 7.8 t -85.5 109.91 18.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.847 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -112.14 172.12 14.57 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.516 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 153.09 69.07 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.652 2.235 . . . . 0.0 112.287 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 84.6 p -74.88 -43.94 51.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.848 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 29.8 t -73.9 138.42 44.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.87 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.487 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 4.3 m -143.67 154.03 43.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 110.859 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 34.0 t -119.71 136.97 54.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.856 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 133.55 44.33 0.13 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.477 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 2.6 t -61.44 114.8 3.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.897 0.379 . . . . 0.0 110.855 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 40.1 t -144.25 169.81 17.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.814 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . 129.1 151.55 7.41 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.533 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 2.0 m -59.75 154.77 17.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.862 0.363 . . . . 0.0 110.848 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 84.8 p -71.27 141.01 50.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -46.15 144.36 1.99 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.88 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 748' ' ' LEU . . . . . 0.443 HD13 ' OH ' ' A' ' 771' ' ' TYR . 35.0 mt -92.11 144.93 29.88 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.597 0.713 . . . . 0.0 110.911 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 156.73 62.6 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.624 2.216 . . . . 0.0 112.325 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.32 147.03 53.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . 0.442 HD11 ' SG ' ' A' ' 800' ' ' CYS . 3.0 tt -102.66 149.66 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.16 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -90.77 141.75 28.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 46.16 49.73 12.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 177.82 -173.67 46.23 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.45 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 755' ' ' TRP . . . . . 0.444 ' NE1' ' HB2' ' A' ' 772' ' ' GLN . 15.4 p90 -154.94 -177.94 6.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.852 0.358 . . . . 0.0 110.896 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.67 165.82 25.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 8.8 t -166.09 146.03 6.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 6.1 t -149.46 151.01 33.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.152 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 18.7 m -98.69 -50.53 4.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -41.06 157.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 44.9 p -54.78 -178.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.142 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -42.1 161.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 763' ' ' LEU . . . . . 0.815 HD21 HD11 ' A' ' 769' ' ' ILE . 37.8 mt -53.73 100.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.955 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . 0.513 ' H ' ' HB2' ' A' ' 767' ' ' ALA . 34.9 m -132.99 177.47 7.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -52.78 108.11 0.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 103.32 10.41 36.31 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.458 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . 0.513 ' HB2' ' H ' ' A' ' 764' ' ' VAL . . . -65.63 140.24 58.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.793 0.33 . . . . 0.0 111.105 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 768' ' ' ARG . . . . . 0.403 ' HG3' ' CG2' ' A' ' 784' ' ' THR . 36.5 ttm180 -130.22 119.56 23.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.904 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 769' ' ' ILE . . . . . 0.815 HD11 HD21 ' A' ' 763' ' ' LEU . 68.8 mt -116.53 144.9 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.136 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 19.1 m -110.0 143.85 39.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.132 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 771' ' ' TYR . . . . . 0.443 ' OH ' HD13 ' A' ' 748' ' ' LEU . 52.1 m-85 -113.18 121.99 46.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.889 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 772' ' ' GLN . . . . . 0.444 ' HB2' ' NE1' ' A' ' 755' ' ' TRP . 22.1 mp0 -110.28 137.43 48.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.942 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 77.5 m -114.59 171.89 7.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.871 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 774' ' ' ASP . . . . . 0.456 ' HB2' ' CD1' ' A' ' 777' ' ' TYR . 0.3 OUTLIER -64.01 154.49 81.71 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.605 0.717 . . . . 0.0 110.832 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 96.03 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.679 2.253 . . . . 0.0 112.368 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 139.32 -5.53 2.96 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.465 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 777' ' ' TYR . . . . . 0.456 ' CD1' ' HB2' ' A' ' 774' ' ' ASP . 18.8 m-85 -106.23 179.26 4.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.868 0.366 . . . . 0.0 110.953 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -134.61 146.08 49.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 779' ' ' ILE . . . . . 0.402 HG23 ' HB2' ' A' ' 798' ' ' PRO . 11.0 mt -91.2 142.13 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.158 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 780' ' ' VAL . . . . . 0.578 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 50.9 t -120.83 108.64 23.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.111 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 127.21 -134.75 8.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 782' ' ' SER . . . . . 0.546 ' O ' HD11 ' A' ' 785' ' ' LEU . 1.3 t -106.84 112.22 25.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.831 0.348 . . . . 0.0 110.877 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -61.17 -36.88 81.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.872 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.532 ' C ' HD12 ' A' ' 785' ' ' LEU . 15.4 m -110.32 123.55 50.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.136 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 785' ' ' LEU . . . . . 0.751 HD21 ' HA ' ' A' ' 797' ' ' PRO . 7.3 mp -115.06 122.25 45.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.945 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . 0.43 HG22 ' N ' ' A' ' 787' ' ' CYS . 20.4 m -107.01 156.82 18.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.132 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 787' ' ' CYS . . . . . 0.43 ' N ' HG22 ' A' ' 786' ' ' THR . 41.4 t -95.81 109.96 22.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.895 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -61.38 168.08 2.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -62.61 -17.77 60.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -94.02 19.91 8.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.848 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 80.5 mt 54.14 37.45 27.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 13.4 m -132.4 123.26 26.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 793' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -58.09 133.45 55.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 15.2 t -37.27 -42.62 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 37.9 m -164.31 164.17 22.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.58 154.77 4.33 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.597 0.713 . . . . 0.0 110.858 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . 0.751 ' HA ' HD21 ' A' ' 785' ' ' LEU . 54.1 Cg_endo -69.77 144.82 55.21 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.656 2.237 . . . . 0.0 112.339 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 798' ' ' PRO . . . . . 0.402 ' HB2' HG23 ' A' ' 779' ' ' ILE . 54.1 Cg_endo -69.75 -164.19 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.68 2.253 . . . . 0.0 112.324 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 799' ' ' PHE . . . . . 0.578 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.9 p90 -156.71 165.52 36.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.882 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 800' ' ' CYS . . . . . 0.442 ' SG ' HD11 ' A' ' 751' ' ' ILE . 3.8 m -102.24 117.51 34.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -117.68 134.47 54.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.935 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -80.59 110.53 16.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 81.1 p -84.24 151.45 24.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.157 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -137.18 165.3 26.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -96.05 -44.84 7.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.843 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 36.4 m -43.87 163.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.849 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -130.03 -158.18 9.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.427 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 121.33 8.02 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.681 2.254 . . . . 0.0 112.341 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 54.4 p -103.51 147.19 27.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 12.3 t -97.07 -50.9 4.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.456 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 1.3 t -162.07 151.07 15.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.894 0.378 . . . . 0.0 110.826 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 50.2 m -69.09 106.57 2.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.854 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -73.66 -78.95 0.54 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.475 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 50.9 p -118.62 131.85 56.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.872 0.368 . . . . 0.0 110.854 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 52.8 m -120.22 44.13 2.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 744' ' ' GLY . . . . . 0.431 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . 53.27 170.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.465 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 3.6 m -60.72 161.25 8.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.86 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 67.4 m -74.84 141.92 44.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -48.86 155.45 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 69.9 mt -105.1 149.05 37.19 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.635 0.731 . . . . 0.0 110.933 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 164.59 33.96 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.684 2.256 . . . . 0.0 112.329 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -73.89 142.08 46.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . 0.699 HD11 ' SG ' ' A' ' 800' ' ' CYS . 3.5 tt -100.74 150.09 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -94.85 141.44 28.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 9.2 m120 54.29 43.34 30.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.856 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 751' ' ' ILE . . . 167.67 -179.75 40.88 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.471 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -154.35 164.75 38.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.878 0.37 . . . . 0.0 110.914 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -101.38 156.69 17.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 45.3 p -134.57 97.48 3.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.127 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 758' ' ' THR . 12.1 t -131.04 45.0 2.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.114 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 88.9 p -84.41 43.81 0.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.865 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 760' ' ' HIS . . . . . 0.461 ' CD2' ' HG1' ' A' ' 761' ' ' THR . 11.7 t60 -99.25 -59.81 1.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.847 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 761' ' ' THR . . . . . 0.461 ' HG1' ' CD2' ' A' ' 760' ' ' HIS . 6.8 m -160.55 146.5 15.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.128 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 761' ' ' THR . 30.5 mt-10 -35.03 136.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 69.4 mt -48.76 99.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.954 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 762' ' ' GLU . 24.9 m -131.14 -179.09 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -60.2 127.63 32.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 95.67 -21.41 44.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.477 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -52.89 141.85 20.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.75 0.309 . . . . 0.0 111.094 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -123.01 140.88 52.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.897 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 769' ' ' ILE . . . . . 0.436 ' CG1' ' CH2' ' A' ' 793' ' ' TRP . 18.5 mm -106.32 148.84 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.162 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 95.6 m -121.04 113.56 20.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.148 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -97.39 124.16 41.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.969 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 43.5 tp60 -127.06 140.95 51.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.948 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 38.9 m -118.3 171.77 7.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.49 159.5 23.7 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.553 0.692 . . . . 0.0 110.888 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 104.29 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.678 2.252 . . . . 0.0 112.357 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 137.28 -19.1 3.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.494 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -100.59 177.04 5.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.0 110.887 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 778' ' ' ASP . . . . . 0.426 ' OD1' ' CG2' ' A' ' 803' ' ' THR . 1.5 m-20 -136.08 151.04 49.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.824 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 3.4 mt -88.81 137.5 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.107 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 780' ' ' VAL . . . . . 0.573 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 65.7 t -115.74 107.32 22.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.155 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 127.73 -140.57 11.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.497 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 782' ' ' SER . . . . . 0.596 ' O ' HD11 ' A' ' 785' ' ' LEU . 3.8 m -105.56 102.23 11.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.879 0.371 . . . . 0.0 110.889 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.58 -53.25 59.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.895 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.714 ' C ' HD12 ' A' ' 785' ' ' LEU . 33.0 m -83.47 132.8 34.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.132 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 785' ' ' LEU . . . . . 0.714 HD12 ' C ' ' A' ' 784' ' ' THR . 9.1 mp -127.03 125.37 41.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 1.8 m -106.36 148.13 28.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.139 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 21.4 t -93.87 115.23 27.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.905 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -71.0 169.58 14.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 789' ' ' TRP . . . . . 0.458 ' CE3' ' O ' ' A' ' 789' ' ' TRP . 10.3 p-90 -66.73 -7.37 20.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -100.58 15.77 26.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.875 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 791' ' ' LEU . . . . . 0.431 HD22 ' CA ' ' A' ' 744' ' ' GLY . 82.5 mt 56.25 31.31 18.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 38.3 m -126.58 128.88 47.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 793' ' ' TRP . . . . . 0.449 ' CE3' ' HB3' ' A' ' 785' ' ' LEU . 98.6 m95 -59.53 137.74 57.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 9.3 t -48.17 -39.48 20.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 78.1 p -155.46 167.73 29.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.59 156.54 32.06 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.59 0.709 . . . . 0.0 110.86 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . 0.427 ' HA ' HD21 ' A' ' 785' ' ' LEU . 54.3 Cg_endo -69.74 141.15 44.53 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.665 2.243 . . . . 0.0 112.403 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -168.15 0.26 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.69 2.26 . . . . 0.0 112.382 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 799' ' ' PHE . . . . . 0.573 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 9.1 p90 -160.0 170.87 20.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.85 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 800' ' ' CYS . . . . . 0.699 ' SG ' HD11 ' A' ' 751' ' ' ILE . 12.0 m -102.52 145.8 29.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.875 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -148.02 134.13 19.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -68.69 127.35 32.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.871 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 803' ' ' THR . . . . . 0.426 ' CG2' ' OD1' ' A' ' 778' ' ' ASP . 37.4 p -52.4 127.59 22.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -71.42 117.44 12.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -108.57 -53.64 2.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.843 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 51.7 m -68.54 131.26 44.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -164.32 146.76 11.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.5 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -14.55 36.06 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.656 2.237 . . . . 0.0 112.365 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 80.3 p -97.12 155.34 16.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.824 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 2.7 m -113.42 -47.96 2.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.842 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.447 -179.972 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 88.7 p -89.01 99.34 12.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.883 0.373 . . . . 0.0 110.863 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 53.5 p -67.57 164.51 18.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.87 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 123.92 -59.58 0.62 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.477 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 53.2 p -60.94 159.96 10.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.852 0.358 . . . . 0.0 110.919 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 2.5 m -162.34 121.99 2.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.858 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 744' ' ' GLY . . . . . 0.415 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . 168.33 175.18 37.74 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.485 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 2.2 m -47.72 154.25 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.847 0.356 . . . . 0.0 110.913 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 41.6 m -69.58 150.82 46.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -72.78 139.29 46.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.891 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 9.6 mt -94.31 146.63 31.9 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.671 0.748 . . . . 0.0 110.867 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -179.78 3.14 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.678 2.252 . . . . 0.0 112.379 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -79.75 142.93 34.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.2 tt -101.16 149.25 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.127 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -94.17 137.75 32.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 62.84 36.83 12.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.922 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 174.4 -177.42 46.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.498 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 755' ' ' TRP . . . . . 0.418 ' CD1' ' C ' ' A' ' 755' ' ' TRP . 2.4 p90 -156.02 169.36 24.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.858 0.361 . . . . 0.0 110.885 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -118.68 161.93 19.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 24.4 p -137.18 149.11 47.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.119 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 25.4 p -142.3 176.51 8.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.182 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 28.0 p -121.77 -67.27 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.833 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -64.2 147.72 51.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 75.7 p -67.46 -13.88 62.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.138 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.62 143.14 43.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 16.6 mt -84.4 101.02 11.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.924 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 27.2 m -111.16 176.01 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.105 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -48.27 138.07 10.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 88.16 -30.74 5.02 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.465 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -40.08 129.07 2.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 34.3 mtt85 -122.0 127.37 50.21 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.846 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 59.1 mt -104.85 148.87 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.141 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 55.7 m -118.31 125.53 50.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.177 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -96.74 132.89 41.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.955 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -126.0 121.89 34.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.973 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 82.9 m -103.86 174.45 5.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.84 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -60.42 156.91 38.7 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.592 0.71 . . . . 0.0 110.899 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 109.93 2.43 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.67 2.247 . . . . 0.0 112.41 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 127.64 -13.07 6.54 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.502 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -105.07 179.03 4.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.879 0.371 . . . . 0.0 110.937 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -139.91 152.06 46.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.825 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 779' ' ' ILE . . . . . 0.577 HG23 ' HB2' ' A' ' 798' ' ' PRO . 57.0 mt -89.67 135.55 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.193 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 780' ' ' VAL . . . . . 0.552 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 60.5 t -108.62 106.68 21.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 126.5 -147.68 16.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.484 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 54.1 p -84.62 103.05 13.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.0 110.874 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.8 -34.21 74.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 98.0 m -112.12 121.97 46.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 785' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.64 135.84 48.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 2.3 m -119.46 150.61 39.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 17.4 t -94.9 107.81 19.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -63.66 162.39 13.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -58.05 -17.04 15.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.38 20.32 12.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 791' ' ' LEU . . . . . 0.415 HD22 ' HA2' ' A' ' 744' ' ' GLY . 74.3 mt 55.16 25.0 6.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.938 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 19.9 m -109.56 125.86 52.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 793' ' ' TRP . . . . . 0.416 ' O ' ' C ' ' A' ' 794' ' ' SER . 75.7 m95 -67.13 135.74 54.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 793' ' ' TRP . 4.3 t -36.93 -44.1 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 10.9 m -173.06 167.06 4.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.832 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -43.79 152.15 0.46 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.596 0.712 . . . . 0.0 110.898 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 146.37 60.46 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 798' ' ' PRO . . . . . 0.577 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.8 Cg_endo -69.8 -167.55 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.685 2.257 . . . . 0.0 112.314 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 799' ' ' PHE . . . . . 0.552 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 1.1 p90 -154.62 170.27 21.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 14.7 m -101.95 127.96 48.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -139.88 126.12 20.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -49.17 140.18 9.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 803' ' ' THR . . . . . 0.561 HG22 ' N ' ' A' ' 804' ' ' GLU . 14.7 m -51.72 165.86 0.16 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.131 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 804' ' ' GLU . . . . . 0.561 ' N ' HG22 ' A' ' 803' ' ' THR . 13.3 mt-10 -94.4 109.06 20.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 39.98 49.01 2.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.846 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -43.16 -26.8 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.831 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -165.75 146.95 11.6 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.457 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 -37.79 8.86 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.731 2.287 . . . . 0.0 112.388 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 4.8 t 66.24 33.99 6.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.84 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 36.0 t -79.32 -56.07 4.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.479 179.991 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 2.4 m 43.05 48.34 5.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 0.0 110.857 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 5.0 t -70.5 132.27 45.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 69.86 91.65 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.48 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 5.4 t -66.35 104.13 1.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.951 0.405 . . . . 0.0 110.852 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 45.9 m -119.76 163.75 16.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.897 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 744' ' ' GLY . . . . . 0.474 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . 137.65 160.2 8.46 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.493 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 9.9 m -45.16 163.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 110.873 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 79.1 p -91.71 163.22 14.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.893 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -61.35 158.72 13.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 46.0 mt -111.52 150.84 42.76 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.59 0.71 . . . . 0.0 110.871 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 157.57 59.95 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.678 2.252 . . . . 0.0 112.362 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.47 148.81 51.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.9 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 2.0 tt -109.06 150.8 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.1 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -103.25 140.61 37.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.933 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 7.4 m120 57.0 43.95 23.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 174.55 -179.94 45.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.537 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 16.5 p90 -156.93 161.19 39.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 110.965 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -116.26 168.27 10.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 18.8 p -130.08 113.34 14.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 56.8 p -109.25 114.3 27.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.139 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 94.7 p -107.27 38.68 2.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.864 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -143.8 119.25 10.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 67.7 p -38.62 -51.11 1.64 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.172 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 764' ' ' VAL . 12.0 mm-40 -135.01 129.14 33.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 763' ' ' LEU . . . . . 0.656 HD13 ' HZ2' ' A' ' 793' ' ' TRP . 69.7 mt -58.87 101.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.922 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . 0.466 HG13 ' O ' ' A' ' 762' ' ' GLU . 34.5 m -112.27 -179.53 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.177 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -59.06 130.01 44.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.866 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 97.56 -35.25 4.6 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.507 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -52.72 145.13 12.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.819 0.342 . . . . 0.0 111.104 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -134.99 151.52 50.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.833 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 29.3 mt -118.44 143.22 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.141 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 98.5 m -104.98 124.03 48.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.143 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -96.95 128.87 44.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -124.62 145.11 49.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.912 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 100.0 m -124.12 174.28 7.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.89 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -60.78 158.28 33.54 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.607 0.717 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 112.84 3.19 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.66 2.24 . . . . 0.0 112.363 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 123.81 -16.28 7.84 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.509 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 777' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 802' ' ' LYS . 13.9 m-85 -104.01 178.66 4.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 0.0 110.939 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -137.9 155.93 48.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 779' ' ' ILE . . . . . 0.675 HG23 ' HB2' ' A' ' 798' ' ' PRO . 46.9 mt -91.01 133.7 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 780' ' ' VAL . . . . . 0.579 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 74.2 t -108.69 111.51 36.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.167 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 124.87 -143.63 14.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.504 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 3.5 m -94.05 101.18 13.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.914 0.387 . . . . 0.0 110.909 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.04 -47.97 76.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.888 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.644 ' C ' HD12 ' A' ' 785' ' ' LEU . 22.6 m -94.15 134.02 37.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.141 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 785' ' ' LEU . . . . . 0.644 HD12 ' C ' ' A' ' 784' ' ' THR . 7.9 mp -122.42 108.84 13.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.928 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . 0.439 HG22 ' N ' ' A' ' 787' ' ' CYS . 23.0 m -97.1 156.8 16.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 787' ' ' CYS . . . . . 0.439 ' N ' HG22 ' A' ' 786' ' ' THR . 13.6 t -98.05 125.18 42.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -86.38 169.14 13.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.933 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 789' ' ' TRP . . . . . 0.442 ' CE2' ' OD1' ' A' ' 790' ' ' ASP . 5.9 p-90 -65.53 -8.49 19.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.938 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . 0.442 ' OD1' ' CE2' ' A' ' 789' ' ' TRP . 87.6 m-20 -100.93 23.29 10.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 791' ' ' LEU . . . . . 0.474 HD22 ' CA ' ' A' ' 744' ' ' GLY . 40.5 mt 50.26 42.75 26.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.902 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.6 t -134.7 149.89 50.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.85 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 793' ' ' TRP . . . . . 0.656 ' HZ2' HD13 ' A' ' 763' ' ' LEU . 94.3 m95 -86.02 144.53 27.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 793' ' ' TRP . 27.9 t -36.38 -40.77 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.838 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 1.7 t -172.29 -175.96 1.51 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.67 157.08 29.52 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.624 0.726 . . . . 0.0 110.832 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . 0.413 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.3 Cg_endo -69.83 141.11 44.07 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.667 2.244 . . . . 0.0 112.299 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 798' ' ' PRO . . . . . 0.675 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.7 Cg_endo -69.81 -176.76 1.61 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.647 2.231 . . . . 0.0 112.361 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 799' ' ' PHE . . . . . 0.579 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 6.6 p90 -153.27 169.96 21.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 3.0 m -101.75 125.88 48.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.888 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -137.82 120.08 15.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 802' ' ' LYS . . . . . 0.406 ' HB2' ' CE2' ' A' ' 777' ' ' TYR . 6.2 ttpm? -53.59 114.35 1.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 27.6 m -83.9 153.85 23.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 33.8 mp0 -64.66 146.08 55.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -148.06 148.13 30.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 60.2 p -67.03 122.48 17.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . 144.99 -160.98 28.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.504 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 97.34 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.683 2.255 . . . . 0.0 112.338 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 15.5 p -143.54 176.74 8.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.807 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 77.4 p -162.86 148.39 12.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.854 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.52 179.992 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 5.5 t -65.51 -58.66 5.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.35 . . . . 0.0 110.878 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 87.3 p -115.74 174.04 6.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.858 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -141.11 54.01 0.64 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.465 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 3.0 m -107.69 129.54 55.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.87 0.367 . . . . 0.0 110.854 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 15.9 m -122.74 31.07 6.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.845 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 744' ' ' GLY . . . . . 0.849 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . 48.66 -177.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.484 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 745' ' ' CYS . . . . . 0.405 ' SG ' ' C ' ' A' ' 791' ' ' LEU . 1.8 m -61.41 152.69 29.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.831 0.348 . . . . 0.0 110.854 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 2.9 m -73.81 166.85 22.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.811 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.39 152.21 38.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.884 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 15.1 mt -103.3 146.85 33.23 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.597 0.713 . . . . 0.0 110.909 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.7 162.65 41.22 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.716 2.278 . . . . 0.0 112.373 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.3 143.97 42.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 5.6 tt -100.69 151.11 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.126 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -94.18 140.49 29.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 28.9 t30 53.71 41.4 32.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -179.99 -176.92 47.75 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.488 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -153.13 159.09 42.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.833 0.349 . . . . 0.0 110.93 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.9 160.85 22.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 3.0 p -146.49 112.19 5.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.099 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . 0.468 ' CG2' HD21 ' A' ' 763' ' ' LEU . 2.4 m -64.69 140.0 58.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.135 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 18.6 m -86.65 -58.14 2.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -81.21 134.58 35.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.882 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 88.6 m -41.87 -58.83 1.9 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -99.57 129.53 45.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.926 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 763' ' ' LEU . . . . . 0.468 HD21 ' CG2' ' A' ' 758' ' ' THR . 22.3 mt -71.81 69.0 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.899 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 35.6 m -103.51 158.87 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.133 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -41.83 122.72 2.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 112.25 -31.91 6.64 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.502 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -56.62 162.07 2.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.759 0.314 . . . . 0.0 111.144 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 768' ' ' ARG . . . . . 0.44 ' C ' HD13 ' A' ' 769' ' ' ILE . 5.7 ptp180 -131.2 146.86 52.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.871 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 769' ' ' ILE . . . . . 0.737 HD11 ' HH2' ' A' ' 793' ' ' TRP . 5.3 mm -113.14 145.83 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.125 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 6.7 m -111.73 149.21 31.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.199 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -130.74 134.68 47.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.933 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -133.45 126.83 32.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 84.9 m -108.75 174.36 5.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.17 158.05 38.81 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.601 0.715 . . . . 0.0 110.872 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 106.95 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.733 2.289 . . . . 0.0 112.378 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 126.56 -10.92 7.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.474 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -106.77 167.54 9.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.865 0.364 . . . . 0.0 110.938 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -128.14 156.86 42.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.861 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 779' ' ' ILE . . . . . 0.66 HG23 ' HB2' ' A' ' 798' ' ' PRO . 75.8 mt -99.49 134.67 37.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.151 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 780' ' ' VAL . . . . . 0.571 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 93.7 t -106.35 107.8 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.073 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 132.56 -132.59 6.68 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.488 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 2.9 m -109.99 110.37 21.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.879 0.371 . . . . 0.0 110.871 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -58.22 -51.71 68.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.814 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 23.7 m -96.89 123.57 40.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 785' ' ' LEU . . . . . 0.424 HD21 ' HA ' ' A' ' 797' ' ' PRO . 8.7 mp -106.99 113.46 26.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 26.3 m -101.32 144.59 29.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.146 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 36.5 t -93.35 140.18 29.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -95.26 166.73 11.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -52.98 -19.37 2.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.936 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -88.82 22.77 2.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.825 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 791' ' ' LEU . . . . . 0.849 HD22 ' HA2' ' A' ' 744' ' ' GLY . 18.6 mt 46.93 35.45 3.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.928 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 22.7 t -121.99 158.36 29.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.839 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 793' ' ' TRP . . . . . 0.737 ' HH2' HD11 ' A' ' 769' ' ' ILE . 95.6 m95 -96.05 139.37 32.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 793' ' ' TRP . 6.6 t -36.8 -47.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.871 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 6.1 m -170.16 174.38 5.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.827 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -50.53 155.31 1.88 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.614 0.721 . . . . 0.0 110.842 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . 0.424 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.7 Cg_endo -69.8 146.21 59.28 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.715 2.277 . . . . 0.0 112.313 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 798' ' ' PRO . . . . . 0.66 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.9 Cg_endo -69.74 -166.99 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.679 2.253 . . . . 0.0 112.353 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 799' ' ' PHE . . . . . 0.571 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 2.6 p90 -154.96 165.59 36.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 9.1 m -101.63 128.0 48.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.9 143.99 47.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 28.8 tttp -68.14 141.78 55.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 27.1 m -62.73 152.99 34.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.13 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -82.11 111.45 18.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.86 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -87.75 120.34 28.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 4.5 t -62.3 145.19 54.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . 97.1 179.66 34.17 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.51 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -21.19 33.59 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.637 2.225 . . . . 0.0 112.327 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 4.2 m -40.78 110.88 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.848 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 6.0 t -136.05 154.47 51.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.505 -179.972 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.437 -0.265 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 64.6 m -137.26 162.36 33.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 0.0 110.83 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 2.3 t -151.26 155.84 39.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.87 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -61.73 -128.43 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.485 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 22.9 t -53.22 150.01 6.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.868 0.366 . . . . 0.0 110.842 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 58.5 p -110.01 156.26 20.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 744' ' ' GLY . . . . . 0.501 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . 168.22 160.13 15.3 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 745' ' ' CYS . . . . . 0.451 ' HB3' ' CE2' ' A' ' 793' ' ' TRP . 1.8 m -44.84 154.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 0.0 110.863 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 17.7 m -64.53 137.4 57.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -55.58 155.34 5.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 748' ' ' LEU . . . . . 0.483 HD12 ' CD1' ' A' ' 769' ' ' ILE . 12.4 mt -119.02 145.49 38.14 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.64 0.733 . . . . 0.0 110.884 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -177.43 1.86 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.674 2.249 . . . . 0.0 112.366 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -88.28 148.3 24.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . 0.411 HG13 ' N ' ' A' ' 752' ' ' GLN . 2.3 tt -101.98 148.67 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.121 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 752' ' ' GLN . . . . . 0.411 ' N ' HG13 ' A' ' 751' ' ' ILE . 5.7 pt20 -86.54 142.35 28.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 3.0 m120 51.48 40.61 27.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -173.63 176.84 46.17 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.501 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 755' ' ' TRP . . . . . 0.469 ' CZ2' ' HG2' ' A' ' 772' ' ' GLN . 44.5 p90 -145.93 151.08 37.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.353 . . . . 0.0 110.897 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -118.98 153.38 34.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 23.3 p -123.29 152.38 41.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.155 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 38.4 p -125.61 167.09 15.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.156 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 75.4 m -103.29 127.07 50.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 760' ' ' HIS . . . . . 0.443 ' O ' ' N ' ' A' ' 762' ' ' GLU . 71.5 m-70 49.11 36.46 8.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 761' ' ' THR . . . . . 0.406 ' C ' ' O ' ' A' ' 760' ' ' HIS . 2.7 m 37.29 31.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.127 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 760' ' ' HIS . 14.2 mm-40 -146.24 119.74 9.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 38.0 mt -78.46 107.16 10.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.863 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.32 174.55 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.142 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -59.21 126.5 27.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 94.0 -17.01 59.62 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.513 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -60.61 140.16 57.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.782 0.325 . . . . 0.0 111.151 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 29.8 ptt85 -127.81 143.9 51.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 769' ' ' ILE . . . . . 0.483 ' CD1' HD12 ' A' ' 748' ' ' LEU . 94.8 mt -107.37 129.95 60.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.108 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 84.3 m -96.3 120.68 37.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.113 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -98.5 118.21 34.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.925 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 772' ' ' GLN . . . . . 0.469 ' HG2' ' CZ2' ' A' ' 755' ' ' TRP . 3.9 tp-100 -113.32 141.44 47.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 74.1 m -119.37 173.47 6.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.46 158.16 31.35 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.589 0.709 . . . . 0.0 110.867 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 106.77 1.73 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.652 2.235 . . . . 0.0 112.351 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 123.26 0.79 9.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.477 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 777' ' ' TYR . . . . . 0.456 ' CE2' ' HB2' ' A' ' 802' ' ' LYS . 23.9 m-85 -115.21 170.17 8.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.848 0.356 . . . . 0.0 110.974 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 778' ' ' ASP . . . . . 0.437 ' OD2' ' CG2' ' A' ' 803' ' ' THR . 45.1 m-20 -129.71 154.76 46.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 779' ' ' ILE . . . . . 0.624 HG23 ' HB2' ' A' ' 798' ' ' PRO . 72.8 mt -97.17 134.62 34.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.142 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 780' ' ' VAL . . . . . 0.561 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 59.8 t -105.61 109.4 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 126.94 -145.12 15.55 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.477 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 782' ' ' SER . . . . . 0.448 ' O ' ' CD1' ' A' ' 785' ' ' LEU . 58.4 m -91.84 96.53 10.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.861 0.362 . . . . 0.0 110.865 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -46.77 -43.76 18.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.857 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.686 ' C ' HD12 ' A' ' 785' ' ' LEU . 6.2 m -106.34 141.24 37.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.168 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 785' ' ' LEU . . . . . 0.686 HD12 ' C ' ' A' ' 784' ' ' THR . 7.5 mp -126.33 110.13 13.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.937 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 7.0 m -94.43 152.39 18.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.109 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 13.8 t -93.15 118.8 31.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -71.98 179.47 3.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 3.2 m95 -71.11 -14.83 62.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -101.87 21.86 13.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.894 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 791' ' ' LEU . . . . . 0.501 HD22 ' HA2' ' A' ' 744' ' ' GLY . 69.3 mt 53.59 26.17 5.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.929 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 4.4 m -113.69 122.71 47.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 793' ' ' TRP . . . . . 0.451 ' CE2' ' HB3' ' A' ' 745' ' ' CYS . 91.6 m95 -61.97 136.07 57.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.918 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 1.4 t -38.38 -44.34 0.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.804 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 58.3 m -161.3 -179.6 7.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -65.17 157.34 77.48 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.588 0.708 . . . . 0.0 110.864 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . 0.538 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.3 Cg_endo -69.83 140.73 43.11 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.648 2.232 . . . . 0.0 112.293 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 798' ' ' PRO . . . . . 0.624 ' HB2' HG23 ' A' ' 779' ' ' ILE . 54.1 Cg_endo -69.71 -164.28 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.675 2.25 . . . . 0.0 112.405 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 799' ' ' PHE . . . . . 0.561 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 6.1 p90 -156.13 173.19 17.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 35.4 m -101.96 137.96 39.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -143.66 142.58 31.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 802' ' ' LYS . . . . . 0.456 ' HB2' ' CE2' ' A' ' 777' ' ' TYR . 4.8 ttpm? -83.37 126.14 32.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 803' ' ' THR . . . . . 0.437 ' CG2' ' OD2' ' A' ' 778' ' ' ASP . 42.2 p -49.87 140.33 12.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.103 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -65.25 123.88 20.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -85.98 139.96 30.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 10.1 m -98.06 122.45 41.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . 113.63 -158.79 14.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.522 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.72 -176.41 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.693 2.262 . . . . 0.0 112.392 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 38.8 t -153.23 141.48 20.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 70.9 p -93.99 132.87 38.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.499 179.981 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 9.8 m -46.6 132.15 10.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.839 0.352 . . . . 0.0 110.849 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 5.8 m -120.71 165.5 15.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.841 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -173.12 154.04 19.6 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.465 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 32.7 m -112.45 -51.14 2.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.892 0.377 . . . . 0.0 110.855 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 64.4 m -127.73 152.95 47.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.846 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 744' ' ' GLY . . . . . 0.561 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . -160.73 177.54 37.09 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.497 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.9 171.37 0.51 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.364 . . . . 0.0 110.843 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 3.4 t -90.38 167.34 12.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -75.4 132.23 40.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.56 152.26 60.07 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.628 0.728 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 167.5 24.37 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.662 2.241 . . . . 0.0 112.296 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -74.87 145.67 42.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.6 tt -100.72 146.52 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.115 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -91.8 130.48 37.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.937 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 61.99 44.34 8.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 179.99 -173.99 45.47 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.453 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 45.6 p90 -157.78 170.13 23.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.799 0.333 . . . . 0.0 110.971 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -118.96 165.55 13.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.917 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 58.6 p -136.25 119.84 17.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.144 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 25.9 p -128.12 148.52 50.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.172 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 47.1 m -93.15 -49.69 5.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -100.32 113.36 26.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.86 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 56.7 p -38.06 -47.36 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.135 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -82.6 124.71 30.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 31.7 mt -86.25 106.18 17.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 35.1 m -107.86 -175.0 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . 0.414 ' CD ' ' HA ' ' A' ' 789' ' ' TRP . 73.7 mtm180 -68.99 134.71 49.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 95.96 -20.56 49.41 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.49 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -60.02 152.94 22.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.809 0.338 . . . . 0.0 111.092 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.62 136.65 43.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.855 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 56.5 mt -114.48 135.99 52.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.118 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 51.8 m -107.67 122.34 46.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.151 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -97.12 126.01 41.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -123.53 135.12 53.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 20.8 m -117.72 173.07 6.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -61.18 159.62 28.06 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.586 0.708 . . . . 0.0 110.852 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 114.98 3.88 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.683 2.255 . . . . 0.0 112.324 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 125.13 -25.2 5.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.468 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -90.83 170.35 10.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 0.0 110.926 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -129.15 154.62 46.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 779' ' ' ILE . . . . . 0.405 HG23 ' HB2' ' A' ' 798' ' ' PRO . 10.9 mt -95.59 137.82 22.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 780' ' ' VAL . . . . . 0.565 ' HB ' ' CE1' ' A' ' 799' ' ' PHE . 58.3 t -114.45 110.38 31.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.128 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 128.33 -132.67 7.41 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.507 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.93 107.56 17.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 110.911 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.02 -34.94 63.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.657 ' C ' HD12 ' A' ' 785' ' ' LEU . 23.7 m -109.39 136.12 49.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.159 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 785' ' ' LEU . . . . . 0.657 HD12 ' C ' ' A' ' 784' ' ' THR . 10.1 mp -126.71 118.61 25.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.93 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 1.2 m -105.83 151.98 23.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.16 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 48.6 t -95.41 108.82 21.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.86 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -62.0 175.67 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 789' ' ' TRP . . . . . 0.414 ' HA ' ' CD ' ' A' ' 765' ' ' ARG . 23.7 p-90 -73.3 -8.22 54.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -98.95 20.37 13.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 791' ' ' LEU . . . . . 0.561 HD22 ' CA ' ' A' ' 744' ' ' GLY . 79.2 mt 54.28 32.9 17.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 73.6 m -131.34 135.65 47.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 793' ' ' TRP . . . . . 0.422 ' O ' ' C ' ' A' ' 794' ' ' SER . 93.4 m95 -73.85 136.66 43.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.919 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 793' ' ' TRP . 11.9 t -35.92 -47.06 0.5 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.829 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 58.5 p -159.12 165.43 33.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -53.78 157.86 3.69 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.617 0.722 . . . . 0.0 110.878 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . 0.492 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.5 Cg_endo -69.8 141.39 44.95 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.687 2.258 . . . . 0.0 112.342 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 798' ' ' PRO . . . . . 0.405 ' HB2' HG23 ' A' ' 779' ' ' ILE . 54.5 Cg_endo -69.7 -167.11 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 0.0 112.389 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 799' ' ' PHE . . . . . 0.565 ' CE1' ' HB ' ' A' ' 780' ' ' VAL . 8.1 p90 -153.33 169.19 23.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 2.8 m -103.33 122.31 44.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.874 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -122.51 147.94 45.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 20.1 tttp -80.21 128.24 33.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 70.8 p -56.81 162.71 2.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.139 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -143.8 148.68 35.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -94.27 -63.3 1.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.934 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 23.3 m -126.93 139.57 52.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.858 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -68.69 -175.8 11.05 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.467 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 102.43 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.688 2.258 . . . . 0.0 112.365 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 41.1 t -46.56 141.48 3.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.835 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 15.1 t -56.58 -46.63 80.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.841 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.503 -179.978 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 4.6 t -73.68 95.58 2.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.877 0.37 . . . . 0.0 110.878 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 2.7 m 49.89 43.64 25.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -116.29 62.06 0.39 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.475 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 55.4 p -52.25 140.51 21.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.883 0.373 . . . . 0.0 110.892 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 68.5 m -93.45 90.69 6.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.877 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 744' ' ' GLY . . . . . 0.467 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . -164.71 164.63 37.03 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.492 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 1.8 m -48.09 158.37 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.878 0.37 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 3.3 m -80.89 148.38 29.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -48.41 159.46 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.879 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 748' ' ' LEU . . . . . 0.541 HD21 ' CD1' ' A' ' 793' ' ' TRP . 92.2 mt -118.24 146.72 40.06 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.662 0.744 . . . . 0.0 110.875 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 139.27 39.7 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.68 2.253 . . . . 0.0 112.31 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -46.81 156.68 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.84 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . 0.623 HD11 ' SG ' ' A' ' 800' ' ' CYS . 1.6 tt -102.04 139.85 22.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.114 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -83.96 130.85 34.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 5.6 t30 55.45 45.02 26.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 177.94 -170.76 43.16 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.491 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 755' ' ' TRP . . . . . 0.45 ' C ' ' CD1' ' A' ' 755' ' ' TRP . 1.6 p90 -153.0 173.01 15.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.874 0.369 . . . . 0.0 110.9 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -135.07 172.0 13.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 3.4 t -164.59 149.66 9.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.138 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . 0.433 HG22 ' CD1' ' A' ' 769' ' ' ILE . 61.2 p -119.42 143.02 47.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.134 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 27.2 t -82.66 -48.14 11.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -61.37 163.42 6.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.865 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 28.0 m -67.67 -45.87 74.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -133.1 165.68 24.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 74.3 mt -75.76 83.28 2.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 28.9 m -113.24 162.17 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.076 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 57.7 mtm-85 -40.94 145.27 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.927 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 82.38 -36.61 2.59 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.491 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -47.02 147.52 1.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.778 0.323 . . . . 0.0 111.076 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -124.85 164.67 19.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 769' ' ' ILE . . . . . 0.433 ' CD1' HG22 ' A' ' 758' ' ' THR . 35.1 mm -118.12 140.3 41.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.123 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 90.8 m -109.93 125.51 52.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.072 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 771' ' ' TYR . . . . . 0.553 ' CE2' ' HD2' ' A' ' 798' ' ' PRO . 24.6 m-85 -107.69 142.86 37.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.95 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -146.91 123.58 11.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 63.7 m -108.89 174.51 5.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.35 161.51 13.46 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.655 0.74 . . . . 0.0 110.859 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 120.57 7.34 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.718 2.279 . . . . 0.0 112.287 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 118.84 -29.09 6.41 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.493 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 777' ' ' TYR . . . . . 0.563 ' CE2' ' HB2' ' A' ' 802' ' ' LYS . 28.9 m-85 -89.94 179.46 5.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.918 0.389 . . . . 0.0 110.926 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -142.3 154.57 44.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.847 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 779' ' ' ILE . . . . . 0.622 HG23 ' HB2' ' A' ' 798' ' ' PRO . 75.9 mt -87.21 135.22 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.184 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 780' ' ' VAL . . . . . 0.569 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 66.5 t -103.06 105.0 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 126.03 -129.22 6.69 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.486 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 1.1 t -114.46 107.68 15.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.884 0.374 . . . . 0.0 110.86 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -55.19 -36.92 66.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.65 ' C ' HD12 ' A' ' 785' ' ' LEU . 33.3 m -101.27 139.39 37.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.139 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 785' ' ' LEU . . . . . 0.65 HD12 ' C ' ' A' ' 784' ' ' THR . 11.2 mp -130.37 111.81 12.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.943 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 11.1 m -90.71 149.96 21.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.134 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 9.3 t -93.23 107.48 19.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -57.79 -179.18 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.953 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 41.3 p-90 -72.44 -25.48 61.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.67 27.79 1.45 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.862 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 791' ' ' LEU . . . . . 0.467 HD22 ' HA2' ' A' ' 744' ' ' GLY . 20.1 mt 49.67 40.83 20.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.8 t -130.98 147.14 52.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 793' ' ' TRP . . . . . 0.541 ' CD1' HD21 ' A' ' 748' ' ' LEU . 83.3 m95 -80.87 134.98 35.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.941 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 793' ' ' TRP . 2.3 m -34.74 -47.34 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.824 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 79.4 p -159.98 165.41 32.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.831 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -44.6 152.96 0.49 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.609 0.719 . . . . 0.0 110.841 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . 0.6 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.6 Cg_endo -69.76 146.69 60.94 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.661 2.241 . . . . 0.0 112.354 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 798' ' ' PRO . . . . . 0.622 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.6 Cg_endo -69.71 -169.31 0.32 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.687 2.258 . . . . 0.0 112.392 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 799' ' ' PHE . . . . . 0.569 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 4.9 p90 -157.76 172.74 17.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.875 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 800' ' ' CYS . . . . . 0.623 ' SG ' HD11 ' A' ' 751' ' ' ILE . 7.2 m -101.96 136.14 42.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -146.71 135.7 22.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 802' ' ' LYS . . . . . 0.563 ' HB2' ' CE2' ' A' ' 777' ' ' TYR . 44.5 tttm -67.56 118.28 10.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.944 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 22.3 p -85.72 164.68 17.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.152 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -47.83 138.71 8.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -86.72 -24.61 25.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 11.2 t 49.17 49.18 20.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -98.21 -163.26 30.79 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.498 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 -13.38 34.56 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.656 2.237 . . . . 0.0 112.339 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 13.7 t -86.92 101.34 13.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 810' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 811' ' ' GLY . 3.8 m -105.84 146.2 30.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 811' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 810' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.495 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 4.5 t -69.5 88.35 0.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 0.0 110.823 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 39.0 t -118.32 147.8 43.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 145.28 125.87 1.81 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.512 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 79.1 p -88.06 -44.23 11.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.88 0.371 . . . . 0.0 110.864 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 6.1 m -53.22 152.93 4.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.88 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 744' ' ' GLY . . . . . 0.451 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . 171.18 145.17 4.69 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.501 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 3.9 m -40.54 154.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 110.895 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 4.4 m -75.9 147.38 39.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.22 117.89 6.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.84 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 748' ' ' LEU . . . . . 0.427 HD21 ' CD1' ' A' ' 793' ' ' TRP . 10.2 mt -70.62 149.34 95.4 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.598 0.713 . . . . 0.0 110.895 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 159.92 51.61 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.666 2.244 . . . . 0.0 112.342 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.08 149.95 43.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 3.7 tt -100.65 148.54 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.121 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -93.41 123.42 36.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.945 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 70.08 41.68 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.883 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 177.54 -174.24 46.77 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.494 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 3.2 p90 -151.35 166.11 32.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.835 0.35 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.24 156.2 43.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 49.2 p -133.33 125.44 29.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 73.7 p -81.34 171.09 15.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 47.6 m -100.22 -66.6 0.9 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.867 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -98.6 171.88 7.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.839 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 2.9 t -72.33 -3.54 24.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.153 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 764' ' ' VAL . 18.2 mt-10 -144.48 124.81 13.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.911 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 65.8 mt -64.97 74.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 762' ' ' GLU . 24.0 m -87.89 162.13 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 765' ' ' ARG . 25.9 mtm105 -51.75 132.88 31.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 99.52 -25.4 28.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.461 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -62.81 131.52 49.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 0.0 111.102 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 19.6 ptt-85 -111.23 147.47 34.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 8.9 mm -104.13 139.98 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.121 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 22.8 m -104.69 119.72 39.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.142 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -104.19 130.45 51.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -135.41 132.48 37.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 39.9 m -112.56 171.81 7.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -60.48 160.63 17.38 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.629 0.728 . . . . 0.0 110.865 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 107.98 1.99 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.663 2.242 . . . . 0.0 112.359 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 133.43 -24.42 3.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.436 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -92.72 170.73 9.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.876 0.37 . . . . 0.0 110.948 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -130.86 155.63 46.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.852 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 779' ' ' ILE . . . . . 0.438 HG23 ' HB2' ' A' ' 798' ' ' PRO . 11.5 mt -91.68 141.62 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.165 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 780' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 58.4 t -116.15 106.6 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 124.61 -126.38 6.04 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 782' ' ' SER . . . . . 0.5 ' O ' HD11 ' A' ' 785' ' ' LEU . 1.3 t -113.52 108.09 16.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.916 0.389 . . . . 0.0 110.871 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.7 -33.87 66.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.904 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.617 ' C ' HD12 ' A' ' 785' ' ' LEU . 9.9 m -111.61 129.22 56.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.123 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 785' ' ' LEU . . . . . 0.617 HD12 ' C ' ' A' ' 784' ' ' THR . 8.8 mp -121.45 118.81 30.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.898 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 51.8 m -96.65 152.59 18.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.087 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 20.0 t -95.63 112.05 23.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -65.41 170.97 4.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.949 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -69.36 -6.58 30.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -105.95 24.28 12.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.844 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 791' ' ' LEU . . . . . 0.451 HD22 ' CA ' ' A' ' 744' ' ' GLY . 34.5 mt 50.5 33.52 8.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.887 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 6.8 m -128.31 123.13 33.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 793' ' ' TRP . . . . . 0.429 ' O ' ' C ' ' A' ' 794' ' ' SER . 86.9 m95 -66.17 137.2 56.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.958 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 793' ' ' TRP . 23.0 t -35.67 -50.56 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.814 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 38.8 p -154.96 165.17 37.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.866 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -51.1 156.74 1.69 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.568 0.699 . . . . 0.0 110.884 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . 0.549 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.5 Cg_endo -69.77 141.81 46.2 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.663 2.242 . . . . 0.0 112.343 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 798' ' ' PRO . . . . . 0.438 ' HB2' HG23 ' A' ' 779' ' ' ILE . 53.6 Cg_endo -69.79 -164.07 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.679 2.252 . . . . 0.0 112.321 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 799' ' ' PHE . . . . . 0.466 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 6.7 p90 -158.56 172.28 18.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 2.7 m -101.7 138.36 38.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -146.72 150.04 34.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -65.36 119.53 11.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 10.1 m -65.13 147.77 52.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.164 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -105.45 136.34 45.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -123.57 -54.0 1.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 25.0 p -111.57 162.29 15.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -78.76 146.18 29.53 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.473 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 119.0 6.02 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.66 2.24 . . . . 0.0 112.377 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 43.5 t -97.13 78.8 2.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.821 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 9.5 t -127.98 178.13 6.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.907 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.447 179.948 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 66.2 m -68.08 172.99 4.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.924 0.392 . . . . 0.0 110.841 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 3.5 m -125.5 104.37 8.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.834 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 57.01 49.69 69.75 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.483 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 4.4 m -93.8 160.71 14.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.868 0.366 . . . . 0.0 110.873 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 92.0 p -97.54 102.61 14.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.846 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 744' ' ' GLY . . . . . 0.489 ' CA ' HD22 ' A' ' 791' ' ' LEU . . . 172.96 140.34 3.12 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.475 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 5.1 m -40.55 155.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.858 0.361 . . . . 0.0 110.867 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 2.8 m -78.5 133.45 37.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -44.53 140.62 2.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 748' ' ' LEU . . . . . 0.553 HD23 ' CD1' ' A' ' 769' ' ' ILE . 4.0 mm? -76.47 148.18 79.86 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.598 0.713 . . . . 0.0 110.932 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.63 168.74 20.51 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.677 2.251 . . . . 0.0 112.38 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -74.31 135.75 42.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . 0.635 HD11 ' SG ' ' A' ' 800' ' ' CYS . 1.4 tt -108.05 141.78 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.15 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -83.1 146.84 28.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.939 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 42.44 48.67 4.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 176.74 172.56 41.5 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.477 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 45.5 p90 -153.88 152.55 30.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.81 0.338 . . . . 0.0 110.901 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . 0.483 ' O ' HG23 ' A' ' 757' ' ' THR . 7.7 ptpp? -109.42 164.26 12.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 756' ' ' LYS . 0.9 OUTLIER -159.45 153.18 22.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.098 179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -157.32 131.9 8.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.107 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 4.1 t -56.1 -63.26 1.24 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.884 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -54.6 101.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.831 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 45.2 m -52.65 -56.68 13.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.149 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -77.18 105.87 8.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 65.3 mt -58.16 94.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.942 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 29.3 m -120.62 174.06 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 49.6 mtm180 -46.78 133.97 10.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.92 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 767' ' ' ALA . . . 91.48 -34.37 4.36 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.515 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 766' ' ' GLY . . . -38.02 131.8 1.05 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 0.0 111.027 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 768' ' ' ARG . . . . . 0.551 ' HG2' HG23 ' A' ' 784' ' ' THR . 7.3 tmm_? -117.04 130.86 56.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.872 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 769' ' ' ILE . . . . . 0.553 ' CD1' HD23 ' A' ' 748' ' ' LEU . 56.9 mt -112.64 141.09 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.18 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 5.7 t -111.53 152.9 26.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.167 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -120.49 116.95 26.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.913 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -110.83 124.43 52.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.942 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 77.4 m -109.21 174.22 5.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -60.43 153.08 62.03 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.665 0.745 . . . . 0.0 110.856 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 93.97 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.708 2.272 . . . . 0.0 112.357 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 140.78 -9.82 2.85 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.535 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -100.91 176.31 5.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.885 0.374 . . . . 0.0 110.947 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -128.57 159.53 35.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.865 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 4.4 mt -104.44 143.34 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 780' ' ' VAL . . . . . 0.571 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 86.4 t -124.04 108.93 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.095 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 128.42 -135.82 8.78 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.493 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 3.0 m -107.29 98.99 8.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.371 . . . . 0.0 110.908 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.57 -48.8 57.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.857 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.667 ' C ' HD12 ' A' ' 785' ' ' LEU . 87.5 m -95.42 135.54 36.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.15 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 785' ' ' LEU . . . . . 0.667 HD12 ' C ' ' A' ' 784' ' ' THR . 7.6 mp -122.19 122.35 38.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.96 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 8.1 m -109.5 150.62 27.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.154 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 6.6 t -95.06 120.44 35.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -81.67 -176.69 6.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.938 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -68.72 -16.87 63.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.8 16.14 16.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.862 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 791' ' ' LEU . . . . . 0.489 HD22 ' CA ' ' A' ' 744' ' ' GLY . 68.4 mt 53.99 25.13 5.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.946 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 44.0 m -115.35 131.38 56.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 793' ' ' TRP . . . . . 0.416 ' CE2' HD21 ' A' ' 748' ' ' LEU . 83.5 m95 -63.05 137.84 58.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 793' ' ' TRP . 9.4 t -37.87 -47.2 1.02 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 68.0 m -156.74 161.99 39.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.866 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -46.4 158.97 0.36 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.59 0.709 . . . . 0.0 110.854 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 140.74 43.08 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.673 2.249 . . . . 0.0 112.293 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 798' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -169.77 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.671 2.247 . . . . 0.0 112.37 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 799' ' ' PHE . . . . . 0.571 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 4.1 p90 -159.29 167.41 29.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 800' ' ' CYS . . . . . 0.635 ' SG ' HD11 ' A' ' 751' ' ' ILE . 3.0 m -103.55 138.51 40.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -141.3 112.79 7.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -44.96 132.61 6.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.908 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 74.4 p -80.21 172.67 13.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.117 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -133.77 121.05 21.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 805' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 806' ' ' SER . 11.5 pt-20 -100.96 -43.69 5.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 806' ' ' SER . . . . . 0.41 ' N ' ' HG3' ' A' ' 805' ' ' GLU . 50.5 m -159.16 164.98 34.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.841 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -170.72 -97.63 0.11 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.456 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 120.81 7.54 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.718 2.279 . . . . 0.0 112.32 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 3.7 m -92.93 -48.22 6.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.832 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 4.0 m -110.25 97.6 7.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.856 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.524 179.975 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.484 -0.247 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 87.7 p -103.8 -13.32 16.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.903 0.382 . . . . 0.0 110.899 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 7.9 t -120.57 154.19 35.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.899 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . -131.9 -113.35 1.5 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.461 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 84.7 p -81.33 114.88 20.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.95 0.405 . . . . 0.0 110.838 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 743' ' ' SER . . . . . . . . . . . . . 24.0 m -163.22 129.6 3.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.855 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 744' ' ' GLY . . . . . 0.556 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . 159.51 -167.77 35.22 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.489 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 3.6 m -45.39 152.22 0.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.881 0.372 . . . . 0.0 110.859 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 68.4 m -75.91 146.24 39.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -56.26 130.31 43.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 12.4 mt -79.45 149.23 71.64 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.606 0.717 . . . . 0.0 110.895 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 165.1 32.16 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.726 2.284 . . . . 0.0 112.312 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -73.67 144.52 45.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 6.7 tt -100.57 151.86 5.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.127 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -97.45 124.44 41.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 67.17 39.41 3.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -173.41 177.54 45.75 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.465 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -158.34 156.72 31.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.815 0.34 . . . . 0.0 110.935 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -98.24 165.14 12.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 81.0 p -124.65 40.61 3.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.123 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . 0.818 HG23 ' CE1' ' A' ' 760' ' ' HIS . 47.7 m -57.13 102.81 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.121 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 83.2 p -82.75 -1.43 51.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.846 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 760' ' ' HIS . . . . . 0.818 ' CE1' HG23 ' A' ' 758' ' ' THR . 17.8 p-80 -107.85 122.3 46.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 82.5 p -62.61 -54.58 37.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.122 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.39 119.17 38.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 10.5 mt -64.34 107.94 1.47 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.914 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 27.7 m -112.77 155.78 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.122 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -48.84 116.09 1.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 112.61 -26.38 10.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.509 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -45.85 129.07 9.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.774 0.321 . . . . 0.0 111.147 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -115.17 120.79 40.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.861 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 769' ' ' ILE . . . . . . . . . . . . . 52.3 mt -102.18 150.33 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.129 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 50.1 m -124.06 128.09 48.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.147 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -98.56 136.92 37.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -129.7 129.95 44.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 35.0 m -110.42 173.4 6.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.78 161.14 23.0 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.575 0.703 . . . . 0.0 110.84 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 117.5 5.12 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.656 2.237 . . . . 0.0 112.315 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 121.92 -22.52 7.62 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.479 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -96.55 172.83 7.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.877 0.37 . . . . 0.0 110.935 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -137.47 149.79 47.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.836 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 779' ' ' ILE . . . . . 0.668 HG23 ' HB2' ' A' ' 798' ' ' PRO . 66.8 mt -88.11 134.26 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.118 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 780' ' ' VAL . . . . . 0.565 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 63.6 t -108.25 108.23 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.12 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 124.45 -156.56 18.56 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.48 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 782' ' ' SER . . . . . 0.479 ' O ' HD11 ' A' ' 785' ' ' LEU . 58.2 m -76.87 95.44 4.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.868 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -49.36 -55.2 13.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.861 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.76 ' C ' HD12 ' A' ' 785' ' ' LEU . 87.4 m -92.27 142.19 27.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.076 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 785' ' ' LEU . . . . . 0.76 HD12 ' C ' ' A' ' 784' ' ' THR . 8.2 mp -128.04 143.09 51.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 55.8 m -128.42 151.99 48.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.144 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 14.4 t -94.6 107.08 19.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -61.15 -179.95 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -69.61 -20.27 63.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.871 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -91.92 23.71 3.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.866 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 791' ' ' LEU . . . . . 0.556 HD22 ' HA2' ' A' ' 744' ' ' GLY . 39.3 mt 51.02 29.55 4.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.8 t -117.9 147.34 43.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.825 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 793' ' ' TRP . . . . . 0.432 ' O ' ' C ' ' A' ' 794' ' ' SER . 95.0 m95 -83.78 134.63 34.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.881 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 793' ' ' TRP . 2.3 t -34.47 -50.51 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 97.7 p -162.07 168.45 22.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.836 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.21 153.14 0.95 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.619 0.723 . . . . 0.0 110.822 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . 0.423 ' HA ' HD21 ' A' ' 785' ' ' LEU . 54.0 Cg_endo -69.74 148.07 64.37 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.707 2.271 . . . . 0.0 112.345 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 798' ' ' PRO . . . . . 0.668 ' HB2' HG23 ' A' ' 779' ' ' ILE . 54.3 Cg_endo -69.71 -167.77 0.24 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.699 2.266 . . . . 0.0 112.339 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 799' ' ' PHE . . . . . 0.565 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 1.6 p90 -157.67 164.61 37.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 5.4 m -102.93 113.49 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -126.6 126.13 43.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -57.76 122.47 12.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 57.0 m -85.38 146.77 26.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.102 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -42.26 161.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.903 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.33 90.4 8.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.902 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 1.4 t -40.34 113.97 0.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . 148.28 -167.48 29.03 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.49 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 87.66 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.627 2.218 . . . . 0.0 112.359 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 2.9 t -100.16 86.09 3.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 53.4 p -70.15 166.92 18.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.865 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.498 -179.998 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 1.9 t -54.24 128.63 32.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 0.0 110.871 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 15.7 m -65.37 127.69 32.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.823 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 74.29 158.52 5.92 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 11.2 t -132.91 -45.07 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 0.0 110.876 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 743' ' ' SER . . . . . 0.85 ' O ' HG12 ' A' ' 764' ' ' VAL . 96.8 p -90.82 161.24 15.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 744' ' ' GLY . . . . . . . . . . . . . . . 178.84 158.11 20.69 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.484 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 7.1 m -48.8 152.63 0.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.809 0.337 . . . . 0.0 110.879 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 32.4 m -72.96 156.69 38.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.817 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.93 131.96 45.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.831 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 748' ' ' LEU . . . . . 0.448 HD12 HD13 ' A' ' 769' ' ' ILE . 12.2 mt -79.93 148.66 68.83 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.566 0.698 . . . . 0.0 110.928 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 175.47 8.01 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.705 2.27 . . . . 0.0 112.36 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -77.93 149.41 34.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 2.0 tt -106.52 145.76 13.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.129 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -89.8 132.27 35.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 4.7 m120 59.92 44.59 13.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.854 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 178.17 179.72 48.24 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.488 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 755' ' ' TRP . . . . . 0.483 ' CZ2' ' HG2' ' A' ' 772' ' ' GLN . 19.0 p90 -156.06 168.56 26.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.834 0.35 . . . . 0.0 110.94 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.91 165.67 14.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.91 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 51.4 p -146.25 134.62 21.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.112 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . 0.41 ' CG2' HG12 ' A' ' 769' ' ' ILE . 80.7 p -139.61 148.19 42.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.159 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 10.1 m -96.9 -46.82 6.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -69.92 177.89 2.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 761' ' ' THR . . . . . . . . . . . . . 90.7 m -113.03 -49.96 2.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.162 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -80.15 128.46 33.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 763' ' ' LEU . . . . . . . . . . . . . 55.8 mt -84.28 46.76 1.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . 0.85 HG12 ' O ' ' A' ' 743' ' ' SER . 23.7 m -84.99 -175.92 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.154 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -53.35 130.68 35.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 103.12 -32.96 6.99 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -50.48 125.14 12.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.755 0.312 . . . . 0.0 111.144 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 768' ' ' ARG . . . . . 0.452 ' HG2' ' CG2' ' A' ' 784' ' ' THR . 8.9 ttp-105 -116.52 145.56 43.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.862 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 769' ' ' ILE . . . . . 0.448 HD13 HD12 ' A' ' 748' ' ' LEU . 39.4 mt -123.89 140.45 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.11 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 18.7 m -108.5 123.01 48.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.147 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -99.67 121.37 41.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.911 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 772' ' ' GLN . . . . . 0.483 ' HG2' ' CZ2' ' A' ' 755' ' ' TRP . 4.3 tp-100 -118.09 143.54 46.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.857 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 73.6 m -124.36 171.1 10.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -62.06 159.68 35.9 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.578 0.704 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 119.66 6.57 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.725 2.283 . . . . 0.0 112.311 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 117.77 -20.21 10.97 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.481 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -96.3 179.31 5.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.882 0.372 . . . . 0.0 110.953 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -141.92 150.41 41.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.847 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 779' ' ' ILE . . . . . . . . . . . . . 5.6 mt -87.58 144.96 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 780' ' ' VAL . . . . . 0.56 ' HB ' ' CE1' ' A' ' 799' ' ' PHE . 75.3 t -120.69 106.14 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.125 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 126.65 -132.62 7.77 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 782' ' ' SER . . . . . . . . . . . . . 3.0 m -101.75 88.34 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.888 0.375 . . . . 0.0 110.891 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -41.65 -33.73 0.51 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.875 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.478 ' C ' HD12 ' A' ' 785' ' ' LEU . 16.7 m -114.7 142.8 46.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 785' ' ' LEU . . . . . 0.88 HD11 ' HD3' ' A' ' 798' ' ' PRO . 9.6 mp -126.64 144.92 50.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 1.9 m -138.18 157.43 46.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.199 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 8.1 t -92.62 118.12 30.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.828 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -77.34 171.85 14.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 1.6 m-90 -59.52 -12.9 7.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -98.0 25.1 6.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 791' ' ' LEU . . . . . . . . . . . . . 90.3 mt 48.08 25.76 0.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.4 t -121.35 147.34 45.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.84 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 793' ' ' TRP . . . . . 0.447 ' O ' ' C ' ' A' ' 794' ' ' SER . 98.0 m95 -77.79 141.15 39.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.958 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 793' ' ' TRP . 36.4 t -34.52 -46.41 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 19.4 p -173.11 170.72 4.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.12 151.54 0.2 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.593 0.711 . . . . 0.0 110.862 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . 0.466 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.8 Cg_endo -69.76 143.95 52.46 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.626 2.218 . . . . 0.0 112.367 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 798' ' ' PRO . . . . . 0.88 ' HD3' HD11 ' A' ' 785' ' ' LEU . 54.0 Cg_endo -69.75 177.51 5.5 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.696 2.264 . . . . 0.0 112.331 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 799' ' ' PHE . . . . . 0.56 ' CE1' ' HB ' ' A' ' 780' ' ' VAL . 10.0 p90 -149.55 172.55 14.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 12.6 m -102.79 129.51 49.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -129.68 129.66 44.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -59.81 136.73 58.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.896 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 5.3 t -65.17 168.89 6.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.133 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 804' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -104.81 164.39 11.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.928 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 805' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -147.39 130.81 16.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 3.0 t -93.04 116.41 29.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.855 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . 137.54 147.17 5.21 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.511 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 179.17 3.89 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.656 2.238 . . . . 0.0 112.364 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 85.0 p -113.05 122.64 48.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.871 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 4.0 m -112.32 -54.79 2.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.857 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.462 179.997 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 738' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 17.4 m -140.54 176.49 8.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 110.836 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 47.1 p -44.05 -55.11 4.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.829 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 741' ' ' GLY . . . . . . . . . . . . . . . 135.95 47.59 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.506 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 742' ' ' SER . . . . . . . . . . . . . 55.9 p -93.1 144.37 25.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.868 0.366 . . . . 0.0 110.868 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 743' ' ' SER . . . . . 0.73 ' O ' HD13 ' A' ' 791' ' ' LEU . 66.5 m -141.38 120.22 12.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.843 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 744' ' ' GLY . . . . . 0.73 ' HA2' HD22 ' A' ' 791' ' ' LEU . . . -92.79 -150.02 25.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.486 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 745' ' ' CYS . . . . . . . . . . . . . 1.8 m -48.29 171.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.348 . . . . 0.0 110.885 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 746' ' ' SER . . . . . . . . . . . . . 56.9 p -100.55 140.7 34.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -46.25 144.01 2.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 748' ' ' LEU . . . . . . . . . . . . . 16.3 mt -94.85 151.09 38.75 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.619 0.723 . . . . 0.0 110.94 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 749' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 151.45 68.99 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.67 2.246 . . . . 0.0 112.349 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 750' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -62.97 143.32 57.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 6.7 tt -100.54 153.24 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 752' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -97.39 128.42 44.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 753' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 61.92 41.3 11.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -173.46 176.21 46.12 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.458 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 755' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -152.22 170.52 19.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.827 0.346 . . . . 0.0 110.931 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 756' ' ' LYS . . . . . 0.766 ' HE3' HG21 ' A' ' 769' ' ' ILE . 9.9 ptmt -130.51 168.43 17.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 40.1 p -126.06 142.91 51.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.129 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 59.3 p -125.82 133.76 51.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.136 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 759' ' ' SER . . . . . . . . . . . . . 1.1 t -96.34 -55.53 2.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 760' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -81.64 131.96 35.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.855 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 761' ' ' THR . . . . . 0.483 HG23 ' N ' ' A' ' 762' ' ' GLU . 8.9 t -43.38 -44.37 5.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.115 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . 0.483 ' N ' HG23 ' A' ' 761' ' ' THR . 68.7 mm-40 -118.87 142.99 47.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.92 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 763' ' ' LEU . . . . . 0.554 HD21 HD11 ' A' ' 769' ' ' ILE . 77.6 mt -67.79 93.69 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.929 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 764' ' ' VAL . . . . . . . . . . . . . 29.4 m -105.55 154.94 6.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.098 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -43.43 124.79 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 766' ' ' GLY . . . . . . . . . . . . . . . 105.23 -25.22 25.65 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.485 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -53.88 137.9 37.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 111.084 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 768' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -121.95 130.47 53.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 769' ' ' ILE . . . . . 0.766 HG21 ' HE3' ' A' ' 756' ' ' LYS . 69.1 mt -110.68 131.93 60.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 770' ' ' THR . . . . . . . . . . . . . 31.1 m -99.01 130.78 45.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.147 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 771' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -98.57 120.19 38.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.937 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 772' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -117.83 124.21 47.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.917 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 773' ' ' CYS . . . . . . . . . . . . . 72.1 m -107.55 173.39 6.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 774' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.66 157.49 37.62 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.6 0.714 . . . . 0.0 110.888 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 775' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 111.3 2.78 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.653 2.236 . . . . 0.0 112.371 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 776' ' ' GLY . . . . . . . . . . . . . . . 125.13 -19.84 6.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.473 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 777' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -97.75 168.52 10.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.863 0.364 . . . . 0.0 110.932 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 778' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -125.72 162.93 23.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.869 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 779' ' ' ILE . . . . . 0.591 HG23 ' HB2' ' A' ' 798' ' ' PRO . 65.4 mt -103.8 135.13 42.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 780' ' ' VAL . . . . . 0.538 ' HB ' ' CE2' ' A' ' 799' ' ' PHE . 61.7 t -112.34 107.52 23.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.12 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 781' ' ' GLY . . . . . . . . . . . . . . . 127.99 -150.32 18.35 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.449 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 782' ' ' SER . . . . . 0.418 ' O ' HD11 ' A' ' 785' ' ' LEU . 5.2 p -81.28 105.29 12.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.857 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 783' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.66 -50.48 73.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 30.7 m -102.47 121.24 41.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.174 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 785' ' ' LEU . . . . . 0.474 HD21 ' HA ' ' A' ' 797' ' ' PRO . 7.8 mp -106.91 148.68 28.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 37.8 m -137.77 153.03 49.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.116 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 787' ' ' CYS . . . . . . . . . . . . . 12.4 t -93.94 115.91 28.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.912 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -71.86 -177.51 2.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.882 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 789' ' ' TRP . . . . . . . . . . . . . 53.5 p-90 -71.42 -16.31 62.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.885 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -92.34 23.68 3.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.833 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 791' ' ' LEU . . . . . 0.73 HD13 ' O ' ' A' ' 743' ' ' SER . 32.3 mt 48.63 37.5 9.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 792' ' ' SER . . . . . . . . . . . . . 1.6 t -134.47 147.57 50.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.846 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 793' ' ' TRP . . . . . 0.44 ' O ' ' C ' ' A' ' 794' ' ' SER . 88.7 m95 -82.44 141.67 32.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.936 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 793' ' ' TRP . 1.3 t -35.41 -45.49 0.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.884 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 22.6 t -171.68 171.55 5.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 796' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -47.56 150.6 1.68 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.647 0.737 . . . . 0.0 110.833 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . 0.474 ' HA ' HD21 ' A' ' 785' ' ' LEU . 53.0 Cg_endo -69.8 149.17 66.25 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.685 2.257 . . . . 0.0 112.285 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 798' ' ' PRO . . . . . 0.591 ' HB2' HG23 ' A' ' 779' ' ' ILE . 54.1 Cg_endo -69.83 -171.79 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.678 2.252 . . . . 0.0 112.355 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 799' ' ' PHE . . . . . 0.538 ' CE2' ' HB ' ' A' ' 780' ' ' VAL . 3.2 p90 -147.22 167.71 23.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.912 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 800' ' ' CYS . . . . . . . . . . . . . 3.9 m -102.05 119.18 38.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 801' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -123.32 132.59 54.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 802' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -58.75 137.8 57.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 803' ' ' THR . . . . . . . . . . . . . 22.1 m -95.96 144.92 25.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.139 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 804' ' ' GLU . . . . . 0.431 ' OE2' ' C ' ' A' ' 805' ' ' GLU . 2.2 tm-20 -140.27 129.64 23.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 805' ' ' GLU . . . . . 0.431 ' C ' ' OE2' ' A' ' 804' ' ' GLU . 0.0 OUTLIER -105.84 115.89 31.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.93 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 806' ' ' SER . . . . . . . . . . . . . 69.2 p -118.31 100.81 7.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . 76.58 148.86 2.76 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.479 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -45.35 1.61 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.65 2.234 . . . . 0.0 112.348 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 58.9 m -134.51 140.8 46.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.831 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 810' ' ' SER . . . . . . . . . . . . . 16.1 m -159.78 150.33 19.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.851 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 811' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.472 -179.994 . . . . . . . . 0 0 . 1 stop_ save_